id	sid	tid	token	lemma	pos
iajs-1773	1	1	microsoft	microsoft	PROPN
iajs-1773	1	2	word	word	NOUN
iajs-1773	1	3	73	73	NUM
iajs-1773	1	4	-	-	SYM
iajs-1773	1	5	86	86	NUM
iajs-1773	1	6	ihsciconf	ihsciconf	PROPN
iajs-1773	1	7	2017	2017	NUM
iajs-1773	1	8	special	special	ADJ
iajs-1773	1	9	issue	issue	NOUN
iajs-1773	1	10	ibn	ibn	PROPN
iajs-1773	1	11	al	al	PROPN
iajs-1773	1	12	-	-	PUNCT
iajs-1773	1	13	haitham	haitham	PROPN
iajs-1773	1	14	journal	journal	PROPN
iajs-1773	1	15	for	for	ADP
iajs-1773	1	16	pure	pure	ADJ
iajs-1773	1	17	and	and	CCONJ
iajs-1773	1	18	applied	apply	VERB
iajs-1773	1	19	science	science	NOUN
iajs-1773	1	20	https://doi.org/	https://doi.org/	NOUN
iajs-1773	1	21	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	1	22	.	.	PUNCT
iajs-1773	1	23	 	 	SPACE
iajs-1773	1	24	1773	1773	NUM
iajs-1773	1	25	for	for	ADP
iajs-1773	1	26	more	more	ADJ
iajs-1773	1	27	information	information	NOUN
iajs-1773	1	28	about	about	ADP
iajs-1773	1	29	the	the	DET
iajs-1773	1	30	conference	conference	NOUN
iajs-1773	1	31	please	please	INTJ
iajs-1773	1	32	visit	visit	VERB
iajs-1773	1	33	the	the	DET
iajs-1773	1	34	websites	website	NOUN
iajs-1773	1	35	:	:	PUNCT
iajs-1773	1	36	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	1	37	  	  	SPACE
iajs-1773	1	38	www.ihsciconf.org	www.ihsciconf.org	NOUN
iajs-1773	1	39	  	  	SPACE
iajs-1773	1	40	biology|73	biology|73	ADP
iajs-1773	1	41	determination	determination	NOUN
iajs-1773	1	42	of	of	ADP
iajs-1773	1	43	integrinα2	integrinα2	NOUN
iajs-1773	1	44	(	(	PUNCT
iajs-1773	1	45	itga2	itga2	NOUN
iajs-1773	1	46	)	)	PUNCT
iajs-1773	1	47	,	,	PUNCT
iajs-1773	1	48	progesterone	progesterone	NOUN
iajs-1773	1	49	,	,	PUNCT
iajs-1773	1	50	prolactin	prolactin	NOUN
iajs-1773	1	51	,	,	PUNCT
iajs-1773	1	52	estradiol	estradiol	PROPN
iajs-1773	1	53	,	,	PUNCT
iajs-1773	1	54	zinc	zinc	NOUN
iajs-1773	1	55	and	and	CCONJ
iajs-1773	1	56	vitamin	vitamin	NOUN
iajs-1773	1	57	c	c	NOUN
iajs-1773	1	58	in	in	ADP
iajs-1773	1	59	serum	serum	NOUN
iajs-1773	1	60	of	of	ADP
iajs-1773	1	61	female	female	ADJ
iajs-1773	1	62	iraqi	iraqi	ADJ
iajs-1773	1	63	patients	patient	NOUN
iajs-1773	1	64	with	with	ADP
iajs-1773	1	65	breast	breast	NOUN
iajs-1773	1	66	cancer	cancer	NOUN
iajs-1773	1	67	hazima	hazima	PROPN
iajs-1773	1	68	mossa	mossa	PROPN
iajs-1773	1	69	al	al	PROPN
iajs-1773	1	70	-	-	PUNCT
iajs-1773	1	71	abassi	abassi	PROPN
iajs-1773	1	72	dept	dept	NOUN
iajs-1773	1	73	.	.	PROPN
iajs-1773	1	74	of	of	ADP
iajs-1773	1	75	biology	biology	NOUN
iajs-1773	1	76	/	/	SYM
iajs-1773	1	77	college	college	NOUN
iajs-1773	1	78	of	of	ADP
iajs-1773	1	79	education	education	NOUN
iajs-1773	1	80	for	for	ADP
iajs-1773	1	81	pure	pure	ADJ
iajs-1773	1	82	science	science	NOUN
iajs-1773	1	83	(	(	PUNCT
iajs-1773	1	84	ibn	ibn	PROPN
iajs-1773	1	85	al	al	PROPN
iajs-1773	1	86	-	-	PUNCT
iajs-1773	1	87	haitham	haitham	PROPN
iajs-1773	1	88	)	)	PUNCT
iajs-1773	1	89	/	/	SYM
iajs-1773	1	90	baghdad	baghdad	PROPN
iajs-1773	1	91	university	university	PROPN
iajs-1773	1	92	asmaa	asmaa	PROPN
iajs-1773	1	93	m.	m.	PROPN
iajs-1773	1	94	salih	salih	PROPN
iajs-1773	1	95	almohaidi	almohaidi	PROPN
iajs-1773	1	96	college	college	PROPN
iajs-1773	1	97	of	of	ADP
iajs-1773	1	98	science	science	NOUN
iajs-1773	1	99	for	for	ADP
iajs-1773	1	100	women	woman	NOUN
iajs-1773	1	101	/	/	SYM
iajs-1773	1	102	baghdad	baghdad	PROPN
iajs-1773	1	103	university	university	PROPN
iajs-1773	2	1	amenah	amenah	PROPN
iajs-1773	2	2	ali	ali	PROPN
iajs-1773	2	3	raheem	raheem	PROPN
iajs-1773	2	4	almusawi	almusawi	PROPN
iajs-1773	3	1	amna.ali.amona@gmail.com	amna.ali.amona@gmail.com	PROPN
iajs-1773	3	2	dept	dept	PROPN
iajs-1773	3	3	.	.	PROPN
iajs-1773	3	4	of	of	ADP
iajs-1773	3	5	biology	biology	NOUN
iajs-1773	3	6	/	/	SYM
iajs-1773	3	7	college	college	NOUN
iajs-1773	3	8	of	of	ADP
iajs-1773	3	9	education	education	NOUN
iajs-1773	3	10	for	for	ADP
iajs-1773	3	11	pure	pure	ADJ
iajs-1773	3	12	science	science	NOUN
iajs-1773	3	13	(	(	PUNCT
iajs-1773	3	14	ibn	ibn	PROPN
iajs-1773	3	15	al	al	PROPN
iajs-1773	3	16	-	-	PUNCT
iajs-1773	3	17	haitham	haitham	PROPN
iajs-1773	3	18	)	)	PUNCT
iajs-1773	3	19	/	/	SYM
iajs-1773	3	20	baghdad	baghdad	PROPN
iajs-1773	3	21	university	university	PROPN
iajs-1773	3	22	abstract	abstract	ADJ
iajs-1773	3	23	cancer	cancer	NOUN
iajs-1773	3	24	is	be	AUX
iajs-1773	3	25	the	the	DET
iajs-1773	3	26	second	second	ADJ
iajs-1773	3	27	leading	leading	ADJ
iajs-1773	3	28	cause	cause	NOUN
iajs-1773	3	29	of	of	ADP
iajs-1773	3	30	death	death	NOUN
iajs-1773	3	31	throughout	throughout	ADP
iajs-1773	3	32	the	the	DET
iajs-1773	3	33	world	world	NOUN
iajs-1773	3	34	.	.	PUNCT
iajs-1773	4	1	breast	breast	NOUN
iajs-1773	4	2	cancer	cancer	NOUN
iajs-1773	4	3	,	,	PUNCT
iajs-1773	4	4	is	be	AUX
iajs-1773	4	5	one	one	NUM
iajs-1773	4	6	of	of	ADP
iajs-1773	4	7	the	the	DET
iajs-1773	4	8	leading	lead	VERB
iajs-1773	4	9	mortality	mortality	NOUN
iajs-1773	4	10	reasons	reason	NOUN
iajs-1773	4	11	in	in	ADP
iajs-1773	4	12	women	woman	NOUN
iajs-1773	4	13	from	from	ADP
iajs-1773	4	14	western	western	ADJ
iajs-1773	4	15	countries	country	NOUN
iajs-1773	4	16	,	,	PUNCT
iajs-1773	4	17	in	in	ADP
iajs-1773	4	18	iraq	iraq	PROPN
iajs-1773	4	19	,	,	PUNCT
iajs-1773	4	20	breast	breast	NOUN
iajs-1773	4	21	cancer	cancer	NOUN
iajs-1773	4	22	is	be	AUX
iajs-1773	4	23	the	the	DET
iajs-1773	4	24	second	second	ADJ
iajs-1773	4	25	reason	reason	NOUN
iajs-1773	4	26	of	of	ADP
iajs-1773	4	27	death	death	NOUN
iajs-1773	4	28	after	after	ADP
iajs-1773	4	29	cardiovascular	cardiovascular	ADJ
iajs-1773	4	30	diseases	disease	NOUN
iajs-1773	4	31	.	.	PUNCT
iajs-1773	5	1	the	the	DET
iajs-1773	5	2	study	study	NOUN
iajs-1773	5	3	was	be	AUX
iajs-1773	5	4	carried	carry	VERB
iajs-1773	5	5	out	out	ADP
iajs-1773	5	6	of	of	ADP
iajs-1773	5	7	period	period	NOUN
iajs-1773	5	8	from	from	ADP
iajs-1773	5	9	october/2016	october/2016	PROPN
iajs-1773	5	10	-	-	PUNCT
iajs-1773	5	11	january	january	NOUN
iajs-1773	5	12	/2017	/2017	PUNCT
iajs-1773	5	13	and	and	CCONJ
iajs-1773	5	14	included	include	VERB
iajs-1773	5	15	(	(	PUNCT
iajs-1773	5	16	90	90	NUM
iajs-1773	5	17	)	)	PUNCT
iajs-1773	5	18	serum	serum	NOUN
iajs-1773	5	19	samples	sample	NOUN
iajs-1773	5	20	for	for	ADP
iajs-1773	5	21	iraqi	iraqi	ADJ
iajs-1773	5	22	women	woman	NOUN
iajs-1773	5	23	suffered	suffer	VERB
iajs-1773	5	24	from	from	ADP
iajs-1773	5	25	breast	breast	NOUN
iajs-1773	5	26	cancer	cancer	NOUN
iajs-1773	5	27	.	.	PUNCT
iajs-1773	6	1	samples	sample	NOUN
iajs-1773	6	2	were	be	AUX
iajs-1773	6	3	divided	divide	VERB
iajs-1773	6	4	into	into	ADP
iajs-1773	6	5	two	two	NUM
iajs-1773	6	6	groups	group	NOUN
iajs-1773	6	7	,	,	PUNCT
iajs-1773	6	8	the	the	DET
iajs-1773	6	9	first	first	ADJ
iajs-1773	6	10	group	group	NOUN
iajs-1773	6	11	included	include	VERB
iajs-1773	6	12	(	(	PUNCT
iajs-1773	6	13	66	66	NUM
iajs-1773	6	14	)	)	PUNCT
iajs-1773	6	15	patients	patient	NOUN
iajs-1773	6	16	(	(	PUNCT
iajs-1773	6	17	females	female	NOUN
iajs-1773	6	18	)	)	PUNCT
iajs-1773	6	19	their	their	PRON
iajs-1773	6	20	age	age	NOUN
iajs-1773	6	21	rang	ring	VERB
iajs-1773	6	22	(	(	PUNCT
iajs-1773	6	23	22	22	NUM
iajs-1773	6	24	-	-	SYM
iajs-1773	6	25	55	55	NUM
iajs-1773	6	26	)	)	PUNCT
iajs-1773	6	27	years	year	NOUN
iajs-1773	6	28	which	which	PRON
iajs-1773	6	29	attended	attend	VERB
iajs-1773	6	30	to	to	ADP
iajs-1773	6	31	(	(	PUNCT
iajs-1773	6	32	tumor	tumor	NOUN
iajs-1773	6	33	unit	unit	NOUN
iajs-1773	6	34	)	)	PUNCT
iajs-1773	6	35	at	at	ADP
iajs-1773	6	36	medical	medical	ADJ
iajs-1773	6	37	city	city	NOUN
iajs-1773	6	38	educational	educational	ADJ
iajs-1773	6	39	oncology	oncology	NOUN
iajs-1773	6	40	hospital	hospital	NOUN
iajs-1773	6	41	and	and	CCONJ
iajs-1773	6	42	al	al	PROPN
iajs-1773	6	43	-	-	PROPN
iajs-1773	6	44	amal	amal	PROPN
iajs-1773	6	45	al	al	PROPN
iajs-1773	6	46	-	-	PUNCT
iajs-1773	6	47	waatanii	waatanii	PROPN
iajs-1773	6	48	hospital	hospital	NOUN
iajs-1773	6	49	in	in	ADP
iajs-1773	6	50	baghdad	baghdad	PROPN
iajs-1773	6	51	,	,	PUNCT
iajs-1773	6	52	the	the	DET
iajs-1773	6	53	second	second	ADJ
iajs-1773	6	54	group	group	NOUN
iajs-1773	6	55	included	include	VERB
iajs-1773	6	56	(	(	PUNCT
iajs-1773	6	57	38	38	NUM
iajs-1773	6	58	)	)	PUNCT
iajs-1773	6	59	for	for	ADP
iajs-1773	6	60	females	female	NOUN
iajs-1773	6	61	apparently	apparently	ADV
iajs-1773	6	62	healthy	healthy	VERB
iajs-1773	6	63	their	their	PRON
iajs-1773	6	64	age	age	NOUN
iajs-1773	6	65	(	(	PUNCT
iajs-1773	6	66	22	22	NUM
iajs-1773	6	67	-	-	SYM
iajs-1773	6	68	55	55	NUM
iajs-1773	6	69	)	)	PUNCT
iajs-1773	6	70	were	be	AUX
iajs-1773	6	71	studied	study	VERB
iajs-1773	6	72	as	as	ADP
iajs-1773	6	73	a	a	DET
iajs-1773	6	74	control	control	NOUN
iajs-1773	6	75	group	group	NOUN
iajs-1773	6	76	.	.	PUNCT
iajs-1773	7	1	all	all	DET
iajs-1773	7	2	patients	patient	NOUN
iajs-1773	7	3	women	woman	NOUN
iajs-1773	7	4	which	which	PRON
iajs-1773	7	5	included	include	VERB
iajs-1773	7	6	in	in	ADP
iajs-1773	7	7	this	this	DET
iajs-1773	7	8	study	study	NOUN
iajs-1773	7	9	were	be	AUX
iajs-1773	7	10	enrolled	enrol	VERB
iajs-1773	7	11	to	to	ADP
iajs-1773	7	12	a	a	DET
iajs-1773	7	13	diagnostic	diagnostic	ADJ
iajs-1773	7	14	criteria	criterion	NOUN
iajs-1773	7	15	which	which	PRON
iajs-1773	7	16	made	make	VERB
iajs-1773	7	17	according	accord	VERB
iajs-1773	7	18	to	to	ADP
iajs-1773	7	19	clinical	clinical	ADJ
iajs-1773	7	20	,	,	PUNCT
iajs-1773	7	21	mamografical	mamografical	ADJ
iajs-1773	7	22	,	,	PUNCT
iajs-1773	7	23	histological	histological	ADJ
iajs-1773	7	24	finding	finding	NOUN
iajs-1773	7	25	.	.	PUNCT
iajs-1773	8	1	all	all	PRON
iajs-1773	8	2	of	of	ADP
iajs-1773	8	3	them	they	PRON
iajs-1773	8	4	were	be	AUX
iajs-1773	8	5	early	early	ADV
iajs-1773	8	6	diagnosed	diagnose	VERB
iajs-1773	8	7	(	(	PUNCT
iajs-1773	8	8	without	without	ADP
iajs-1773	8	9	treatment	treatment	NOUN
iajs-1773	8	10	)	)	PUNCT
iajs-1773	8	11	.	.	PUNCT
iajs-1773	9	1	the	the	DET
iajs-1773	9	2	disease	disease	NOUN
iajs-1773	9	3	was	be	AUX
iajs-1773	9	4	diagnosed	diagnose	VERB
iajs-1773	9	5	by	by	ADP
iajs-1773	9	6	consultant	consultant	NOUN
iajs-1773	9	7	medical	medical	ADJ
iajs-1773	9	8	staff	staff	NOUN
iajs-1773	9	9	at	at	ADP
iajs-1773	9	10	the	the	DET
iajs-1773	9	11	hospital	hospital	NOUN
iajs-1773	9	12	.	.	PUNCT
iajs-1773	10	1	three	three	NUM
iajs-1773	10	2	(	(	PUNCT
iajs-1773	10	3	3ml	3ml	NOUN
iajs-1773	10	4	)	)	PUNCT
iajs-1773	10	5	of	of	ADP
iajs-1773	10	6	peripheral	peripheral	ADJ
iajs-1773	10	7	blood	blood	NOUN
iajs-1773	10	8	has	have	AUX
iajs-1773	10	9	been	be	AUX
iajs-1773	10	10	drawn	draw	VERB
iajs-1773	10	11	from	from	ADP
iajs-1773	10	12	both	both	DET
iajs-1773	10	13	understudying	understudy	VERB
iajs-1773	10	14	groups	group	NOUN
iajs-1773	10	15	,	,	PUNCT
iajs-1773	10	16	serum	serum	NOUN
iajs-1773	10	17	isolated	isolate	VERB
iajs-1773	10	18	and	and	CCONJ
iajs-1773	10	19	placed	place	VERB
iajs-1773	10	20	in	in	ADP
iajs-1773	10	21	eppendorf	eppendorf	NOUN
iajs-1773	10	22	tube	tube	NOUN
iajs-1773	10	23	in	in	ADP
iajs-1773	10	24	deep	deep	ADJ
iajs-1773	10	25	freeze	freeze	NOUN
iajs-1773	10	26	(	(	PUNCT
iajs-1773	10	27	-20	-20	NUM
iajs-1773	10	28	)	)	PUNCT
iajs-1773	10	29	until	until	SCONJ
iajs-1773	10	30	used	use	VERB
iajs-1773	10	31	.	.	PUNCT
iajs-1773	11	1	to	to	PART
iajs-1773	11	2	determin	determin	VERB
iajs-1773	11	3	the	the	DET
iajs-1773	11	4	understudying	understudy	VERB
iajs-1773	11	5	hormones	hormone	NOUN
iajs-1773	11	6	(	(	PUNCT
iajs-1773	11	7	progesterone	progesterone	NOUN
iajs-1773	11	8	,	,	PUNCT
iajs-1773	11	9	prolactin	prolactin	NOUN
iajs-1773	11	10	and	and	CCONJ
iajs-1773	11	11	estradiol	estradiol	PROPN
iajs-1773	11	12	)	)	PUNCT
iajs-1773	11	13	,	,	PUNCT
iajs-1773	11	14	eliza	eliza	NOUN
iajs-1773	11	15	technique	technique	NOUN
iajs-1773	11	16	has	have	AUX
iajs-1773	11	17	been	be	AUX
iajs-1773	11	18	used	use	VERB
iajs-1773	11	19	while	while	SCONJ
iajs-1773	11	20	vitamin	vitamin	NOUN
iajs-1773	11	21	c	c	NOUN
iajs-1773	11	22	and	and	CCONJ
iajs-1773	11	23	zinc	zinc	NOUN
iajs-1773	11	24	were	be	AUX
iajs-1773	11	25	determined	determine	VERB
iajs-1773	11	26	sepctrophotometricly	sepctrophotometricly	ADV
iajs-1773	11	27	.	.	PUNCT
iajs-1773	12	1	by	by	ADP
iajs-1773	12	2	elisa	elisa	NOUN
iajs-1773	12	3	technique	technique	NOUN
iajs-1773	12	4	(	(	PUNCT
iajs-1773	12	5	itga2	itga2	NOUN
iajs-1773	12	6	)	)	PUNCT
iajs-1773	12	7	recorded	record	VERB
iajs-1773	12	8	a	a	DET
iajs-1773	12	9	non	non	ADJ
iajs-1773	12	10	-	-	ADJ
iajs-1773	12	11	significant	significant	ADJ
iajs-1773	12	12	differences	difference	NOUN
iajs-1773	12	13	in	in	ADP
iajs-1773	12	14	patients	patient	NOUN
iajs-1773	12	15	.	.	PUNCT
iajs-1773	13	1	progesterone	progesterone	NOUN
iajs-1773	13	2	recorded	record	VERB
iajs-1773	13	3	a	a	DET
iajs-1773	13	4	significantly	significantly	ADV
iajs-1773	13	5	increasing	increase	VERB
iajs-1773	13	6	in	in	ADP
iajs-1773	13	7	patients	patient	NOUN
iajs-1773	13	8	(	(	PUNCT
iajs-1773	13	9	p<0.01	p<0.01	PROPN
iajs-1773	13	10	)	)	PUNCT
iajs-1773	13	11	.	.	PUNCT
iajs-1773	14	1	prolactin	prolactin	PROPN
iajs-1773	14	2	showed	show	VERB
iajs-1773	14	3	a	a	DET
iajs-1773	14	4	higher	high	ADJ
iajs-1773	14	5	significantly	significantly	ADV
iajs-1773	14	6	increasing	increase	VERB
iajs-1773	14	7	in	in	ADP
iajs-1773	14	8	patients	patient	NOUN
iajs-1773	14	9	(	(	PUNCT
iajs-1773	14	10	p	p	X
iajs-1773	14	11	<	<	X
iajs-1773	14	12	0.01	0.01	NUM
iajs-1773	14	13	)	)	PUNCT
iajs-1773	14	14	,	,	PUNCT
iajs-1773	14	15	while	while	SCONJ
iajs-1773	14	16	estradiol	estradiol	PROPN
iajs-1773	14	17	serum	serum	PROPN
iajs-1773	14	18	level	level	PROPN
iajs-1773	14	19	recorded	record	VERB
iajs-1773	14	20	a	a	DET
iajs-1773	14	21	higher	high	ADJ
iajs-1773	14	22	significantly	significantly	ADV
iajs-1773	14	23	decreasing	decrease	VERB
iajs-1773	14	24	(	(	PUNCT
iajs-1773	14	25	p<0.01	p<0.01	PROPN
iajs-1773	14	26	)	)	PUNCT
iajs-1773	14	27	in	in	ADP
iajs-1773	14	28	patients	patient	NOUN
iajs-1773	14	29	.	.	PUNCT
iajs-1773	15	1	the	the	DET
iajs-1773	15	2	result	result	NOUN
iajs-1773	15	3	of	of	ADP
iajs-1773	15	4	biochemistry	biochemistry	NOUN
iajs-1773	15	5	study	study	NOUN
iajs-1773	15	6	part	part	NOUN
iajs-1773	15	7	which	which	PRON
iajs-1773	15	8	included	include	VERB
iajs-1773	15	9	zinc	zinc	NOUN
iajs-1773	15	10	and	and	CCONJ
iajs-1773	15	11	vitamin	vitamin	NOUN
iajs-1773	15	12	c	c	NOUN
iajs-1773	15	13	,	,	PUNCT
iajs-1773	15	14	zinc	zinc	NOUN
iajs-1773	15	15	recorded	record	VERB
iajs-1773	15	16	a	a	DET
iajs-1773	15	17	highest	high	ADJ
iajs-1773	15	18	significantly	significantly	ADV
iajs-1773	15	19	decreasing	decrease	VERB
iajs-1773	15	20	(	(	PUNCT
iajs-1773	15	21	p<0.01	p<0.01	PROPN
iajs-1773	15	22	)	)	PUNCT
iajs-1773	15	23	in	in	ADP
iajs-1773	15	24	patients	patient	NOUN
iajs-1773	15	25	,	,	PUNCT
iajs-1773	15	26	as	as	ADV
iajs-1773	15	27	well	well	ADV
iajs-1773	15	28	as	as	ADP
iajs-1773	15	29	vitamin	vitamin	NOUN
iajs-1773	15	30	c	c	NOUN
iajs-1773	15	31	recorded	record	VERB
iajs-1773	15	32	a	a	DET
iajs-1773	15	33	significantly	significantly	ADV
iajs-1773	15	34	decreasing	decrease	VERB
iajs-1773	15	35	(	(	PUNCT
iajs-1773	15	36	p<0.05	p<0.05	NOUN
iajs-1773	15	37	)	)	PUNCT
iajs-1773	15	38	in	in	ADP
iajs-1773	15	39	patients	patient	NOUN
iajs-1773	15	40	.	.	PUNCT
iajs-1773	16	1	according	accord	VERB
iajs-1773	16	2	to	to	ADP
iajs-1773	16	3	the	the	DET
iajs-1773	16	4	significant	significant	ADJ
iajs-1773	16	5	correlation	correlation	NOUN
iajs-1773	16	6	between	between	ADP
iajs-1773	16	7	the	the	DET
iajs-1773	16	8	three	three	NUM
iajs-1773	16	9	studied	studied	ADJ
iajs-1773	16	10	factors	factor	NOUN
iajs-1773	16	11	(	(	PUNCT
iajs-1773	16	12	integrin	integrin	NOUN
iajs-1773	16	13	,	,	PUNCT
iajs-1773	16	14	progesterone	progesterone	NOUN
iajs-1773	16	15	and	and	CCONJ
iajs-1773	16	16	vitamin	vitamin	NOUN
iajs-1773	16	17	c	c	NOUN
iajs-1773	16	18	)	)	PUNCT
iajs-1773	16	19	we	we	PRON
iajs-1773	16	20	may	may	AUX
iajs-1773	16	21	conclude	conclude	VERB
iajs-1773	16	22	that	that	SCONJ
iajs-1773	16	23	increasing	increase	VERB
iajs-1773	16	24	level	level	NOUN
iajs-1773	16	25	of	of	ADP
iajs-1773	16	26	progesterone	progesterone	NOUN
iajs-1773	16	27	and	and	CCONJ
iajs-1773	16	28	decreasing	decrease	VERB
iajs-1773	16	29	level	level	NOUN
iajs-1773	16	30	of	of	ADP
iajs-1773	16	31	vitamin	vitamin	NOUN
iajs-1773	16	32	c	c	NOUN
iajs-1773	16	33	may	may	AUX
iajs-1773	16	34	effect	effect	VERB
iajs-1773	16	35	integrin	integrin	NOUN
iajs-1773	16	36	expression	expression	NOUN
iajs-1773	16	37	in	in	ADP
iajs-1773	16	38	a	a	DET
iajs-1773	16	39	downregulation	downregulation	NOUN
iajs-1773	16	40	manner	manner	NOUN
iajs-1773	16	41	and	and	CCONJ
iajs-1773	16	42	perhaps	perhaps	ADV
iajs-1773	16	43	breast	breast	NOUN
iajs-1773	16	44	cancer	cancer	NOUN
iajs-1773	16	45	occurring	occurring	NOUN
iajs-1773	16	46	and	and	CCONJ
iajs-1773	16	47	prognosis	prognosis	NOUN
iajs-1773	16	48	.	.	PUNCT
iajs-1773	17	1	keywords	keyword	NOUN
iajs-1773	17	2	:	:	PUNCT
iajs-1773	17	3	breast	breast	NOUN
iajs-1773	17	4	cancer	cancer	NOUN
iajs-1773	17	5	,	,	PUNCT
iajs-1773	17	6	integrinα2	integrinα2	NOUN
iajs-1773	17	7	,	,	PUNCT
iajs-1773	17	8	progesterone	progesterone	NOUN
iajs-1773	17	9	,	,	PUNCT
iajs-1773	17	10	prolactin	prolactin	NOUN
iajs-1773	17	11	,	,	PUNCT
iajs-1773	17	12	estradiol	estradiol	PROPN
iajs-1773	17	13	,	,	PUNCT
iajs-1773	17	14	zinc	zinc	NOUN
iajs-1773	17	15	vitamin	vitamin	NOUN
iajs-1773	17	16	c.	c.	PROPN
iajs-1773	17	17	ihsciconf	ihsciconf	PROPN
iajs-1773	17	18	2017	2017	NUM
iajs-1773	17	19	special	special	ADJ
iajs-1773	17	20	issue	issue	NOUN
iajs-1773	17	21	ibn	ibn	PROPN
iajs-1773	17	22	al	al	PROPN
iajs-1773	17	23	-	-	PUNCT
iajs-1773	17	24	haitham	haitham	PROPN
iajs-1773	17	25	journal	journal	PROPN
iajs-1773	17	26	for	for	ADP
iajs-1773	17	27	pure	pure	ADJ
iajs-1773	17	28	and	and	CCONJ
iajs-1773	17	29	applied	apply	VERB
iajs-1773	17	30	science	science	NOUN
iajs-1773	17	31	https://doi.org/	https://doi.org/	NOUN
iajs-1773	17	32	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	17	33	.	.	PUNCT
iajs-1773	17	34	 	 	SPACE
iajs-1773	17	35	1773	1773	NUM
iajs-1773	17	36	for	for	ADP
iajs-1773	17	37	more	more	ADJ
iajs-1773	17	38	information	information	NOUN
iajs-1773	17	39	about	about	ADP
iajs-1773	17	40	the	the	DET
iajs-1773	17	41	conference	conference	NOUN
iajs-1773	17	42	please	please	INTJ
iajs-1773	17	43	visit	visit	VERB
iajs-1773	17	44	the	the	DET
iajs-1773	17	45	websites	website	NOUN
iajs-1773	17	46	:	:	PUNCT
iajs-1773	17	47	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	17	48	  	  	SPACE
iajs-1773	17	49	www.ihsciconf.org	www.ihsciconf.org	NOUN
iajs-1773	17	50	  	  	SPACE
iajs-1773	17	51	biology|74	biology|74	X
iajs-1773	17	52	1	1	X
iajs-1773	17	53	.	.	X
iajs-1773	17	54	introduction	introduction	NOUN
iajs-1773	17	55	cancer	cancer	NOUN
iajs-1773	17	56	is	be	AUX
iajs-1773	17	57	the	the	DET
iajs-1773	17	58	second	second	ADJ
iajs-1773	17	59	leading	leading	ADJ
iajs-1773	17	60	cause	cause	NOUN
iajs-1773	17	61	of	of	ADP
iajs-1773	17	62	death	death	NOUN
iajs-1773	17	63	throughout	throughout	ADP
iajs-1773	17	64	the	the	DET
iajs-1773	17	65	world	world	NOUN
iajs-1773	17	66	.	.	PUNCT
iajs-1773	18	1	breast	breast	NOUN
iajs-1773	18	2	cancer	cancer	NOUN
iajs-1773	18	3	is	be	AUX
iajs-1773	18	4	one	one	NUM
iajs-1773	18	5	of	of	ADP
iajs-1773	18	6	the	the	DET
iajs-1773	18	7	leading	lead	VERB
iajs-1773	18	8	mortality	mortality	NOUN
iajs-1773	18	9	reasons	reason	NOUN
iajs-1773	18	10	in	in	ADP
iajs-1773	18	11	women	woman	NOUN
iajs-1773	18	12	from	from	ADP
iajs-1773	18	13	western	western	ADJ
iajs-1773	18	14	countries	country	NOUN
iajs-1773	18	15	.	.	PUNCT
iajs-1773	19	1	in	in	ADP
iajs-1773	19	2	iraq	iraq	PROPN
iajs-1773	19	3	,	,	PUNCT
iajs-1773	19	4	breast	breast	NOUN
iajs-1773	19	5	cancer	cancer	NOUN
iajs-1773	19	6	is	be	AUX
iajs-1773	19	7	the	the	DET
iajs-1773	19	8	second	second	ADJ
iajs-1773	19	9	reason	reason	NOUN
iajs-1773	19	10	of	of	ADP
iajs-1773	19	11	death	death	NOUN
iajs-1773	19	12	after	after	ADP
iajs-1773	19	13	cardiovascular	cardiovascular	ADJ
iajs-1773	19	14	diseases	disease	NOUN
iajs-1773	19	15	[	[	X
iajs-1773	19	16	1	1	NUM
iajs-1773	19	17	]	]	PUNCT
iajs-1773	19	18	.	.	PUNCT
iajs-1773	20	1	breast	breast	NOUN
iajs-1773	20	2	cancer	cancer	NOUN
iajs-1773	20	3	is	be	AUX
iajs-1773	20	4	a	a	DET
iajs-1773	20	5	type	type	NOUN
iajs-1773	20	6	of	of	ADP
iajs-1773	20	7	cancer	cancer	NOUN
iajs-1773	20	8	producing	produce	VERB
iajs-1773	20	9	from	from	ADP
iajs-1773	20	10	breast	breast	NOUN
iajs-1773	20	11	tissue	tissue	NOUN
iajs-1773	20	12	,	,	PUNCT
iajs-1773	20	13	usually	usually	ADV
iajs-1773	20	14	from	from	ADP
iajs-1773	20	15	the	the	DET
iajs-1773	20	16	inner	inner	ADJ
iajs-1773	20	17	lining	lining	NOUN
iajs-1773	20	18	of	of	ADP
iajs-1773	20	19	milk	milk	NOUN
iajs-1773	20	20	ducts	duct	NOUN
iajs-1773	20	21	,	,	PUNCT
iajs-1773	20	22	or	or	CCONJ
iajs-1773	20	23	lobules	lobule	NOUN
iajs-1773	20	24	that	that	PRON
iajs-1773	20	25	must	must	AUX
iajs-1773	20	26	provide	provide	VERB
iajs-1773	20	27	the	the	DET
iajs-1773	20	28	ducts	duct	NOUN
iajs-1773	20	29	with	with	ADP
iajs-1773	20	30	milk	milk	NOUN
iajs-1773	20	31	[	[	X
iajs-1773	20	32	2	2	NUM
iajs-1773	20	33	]	]	PUNCT
iajs-1773	20	34	.	.	PUNCT
iajs-1773	21	1	there	there	PRON
iajs-1773	21	2	were	be	VERB
iajs-1773	21	3	(	(	PUNCT
iajs-1773	21	4	3763	3763	NUM
iajs-1773	21	5	)	)	PUNCT
iajs-1773	21	6	cases	case	NOUN
iajs-1773	21	7	of	of	ADP
iajs-1773	21	8	breast	breast	NOUN
iajs-1773	21	9	cancer	cancer	NOUN
iajs-1773	21	10	with	with	ADP
iajs-1773	21	11	incidence	incidence	ADJ
iajs-1773	21	12	rate	rate	NOUN
iajs-1773	21	13	about	about	ADP
iajs-1773	21	14	(	(	PUNCT
iajs-1773	21	15	23.01	23.01	NUM
iajs-1773	21	16	)	)	PUNCT
iajs-1773	21	17	per	per	ADP
iajs-1773	21	18	100,000	100,000	NUM
iajs-1773	21	19	female	female	ADJ
iajs-1773	21	20	population	population	NOUN
iajs-1773	21	21	in	in	ADP
iajs-1773	21	22	2011	2011	NUM
iajs-1773	21	23	,	,	PUNCT
iajs-1773	21	24	compared	compare	VERB
iajs-1773	21	25	to	to	ADP
iajs-1773	21	26	(	(	PUNCT
iajs-1773	21	27	16.65	16.65	NUM
iajs-1773	21	28	)	)	PUNCT
iajs-1773	21	29	per	per	ADP
iajs-1773	21	30	100,00	100,00	NUM
iajs-1773	21	31	female	female	ADJ
iajs-1773	21	32	populations	population	NOUN
iajs-1773	21	33	in	in	ADP
iajs-1773	21	34	2008	2008	NUM
iajs-1773	21	35	in	in	ADP
iajs-1773	21	36	iraq	iraq	PROPN
iajs-1773	21	37	[	[	X
iajs-1773	21	38	1	1	NUM
iajs-1773	21	39	]	]	PUNCT
iajs-1773	21	40	.	.	PUNCT
iajs-1773	22	1	integrin	integrin	PROPN
iajs-1773	23	1	α2β1	α2β1	AUX
iajs-1773	23	2	is	be	AUX
iajs-1773	23	3	play	play	VERB
iajs-1773	23	4	an	an	DET
iajs-1773	23	5	important	important	ADJ
iajs-1773	23	6	role	role	NOUN
iajs-1773	23	7	in	in	ADP
iajs-1773	23	8	cancer	cancer	NOUN
iajs-1773	23	9	migration	migration	NOUN
iajs-1773	23	10	and	and	CCONJ
iajs-1773	23	11	invasion	invasion	NOUN
iajs-1773	23	12	.	.	PUNCT
iajs-1773	24	1	in	in	ADP
iajs-1773	24	2	recent	recent	ADJ
iajs-1773	24	3	study	study	NOUN
iajs-1773	24	4	it	it	PRON
iajs-1773	24	5	has	have	AUX
iajs-1773	24	6	been	be	AUX
iajs-1773	24	7	observed	observe	VERB
iajs-1773	24	8	that	that	SCONJ
iajs-1773	24	9	α2β1	α2β1	PRON
iajs-1773	24	10	integrins	integrin	NOUN
iajs-1773	24	11	is	be	AUX
iajs-1773	24	12	organize	organize	VERB
iajs-1773	24	13	cancer	cancer	NOUN
iajs-1773	24	14	metastasis	metastasis	NOUN
iajs-1773	24	15	either	either	CCONJ
iajs-1773	24	16	via	via	ADP
iajs-1773	24	17	enhancing	enhance	VERB
iajs-1773	24	18	or	or	CCONJ
iajs-1773	24	19	inhibiting	inhibit	VERB
iajs-1773	24	20	the	the	DET
iajs-1773	24	21	dissemination	dissemination	NOUN
iajs-1773	24	22	process	process	NOUN
iajs-1773	24	23	of	of	ADP
iajs-1773	24	24	cancer	cancer	NOUN
iajs-1773	24	25	cells	cell	NOUN
iajs-1773	24	26	.	.	PUNCT
iajs-1773	25	1	integrin	integrin	NOUN
iajs-1773	25	2	α2β1	α2β1	X
iajs-1773	25	3	functions	function	NOUN
iajs-1773	25	4	as	as	ADP
iajs-1773	25	5	a	a	DET
iajs-1773	25	6	collagen	collagen	NOUN
iajs-1773	25	7	receptor	receptor	NOUN
iajs-1773	25	8	on	on	ADP
iajs-1773	25	9	platelets	platelet	NOUN
iajs-1773	25	10	and	and	CCONJ
iajs-1773	25	11	fibroblastes	fibroblaste	NOUN
iajs-1773	25	12	and	and	CCONJ
iajs-1773	25	13	as	as	ADP
iajs-1773	25	14	both	both	CCONJ
iajs-1773	25	15	a	a	DET
iajs-1773	25	16	collagen	collagen	NOUN
iajs-1773	25	17	and	and	CCONJ
iajs-1773	25	18	laminin	laminin	NOUN
iajs-1773	25	19	receptor	receptor	NOUN
iajs-1773	25	20	on	on	ADP
iajs-1773	25	21	endothelial	endothelial	ADJ
iajs-1773	25	22	cells	cell	NOUN
iajs-1773	25	23	and	and	CCONJ
iajs-1773	25	24	most	most	ADJ
iajs-1773	25	25	epithelial	epithelial	ADJ
iajs-1773	25	26	cell	cell	NOUN
iajs-1773	25	27	typs	typ	NOUN
iajs-1773	26	1	[	[	X
iajs-1773	26	2	3	3	NUM
iajs-1773	26	3	,	,	PUNCT
iajs-1773	26	4	4	4	NUM
iajs-1773	26	5	]	]	PUNCT
iajs-1773	26	6	.	.	PUNCT
iajs-1773	27	1	the	the	DET
iajs-1773	27	2	previous	previous	ADJ
iajs-1773	27	3	study	study	NOUN
iajs-1773	27	4	revealed	reveal	VERB
iajs-1773	27	5	that	that	SCONJ
iajs-1773	27	6	the	the	DET
iajs-1773	27	7	progesterone	progesterone	NOUN
iajs-1773	27	8	receptor	receptor	NOUN
iajs-1773	27	9	pr	pr	NOUN
iajs-1773	27	10	may	may	AUX
iajs-1773	27	11	enhance	enhance	VERB
iajs-1773	27	12	breast	breast	NOUN
iajs-1773	27	13	cancer	cancer	NOUN
iajs-1773	27	14	in	in	ADP
iajs-1773	27	15	women	woman	NOUN
iajs-1773	27	16	[	[	X
iajs-1773	27	17	5	5	NUM
iajs-1773	27	18	,	,	PUNCT
iajs-1773	27	19	6	6	NUM
iajs-1773	27	20	]	]	PUNCT
iajs-1773	27	21	.	.	PUNCT
iajs-1773	28	1	prolactin	prolactin	NOUN
iajs-1773	28	2	(	(	PUNCT
iajs-1773	28	3	prl	prl	NOUN
iajs-1773	28	4	)	)	PUNCT
iajs-1773	28	5	stimulate	stimulate	VERB
iajs-1773	28	6	proliferation	proliferation	NOUN
iajs-1773	28	7	of	of	ADP
iajs-1773	28	8	breast	breast	NOUN
iajs-1773	28	9	cancer	cancer	NOUN
iajs-1773	28	10	cells	cell	NOUN
iajs-1773	28	11	proposed	propose	VERB
iajs-1773	28	12	that	that	SCONJ
iajs-1773	28	13	the	the	DET
iajs-1773	28	14	increasing	increase	VERB
iajs-1773	28	15	in	in	ADP
iajs-1773	28	16	the	the	DET
iajs-1773	28	17	growth	growth	NOUN
iajs-1773	28	18	of	of	ADP
iajs-1773	28	19	mammary	mammary	ADJ
iajs-1773	28	20	carcinomas	carcinoma	NOUN
iajs-1773	29	1	[	[	X
iajs-1773	29	2	7	7	NUM
iajs-1773	29	3	,	,	PUNCT
iajs-1773	29	4	8	8	NUM
iajs-1773	29	5	]	]	PUNCT
iajs-1773	29	6	.	.	PUNCT
iajs-1773	30	1	estradiol	estradiol	PROPN
iajs-1773	30	2	concentration	concentration	NOUN
iajs-1773	30	3	in	in	ADP
iajs-1773	30	4	the	the	DET
iajs-1773	30	5	serum	serum	NOUN
iajs-1773	30	6	was	be	AUX
iajs-1773	30	7	obviously	obviously	ADV
iajs-1773	30	8	lower	low	ADJ
iajs-1773	30	9	in	in	ADP
iajs-1773	30	10	breast	breast	NOUN
iajs-1773	30	11	cancer	cancer	NOUN
iajs-1773	30	12	patient	patient	NOUN
iajs-1773	30	13	.	.	PUNCT
iajs-1773	31	1	early	early	ADJ
iajs-1773	31	2	diagnosis	diagnosis	NOUN
iajs-1773	31	3	for	for	ADP
iajs-1773	31	4	breast	breast	NOUN
iajs-1773	31	5	cancer	cancer	NOUN
iajs-1773	31	6	patients	patient	NOUN
iajs-1773	31	7	is	be	AUX
iajs-1773	31	8	important	important	ADJ
iajs-1773	31	9	to	to	PART
iajs-1773	31	10	progress	progress	VERB
iajs-1773	31	11	outcome	outcome	NOUN
iajs-1773	31	12	,	,	PUNCT
iajs-1773	31	13	and	and	CCONJ
iajs-1773	31	14	a	a	DET
iajs-1773	31	15	biomarker	biomarker	NOUN
iajs-1773	31	16	that	that	PRON
iajs-1773	31	17	can	can	AUX
iajs-1773	31	18	detect	detect	VERB
iajs-1773	31	19	the	the	DET
iajs-1773	31	20	disease	disease	NOUN
iajs-1773	31	21	at	at	ADP
iajs-1773	31	22	early	early	ADJ
iajs-1773	31	23	stage	stage	NOUN
iajs-1773	31	24	.	.	PUNCT
iajs-1773	32	1	high	high	ADJ
iajs-1773	32	2	concentrations	concentration	NOUN
iajs-1773	32	3	of	of	ADP
iajs-1773	32	4	zinc	zinc	NOUN
iajs-1773	32	5	(	(	PUNCT
iajs-1773	32	6	zn	zn	NOUN
iajs-1773	32	7	)	)	PUNCT
iajs-1773	32	8	have	have	AUX
iajs-1773	32	9	been	be	AUX
iajs-1773	32	10	noted	note	VERB
iajs-1773	32	11	in	in	ADP
iajs-1773	32	12	breast	breast	NOUN
iajs-1773	32	13	cancer	cancer	NOUN
iajs-1773	32	14	tissue	tissue	NOUN
iajs-1773	32	15	for	for	ADP
iajs-1773	32	16	over	over	ADP
iajs-1773	32	17	a	a	PRON
iajs-1773	32	18	decade	decade	NOUN
iajs-1773	33	1	[	[	X
iajs-1773	33	2	9	9	NUM
iajs-1773	33	3	]	]	PUNCT
iajs-1773	33	4	.the	.the	PRON
iajs-1773	33	5	causative	causative	ADJ
iajs-1773	33	6	alters	alter	VERB
iajs-1773	33	7	in	in	ADP
iajs-1773	33	8	zn	zn	PROPN
iajs-1773	33	9	metabolism	metabolism	NOUN
iajs-1773	33	10	at	at	ADP
iajs-1773	33	11	the	the	DET
iajs-1773	33	12	molecular	molecular	ADJ
iajs-1773	33	13	level	level	NOUN
iajs-1773	33	14	have	have	AUX
iajs-1773	33	15	stayed	stay	VERB
iajs-1773	33	16	elusive	elusive	ADJ
iajs-1773	33	17	[	[	X
iajs-1773	33	18	10	10	NUM
iajs-1773	33	19	]	]	PUNCT
iajs-1773	33	20	.	.	PUNCT
iajs-1773	34	1	there	there	PRON
iajs-1773	34	2	is	be	VERB
iajs-1773	34	3	no	no	DET
iajs-1773	34	4	high	high	ADJ
iajs-1773	34	5	-	-	PUNCT
iajs-1773	34	6	quality	quality	NOUN
iajs-1773	34	7	evidence	evidence	NOUN
iajs-1773	34	8	to	to	PART
iajs-1773	34	9	suppose	suppose	VERB
iajs-1773	34	10	that	that	SCONJ
iajs-1773	34	11	a	a	DET
iajs-1773	34	12	vitamin	vitamin	NOUN
iajs-1773	34	13	c	c	NOUN
iajs-1773	34	14	supplementation	supplementation	NOUN
iajs-1773	34	15	in	in	ADP
iajs-1773	34	16	cancer	cancer	NOUN
iajs-1773	34	17	patients	patient	NOUN
iajs-1773	34	18	either	either	CCONJ
iajs-1773	34	19	enhances	enhance	VERB
iajs-1773	34	20	the	the	DET
iajs-1773	34	21	antitumor	antitumor	PROPN
iajs-1773	34	22	impacts	impact	NOUN
iajs-1773	34	23	of	of	ADP
iajs-1773	34	24	chemotherapy	chemotherapy	NOUN
iajs-1773	34	25	or	or	CCONJ
iajs-1773	34	26	decreases	decrease	VERB
iajs-1773	34	27	its	its	PRON
iajs-1773	34	28	toxicity	toxicity	NOUN
iajs-1773	34	29	[	[	X
iajs-1773	34	30	11	11	NUM
iajs-1773	34	31	]	]	PUNCT
iajs-1773	34	32	.	.	PUNCT
iajs-1773	35	1	the	the	DET
iajs-1773	35	2	study	study	NOUN
iajs-1773	35	3	aimed	aim	VERB
iajs-1773	35	4	to	to	ADP
iajs-1773	35	5	:	:	PUNCT
iajs-1773	35	6	1	1	X
iajs-1773	35	7	.	.	PUNCT
iajs-1773	35	8	to	to	PART
iajs-1773	35	9	shied	shy	VERB
iajs-1773	35	10	light	light	NOUN
iajs-1773	35	11	on	on	ADP
iajs-1773	35	12	integrin	integrin	NOUN
iajs-1773	35	13	α2	α2	PROPN
iajs-1773	35	14	which	which	PRON
iajs-1773	35	15	may	may	AUX
iajs-1773	35	16	represent	represent	VERB
iajs-1773	35	17	a	a	DET
iajs-1773	35	18	therapeutic	therapeutic	ADJ
iajs-1773	35	19	target	target	NOUN
iajs-1773	35	20	against	against	ADP
iajs-1773	35	21	metastasis	metastasis	NOUN
iajs-1773	35	22	.	.	PUNCT
iajs-1773	36	1	2	2	X
iajs-1773	36	2	.	.	NOUN
iajs-1773	36	3	serological	serological	ADJ
iajs-1773	36	4	estimation	estimation	NOUN
iajs-1773	36	5	of	of	ADP
iajs-1773	36	6	certain	certain	ADJ
iajs-1773	36	7	hormones	hormone	NOUN
iajs-1773	36	8	(	(	PUNCT
iajs-1773	36	9	prolactin	prolactin	NOUN
iajs-1773	36	10	,	,	PUNCT
iajs-1773	36	11	progesterone	progesterone	NOUN
iajs-1773	36	12	,	,	PUNCT
iajs-1773	36	13	estradiol	estradiol	PROPN
iajs-1773	36	14	vitamin	vitamin	PROPN
iajs-1773	36	15	c	c	PROPN
iajs-1773	36	16	and	and	CCONJ
iajs-1773	36	17	zinc	zinc	NOUN
iajs-1773	36	18	to	to	PART
iajs-1773	36	19	illustrate	illustrate	VERB
iajs-1773	36	20	whether	whether	SCONJ
iajs-1773	36	21	these	these	DET
iajs-1773	36	22	factors	factor	NOUN
iajs-1773	36	23	have	have	VERB
iajs-1773	36	24	a	a	DET
iajs-1773	36	25	relationship	relationship	NOUN
iajs-1773	36	26	with	with	ADP
iajs-1773	36	27	itga2	itga2	NOUN
iajs-1773	36	28	level	level	NOUN
iajs-1773	36	29	and	and	CCONJ
iajs-1773	36	30	with	with	ADP
iajs-1773	36	31	breast	breast	NOUN
iajs-1773	36	32	cancer	cancer	NOUN
iajs-1773	36	33	risk	risk	NOUN
iajs-1773	36	34	.	.	PUNCT
iajs-1773	37	1	2	2	X
iajs-1773	37	2	.	.	X
iajs-1773	37	3	material	material	NOUN
iajs-1773	37	4	and	and	CCONJ
iajs-1773	37	5	method	method	VERB
iajs-1773	37	6	2.1	2.1	NUM
iajs-1773	37	7	.	.	PUNCT
iajs-1773	38	1	samples	sample	NOUN
iajs-1773	38	2	collection	collection	NOUN
iajs-1773	38	3	the	the	DET
iajs-1773	38	4	study	study	NOUN
iajs-1773	38	5	was	be	AUX
iajs-1773	38	6	carried	carry	VERB
iajs-1773	38	7	out	out	ADP
iajs-1773	38	8	at	at	ADP
iajs-1773	38	9	the	the	DET
iajs-1773	38	10	period	period	NOUN
iajs-1773	38	11	from	from	ADP
iajs-1773	38	12	october/2016	october/2016	PROPN
iajs-1773	38	13	to	to	ADP
iajs-1773	38	14	january	january	PROPN
iajs-1773	38	15	/2017	/2017	PUNCT
iajs-1773	38	16	and	and	CCONJ
iajs-1773	38	17	included	include	VERB
iajs-1773	38	18	(	(	PUNCT
iajs-1773	38	19	90	90	NUM
iajs-1773	38	20	)	)	PUNCT
iajs-1773	38	21	serum	serum	NOUN
iajs-1773	38	22	samples	sample	NOUN
iajs-1773	38	23	for	for	ADP
iajs-1773	38	24	iraqi	iraqi	ADJ
iajs-1773	38	25	women	woman	NOUN
iajs-1773	38	26	suffered	suffer	VERB
iajs-1773	38	27	from	from	ADP
iajs-1773	38	28	breast	breast	NOUN
iajs-1773	38	29	cancer	cancer	NOUN
iajs-1773	38	30	.	.	PUNCT
iajs-1773	39	1	samples	sample	NOUN
iajs-1773	39	2	were	be	AUX
iajs-1773	39	3	divided	divide	VERB
iajs-1773	39	4	into	into	ADP
iajs-1773	39	5	two	two	NUM
iajs-1773	39	6	groups	group	NOUN
iajs-1773	39	7	,	,	PUNCT
iajs-1773	39	8	the	the	DET
iajs-1773	39	9	first	first	ADJ
iajs-1773	39	10	group	group	NOUN
iajs-1773	39	11	included	include	VERB
iajs-1773	39	12	(	(	PUNCT
iajs-1773	39	13	66	66	NUM
iajs-1773	39	14	)	)	PUNCT
iajs-1773	39	15	patients	patient	NOUN
iajs-1773	39	16	(	(	PUNCT
iajs-1773	39	17	females	female	NOUN
iajs-1773	39	18	)	)	PUNCT
iajs-1773	39	19	their	their	PRON
iajs-1773	39	20	age	age	NOUN
iajs-1773	39	21	rang	ring	VERB
iajs-1773	39	22	(	(	PUNCT
iajs-1773	39	23	22	22	NUM
iajs-1773	39	24	-	-	SYM
iajs-1773	39	25	55	55	NUM
iajs-1773	39	26	)	)	PUNCT
iajs-1773	39	27	years	year	NOUN
iajs-1773	39	28	which	which	PRON
iajs-1773	39	29	attended	attend	VERB
iajs-1773	39	30	to	to	ADP
iajs-1773	39	31	(	(	PUNCT
iajs-1773	39	32	tumor	tumor	NOUN
iajs-1773	39	33	unit	unit	NOUN
iajs-1773	39	34	)	)	PUNCT
iajs-1773	39	35	at	at	ADP
iajs-1773	39	36	medical	medical	ADJ
iajs-1773	39	37	city	city	NOUN
iajs-1773	39	38	educational	educational	ADJ
iajs-1773	39	39	oncology	oncology	NOUN
iajs-1773	39	40	hospital	hospital	NOUN
iajs-1773	39	41	and	and	CCONJ
iajs-1773	39	42	alamal	alamal	ADJ
iajs-1773	39	43	al	al	PROPN
iajs-1773	39	44	-	-	PUNCT
iajs-1773	39	45	waatnii	waatnii	NOUN
iajs-1773	39	46	hospital	hospital	NOUN
iajs-1773	39	47	in	in	ADP
iajs-1773	39	48	baghdad	baghdad	PROPN
iajs-1773	39	49	,	,	PUNCT
iajs-1773	39	50	the	the	DET
iajs-1773	39	51	second	second	ADJ
iajs-1773	39	52	group	group	NOUN
iajs-1773	39	53	included	include	VERB
iajs-1773	39	54	(	(	PUNCT
iajs-1773	39	55	38	38	NUM
iajs-1773	39	56	)	)	PUNCT
iajs-1773	39	57	for	for	ADP
iajs-1773	39	58	females	female	NOUN
iajs-1773	39	59	apparently	apparently	ADV
iajs-1773	39	60	healthy	healthy	VERB
iajs-1773	39	61	their	their	PRON
iajs-1773	39	62	age	age	NOUN
iajs-1773	39	63	(	(	PUNCT
iajs-1773	39	64	22	22	NUM
iajs-1773	39	65	-	-	SYM
iajs-1773	39	66	55	55	NUM
iajs-1773	39	67	)	)	PUNCT
iajs-1773	39	68	were	be	AUX
iajs-1773	39	69	studied	study	VERB
iajs-1773	39	70	as	as	ADP
iajs-1773	39	71	a	a	DET
iajs-1773	39	72	control	control	NOUN
iajs-1773	39	73	group	group	NOUN
iajs-1773	39	74	.	.	PUNCT
iajs-1773	40	1	all	all	DET
iajs-1773	40	2	patients	patient	NOUN
iajs-1773	40	3	women	woman	NOUN
iajs-1773	40	4	which	which	PRON
iajs-1773	40	5	included	include	VERB
iajs-1773	40	6	in	in	ADP
iajs-1773	40	7	this	this	DET
iajs-1773	40	8	study	study	NOUN
iajs-1773	40	9	were	be	AUX
iajs-1773	40	10	enrolled	enrol	VERB
iajs-1773	40	11	to	to	ADP
iajs-1773	40	12	a	a	DET
iajs-1773	40	13	diagnostic	diagnostic	ADJ
iajs-1773	40	14	criteria	criterion	NOUN
iajs-1773	40	15	which	which	PRON
iajs-1773	40	16	made	make	VERB
iajs-1773	40	17	according	accord	VERB
iajs-1773	40	18	to	to	ADP
iajs-1773	40	19	clinical	clinical	ADJ
iajs-1773	40	20	,	,	PUNCT
iajs-1773	40	21	mamografical	mamografical	ADJ
iajs-1773	40	22	,	,	PUNCT
iajs-1773	40	23	histological	histological	ADJ
iajs-1773	40	24	finding	finding	NOUN
iajs-1773	40	25	.	.	PUNCT
iajs-1773	41	1	all	all	PRON
iajs-1773	41	2	of	of	ADP
iajs-1773	41	3	them	they	PRON
iajs-1773	41	4	were	be	AUX
iajs-1773	41	5	early	early	ADV
iajs-1773	41	6	diagnosed	diagnose	VERB
iajs-1773	41	7	(	(	PUNCT
iajs-1773	41	8	without	without	ADP
iajs-1773	41	9	treatment	treatment	NOUN
iajs-1773	41	10	)	)	PUNCT
iajs-1773	41	11	.	.	PUNCT
iajs-1773	42	1	the	the	DET
iajs-1773	42	2	disease	disease	NOUN
iajs-1773	42	3	was	be	AUX
iajs-1773	42	4	diagnosed	diagnose	VERB
iajs-1773	42	5	by	by	ADP
iajs-1773	42	6	consultant	consultant	NOUN
iajs-1773	42	7	medical	medical	ADJ
iajs-1773	42	8	staff	staff	NOUN
iajs-1773	42	9	at	at	ADP
iajs-1773	42	10	the	the	DET
iajs-1773	42	11	hospital	hospital	NOUN
iajs-1773	42	12	.	.	PUNCT
iajs-1773	43	1	three	three	NUM
iajs-1773	43	2	(	(	PUNCT
iajs-1773	43	3	3ml	3ml	NOUN
iajs-1773	43	4	)	)	PUNCT
iajs-1773	43	5	of	of	ADP
iajs-1773	43	6	peripheral	peripheral	ADJ
iajs-1773	43	7	blood	blood	NOUN
iajs-1773	43	8	has	have	AUX
iajs-1773	43	9	been	be	AUX
iajs-1773	43	10	drawn	draw	VERB
iajs-1773	43	11	from	from	ADP
iajs-1773	43	12	both	both	DET
iajs-1773	43	13	understudying	understudy	VERB
iajs-1773	43	14	groups	group	NOUN
iajs-1773	43	15	,	,	PUNCT
iajs-1773	43	16	serum	serum	NOUN
iajs-1773	43	17	isolated	isolate	VERB
iajs-1773	43	18	and	and	CCONJ
iajs-1773	43	19	placed	place	VERB
iajs-1773	43	20	in	in	ADP
iajs-1773	43	21	eppendorf	eppendorf	NOUN
iajs-1773	43	22	tube	tube	NOUN
iajs-1773	43	23	in	in	ADP
iajs-1773	43	24	deep	deep	ADJ
iajs-1773	43	25	freez	freez	NOUN
iajs-1773	43	26	(	(	PUNCT
iajs-1773	43	27	-20	-20	NUM
iajs-1773	43	28	)	)	PUNCT
iajs-1773	43	29	until	until	SCONJ
iajs-1773	43	30	used	use	VERB
iajs-1773	43	31	.	.	PUNCT
iajs-1773	44	1	to	to	PART
iajs-1773	44	2	determine	determine	VERB
iajs-1773	44	3	the	the	DET
iajs-1773	44	4	understudying	understudy	VERB
iajs-1773	44	5	hormones	hormone	NOUN
iajs-1773	44	6	(	(	PUNCT
iajs-1773	44	7	progesterone	progesterone	NOUN
iajs-1773	44	8	,	,	PUNCT
iajs-1773	44	9	prolactin	prolactin	NOUN
iajs-1773	44	10	and	and	CCONJ
iajs-1773	44	11	estradiol	estradiol	PROPN
iajs-1773	44	12	)	)	PUNCT
iajs-1773	44	13	,	,	PUNCT
iajs-1773	44	14	eliza	eliza	NOUN
iajs-1773	44	15	technique	technique	NOUN
iajs-1773	44	16	has	have	AUX
iajs-1773	44	17	been	be	AUX
iajs-1773	44	18	used	use	VERB
iajs-1773	44	19	while	while	SCONJ
iajs-1773	44	20	vitamin	vitamin	NOUN
iajs-1773	44	21	c	c	NOUN
iajs-1773	44	22	and	and	CCONJ
iajs-1773	44	23	zinc	zinc	NOUN
iajs-1773	44	24	were	be	AUX
iajs-1773	44	25	determined	determine	VERB
iajs-1773	44	26	sepctrophotometricly	sepctrophotometricly	ADV
iajs-1773	44	27	.	.	PUNCT
iajs-1773	45	1	2.2	2.2	NUM
iajs-1773	45	2	.	.	PUNCT
iajs-1773	45	3	carried	carry	VERB
iajs-1773	45	4	out	out	ADP
iajs-1773	45	5	by	by	ADP
iajs-1773	45	6	using	use	VERB
iajs-1773	45	7	eliza	eliza	PROPN
iajs-1773	45	8	kite	kite	PROPN
iajs-1773	45	9	human	human	PROPN
iajs-1773	45	10	integrin	integrin	PROPN
iajs-1773	45	11	alpha-2	alpha-2	PROPN
iajs-1773	45	12	was	be	AUX
iajs-1773	45	13	purchased	purchase	VERB
iajs-1773	45	14	from	from	ADP
iajs-1773	45	15	cusabio	cusabio	PROPN
iajs-1773	45	16	,	,	PUNCT
iajs-1773	45	17	china	china	PROPN
iajs-1773	45	18	stored	store	VERB
iajs-1773	45	19	at	at	ADP
iajs-1773	45	20	4	4	NUM
iajs-1773	45	21	◦	◦	NOUN
iajs-1773	45	22	cprogesterone	cprogesterone	NOUN
iajs-1773	45	23	ng	ng	PROPN
iajs-1773	45	24	/	/	SYM
iajs-1773	45	25	ml	ml	PROPN
iajs-1773	45	26	was	be	AUX
iajs-1773	45	27	purchased	purchase	VERB
iajs-1773	45	28	from	from	ADP
iajs-1773	45	29	accubind	accubind	PROPN
iajs-1773	45	30	,	,	PUNCT
iajs-1773	45	31	usa	usa	PROPN
iajs-1773	45	32	stored	store	VERB
iajs-1773	45	33	at	at	ADP
iajs-1773	45	34	-4	-4	PROPN
iajs-1773	45	35	◦	◦	NOUN
iajs-1773	45	36	c	c	PROPN
iajs-1773	45	37	prolactin	prolactin	PROPN
iajs-1773	45	38	ng	ng	PROPN
iajs-1773	45	39	/	/	SYM
iajs-1773	45	40	ml	ml	NOUN
iajs-1773	45	41	ihsciconf	ihsciconf	NOUN
iajs-1773	45	42	2017	2017	NUM
iajs-1773	45	43	special	special	ADJ
iajs-1773	45	44	issue	issue	NOUN
iajs-1773	45	45	ibn	ibn	PROPN
iajs-1773	45	46	al	al	PROPN
iajs-1773	45	47	-	-	PUNCT
iajs-1773	45	48	haitham	haitham	PROPN
iajs-1773	45	49	journal	journal	PROPN
iajs-1773	45	50	for	for	ADP
iajs-1773	45	51	pure	pure	ADJ
iajs-1773	45	52	and	and	CCONJ
iajs-1773	45	53	applied	apply	VERB
iajs-1773	45	54	science	science	NOUN
iajs-1773	45	55	https://doi.org/	https://doi.org/	NOUN
iajs-1773	45	56	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	45	57	.	.	PUNCT
iajs-1773	45	58	 	 	SPACE
iajs-1773	45	59	1773	1773	NUM
iajs-1773	45	60	for	for	ADP
iajs-1773	45	61	more	more	ADJ
iajs-1773	45	62	information	information	NOUN
iajs-1773	45	63	about	about	ADP
iajs-1773	45	64	the	the	DET
iajs-1773	45	65	conference	conference	NOUN
iajs-1773	45	66	please	please	INTJ
iajs-1773	45	67	visit	visit	VERB
iajs-1773	45	68	the	the	DET
iajs-1773	45	69	websites	website	NOUN
iajs-1773	45	70	:	:	PUNCT
iajs-1773	45	71	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	45	72	  	  	SPACE
iajs-1773	45	73	www.ihsciconf.org	www.ihsciconf.org	ADV
iajs-1773	45	74	  	  	SPACE
iajs-1773	45	75	biology|75	biology|75	PUNCT
iajs-1773	45	76	was	be	AUX
iajs-1773	45	77	purchased	purchase	VERB
iajs-1773	45	78	from	from	ADP
iajs-1773	45	79	human	human	PROPN
iajs-1773	45	80	,	,	PUNCT
iajs-1773	45	81	germany	germany	PROPN
iajs-1773	45	82	stored	store	VERB
iajs-1773	45	83	-4	-4	INTJ
iajs-1773	45	84	◦	◦	NOUN
iajs-1773	45	85	c	c	NOUN
iajs-1773	45	86	was	be	AUX
iajs-1773	45	87	purchased	purchase	VERB
iajs-1773	45	88	from	from	ADP
iajs-1773	45	89	bioactive	bioactive	PROPN
iajs-1773	45	90	,	,	PUNCT
iajs-1773	45	91	germany	germany	PROPN
iajs-1773	45	92	storied	story	VERB
iajs-1773	45	93	at	at	ADP
iajs-1773	45	94	-4	-4	PROPN
iajs-1773	45	95	◦	◦	PROPN
iajs-1773	45	96	c	c	PROPN
iajs-1773	45	97	estradiol	estradiol	PROPN
iajs-1773	45	98	pg	pg	PROPN
iajs-1773	45	99	/	/	SYM
iajs-1773	45	100	ml	ml	VERB
iajs-1773	45	101	stored	store	VERB
iajs-1773	45	102	at-4	at-4	NUM
iajs-1773	45	103	◦	◦	NOUN
iajs-1773	45	104	c	c	NOUN
iajs-1773	45	105	itaonline	itaonline	NOUN
iajs-1773	45	106	,	,	PUNCT
iajs-1773	45	107	italy	italy	PROPN
iajs-1773	45	108	,	,	PUNCT
iajs-1773	45	109	zinc	zinc	NOUN
iajs-1773	45	110	µg	µg	NOUN
iajs-1773	45	111	/	/	SYM
iajs-1773	45	112	dl	dl	PROPN
iajs-1773	45	113	was	be	AUX
iajs-1773	45	114	purchased	purchase	VERB
iajs-1773	45	115	from	from	ADP
iajs-1773	45	116	ascorbic	ascorbic	NOUN
iajs-1773	45	117	acid	acid	NOUN
iajs-1773	45	118	assay	assay	NOUN
iajs-1773	45	119	was	be	AUX
iajs-1773	45	120	purchased	purchase	VERB
iajs-1773	45	121	from	from	ADP
iajs-1773	45	122	szakits	szakit	NOUN
iajs-1773	45	123	,	,	PUNCT
iajs-1773	45	124	usa	usa	PROPN
iajs-1773	45	125	stored	store	VERB
iajs-1773	45	126	at	at	ADP
iajs-1773	45	127	-4	-4	PROPN
iajs-1773	45	128	◦	◦	NOUN
iajs-1773	45	129	c	c	NOUN
iajs-1773	45	130	2.3	2.3	NUM
iajs-1773	45	131	.	.	PUNCT
iajs-1773	46	1	statistical	statistical	ADJ
iajs-1773	46	2	analysis	analysis	NOUN
iajs-1773	46	3	in	in	ADP
iajs-1773	46	4	order	order	NOUN
iajs-1773	46	5	to	to	PART
iajs-1773	46	6	analyze	analyze	VERB
iajs-1773	46	7	the	the	DET
iajs-1773	46	8	result	result	NOUN
iajs-1773	46	9	,	,	PUNCT
iajs-1773	46	10	the	the	DET
iajs-1773	46	11	statistical	statistical	ADJ
iajs-1773	46	12	analysis	analysis	NOUN
iajs-1773	46	13	systemsas	systemsa	NOUN
iajs-1773	46	14	(	(	PUNCT
iajs-1773	46	15	2012	2012	NUM
iajs-1773	46	16	)	)	PUNCT
iajs-1773	46	17	program	program	NOUN
iajs-1773	46	18	was	be	AUX
iajs-1773	46	19	used	use	VERB
iajs-1773	46	20	to	to	PART
iajs-1773	46	21	study	study	VERB
iajs-1773	46	22	the	the	DET
iajs-1773	46	23	effect	effect	NOUN
iajs-1773	46	24	of	of	ADP
iajs-1773	46	25	different	different	ADJ
iajs-1773	46	26	factor	factor	NOUN
iajs-1773	46	27	in	in	ADP
iajs-1773	46	28	study	study	NOUN
iajs-1773	46	29	parameters	parameter	NOUN
iajs-1773	46	30	.	.	PUNCT
iajs-1773	47	1	type	type	NOUN
iajs-1773	47	2	of	of	ADP
iajs-1773	47	3	statistical	statistical	ADJ
iajs-1773	47	4	including	include	VERB
iajs-1773	47	5	lsd	lsd	NOUN
iajs-1773	47	6	test	test	NOUN
iajs-1773	47	7	,	,	PUNCT
iajs-1773	47	8	t	t	PROPN
iajs-1773	47	9	test	test	NOUN
iajs-1773	47	10	was	be	AUX
iajs-1773	47	11	used	use	VERB
iajs-1773	47	12	to	to	PART
iajs-1773	47	13	significant	significant	ADJ
iajs-1773	47	14	compare	compare	NOUN
iajs-1773	47	15	between	between	ADP
iajs-1773	47	16	means	mean	NOUN
iajs-1773	47	17	in	in	ADP
iajs-1773	47	18	this	this	DET
iajs-1773	47	19	study	study	NOUN
iajs-1773	47	20	.	.	PUNCT
iajs-1773	48	1	estimate	estimate	NOUN
iajs-1773	48	2	of	of	ADP
iajs-1773	48	3	correlation	correlation	NOUN
iajs-1773	48	4	coefficient	coefficient	NOUN
iajs-1773	48	5	between	between	ADP
iajs-1773	48	6	difference	difference	NOUN
iajs-1773	48	7	variables	variable	NOUN
iajs-1773	48	8	sas	sas	VERB
iajs-1773	48	9	[	[	X
iajs-1773	48	10	12	12	NUM
iajs-1773	48	11	]	]	PUNCT
iajs-1773	48	12	.	.	PUNCT
iajs-1773	49	1	3	3	X
iajs-1773	49	2	.	.	NOUN
iajs-1773	49	3	results	result	NOUN
iajs-1773	49	4	and	and	CCONJ
iajs-1773	49	5	discussion	discussion	NOUN
iajs-1773	49	6	3.1	3.1	NUM
iajs-1773	49	7	.	.	NOUN
iajs-1773	49	8	serological	serological	ADJ
iajs-1773	49	9	and	and	CCONJ
iajs-1773	49	10	biochemistry	biochemistry	NOUN
iajs-1773	49	11	study	study	NOUN
iajs-1773	49	12	3.1.1	3.1.1	NUM
iajs-1773	49	13	.	.	PUNCT
iajs-1773	50	1	integrin	integrin	NOUN
iajs-1773	50	2	alpha	alpha	NOUN
iajs-1773	50	3	2	2	NUM
iajs-1773	50	4	(	(	PUNCT
iajs-1773	50	5	itga2	itga2	NOUN
iajs-1773	50	6	ng	ng	PROPN
iajs-1773	50	7	/	/	SYM
iajs-1773	50	8	ml	ml	NOUN
iajs-1773	50	9	)	)	PUNCT
iajs-1773	50	10	level	level	NOUN
iajs-1773	50	11	in	in	ADP
iajs-1773	50	12	serum	serum	NOUN
iajs-1773	50	13	in	in	ADP
iajs-1773	50	14	present	present	ADJ
iajs-1773	50	15	study	study	NOUN
iajs-1773	50	16	as	as	SCONJ
iajs-1773	50	17	shown	show	VERB
iajs-1773	50	18	in	in	ADP
iajs-1773	50	19	table	table	NOUN
iajs-1773	50	20	.1	.1	NOUN
iajs-1773	51	1	the	the	DET
iajs-1773	51	2	result	result	NOUN
iajs-1773	51	3	of	of	ADP
iajs-1773	51	4	integrin	integrin	NOUN
iajs-1773	51	5	alpha	alpha	NOUN
iajs-1773	51	6	-2	-2	INTJ
iajs-1773	51	7	level	level	NOUN
iajs-1773	51	8	serum	serum	NOUN
iajs-1773	51	9	showed	show	VERB
iajs-1773	51	10	a	a	DET
iajs-1773	51	11	non	non	ADJ
iajs-1773	51	12	-	-	ADJ
iajs-1773	51	13	significant	significant	ADJ
iajs-1773	51	14	increasing	increasing	NOUN
iajs-1773	51	15	in	in	ADP
iajs-1773	51	16	patients	patient	NOUN
iajs-1773	51	17	group	group	NOUN
iajs-1773	51	18	(	(	PUNCT
iajs-1773	51	19	25.17	25.17	NUM
iajs-1773	51	20	±	±	NUM
iajs-1773	51	21	1.15	1.15	NUM
iajs-1773	51	22	)	)	PUNCT
iajs-1773	51	23	compared	compare	VERB
iajs-1773	51	24	to	to	ADP
iajs-1773	51	25	control	control	VERB
iajs-1773	51	26	(	(	PUNCT
iajs-1773	51	27	24.20	24.20	NUM
iajs-1773	51	28	±	±	NUM
iajs-1773	51	29	2.03	2.03	NUM
iajs-1773	51	30	)	)	PUNCT
iajs-1773	51	31	.	.	PUNCT
iajs-1773	52	1	by	by	ADP
iajs-1773	52	2	using	use	VERB
iajs-1773	52	3	a	a	DET
iajs-1773	52	4	statistical	statistical	ADJ
iajs-1773	52	5	testing	testing	NOUN
iajs-1773	52	6	(	(	PUNCT
iajs-1773	52	7	t	t	PROPN
iajs-1773	52	8	test	test	NOUN
iajs-1773	52	9	)	)	PUNCT
iajs-1773	52	10	.	.	PUNCT
iajs-1773	53	1	table	table	NOUN
iajs-1773	53	2	(	(	PUNCT
iajs-1773	53	3	1	1	NUM
iajs-1773	53	4	):	):	PUNCT
iajs-1773	53	5	serum	serum	NOUN
iajs-1773	53	6	level	level	NOUN
iajs-1773	53	7	of	of	ADP
iajs-1773	53	8	itga2	itga2	PROPN
iajs-1773	53	9	ng	ng	PROPN
iajs-1773	53	10	/	/	SYM
iajs-1773	53	11	ml	ml	X
iajs-1773	53	12	in	in	ADP
iajs-1773	53	13	patients	patient	NOUN
iajs-1773	53	14	and	and	CCONJ
iajs-1773	53	15	control	control	VERB
iajs-1773	53	16	the	the	DET
iajs-1773	53	17	group	group	NOUN
iajs-1773	53	18	no	no	INTJ
iajs-1773	53	19	.	.	PUNCT
iajs-1773	54	1	mean	mean	PROPN
iajs-1773	54	2	±	±	PROPN
iajs-1773	54	3	se	se	X
iajs-1773	54	4	of	of	ADP
iajs-1773	54	5	itga2	itga2	PROPN
iajs-1773	54	6	patients	patient	NOUN
iajs-1773	54	7	64	64	NUM
iajs-1773	54	8	25.17	25.17	NUM
iajs-1773	54	9	±	±	NUM
iajs-1773	54	10	1.15	1.15	NUM
iajs-1773	54	11	control	control	NOUN
iajs-1773	54	12	24	24	NUM
iajs-1773	54	13	24.20	24.20	NUM
iajs-1773	54	14	±	±	NUM
iajs-1773	54	15	2.03	2.03	NUM
iajs-1773	54	16	t	t	NOUN
iajs-1773	54	17	-	-	PUNCT
iajs-1773	54	18	test	test	NOUN
iajs-1773	54	19	--4.686	--4.686	PUNCT
iajs-1773	54	20	ns	ns	CCONJ
iajs-1773	54	21	p	p	NOUN
iajs-1773	54	22	-	-	PUNCT
iajs-1773	54	23	value	value	NOUN
iajs-1773	54	24	--0.6798	--0.6798	NOUN
iajs-1773	54	25	ns	ns	NOUN
iajs-1773	54	26	:	:	PUNCT
iajs-1773	54	27	non	non	ADJ
iajs-1773	54	28	-	-	ADJ
iajs-1773	54	29	significant	significant	ADJ
iajs-1773	54	30	.	.	PUNCT
iajs-1773	55	1	integrin	integrin	NOUN
iajs-1773	55	2	is	be	AUX
iajs-1773	55	3	formation	formation	NOUN
iajs-1773	55	4	of	of	ADP
iajs-1773	55	5	non	non	ADJ
iajs-1773	55	6	-	-	ADJ
iajs-1773	55	7	covalent	covalent	ADJ
iajs-1773	55	8	,	,	PUNCT
iajs-1773	55	9	heterodimeric	heterodimeric	ADJ
iajs-1773	55	10	complexes	complex	NOUN
iajs-1773	55	11	of	of	ADP
iajs-1773	55	12	an	an	DET
iajs-1773	55	13	α	α	NOUN
iajs-1773	55	14	and	and	CCONJ
iajs-1773	55	15	β	β	X
iajs-1773	55	16	subunit	subunit	NOUN
iajs-1773	56	1	[	[	X
iajs-1773	56	2	13	13	NUM
iajs-1773	56	3	]	]	PUNCT
iajs-1773	56	4	.	.	PUNCT
iajs-1773	57	1	α2β1	α2β1	X
iajs-1773	57	2	integrin	integrin	NOUN
iajs-1773	57	3	functions	function	NOUN
iajs-1773	57	4	as	as	ADP
iajs-1773	57	5	a	a	DET
iajs-1773	57	6	collagen	collagen	NOUN
iajs-1773	57	7	receptor	receptor	NOUN
iajs-1773	57	8	on	on	ADP
iajs-1773	57	9	platelets	platelet	NOUN
iajs-1773	57	10	and	and	CCONJ
iajs-1773	57	11	fibroblasts	fibroblast	NOUN
iajs-1773	57	12	and	and	CCONJ
iajs-1773	57	13	as	as	ADP
iajs-1773	57	14	both	both	CCONJ
iajs-1773	57	15	a	a	DET
iajs-1773	57	16	collagen	collagen	NOUN
iajs-1773	57	17	and	and	CCONJ
iajs-1773	57	18	laminin	laminin	NOUN
iajs-1773	57	19	receptor	receptor	NOUN
iajs-1773	57	20	on	on	ADP
iajs-1773	57	21	endothelial	endothelial	ADJ
iajs-1773	57	22	cells	cell	NOUN
iajs-1773	57	23	and	and	CCONJ
iajs-1773	57	24	most	most	ADJ
iajs-1773	57	25	epithelial	epithelial	ADJ
iajs-1773	57	26	cells	cell	NOUN
iajs-1773	57	27	kinds	kind	NOUN
iajs-1773	57	28	[	[	X
iajs-1773	57	29	3	3	NUM
iajs-1773	57	30	,	,	PUNCT
iajs-1773	57	31	4	4	NUM
iajs-1773	57	32	]	]	PUNCT
iajs-1773	57	33	.the	.the	DET
iajs-1773	57	34	integrin	integrin	PROPN
iajs-1773	57	35	alpha	alpha	NOUN
iajs-1773	57	36	2	2	NUM
iajs-1773	57	37	beta	beta	NOUN
iajs-1773	57	38	1	1	NUM
iajs-1773	57	39	play	play	VERB
iajs-1773	57	40	an	an	DET
iajs-1773	57	41	important	important	ADJ
iajs-1773	57	42	role	role	NOUN
iajs-1773	57	43	in	in	ADP
iajs-1773	57	44	cell	cell	NOUN
iajs-1773	57	45	migration	migration	NOUN
iajs-1773	57	46	,	,	PUNCT
iajs-1773	58	1	cell	cell	NOUN
iajs-1773	58	2	invasion	invasion	NOUN
iajs-1773	58	3	in	in	ADP
iajs-1773	58	4	to	to	ADP
iajs-1773	58	5	collagen	collagen	NOUN
iajs-1773	58	6	and	and	CCONJ
iajs-1773	58	7	integrin	integrin	NOUN
iajs-1773	58	8	have	have	VERB
iajs-1773	58	9	also	also	ADV
iajs-1773	58	10	important	important	ADJ
iajs-1773	58	11	role	role	NOUN
iajs-1773	58	12	in	in	ADP
iajs-1773	58	13	signal	signal	ADJ
iajs-1773	58	14	transduction	transduction	NOUN
iajs-1773	58	15	,	,	PUNCT
iajs-1773	58	16	integrin	integrin	NOUN
iajs-1773	58	17	alpha	alpha	NOUN
iajs-1773	58	18	2	2	NUM
iajs-1773	58	19	beta	beta	NOUN
iajs-1773	58	20	1	1	NUM
iajs-1773	58	21	has	have	VERB
iajs-1773	58	22	addition	addition	NOUN
iajs-1773	58	23	capacity	capacity	NOUN
iajs-1773	58	24	of	of	ADP
iajs-1773	58	25	boosting	boost	VERB
iajs-1773	58	26	cell	cell	NOUN
iajs-1773	58	27	proliferation	proliferation	NOUN
iajs-1773	58	28	depending	depend	VERB
iajs-1773	58	29	on	on	ADP
iajs-1773	58	30	the	the	DET
iajs-1773	58	31	kind	kind	NOUN
iajs-1773	58	32	and	and	CCONJ
iajs-1773	58	33	physical	physical	ADJ
iajs-1773	58	34	state	state	NOUN
iajs-1773	58	35	of	of	ADP
iajs-1773	58	36	collagenous	collagenous	ADJ
iajs-1773	58	37	matrix	matrix	NOUN
iajs-1773	58	38	[	[	X
iajs-1773	58	39	14	14	NUM
iajs-1773	58	40	]	]	PUNCT
iajs-1773	58	41	.	.	PUNCT
iajs-1773	59	1	although	although	SCONJ
iajs-1773	59	2	there	there	PRON
iajs-1773	59	3	were	be	VERB
iajs-1773	59	4	a	a	DET
iajs-1773	59	5	lot	lot	NOUN
iajs-1773	59	6	of	of	ADP
iajs-1773	59	7	study	study	NOUN
iajs-1773	59	8	which	which	PRON
iajs-1773	59	9	asses	asse	VERB
iajs-1773	59	10	the	the	DET
iajs-1773	59	11	concentration	concentration	NOUN
iajs-1773	59	12	of	of	ADP
iajs-1773	59	13	integrin	integrin	NOUN
iajs-1773	59	14	alpha	alpha	NOUN
iajs-1773	59	15	2	2	NUM
iajs-1773	59	16	(	(	PUNCT
iajs-1773	59	17	itga2	itga2	NOUN
iajs-1773	59	18	)	)	PUNCT
iajs-1773	59	19	as	as	ADP
iajs-1773	59	20	protein	protein	NOUN
iajs-1773	59	21	in	in	ADP
iajs-1773	59	22	tissues	tissue	NOUN
iajs-1773	59	23	but	but	CCONJ
iajs-1773	59	24	this	this	PRON
iajs-1773	59	25	is	be	AUX
iajs-1773	59	26	the	the	DET
iajs-1773	59	27	first	first	ADJ
iajs-1773	59	28	time	time	NOUN
iajs-1773	59	29	which	which	PRON
iajs-1773	59	30	asses	asse	VERB
iajs-1773	59	31	its	its	PRON
iajs-1773	59	32	concentration	concentration	NOUN
iajs-1773	59	33	in	in	ADP
iajs-1773	59	34	human	human	ADJ
iajs-1773	59	35	serum	serum	NOUN
iajs-1773	59	36	(	(	PUNCT
iajs-1773	59	37	locally	locally	ADV
iajs-1773	59	38	in	in	ADP
iajs-1773	59	39	iraq	iraq	PROPN
iajs-1773	59	40	and	and	CCONJ
iajs-1773	59	41	universally	universally	ADV
iajs-1773	59	42	)	)	PUNCT
iajs-1773	59	43	.the	.the	PUNCT
iajs-1773	59	44	present	present	ADJ
iajs-1773	59	45	study	study	NOUN
iajs-1773	59	46	revealed	reveal	VERB
iajs-1773	59	47	that	that	SCONJ
iajs-1773	59	48	there	there	PRON
iajs-1773	59	49	was	be	VERB
iajs-1773	59	50	a	a	DET
iajs-1773	59	51	non	non	ADJ
iajs-1773	59	52	-	-	ADJ
iajs-1773	59	53	significant	significant	ADJ
iajs-1773	59	54	difference	difference	NOUN
iajs-1773	59	55	in	in	ADP
iajs-1773	59	56	level	level	NOUN
iajs-1773	59	57	serum	serum	NOUN
iajs-1773	59	58	of	of	ADP
iajs-1773	59	59	itga2	itga2	NOUN
iajs-1773	59	60	in	in	ADP
iajs-1773	59	61	patient	patient	NOUN
iajs-1773	59	62	as	as	SCONJ
iajs-1773	59	63	compared	compare	VERB
iajs-1773	59	64	to	to	PART
iajs-1773	59	65	control	control	VERB
iajs-1773	59	66	as	as	SCONJ
iajs-1773	59	67	shown	show	VERB
iajs-1773	59	68	in	in	ADP
iajs-1773	59	69	(	(	PUNCT
iajs-1773	59	70	table1),the	table1),the	DET
iajs-1773	59	71	result	result	NOUN
iajs-1773	59	72	was	be	AUX
iajs-1773	59	73	disagree	disagree	VERB
iajs-1773	59	74	ding	de	VERB
iajs-1773	59	75	et	et	ADP
iajs-1773	59	76	al	al	PROPN
iajs-1773	60	1	[	[	X
iajs-1773	60	2	15	15	NUM
iajs-1773	60	3	]	]	PUNCT
iajs-1773	60	4	who	who	PRON
iajs-1773	60	5	recorded	record	VERB
iajs-1773	60	6	that	that	SCONJ
iajs-1773	60	7	the	the	DET
iajs-1773	60	8	lower	low	ADJ
iajs-1773	60	9	itga2	itga2	NOUN
iajs-1773	60	10	protein	protein	NOUN
iajs-1773	60	11	level	level	NOUN
iajs-1773	60	12	was	be	AUX
iajs-1773	60	13	recorded	record	VERB
iajs-1773	60	14	in	in	ADP
iajs-1773	60	15	breast	breast	NOUN
iajs-1773	60	16	cancer	cancer	NOUN
iajs-1773	60	17	compared	compare	VERB
iajs-1773	60	18	to	to	AUX
iajs-1773	60	19	close	close	VERB
iajs-1773	60	20	noncancerous	noncancerous	ADJ
iajs-1773	60	21	breast	breast	NOUN
iajs-1773	60	22	tissues	tissue	NOUN
iajs-1773	60	23	(	(	PUNCT
iajs-1773	60	24	p>0.001	p>0.001	NOUN
iajs-1773	60	25	)	)	PUNCT
iajs-1773	60	26	.	.	PUNCT
iajs-1773	61	1	in	in	ADP
iajs-1773	61	2	addition	addition	NOUN
iajs-1773	61	3	the	the	DET
iajs-1773	61	4	previous	previous	ADJ
iajs-1773	61	5	studies	study	NOUN
iajs-1773	61	6	recorded	record	VERB
iajs-1773	61	7	that	that	SCONJ
iajs-1773	61	8	phosphates	phosphate	NOUN
iajs-1773	61	9	of	of	ADP
iajs-1773	61	10	regenerating	regenerate	VERB
iajs-1773	61	11	liver-3	liver-3	PROPN
iajs-1773	61	12	repressed	repress	VERB
iajs-1773	61	13	itga2	itga2	NOUN
iajs-1773	61	14	expression	expression	NOUN
iajs-1773	61	15	in	in	ADP
iajs-1773	61	16	ovarian	ovarian	ADJ
iajs-1773	61	17	cancer	cancer	NOUN
iajs-1773	61	18	cells	cell	NOUN
iajs-1773	61	19	[	[	X
iajs-1773	61	20	16	16	NUM
iajs-1773	61	21	]	]	PUNCT
iajs-1773	61	22	and	and	CCONJ
iajs-1773	61	23	other	other	ADJ
iajs-1773	61	24	study	study	NOUN
iajs-1773	61	25	cox2	cox2	NOUN
iajs-1773	61	26	increased	increase	VERB
iajs-1773	61	27	active	active	ADJ
iajs-1773	61	28	itga2	itga2	NOUN
iajs-1773	61	29	expression	expression	NOUN
iajs-1773	61	30	during	during	ADP
iajs-1773	61	31	the	the	DET
iajs-1773	61	32	ep1	ep1	PROPN
iajs-1773	61	33	/	/	SYM
iajs-1773	61	34	plc	plc	PROPN
iajs-1773	61	35	/	/	SYM
iajs-1773	61	36	pkca2	pkca2	PROPN
iajs-1773	61	37	c	c	X
iajs-1773	61	38	-	-	PUNCT
iajs-1773	61	39	sre/	sre/	NOUN
iajs-1773	61	40	nf.kb	nf.kb	NOUN
iajs-1773	61	41	signal	signal	VERB
iajs-1773	61	42	transduction	transduction	NOUN
iajs-1773	61	43	cells	cell	NOUN
iajs-1773	61	44	[	[	X
iajs-1773	61	45	17	17	NUM
iajs-1773	61	46	]	]	PUNCT
iajs-1773	61	47	.	.	PUNCT
iajs-1773	62	1	3.1.2	3.1.2	X
iajs-1773	62	2	.	.	PUNCT
iajs-1773	62	3	serum	serum	NOUN
iajs-1773	62	4	levels	level	NOUN
iajs-1773	62	5	of	of	ADP
iajs-1773	62	6	hormones	hormone	NOUN
iajs-1773	62	7	in	in	ADP
iajs-1773	62	8	this	this	DET
iajs-1773	62	9	study	study	NOUN
iajs-1773	62	10	the	the	DET
iajs-1773	62	11	mean	mean	NOUN
iajs-1773	62	12	of	of	ADP
iajs-1773	62	13	progesterone	progesterone	NOUN
iajs-1773	62	14	concentration	concentration	NOUN
iajs-1773	62	15	in	in	ADP
iajs-1773	62	16	serum	serum	NOUN
iajs-1773	62	17	showed	show	VERB
iajs-1773	62	18	a	a	DET
iajs-1773	62	19	significant	significant	ADJ
iajs-1773	62	20	increasing	increasing	NOUN
iajs-1773	62	21	in	in	ADP
iajs-1773	62	22	patients	patient	NOUN
iajs-1773	62	23	(	(	PUNCT
iajs-1773	62	24	6.319±0.75	6.319±0.75	PROPN
iajs-1773	62	25	)	)	PUNCT
iajs-1773	62	26	ng	ng	PROPN
iajs-1773	62	27	/	/	SYM
iajs-1773	62	28	ml	ml	PROPN
iajs-1773	62	29	compared	compare	VERB
iajs-1773	62	30	to	to	ADP
iajs-1773	62	31	control	control	NOUN
iajs-1773	62	32	(	(	PUNCT
iajs-1773	62	33	3.206±1.08	3.206±1.08	NUM
iajs-1773	62	34	)	)	PUNCT
iajs-1773	62	35	ng	ng	PROPN
iajs-1773	62	36	/	/	SYM
iajs-1773	62	37	ml	ml	PROPN
iajs-1773	62	38	(	(	PUNCT
iajs-1773	62	39	p<0.05	p<0.05	NOUN
iajs-1773	62	40	)	)	PUNCT
iajs-1773	62	41	.	.	PUNCT
iajs-1773	63	1	the	the	DET
iajs-1773	63	2	prolactin	prolactin	NOUN
iajs-1773	63	3	recorded	record	VERB
iajs-1773	63	4	a	a	DET
iajs-1773	63	5	highly	highly	ADV
iajs-1773	63	6	significant	significant	ADJ
iajs-1773	63	7	increasing	increasing	NOUN
iajs-1773	63	8	in	in	ADP
iajs-1773	63	9	patients	patient	NOUN
iajs-1773	63	10	(	(	PUNCT
iajs-1773	63	11	24.89±3.26	24.89±3.26	X
iajs-1773	63	12	)	)	PUNCT
iajs-1773	63	13	ng	ng	PROPN
iajs-1773	63	14	/	/	SYM
iajs-1773	63	15	ml	ml	PROPN
iajs-1773	63	16	compared	compare	VERB
iajs-1773	63	17	to	to	ADP
iajs-1773	63	18	control	control	NOUN
iajs-1773	63	19	group	group	NOUN
iajs-1773	63	20	(	(	PUNCT
iajs-1773	63	21	5.833±1.41	5.833±1.41	NUM
iajs-1773	63	22	)	)	PUNCT
iajs-1773	63	23	ng	ng	PROPN
iajs-1773	63	24	/	/	SYM
iajs-1773	63	25	ml	ml	PROPN
iajs-1773	63	26	(	(	PUNCT
iajs-1773	63	27	p<0.01	p<0.01	PROPN
iajs-1773	63	28	)	)	PUNCT
iajs-1773	63	29	.	.	PUNCT
iajs-1773	64	1	as	as	ADV
iajs-1773	64	2	well	well	ADV
iajs-1773	64	3	as	as	SCONJ
iajs-1773	64	4	the	the	DET
iajs-1773	64	5	estradiol	estradiol	PROPN
iajs-1773	64	6	observed	observe	VERB
iajs-1773	64	7	a	a	DET
iajs-1773	64	8	higher	high	ADJ
iajs-1773	64	9	significant	significant	ADJ
iajs-1773	64	10	decreasing	decrease	VERB
iajs-1773	64	11	difference	difference	NOUN
iajs-1773	64	12	level	level	NOUN
iajs-1773	64	13	in	in	ADP
iajs-1773	64	14	patient	patient	ADJ
iajs-1773	64	15	(	(	PUNCT
iajs-1773	64	16	540.88±17.97	540.88±17.97	NOUN
iajs-1773	64	17	)	)	PUNCT
iajs-1773	64	18	pg	pg	VERB
iajs-1773	64	19	/	/	SYM
iajs-1773	64	20	ml	ml	VERB
iajs-1773	64	21	compared	compare	VERB
iajs-1773	64	22	to	to	ADP
iajs-1773	64	23	control	control	NOUN
iajs-1773	64	24	(	(	PUNCT
iajs-1773	64	25	635.79±36.03	635.79±36.03	NUM
iajs-1773	64	26	pg	pg	PROPN
iajs-1773	64	27	/	/	SYM
iajs-1773	64	28	ml	ml	PROPN
iajs-1773	64	29	(	(	PUNCT
iajs-1773	64	30	p<0.01	p<0.01	PROPN
iajs-1773	64	31	)	)	PUNCT
iajs-1773	64	32	as	as	SCONJ
iajs-1773	64	33	shown	show	VERB
iajs-1773	64	34	in	in	ADP
iajs-1773	64	35	table	table	NOUN
iajs-1773	64	36	2	2	NUM
iajs-1773	64	37	.	.	PUNCT
iajs-1773	64	38	ihsciconf	ihsciconf	PROPN
iajs-1773	64	39	2017	2017	NUM
iajs-1773	64	40	special	special	ADJ
iajs-1773	64	41	issue	issue	NOUN
iajs-1773	64	42	ibn	ibn	PROPN
iajs-1773	64	43	al	al	PROPN
iajs-1773	64	44	-	-	PUNCT
iajs-1773	64	45	haitham	haitham	PROPN
iajs-1773	64	46	journal	journal	PROPN
iajs-1773	64	47	for	for	ADP
iajs-1773	64	48	pure	pure	ADJ
iajs-1773	64	49	and	and	CCONJ
iajs-1773	64	50	applied	apply	VERB
iajs-1773	64	51	science	science	NOUN
iajs-1773	64	52	https://doi.org/	https://doi.org/	NOUN
iajs-1773	64	53	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	64	54	.	.	PUNCT
iajs-1773	64	55	 	 	SPACE
iajs-1773	64	56	1773	1773	NUM
iajs-1773	64	57	for	for	ADP
iajs-1773	64	58	more	more	ADJ
iajs-1773	64	59	information	information	NOUN
iajs-1773	64	60	about	about	ADP
iajs-1773	64	61	the	the	DET
iajs-1773	64	62	conference	conference	NOUN
iajs-1773	64	63	please	please	INTJ
iajs-1773	64	64	visit	visit	VERB
iajs-1773	64	65	the	the	DET
iajs-1773	64	66	websites	website	NOUN
iajs-1773	64	67	:	:	PUNCT
iajs-1773	64	68	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	64	69	  	  	SPACE
iajs-1773	64	70	www.ihsciconf.org	www.ihsciconf.org	ADV
iajs-1773	64	71	  	  	SPACE
iajs-1773	64	72	biology|76	biology|76	PROPN
iajs-1773	64	73	table	table	NOUN
iajs-1773	64	74	(	(	PUNCT
iajs-1773	64	75	2	2	NUM
iajs-1773	64	76	):	):	PUNCT
iajs-1773	64	77	compare	compare	NOUN
iajs-1773	64	78	between	between	ADP
iajs-1773	64	79	patients	patient	NOUN
iajs-1773	64	80	and	and	CCONJ
iajs-1773	64	81	control	control	NOUN
iajs-1773	64	82	in	in	ADP
iajs-1773	64	83	levels	level	NOUN
iajs-1773	64	84	of	of	ADP
iajs-1773	64	85	hormones	hormone	NOUN
iajs-1773	64	86	the	the	DET
iajs-1773	64	87	group	group	NOUN
iajs-1773	64	88	mean	mean	VERB
iajs-1773	64	89	±	±	PROPN
iajs-1773	64	90	se	se	X
iajs-1773	64	91	progesterone	progesterone	PROPN
iajs-1773	64	92	ng	ng	PROPN
iajs-1773	64	93	/	/	SYM
iajs-1773	64	94	ml	ml	AUX
iajs-1773	64	95	prolactin	prolactin	PROPN
iajs-1773	64	96	ng	ng	PROPN
iajs-1773	64	97	/	/	SYM
iajs-1773	64	98	ml	ml	PROPN
iajs-1773	64	99	estradiol	estradiol	PROPN
iajs-1773	64	100	pg	pg	PROPN
iajs-1773	64	101	/	/	SYM
iajs-1773	64	102	ml	ml	ADJ
iajs-1773	64	103	patients	patient	NOUN
iajs-1773	64	104	6.319	6.319	NUM
iajs-1773	64	105	±	±	NUM
iajs-1773	64	106	0.75	0.75	NUM
iajs-1773	64	107	24.89	24.89	NUM
iajs-1773	64	108	±	±	NUM
iajs-1773	64	109	3.26	3.26	NUM
iajs-1773	64	110	540.88	540.88	NUM
iajs-1773	64	111	±	±	NUM
iajs-1773	64	112	17.97	17.97	NUM
iajs-1773	64	113	control	control	NOUN
iajs-1773	64	114	3.206	3.206	NUM
iajs-1773	64	115	±	±	NUM
iajs-1773	64	116	1.08	1.08	NUM
iajs-1773	64	117	5.833	5.833	NUM
iajs-1773	64	118	±	±	NUM
iajs-1773	64	119	1.41	1.41	NUM
iajs-1773	64	120	635.79	635.79	NUM
iajs-1773	64	121	±	±	NUM
iajs-1773	64	122	36.03	36.03	NUM
iajs-1773	64	123	t	t	NOUN
iajs-1773	64	124	-	-	PUNCT
iajs-1773	64	125	test	test	NOUN
iajs-1773	64	126	2.932	2.932	NUM
iajs-1773	64	127	*	*	PUNCT
iajs-1773	64	128	11.734	11.734	NUM
iajs-1773	64	129	*	*	PUNCT
iajs-1773	64	130	*	*	PUNCT
iajs-1773	64	131	75.298	75.298	NUM
iajs-1773	65	1	*	*	PUNCT
iajs-1773	65	2	*	*	PUNCT
iajs-1773	65	3	p	p	NOUN
iajs-1773	65	4	-	-	PUNCT
iajs-1773	65	5	value	value	NOUN
iajs-1773	65	6	0.0378	0.0378	NUM
iajs-1773	65	7	0.0018	0.0018	NUM
iajs-1773	65	8	0.0114	0.0114	NUM
iajs-1773	65	9	*	*	PUNCT
iajs-1773	65	10	(	(	PUNCT
iajs-1773	65	11	p<0.05	p<0.05	NOUN
iajs-1773	65	12	)	)	PUNCT
iajs-1773	65	13	significant	significant	ADJ
iajs-1773	65	14	,	,	PUNCT
iajs-1773	65	15	*	*	PUNCT
iajs-1773	65	16	*	*	PUNCT
iajs-1773	65	17	(	(	PUNCT
iajs-1773	65	18	p<0.01	p<0.01	PROPN
iajs-1773	65	19	)	)	PUNCT
iajs-1773	65	20	,	,	PUNCT
iajs-1773	65	21	high	high	ADV
iajs-1773	65	22	significant	significant	ADJ
iajs-1773	65	23	.	.	PUNCT
iajs-1773	66	1	3.1.2	3.1.2	X
iajs-1773	66	2	.	.	PUNCT
iajs-1773	66	3	progesterone	progesterone	NOUN
iajs-1773	66	4	level	level	NOUN
iajs-1773	66	5	in	in	ADP
iajs-1773	66	6	serum	serum	NOUN
iajs-1773	66	7	the	the	DET
iajs-1773	66	8	present	present	ADJ
iajs-1773	66	9	study	study	NOUN
iajs-1773	66	10	showed	show	VERB
iajs-1773	66	11	a	a	DET
iajs-1773	66	12	significant	significant	ADJ
iajs-1773	66	13	increasing	increasing	NOUN
iajs-1773	66	14	in	in	ADP
iajs-1773	66	15	level	level	NOUN
iajs-1773	66	16	serum	serum	NOUN
iajs-1773	66	17	of	of	ADP
iajs-1773	66	18	progesterone	progesterone	NOUN
iajs-1773	66	19	hormone	hormone	NOUN
iajs-1773	66	20	in	in	ADP
iajs-1773	66	21	patients	patient	NOUN
iajs-1773	66	22	(	(	PUNCT
iajs-1773	66	23	6.319	6.319	NUM
iajs-1773	66	24	±	±	NUM
iajs-1773	66	25	0.75	0.75	NUM
iajs-1773	66	26	)	)	PUNCT
iajs-1773	66	27	as	as	ADP
iajs-1773	66	28	compared	compare	VERB
iajs-1773	66	29	with	with	ADP
iajs-1773	66	30	control	control	NOUN
iajs-1773	66	31	(	(	PUNCT
iajs-1773	66	32	3.206	3.206	NUM
iajs-1773	66	33	±	±	NUM
iajs-1773	66	34	1.08	1.08	NUM
iajs-1773	66	35	)	)	PUNCT
iajs-1773	66	36	under	under	ADP
iajs-1773	66	37	p<0.05	p<0.05	NOUN
iajs-1773	66	38	.	.	PUNCT
iajs-1773	67	1	progesterone	progesterone	NOUN
iajs-1773	67	2	is	be	AUX
iajs-1773	67	3	one	one	NUM
iajs-1773	67	4	of	of	ADP
iajs-1773	67	5	ovarian	ovarian	ADJ
iajs-1773	67	6	steroid	steroid	NOUN
iajs-1773	67	7	hormones	hormone	NOUN
iajs-1773	67	8	,	,	PUNCT
iajs-1773	67	9	previous	previous	ADJ
iajs-1773	67	10	studies	study	NOUN
iajs-1773	67	11	have	have	AUX
iajs-1773	67	12	found	find	VERB
iajs-1773	67	13	that	that	SCONJ
iajs-1773	67	14	progesterone	progesterone	NOUN
iajs-1773	67	15	hormone	hormone	NOUN
iajs-1773	67	16	is	be	AUX
iajs-1773	67	17	very	very	ADV
iajs-1773	67	18	important	important	ADJ
iajs-1773	67	19	as	as	ADP
iajs-1773	67	20	a	a	DET
iajs-1773	67	21	risk	risk	NOUN
iajs-1773	67	22	factor	factor	NOUN
iajs-1773	67	23	for	for	ADP
iajs-1773	67	24	breast	breast	NOUN
iajs-1773	67	25	cancer	cancer	NOUN
iajs-1773	67	26	occurring	occur	VERB
iajs-1773	67	27	in	in	ADP
iajs-1773	67	28	mice	mouse	NOUN
iajs-1773	67	29	[	[	X
iajs-1773	67	30	18	18	NUM
iajs-1773	67	31	]	]	PUNCT
iajs-1773	67	32	.	.	PUNCT
iajs-1773	68	1	as	as	ADV
iajs-1773	68	2	well	well	ADV
iajs-1773	68	3	as	as	SCONJ
iajs-1773	68	4	it	it	PRON
iajs-1773	68	5	has	have	AUX
iajs-1773	68	6	been	be	AUX
iajs-1773	68	7	recorded	record	VERB
iajs-1773	68	8	that	that	SCONJ
iajs-1773	68	9	progesterone	progesterone	NOUN
iajs-1773	68	10	receptor	receptor	NOUN
iajs-1773	68	11	(	(	PUNCT
iajs-1773	68	12	pr	pr	NOUN
iajs-1773	68	13	)	)	PUNCT
iajs-1773	68	14	expression	expression	NOUN
iajs-1773	68	15	is	be	AUX
iajs-1773	68	16	utilized	utilize	VERB
iajs-1773	68	17	as	as	ADP
iajs-1773	68	18	biomarker	biomarker	NOUN
iajs-1773	68	19	of	of	ADP
iajs-1773	68	20	estrogen	estrogen	NOUN
iajs-1773	68	21	receptor	receptor	NOUN
iajs-1773	68	22	–	–	PUNCT
iajs-1773	68	23	α	α	NOUN
iajs-1773	68	24	(	(	PUNCT
iajs-1773	68	25	erα	erα	ADJ
iajs-1773	68	26	)	)	PUNCT
iajs-1773	68	27	function	function	NOUN
iajs-1773	68	28	and	and	CCONJ
iajs-1773	68	29	as	as	ADP
iajs-1773	68	30	a	a	DET
iajs-1773	68	31	biomarker	biomarker	NOUN
iajs-1773	68	32	of	of	ADP
iajs-1773	68	33	breast	breast	NOUN
iajs-1773	68	34	cancer	cancer	NOUN
iajs-1773	68	35	prognosis	prognosis	NOUN
iajs-1773	68	36	,	,	PUNCT
iajs-1773	68	37	it	it	PRON
iajs-1773	68	38	was	be	AUX
iajs-1773	68	39	also	also	ADV
iajs-1773	68	40	supposed	suppose	VERB
iajs-1773	68	41	that	that	SCONJ
iajs-1773	68	42	the	the	DET
iajs-1773	68	43	elevated	elevated	ADJ
iajs-1773	68	44	level	level	NOUN
iajs-1773	68	45	of	of	ADP
iajs-1773	68	46	progesterone	progesterone	NOUN
iajs-1773	68	47	in	in	ADP
iajs-1773	68	48	serum	serum	NOUN
iajs-1773	68	49	perhaps	perhaps	ADV
iajs-1773	68	50	represent	represent	VERB
iajs-1773	68	51	a	a	DET
iajs-1773	68	52	danger	danger	NOUN
iajs-1773	68	53	factor	factor	NOUN
iajs-1773	68	54	for	for	ADP
iajs-1773	68	55	breast	breast	NOUN
iajs-1773	68	56	cancer	cancer	NOUN
iajs-1773	68	57	occurring	occurring	NOUN
iajs-1773	68	58	,	,	PUNCT
iajs-1773	68	59	and	and	CCONJ
iajs-1773	68	60	it	it	PRON
iajs-1773	68	61	may	may	AUX
iajs-1773	68	62	have	have	VERB
iajs-1773	68	63	a	a	DET
iajs-1773	68	64	role	role	NOUN
iajs-1773	68	65	in	in	ADP
iajs-1773	68	66	initiation	initiation	NOUN
iajs-1773	68	67	of	of	ADP
iajs-1773	68	68	cancer	cancer	NOUN
iajs-1773	68	69	[	[	X
iajs-1773	68	70	19	19	NUM
iajs-1773	68	71	]	]	PUNCT
iajs-1773	68	72	.	.	PUNCT
iajs-1773	69	1	the	the	DET
iajs-1773	69	2	current	current	ADJ
iajs-1773	69	3	study	study	NOUN
iajs-1773	69	4	was	be	AUX
iajs-1773	69	5	disagree	disagree	VERB
iajs-1773	69	6	with	with	ADP
iajs-1773	69	7	kaaks	kaaks	PROPN
iajs-1773	69	8	el	el	PROPN
iajs-1773	69	9	al	al	PROPN
iajs-1773	70	1	[	[	X
iajs-1773	70	2	20	20	NUM
iajs-1773	70	3	]	]	PUNCT
iajs-1773	70	4	which	which	PRON
iajs-1773	70	5	showed	show	VERB
iajs-1773	70	6	a	a	DET
iajs-1773	70	7	nonsignificant	nonsignificant	ADJ
iajs-1773	70	8	association	association	NOUN
iajs-1773	70	9	of	of	ADP
iajs-1773	70	10	progesterone	progesterone	NOUN
iajs-1773	70	11	with	with	ADP
iajs-1773	70	12	breast	breast	NOUN
iajs-1773	70	13	cancer	cancer	NOUN
iajs-1773	70	14	danger	danger	NOUN
iajs-1773	70	15	via	via	ADP
iajs-1773	70	16	menstrual	menstrual	ADJ
iajs-1773	70	17	cycle	cycle	NOUN
iajs-1773	70	18	phase	phase	NOUN
iajs-1773	70	19	or	or	CCONJ
iajs-1773	70	20	via	via	ADP
iajs-1773	70	21	tumor	tumor	NOUN
iajs-1773	70	22	receptor	receptor	NOUN
iajs-1773	70	23	status	status	NOUN
iajs-1773	70	24	.	.	PUNCT
iajs-1773	71	1	although	although	SCONJ
iajs-1773	71	2	a	a	DET
iajs-1773	71	3	possible	possible	ADJ
iajs-1773	71	4	risk	risk	NOUN
iajs-1773	71	5	increasing	increase	VERB
iajs-1773	71	6	with	with	ADP
iajs-1773	71	7	the	the	DET
iajs-1773	71	8	highest	high	ADJ
iajs-1773	71	9	estradiol	estradiol	NOUN
iajs-1773	71	10	,	,	PUNCT
iajs-1773	71	11	dowett	dowett	VERB
iajs-1773	71	12	[	[	X
iajs-1773	71	13	21	21	NUM
iajs-1773	71	14	]	]	PUNCT
iajs-1773	71	15	recorded	record	VERB
iajs-1773	71	16	that	that	SCONJ
iajs-1773	71	17	the	the	DET
iajs-1773	71	18	low	low	ADJ
iajs-1773	71	19	levels	level	NOUN
iajs-1773	71	20	of	of	ADP
iajs-1773	71	21	progesterone	progesterone	NOUN
iajs-1773	71	22	in	in	ADP
iajs-1773	71	23	obese	obese	ADJ
iajs-1773	71	24	premenopausal	premenopausal	NOUN
iajs-1773	71	25	women	woman	NOUN
iajs-1773	71	26	are	be	AUX
iajs-1773	71	27	responsible	responsible	ADJ
iajs-1773	71	28	for	for	ADP
iajs-1773	71	29	the	the	DET
iajs-1773	71	30	reduction	reduction	NOUN
iajs-1773	71	31	of	of	ADP
iajs-1773	71	32	incidence	incidence	NOUN
iajs-1773	71	33	of	of	ADP
iajs-1773	71	34	breast	breast	NOUN
iajs-1773	71	35	cancer	cancer	NOUN
iajs-1773	71	36	in	in	ADP
iajs-1773	71	37	these	these	DET
iajs-1773	71	38	women	woman	NOUN
iajs-1773	71	39	.	.	PUNCT
iajs-1773	72	1	pervious	pervious	ADJ
iajs-1773	72	2	study	study	NOUN
iajs-1773	72	3	showed	show	VERB
iajs-1773	72	4	that	that	SCONJ
iajs-1773	72	5	serum	serum	NOUN
iajs-1773	72	6	progesterone	progesterone	NOUN
iajs-1773	72	7	levels	level	NOUN
iajs-1773	72	8	represent	represent	VERB
iajs-1773	72	9	a	a	DET
iajs-1773	72	10	beneficial	beneficial	ADJ
iajs-1773	72	11	biomarker	biomarker	NOUN
iajs-1773	72	12	for	for	ADP
iajs-1773	72	13	predicting	predict	VERB
iajs-1773	72	14	cancer	cancer	NOUN
iajs-1773	72	15	histology	histology	NOUN
iajs-1773	72	16	preoperatively	preoperatively	ADV
iajs-1773	72	17	,	,	PUNCT
iajs-1773	72	18	which	which	PRON
iajs-1773	72	19	would	would	AUX
iajs-1773	72	20	help	help	VERB
iajs-1773	72	21	therapy	therapy	NOUN
iajs-1773	72	22	planning	planning	NOUN
iajs-1773	72	23	while	while	SCONJ
iajs-1773	72	24	serum	serum	NOUN
iajs-1773	72	25	progesterone	progesterone	NOUN
iajs-1773	72	26	levels	level	NOUN
iajs-1773	72	27	were	be	AUX
iajs-1773	72	28	significantly	significantly	ADV
iajs-1773	72	29	elevated	elevate	VERB
iajs-1773	72	30	in	in	ADP
iajs-1773	72	31	postmenopausal	postmenopausal	ADJ
iajs-1773	72	32	women	woman	NOUN
iajs-1773	72	33	with	with	ADP
iajs-1773	72	34	mucinous	mucinous	ADJ
iajs-1773	72	35	ovarian	ovarian	ADJ
iajs-1773	72	36	cancer	cancer	NOUN
iajs-1773	72	37	.	.	PUNCT
iajs-1773	73	1	in	in	ADP
iajs-1773	73	2	these	these	DET
iajs-1773	73	3	women	woman	NOUN
iajs-1773	73	4	[	[	X
iajs-1773	73	5	22	22	NUM
iajs-1773	73	6	]	]	PUNCT
iajs-1773	73	7	.	.	PUNCT
iajs-1773	74	1	3.1.3	3.1.3	NUM
iajs-1773	74	2	.	.	PUNCT
iajs-1773	74	3	prolactin	prolactin	ADJ
iajs-1773	74	4	level	level	NOUN
iajs-1773	74	5	in	in	ADP
iajs-1773	74	6	serum	serum	NOUN
iajs-1773	74	7	prolactin	prolactin	NOUN
iajs-1773	74	8	(	(	PUNCT
iajs-1773	74	9	prl	prl	NOUN
iajs-1773	74	10	)	)	PUNCT
iajs-1773	74	11	hormone	hormone	NOUN
iajs-1773	74	12	plays	play	VERB
iajs-1773	74	13	a	a	DET
iajs-1773	74	14	significant	significant	ADJ
iajs-1773	74	15	role	role	NOUN
iajs-1773	74	16	in	in	ADP
iajs-1773	74	17	the	the	DET
iajs-1773	74	18	development	development	NOUN
iajs-1773	74	19	of	of	ADP
iajs-1773	74	20	the	the	DET
iajs-1773	74	21	mammary	mammary	ADJ
iajs-1773	74	22	gland	gland	NOUN
iajs-1773	74	23	and	and	CCONJ
iajs-1773	74	24	terminal	terminal	ADJ
iajs-1773	74	25	diversity	diversity	NOUN
iajs-1773	74	26	of	of	ADP
iajs-1773	74	27	the	the	DET
iajs-1773	74	28	mammary	mammary	ADJ
iajs-1773	74	29	epithelial	epithelial	ADJ
iajs-1773	74	30	cells	cell	NOUN
iajs-1773	74	31	[	[	X
iajs-1773	74	32	23	23	NUM
iajs-1773	74	33	]	]	PUNCT
iajs-1773	74	34	.	.	PUNCT
iajs-1773	75	1	the	the	DET
iajs-1773	75	2	result	result	NOUN
iajs-1773	75	3	of	of	ADP
iajs-1773	75	4	the	the	DET
iajs-1773	75	5	present	present	ADJ
iajs-1773	75	6	study	study	NOUN
iajs-1773	75	7	showed	show	VERB
iajs-1773	75	8	that	that	SCONJ
iajs-1773	75	9	prolactin	prolactin	ADJ
iajs-1773	75	10	level	level	NOUN
iajs-1773	75	11	in	in	ADP
iajs-1773	75	12	serum	serum	NOUN
iajs-1773	75	13	recorded	record	VERB
iajs-1773	75	14	a	a	DET
iajs-1773	75	15	high	high	ADJ
iajs-1773	75	16	significant	significant	ADJ
iajs-1773	75	17	increasing	increasing	NOUN
iajs-1773	75	18	in	in	ADP
iajs-1773	75	19	patient	patient	NOUN
iajs-1773	75	20	compared	compare	VERB
iajs-1773	75	21	to	to	ADP
iajs-1773	75	22	control	control	NOUN
iajs-1773	75	23	,	,	PUNCT
iajs-1773	75	24	(	(	PUNCT
iajs-1773	75	25	so	so	ADV
iajs-1773	75	26	we	we	PRON
iajs-1773	75	27	can	can	AUX
iajs-1773	75	28	suggest	suggest	VERB
iajs-1773	75	29	that	that	SCONJ
iajs-1773	75	30	the	the	DET
iajs-1773	75	31	increasing	increase	VERB
iajs-1773	75	32	level	level	NOUN
iajs-1773	75	33	of	of	ADP
iajs-1773	75	34	prolactin	prolactin	NOUN
iajs-1773	75	35	in	in	ADP
iajs-1773	75	36	serum	serum	NOUN
iajs-1773	75	37	linked	link	VERB
iajs-1773	75	38	with	with	ADP
iajs-1773	75	39	breast	breast	NOUN
iajs-1773	75	40	cancer	cancer	NOUN
iajs-1773	75	41	.and	.and	VERB
iajs-1773	75	42	consider	consider	VERB
iajs-1773	75	43	it	it	PRON
iajs-1773	75	44	a	a	DET
iajs-1773	75	45	biomarker	biomarker	NOUN
iajs-1773	75	46	to	to	PART
iajs-1773	75	47	detect	detect	VERB
iajs-1773	75	48	the	the	DET
iajs-1773	75	49	breast	breast	NOUN
iajs-1773	75	50	cancer	cancer	NOUN
iajs-1773	75	51	prognosis	prognosis	NOUN
iajs-1773	75	52	)	)	PUNCT
iajs-1773	75	53	as	as	SCONJ
iajs-1773	75	54	shown	show	VERB
iajs-1773	75	55	in	in	ADP
iajs-1773	75	56	(	(	PUNCT
iajs-1773	75	57	table	table	NOUN
iajs-1773	75	58	2	2	NUM
iajs-1773	75	59	)	)	PUNCT
iajs-1773	75	60	.	.	PUNCT
iajs-1773	76	1	our	our	PRON
iajs-1773	76	2	study	study	NOUN
iajs-1773	76	3	disagree	disagree	VERB
iajs-1773	76	4	with	with	ADP
iajs-1773	76	5	nyante	nyante	NOUN
iajs-1773	76	6	et	et	PROPN
iajs-1773	76	7	al	al	PROPN
iajs-1773	77	1	[	[	X
iajs-1773	77	2	24]which	24]which	NUM
iajs-1773	77	3	showed	show	VERB
iajs-1773	77	4	alter	alter	PROPN
iajs-1773	77	5	serum	serum	PROPN
iajs-1773	77	6	prolactin	prolactin	PROPN
iajs-1773	77	7	levels	level	NOUN
iajs-1773	77	8	were	be	AUX
iajs-1773	77	9	not	not	PART
iajs-1773	77	10	associated	associate	VERB
iajs-1773	77	11	with	with	ADP
iajs-1773	77	12	breast	breast	NOUN
iajs-1773	77	13	cancer	cancer	NOUN
iajs-1773	77	14	risk	risk	NOUN
iajs-1773	77	15	,	,	PUNCT
iajs-1773	77	16	while	while	SCONJ
iajs-1773	77	17	present	present	ADJ
iajs-1773	77	18	study	study	NOUN
iajs-1773	77	19	agree	agree	VERB
iajs-1773	77	20	with	with	ADP
iajs-1773	77	21	tworoger	tworog	ADJ
iajs-1773	77	22	[	[	X
iajs-1773	77	23	25	25	NUM
iajs-1773	77	24	]	]	PUNCT
iajs-1773	77	25	which	which	PRON
iajs-1773	77	26	supposed	suppose	VERB
iajs-1773	77	27	that	that	DET
iajs-1773	77	28	prolactin	prolactin	NOUN
iajs-1773	77	29	in	in	ADP
iajs-1773	77	30	serum	serum	NOUN
iajs-1773	77	31	is	be	AUX
iajs-1773	77	32	positively	positively	ADV
iajs-1773	77	33	related	relate	VERB
iajs-1773	77	34	with	with	ADP
iajs-1773	77	35	breast	breast	NOUN
iajs-1773	77	36	cancer	cancer	NOUN
iajs-1773	77	37	risk	risk	NOUN
iajs-1773	77	38	.	.	PUNCT
iajs-1773	78	1	as	as	ADV
iajs-1773	78	2	well	well	ADV
iajs-1773	78	3	as	as	ADP
iajs-1773	78	4	prl	prl	PROPN
iajs-1773	78	5	expression	expression	NOUN
iajs-1773	78	6	was	be	AUX
iajs-1773	78	7	significantly	significantly	ADV
iajs-1773	78	8	(	(	PUNCT
iajs-1773	78	9	p<0.01	p<0.01	PROPN
iajs-1773	78	10	)	)	PUNCT
iajs-1773	78	11	linked	link	VERB
iajs-1773	78	12	with	with	ADP
iajs-1773	78	13	long	long	ADJ
iajs-1773	78	14	distant	distant	ADJ
iajs-1773	78	15	metastasis	metastasis	NOUN
iajs-1773	78	16	–	–	PUNCT
iajs-1773	78	17	free	free	ADJ
iajs-1773	78	18	survival	survival	NOUN
iajs-1773	78	19	in	in	ADP
iajs-1773	78	20	breast	breast	NOUN
iajs-1773	78	21	cancer	cancer	NOUN
iajs-1773	78	22	patients	patient	NOUN
iajs-1773	78	23	[	[	X
iajs-1773	78	24	23	23	NUM
iajs-1773	78	25	]	]	PUNCT
iajs-1773	78	26	.our	.our	PRON
iajs-1773	78	27	current	current	ADJ
iajs-1773	78	28	study	study	NOUN
iajs-1773	78	29	was	be	AUX
iajs-1773	78	30	agree	agree	VERB
iajs-1773	78	31	with	with	ADP
iajs-1773	78	32	tikk	tikk	PROPN
iajs-1773	78	33	et	et	PROPN
iajs-1773	78	34	al	al	PROPN
iajs-1773	79	1	[	[	X
iajs-1773	79	2	26	26	NUM
iajs-1773	79	3	]	]	PUNCT
iajs-1773	79	4	which	which	PRON
iajs-1773	79	5	suppose	suppose	VERB
iajs-1773	79	6	that	that	SCONJ
iajs-1773	79	7	there	there	PRON
iajs-1773	79	8	was	be	VERB
iajs-1773	79	9	a	a	DET
iajs-1773	79	10	relation	relation	NOUN
iajs-1773	79	11	between	between	ADP
iajs-1773	79	12	serum	serum	NOUN
iajs-1773	79	13	level	level	NOUN
iajs-1773	79	14	prolactin	prolactin	ADJ
iajs-1773	79	15	and	and	CCONJ
iajs-1773	79	16	invasive	invasive	ADJ
iajs-1773	79	17	type	type	NOUN
iajs-1773	79	18	of	of	ADP
iajs-1773	79	19	breast	breast	NOUN
iajs-1773	79	20	cancer	cancer	NOUN
iajs-1773	79	21	to	to	ADP
iajs-1773	79	22	the	the	DET
iajs-1773	79	23	outcome	outcome	NOUN
iajs-1773	79	24	of	of	ADP
iajs-1773	79	25	in	in	ADP
iajs-1773	79	26	situ	situ	ADJ
iajs-1773	79	27	breast	breast	NOUN
iajs-1773	79	28	cancer	cancer	NOUN
iajs-1773	79	29	.	.	PUNCT
iajs-1773	80	1	clendenen	clendenen	PROPN
iajs-1773	80	2	et	et	PROPN
iajs-1773	80	3	al	al	PROPN
iajs-1773	80	4	.	.	PUNCT
iajs-1773	81	1	[	[	X
iajs-1773	81	2	27	27	NUM
iajs-1773	81	3	]	]	PUNCT
iajs-1773	81	4	which	which	PRON
iajs-1773	81	5	also	also	ADV
iajs-1773	81	6	suppose	suppose	VERB
iajs-1773	81	7	that	that	SCONJ
iajs-1773	81	8	prolactin	prolactin	NOUN
iajs-1773	81	9	perhaps	perhaps	ADV
iajs-1773	81	10	linked	link	VERB
iajs-1773	81	11	with	with	ADP
iajs-1773	81	12	increased	increase	VERB
iajs-1773	81	13	danger	danger	NOUN
iajs-1773	81	14	of	of	ADP
iajs-1773	81	15	ovarian	ovarian	ADJ
iajs-1773	81	16	cancer	cancer	NOUN
iajs-1773	81	17	.	.	PUNCT
iajs-1773	82	1	3.1.4	3.1.4	NUM
iajs-1773	82	2	.	.	PUNCT
iajs-1773	82	3	estradiol	estradiol	PROPN
iajs-1773	82	4	level	level	PROPN
iajs-1773	82	5	in	in	ADP
iajs-1773	82	6	serum	serum	PROPN
iajs-1773	82	7	17β	17β	PROPN
iajs-1773	82	8	estradiol	estradiol	PROPN
iajs-1773	82	9	(	(	PUNCT
iajs-1773	82	10	e2	e2	PROPN
iajs-1773	82	11	)	)	PUNCT
iajs-1773	82	12	is	be	AUX
iajs-1773	82	13	the	the	DET
iajs-1773	82	14	primary	primary	ADJ
iajs-1773	82	15	form	form	NOUN
iajs-1773	82	16	of	of	ADP
iajs-1773	82	17	estrogen	estrogen	NOUN
iajs-1773	82	18	,	,	PUNCT
iajs-1773	82	19	a	a	DET
iajs-1773	82	20	female	female	ADJ
iajs-1773	82	21	sex	sex	NOUN
iajs-1773	82	22	hormone	hormone	NOUN
iajs-1773	82	23	that	that	PRON
iajs-1773	82	24	is	be	AUX
iajs-1773	82	25	produced	produce	VERB
iajs-1773	82	26	via	via	ADP
iajs-1773	82	27	the	the	DET
iajs-1773	82	28	ovaries	ovary	NOUN
iajs-1773	82	29	and	and	CCONJ
iajs-1773	82	30	important	important	ADJ
iajs-1773	82	31	involved	involve	VERB
iajs-1773	82	32	in	in	ADP
iajs-1773	82	33	women	woman	NOUN
iajs-1773	82	34	’s	’s	PART
iajs-1773	82	35	monthly	monthly	ADJ
iajs-1773	82	36	menstrual	menstrual	ADJ
iajs-1773	82	37	cycle	cycle	NOUN
iajs-1773	83	1	[	[	X
iajs-1773	83	2	28	28	NUM
iajs-1773	83	3	]	]	PUNCT
iajs-1773	83	4	.our	.our	PUNCT
iajs-1773	83	5	study	study	NOUN
iajs-1773	83	6	showed	show	VERB
iajs-1773	83	7	that	that	SCONJ
iajs-1773	83	8	the	the	DET
iajs-1773	83	9	serum	serum	NOUN
iajs-1773	83	10	level	level	NOUN
iajs-1773	83	11	estradiol	estradiol	PROPN
iajs-1773	83	12	(	(	PUNCT
iajs-1773	83	13	e2	e2	PROPN
iajs-1773	83	14	)	)	PUNCT
iajs-1773	83	15	was	be	AUX
iajs-1773	83	16	very	very	ADV
iajs-1773	83	17	low	low	ADJ
iajs-1773	83	18	in	in	ADP
iajs-1773	83	19	breast	breast	NOUN
iajs-1773	83	20	cancer	cancer	NOUN
iajs-1773	83	21	patients	patient	NOUN
iajs-1773	83	22	.	.	PUNCT
iajs-1773	84	1	our	our	PRON
iajs-1773	84	2	study	study	NOUN
iajs-1773	84	3	data	datum	NOUN
iajs-1773	84	4	was	be	AUX
iajs-1773	84	5	agree	agree	VERB
iajs-1773	84	6	with	with	ADP
iajs-1773	84	7	honma	honma	PROPN
iajs-1773	84	8	et	et	PROPN
iajs-1773	84	9	al	al	PROPN
iajs-1773	85	1	[	[	X
iajs-1773	85	2	8	8	X
iajs-1773	85	3	]	]	PUNCT
iajs-1773	85	4	which	which	PRON
iajs-1773	85	5	revealed	reveal	VERB
iajs-1773	85	6	that	that	SCONJ
iajs-1773	85	7	the	the	DET
iajs-1773	85	8	estradiol	estradiol	PROPN
iajs-1773	85	9	level	level	NOUN
iajs-1773	85	10	in	in	ADP
iajs-1773	85	11	ihsciconf	ihsciconf	PROPN
iajs-1773	85	12	2017	2017	NUM
iajs-1773	85	13	special	special	ADJ
iajs-1773	85	14	issue	issue	NOUN
iajs-1773	85	15	ibn	ibn	PROPN
iajs-1773	85	16	al	al	PROPN
iajs-1773	85	17	-	-	PUNCT
iajs-1773	85	18	haitham	haitham	PROPN
iajs-1773	85	19	journal	journal	PROPN
iajs-1773	85	20	for	for	ADP
iajs-1773	85	21	pure	pure	ADJ
iajs-1773	85	22	and	and	CCONJ
iajs-1773	85	23	applied	apply	VERB
iajs-1773	85	24	science	science	NOUN
iajs-1773	85	25	https://doi.org/	https://doi.org/	NOUN
iajs-1773	85	26	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	85	27	.	.	PUNCT
iajs-1773	85	28	 	 	SPACE
iajs-1773	85	29	1773	1773	NUM
iajs-1773	85	30	for	for	ADP
iajs-1773	85	31	more	more	ADJ
iajs-1773	85	32	information	information	NOUN
iajs-1773	85	33	about	about	ADP
iajs-1773	85	34	the	the	DET
iajs-1773	85	35	conference	conference	NOUN
iajs-1773	85	36	please	please	INTJ
iajs-1773	85	37	visit	visit	VERB
iajs-1773	85	38	the	the	DET
iajs-1773	85	39	websites	website	NOUN
iajs-1773	85	40	:	:	PUNCT
iajs-1773	85	41	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	85	42	  	  	SPACE
iajs-1773	85	43	www.ihsciconf.org	www.ihsciconf.org	NOUN
iajs-1773	85	44	  	  	SPACE
iajs-1773	85	45	biology|77	biology|77	VERB
iajs-1773	85	46	the	the	DET
iajs-1773	85	47	serum	serum	NOUN
iajs-1773	85	48	was	be	AUX
iajs-1773	85	49	obviously	obviously	ADV
iajs-1773	85	50	lower	low	ADJ
iajs-1773	85	51	in	in	ADP
iajs-1773	85	52	breast	breast	NOUN
iajs-1773	85	53	cancer	cancer	NOUN
iajs-1773	85	54	patients	patient	NOUN
iajs-1773	85	55	.this	.this	PRON
iajs-1773	85	56	study	study	NOUN
iajs-1773	85	57	disagree	disagree	VERB
iajs-1773	85	58	with	with	ADP
iajs-1773	85	59	kakugawa	kakugawa	PROPN
iajs-1773	85	60	et	et	PROPN
iajs-1773	85	61	al	al	PROPN
iajs-1773	86	1	[	[	X
iajs-1773	86	2	29]which	29]which	NUM
iajs-1773	86	3	appeared	appear	VERB
iajs-1773	86	4	that	that	PRON
iajs-1773	86	5	tissue	tissue	NOUN
iajs-1773	86	6	estradiol	estradiol	PROPN
iajs-1773	86	7	(	(	PUNCT
iajs-1773	86	8	e2	e2	PROPN
iajs-1773	86	9	)	)	PUNCT
iajs-1773	86	10	is	be	AUX
iajs-1773	86	11	associated	associate	VERB
iajs-1773	86	12	with	with	ADP
iajs-1773	86	13	growth	growth	NOUN
iajs-1773	86	14	of	of	ADP
iajs-1773	86	15	receptor	receptor	NOUN
iajs-1773	86	16	–	–	PUNCT
iajs-1773	86	17	positive	positive	ADJ
iajs-1773	86	18	breast	breast	NOUN
iajs-1773	86	19	cancer	cancer	NOUN
iajs-1773	86	20	.	.	PUNCT
iajs-1773	87	1	also	also	ADV
iajs-1773	87	2	our	our	PRON
iajs-1773	87	3	data	datum	NOUN
iajs-1773	87	4	was	be	AUX
iajs-1773	87	5	disagreeing	disagree	VERB
iajs-1773	87	6	with	with	ADP
iajs-1773	87	7	pasqualini	pasqualini	PROPN
iajs-1773	87	8	et	et	PROPN
iajs-1773	87	9	al	al	PROPN
iajs-1773	88	1	[	[	X
iajs-1773	88	2	30	30	NUM
iajs-1773	88	3	]	]	PUNCT
iajs-1773	88	4	who	who	PRON
iajs-1773	88	5	revealed	reveal	VERB
iajs-1773	88	6	that	that	SCONJ
iajs-1773	88	7	estrogen	estrogen	NOUN
iajs-1773	88	8	concentration	concentration	NOUN
iajs-1773	88	9	are	be	AUX
iajs-1773	88	10	higher	high	ADJ
iajs-1773	88	11	within	within	ADP
iajs-1773	88	12	breast	breast	NOUN
iajs-1773	88	13	tumor	tumor	NOUN
iajs-1773	88	14	tissue	tissue	NOUN
iajs-1773	88	15	than	than	ADP
iajs-1773	88	16	in	in	ADP
iajs-1773	88	17	serum	serum	NOUN
iajs-1773	88	18	.	.	PUNCT
iajs-1773	89	1	our	our	PRON
iajs-1773	89	2	study	study	NOUN
iajs-1773	89	3	showed	show	VERB
iajs-1773	89	4	that	that	SCONJ
iajs-1773	89	5	the	the	DET
iajs-1773	89	6	concentration	concentration	NOUN
iajs-1773	89	7	estradiol	estradiol	ADV
iajs-1773	89	8	become	become	VERB
iajs-1773	89	9	a	a	DET
iajs-1773	89	10	lower	low	ADJ
iajs-1773	89	11	in	in	ADP
iajs-1773	89	12	women	woman	NOUN
iajs-1773	89	13	with	with	ADP
iajs-1773	89	14	breast	breast	NOUN
iajs-1773	89	15	cancer	cancer	NOUN
iajs-1773	89	16	.	.	PUNCT
iajs-1773	90	1	anthers	anther	NOUN
iajs-1773	90	2	recent	recent	ADJ
iajs-1773	90	3	study	study	NOUN
iajs-1773	90	4	showed	show	VERB
iajs-1773	90	5	that	that	SCONJ
iajs-1773	90	6	a	a	DET
iajs-1773	90	7	higher	high	ADJ
iajs-1773	90	8	serum	serum	NOUN
iajs-1773	90	9	e2	e2	PROPN
iajs-1773	90	10	level	level	NOUN
iajs-1773	90	11	was	be	AUX
iajs-1773	90	12	related	relate	VERB
iajs-1773	90	13	with	with	ADP
iajs-1773	90	14	an	an	DET
iajs-1773	90	15	increasing	increase	VERB
iajs-1773	90	16	danger	danger	NOUN
iajs-1773	90	17	of	of	ADP
iajs-1773	90	18	postmenopausal	postmenopausal	ADJ
iajs-1773	90	19	breast	breast	NOUN
iajs-1773	90	20	cancer	cancer	NOUN
iajs-1773	91	1	[	[	X
iajs-1773	91	2	31	31	NUM
iajs-1773	91	3	]	]	PUNCT
iajs-1773	91	4	.	.	PUNCT
iajs-1773	92	1	therefore	therefore	ADV
iajs-1773	92	2	,	,	PUNCT
iajs-1773	92	3	local	local	ADJ
iajs-1773	92	4	estrogen	estrogen	NOUN
iajs-1773	92	5	synthesis	synthesis	NOUN
iajs-1773	92	6	from	from	ADP
iajs-1773	92	7	circulating	circulate	VERB
iajs-1773	92	8	steroid	steroid	NOUN
iajs-1773	92	9	hormone	hormone	NOUN
iajs-1773	92	10	precursors	precursor	NOUN
iajs-1773	92	11	via	via	ADP
iajs-1773	92	12	steroid	steroid	NOUN
iajs-1773	92	13	-	-	PUNCT
iajs-1773	92	14	forming	form	VERB
iajs-1773	92	15	and	and	CCONJ
iajs-1773	92	16	steroid	steroid	NOUN
iajs-1773	92	17	-	-	PUNCT
iajs-1773	92	18	inactivating	inactivate	VERB
iajs-1773	92	19	enzymes	enzyme	NOUN
iajs-1773	92	20	may	may	AUX
iajs-1773	92	21	be	be	AUX
iajs-1773	92	22	significant	significant	ADJ
iajs-1773	92	23	to	to	PART
iajs-1773	92	24	drive	drive	VERB
iajs-1773	92	25	ovarian	ovarian	ADJ
iajs-1773	92	26	cancer	cancer	NOUN
iajs-1773	92	27	progression	progression	NOUN
iajs-1773	92	28	in	in	ADP
iajs-1773	92	29	women	woman	NOUN
iajs-1773	92	30	postmenopausal	postmenopausal	NOUN
iajs-1773	93	1	[	[	X
iajs-1773	93	2	32	32	NUM
iajs-1773	93	3	]	]	PUNCT
iajs-1773	93	4	.	.	PUNCT
iajs-1773	94	1	3.2	3.2	NUM
iajs-1773	94	2	.	.	PUNCT
iajs-1773	95	1	the	the	DET
iajs-1773	95	2	level	level	NOUN
iajs-1773	95	3	of	of	ADP
iajs-1773	95	4	trace	trace	NOUN
iajs-1773	95	5	elements	element	NOUN
iajs-1773	95	6	in	in	ADP
iajs-1773	95	7	the	the	DET
iajs-1773	95	8	serum	serum	NOUN
iajs-1773	95	9	the	the	DET
iajs-1773	95	10	result	result	NOUN
iajs-1773	95	11	revealed	reveal	VERB
iajs-1773	95	12	that	that	SCONJ
iajs-1773	95	13	zinc	zinc	NOUN
iajs-1773	95	14	has	have	VERB
iajs-1773	95	15	a	a	DET
iajs-1773	95	16	highly	highly	ADV
iajs-1773	95	17	significant	significant	ADJ
iajs-1773	95	18	difference	difference	NOUN
iajs-1773	95	19	in	in	ADP
iajs-1773	95	20	patients	patient	NOUN
iajs-1773	95	21	(	(	PUNCT
iajs-1773	95	22	39.92	39.92	NUM
iajs-1773	95	23	±	±	NUM
iajs-1773	95	24	3.44	3.44	NUM
iajs-1773	95	25	)	)	PUNCT
iajs-1773	95	26	µg	µg	PROPN
iajs-1773	95	27	/	/	SYM
iajs-1773	95	28	dl	dl	NOUN
iajs-1773	95	29	as	as	SCONJ
iajs-1773	95	30	compared	compare	VERB
iajs-1773	95	31	with	with	ADP
iajs-1773	95	32	control	control	NOUN
iajs-1773	95	33	(	(	PUNCT
iajs-1773	95	34	92.81	92.81	NUM
iajs-1773	95	35	±	±	NUM
iajs-1773	95	36	2.69	2.69	NUM
iajs-1773	95	37	)	)	PUNCT
iajs-1773	95	38	µg	µg	PROPN
iajs-1773	95	39	/	/	SYM
iajs-1773	95	40	dl	dl	PROPN
iajs-1773	95	41	.	.	PROPN
iajs-1773	95	42	zinc	zinc	NOUN
iajs-1773	95	43	has	have	VERB
iajs-1773	95	44	a	a	DET
iajs-1773	95	45	significant	significant	ADJ
iajs-1773	95	46	decreasing	decrease	VERB
iajs-1773	95	47	(	(	PUNCT
iajs-1773	95	48	p<0.01	p<0.01	PROPN
iajs-1773	95	49	)	)	PUNCT
iajs-1773	95	50	.	.	PUNCT
iajs-1773	96	1	as	as	ADV
iajs-1773	96	2	well	well	ADV
iajs-1773	96	3	as	as	ADP
iajs-1773	96	4	vitamin	vitamin	NOUN
iajs-1773	96	5	c	c	NOUN
iajs-1773	96	6	showed	show	VERB
iajs-1773	96	7	a	a	DET
iajs-1773	96	8	significant	significant	ADJ
iajs-1773	96	9	decreasing	decreasing	NOUN
iajs-1773	96	10	in	in	ADP
iajs-1773	96	11	patients	patient	NOUN
iajs-1773	96	12	(	(	PUNCT
iajs-1773	96	13	3.85	3.85	NUM
iajs-1773	96	14	±	±	NUM
iajs-1773	96	15	0.48	0.48	NUM
iajs-1773	96	16	)	)	PUNCT
iajs-1773	96	17	ppm	ppm	NOUN
iajs-1773	96	18	as	as	SCONJ
iajs-1773	96	19	compared	compare	VERB
iajs-1773	96	20	with	with	ADP
iajs-1773	96	21	control	control	NOUN
iajs-1773	96	22	(	(	PUNCT
iajs-1773	96	23	5.72	5.72	NUM
iajs-1773	96	24	±	±	NUM
iajs-1773	96	25	0.49	0.49	NUM
iajs-1773	96	26	)	)	PUNCT
iajs-1773	96	27	ppm	ppm	NOUN
iajs-1773	96	28	(	(	PUNCT
iajs-1773	96	29	p<0.05	p<0.05	NOUN
iajs-1773	96	30	)	)	PUNCT
iajs-1773	96	31	as	as	SCONJ
iajs-1773	96	32	shown	show	VERB
iajs-1773	96	33	in	in	ADP
iajs-1773	96	34	table	table	NOUN
iajs-1773	96	35	3	3	NUM
iajs-1773	96	36	.	.	PUNCT
iajs-1773	96	37	table	table	NOUN
iajs-1773	96	38	(	(	PUNCT
iajs-1773	96	39	3	3	NUM
iajs-1773	96	40	):	):	PUNCT
iajs-1773	96	41	compare	compare	NOUN
iajs-1773	96	42	between	between	ADP
iajs-1773	96	43	patients	patient	NOUN
iajs-1773	96	44	and	and	CCONJ
iajs-1773	96	45	control	control	NOUN
iajs-1773	96	46	in	in	ADP
iajs-1773	96	47	levels	level	NOUN
iajs-1773	96	48	of	of	ADP
iajs-1773	96	49	zinc	zinc	NOUN
iajs-1773	96	50	and	and	CCONJ
iajs-1773	96	51	vitamin	vitamin	NOUN
iajs-1773	96	52	c.	c.	NOUN
iajs-1773	96	53	the	the	DET
iajs-1773	96	54	group	group	NOUN
iajs-1773	96	55	mean	mean	VERB
iajs-1773	96	56	±	±	NUM
iajs-1773	96	57	se	se	X
iajs-1773	96	58	zinc	zinc	PROPN
iajs-1773	96	59	µg	µg	NOUN
iajs-1773	96	60	/	/	SYM
iajs-1773	96	61	dl	dl	NOUN
iajs-1773	96	62	vitamin	vitamin	NOUN
iajs-1773	96	63	.	.	PUNCT
iajs-1773	97	1	c	c	NOUN
iajs-1773	97	2	ppm	ppm	NOUN
iajs-1773	97	3	patients	patient	NOUN
iajs-1773	97	4	39.92	39.92	NUM
iajs-1773	97	5	±	±	NUM
iajs-1773	97	6	3.44	3.44	NUM
iajs-1773	97	7	3.85	3.85	NUM
iajs-1773	97	8	±	±	NUM
iajs-1773	97	9	0.48	0.48	NUM
iajs-1773	97	10	control	control	NOUN
iajs-1773	97	11	92.81	92.81	NUM
iajs-1773	97	12	±	±	NUM
iajs-1773	97	13	2.69	2.69	NUM
iajs-1773	97	14	5.72	5.72	NUM
iajs-1773	97	15	±	±	NUM
iajs-1773	97	16	0.49	0.49	NUM
iajs-1773	97	17	t	t	NOUN
iajs-1773	97	18	-	-	PUNCT
iajs-1773	97	19	test	test	NOUN
iajs-1773	97	20	12.641	12.641	NUM
iajs-1773	97	21	*	*	PUNCT
iajs-1773	97	22	*	*	PUNCT
iajs-1773	98	1	1.786	1.786	NUM
iajs-1773	98	2	*	*	PUNCT
iajs-1773	98	3	p	p	NOUN
iajs-1773	98	4	-	-	PUNCT
iajs-1773	98	5	value	value	NOUN
iajs-1773	98	6	0.0001	0.0001	NUM
iajs-1773	98	7	0.0406	0.0406	NUM
iajs-1773	98	8	*	*	PUNCT
iajs-1773	98	9	(	(	PUNCT
iajs-1773	98	10	p<0.05	p<0.05	NOUN
iajs-1773	98	11	)	)	PUNCT
iajs-1773	98	12	significant	significant	ADJ
iajs-1773	98	13	,	,	PUNCT
iajs-1773	98	14	*	*	PUNCT
iajs-1773	98	15	*	*	PUNCT
iajs-1773	98	16	(	(	PUNCT
iajs-1773	98	17	p<0.01	p<0.01	PROPN
iajs-1773	98	18	)	)	PUNCT
iajs-1773	98	19	high	high	ADV
iajs-1773	98	20	significant	significant	ADJ
iajs-1773	98	21	.	.	PUNCT
iajs-1773	99	1	3.2.1	3.2.1	X
iajs-1773	99	2	.	.	X
iajs-1773	99	3	zinc	zinc	NOUN
iajs-1773	99	4	level	level	NOUN
iajs-1773	99	5	in	in	ADP
iajs-1773	99	6	serum	serum	NOUN
iajs-1773	99	7	zinc	zinc	NOUN
iajs-1773	99	8	is	be	AUX
iajs-1773	99	9	a	a	DET
iajs-1773	99	10	trace	trace	NOUN
iajs-1773	99	11	element	element	NOUN
iajs-1773	99	12	that	that	PRON
iajs-1773	99	13	is	be	AUX
iajs-1773	99	14	pivotal	pivotal	ADJ
iajs-1773	99	15	for	for	ADP
iajs-1773	99	16	the	the	DET
iajs-1773	99	17	function	function	NOUN
iajs-1773	99	18	of	of	ADP
iajs-1773	99	19	several	several	ADJ
iajs-1773	99	20	cellular	cellular	ADJ
iajs-1773	99	21	process	process	NOUN
iajs-1773	99	22	and	and	CCONJ
iajs-1773	99	23	perhaps	perhaps	ADV
iajs-1773	99	24	play	play	VERB
iajs-1773	99	25	a	a	DET
iajs-1773	99	26	serious	serious	ADJ
iajs-1773	99	27	role	role	NOUN
iajs-1773	99	28	in	in	ADP
iajs-1773	99	29	cancer	cancer	NOUN
iajs-1773	99	30	etiology	etiology	NOUN
iajs-1773	99	31	[	[	X
iajs-1773	99	32	33	33	NUM
iajs-1773	99	33	]	]	PUNCT
iajs-1773	99	34	.	.	PUNCT
iajs-1773	100	1	the	the	DET
iajs-1773	100	2	present	present	ADJ
iajs-1773	100	3	study	study	NOUN
iajs-1773	100	4	revealed	reveal	VERB
iajs-1773	100	5	that	that	SCONJ
iajs-1773	100	6	the	the	DET
iajs-1773	100	7	serum	serum	NOUN
iajs-1773	100	8	level	level	NOUN
iajs-1773	100	9	of	of	ADP
iajs-1773	100	10	zinc	zinc	NOUN
iajs-1773	100	11	has	have	VERB
iajs-1773	100	12	a	a	DET
iajs-1773	100	13	highest	high	ADJ
iajs-1773	100	14	significant	significant	ADJ
iajs-1773	100	15	decreasing	decreasing	NOUN
iajs-1773	100	16	in	in	ADP
iajs-1773	100	17	patients	patient	NOUN
iajs-1773	100	18	and	and	CCONJ
iajs-1773	100	19	control	control	NOUN
iajs-1773	100	20	,	,	PUNCT
iajs-1773	100	21	present	present	ADJ
iajs-1773	100	22	study	study	NOUN
iajs-1773	100	23	was	be	AUX
iajs-1773	100	24	agree	agree	VERB
iajs-1773	100	25	with	with	ADP
iajs-1773	100	26	pavithra	pavithra	PROPN
iajs-1773	100	27	et	et	PROPN
iajs-1773	100	28	al	al	PROPN
iajs-1773	100	29	and	and	CCONJ
iajs-1773	100	30	kuo	kuo	PROPN
iajs-1773	100	31	et	et	PROPN
iajs-1773	100	32	al	al	PROPN
iajs-1773	100	33	.	.	PUNCT
iajs-1773	101	1	[	[	X
iajs-1773	101	2	38	38	NUM
iajs-1773	101	3	,	,	PUNCT
iajs-1773	101	4	34	34	NUM
iajs-1773	101	5	]	]	PUNCT
iajs-1773	101	6	who	who	PRON
iajs-1773	101	7	showed	show	VERB
iajs-1773	101	8	that	that	SCONJ
iajs-1773	101	9	the	the	DET
iajs-1773	101	10	serum	serum	NOUN
iajs-1773	101	11	level	level	NOUN
iajs-1773	101	12	of	of	ADP
iajs-1773	101	13	zinc	zinc	NOUN
iajs-1773	101	14	has	have	VERB
iajs-1773	101	15	a	a	DET
iajs-1773	101	16	significant	significant	ADJ
iajs-1773	101	17	reduction	reduction	NOUN
iajs-1773	101	18	in	in	ADP
iajs-1773	101	19	breast	breast	NOUN
iajs-1773	101	20	cancer	cancer	NOUN
iajs-1773	101	21	patients	patient	NOUN
iajs-1773	101	22	.	.	PUNCT
iajs-1773	102	1	while	while	SCONJ
iajs-1773	102	2	it	it	PRON
iajs-1773	102	3	was	be	AUX
iajs-1773	102	4	disagreeing	disagree	VERB
iajs-1773	102	5	with	with	ADP
iajs-1773	102	6	wu	wu	PROPN
iajs-1773	103	1	[	[	X
iajs-1773	103	2	37	37	NUM
iajs-1773	103	3	]	]	PUNCT
iajs-1773	103	4	which	which	PRON
iajs-1773	103	5	recorded	record	VERB
iajs-1773	103	6	a	a	DET
iajs-1773	103	7	non	non	ADJ
iajs-1773	103	8	-	-	ADJ
iajs-1773	103	9	significant	significant	ADJ
iajs-1773	103	10	variation	variation	NOUN
iajs-1773	103	11	in	in	ADP
iajs-1773	103	12	serum	serum	NOUN
iajs-1773	103	13	zinc	zinc	NOUN
iajs-1773	103	14	concentration	concentration	NOUN
iajs-1773	103	15	between	between	ADP
iajs-1773	103	16	patients	patient	NOUN
iajs-1773	103	17	and	and	CCONJ
iajs-1773	103	18	control	control	NOUN
iajs-1773	103	19	.	.	PUNCT
iajs-1773	104	1	many	many	ADJ
iajs-1773	104	2	studies	study	NOUN
iajs-1773	104	3	support	support	VERB
iajs-1773	104	4	a	a	DET
iajs-1773	104	5	new	new	ADJ
iajs-1773	104	6	idea	idea	NOUN
iajs-1773	104	7	about	about	ADP
iajs-1773	104	8	the	the	DET
iajs-1773	104	9	role	role	NOUN
iajs-1773	104	10	of	of	ADP
iajs-1773	104	11	zinc	zinc	NOUN
iajs-1773	104	12	in	in	ADP
iajs-1773	104	13	the	the	DET
iajs-1773	104	14	growth	growth	NOUN
iajs-1773	104	15	of	of	ADP
iajs-1773	104	16	pancreatic	pancreatic	ADJ
iajs-1773	104	17	adenocarcinoma	adenocarcinoma	NOUN
iajs-1773	104	18	[	[	X
iajs-1773	104	19	35	35	NUM
iajs-1773	104	20	]	]	PUNCT
iajs-1773	104	21	.	.	PUNCT
iajs-1773	105	1	epstein	epstein	PROPN
iajs-1773	105	2	et	et	PROPN
iajs-1773	105	3	al	al	PROPN
iajs-1773	106	1	[	[	X
iajs-1773	106	2	36	36	NUM
iajs-1773	106	3	]	]	PUNCT
iajs-1773	106	4	study	study	NOUN
iajs-1773	106	5	was	be	AUX
iajs-1773	106	6	suggested	suggest	VERB
iajs-1773	106	7	that	that	SCONJ
iajs-1773	106	8	high	high	ADJ
iajs-1773	106	9	dietary	dietary	ADJ
iajs-1773	106	10	absorption	absorption	NOUN
iajs-1773	106	11	of	of	ADP
iajs-1773	106	12	zinc	zinc	NOUN
iajs-1773	106	13	was	be	AUX
iajs-1773	106	14	linked	link	VERB
iajs-1773	106	15	with	with	ADP
iajs-1773	106	16	reduction	reduction	NOUN
iajs-1773	106	17	of	of	ADP
iajs-1773	106	18	prostate	prostate	NOUN
iajs-1773	106	19	cancer	cancer	NOUN
iajs-1773	106	20	after	after	ADP
iajs-1773	106	21	diagnosis	diagnosis	NOUN
iajs-1773	106	22	.	.	PUNCT
iajs-1773	107	1	shankar	shankar	PROPN
iajs-1773	107	2	and	and	CCONJ
iajs-1773	107	3	prasad	prasad	PROPN
iajs-1773	107	4	which	which	PRON
iajs-1773	107	5	revealed	reveal	VERB
iajs-1773	107	6	zinc	zinc	NOUN
iajs-1773	107	7	has	have	VERB
iajs-1773	107	8	an	an	DET
iajs-1773	107	9	essential	essential	ADJ
iajs-1773	107	10	role	role	NOUN
iajs-1773	107	11	in	in	ADP
iajs-1773	107	12	polynucleotide	polynucleotide	NOUN
iajs-1773	107	13	transcription	transcription	NOUN
iajs-1773	107	14	and	and	CCONJ
iajs-1773	107	15	thus	thus	ADV
iajs-1773	107	16	in	in	ADP
iajs-1773	107	17	the	the	DET
iajs-1773	107	18	progress	progress	NOUN
iajs-1773	107	19	of	of	ADP
iajs-1773	107	20	genetic	genetic	ADJ
iajs-1773	107	21	expression	expression	NOUN
iajs-1773	107	22	.	.	PUNCT
iajs-1773	108	1	zinc	zinc	NOUN
iajs-1773	108	2	plays	play	VERB
iajs-1773	108	3	a	a	DET
iajs-1773	108	4	central	central	ADJ
iajs-1773	108	5	role	role	NOUN
iajs-1773	108	6	in	in	ADP
iajs-1773	108	7	the	the	DET
iajs-1773	108	8	immune	immune	ADJ
iajs-1773	108	9	system	system	NOUN
iajs-1773	108	10	,	,	PUNCT
iajs-1773	108	11	affecting	affect	VERB
iajs-1773	108	12	a	a	DET
iajs-1773	108	13	number	number	NOUN
iajs-1773	108	14	of	of	ADP
iajs-1773	108	15	aspects	aspect	NOUN
iajs-1773	108	16	of	of	ADP
iajs-1773	108	17	cellular	cellular	ADJ
iajs-1773	108	18	and	and	CCONJ
iajs-1773	108	19	humeral	humeral	ADJ
iajs-1773	108	20	immunity	immunity	NOUN
iajs-1773	108	21	[	[	X
iajs-1773	108	22	39	39	NUM
iajs-1773	108	23	]	]	PUNCT
iajs-1773	108	24	.	.	PUNCT
iajs-1773	109	1	the	the	DET
iajs-1773	109	2	impairments	impairment	NOUN
iajs-1773	109	3	of	of	ADP
iajs-1773	109	4	immune	immune	ADJ
iajs-1773	109	5	defense	defense	NOUN
iajs-1773	109	6	are	be	AUX
iajs-1773	109	7	so	so	ADV
iajs-1773	109	8	far	far	ADV
iajs-1773	109	9	the	the	DET
iajs-1773	109	10	only	only	ADV
iajs-1773	109	11	clearly	clearly	ADV
iajs-1773	109	12	demonstrated	demonstrate	VERB
iajs-1773	109	13	sign	sign	NOUN
iajs-1773	109	14	of	of	ADP
iajs-1773	109	15	mild	mild	ADJ
iajs-1773	109	16	zinc	zinc	NOUN
iajs-1773	109	17	deficiency	deficiency	NOUN
iajs-1773	109	18	in	in	ADP
iajs-1773	109	19	human	human	NOUN
iajs-1773	109	20	.	.	PUNCT
iajs-1773	110	1	zinc	zinc	NOUN
iajs-1773	110	2	is	be	AUX
iajs-1773	110	3	essential	essential	ADJ
iajs-1773	110	4	for	for	ADP
iajs-1773	110	5	cell	cell	NOUN
iajs-1773	110	6	proliferation	proliferation	NOUN
iajs-1773	110	7	,	,	PUNCT
iajs-1773	110	8	differentiation	differentiation	NOUN
iajs-1773	110	9	,	,	PUNCT
iajs-1773	110	10	regulation	regulation	NOUN
iajs-1773	110	11	of	of	ADP
iajs-1773	110	12	dna	dna	PROPN
iajs-1773	110	13	synthesis	synthesis	NOUN
iajs-1773	110	14	and	and	CCONJ
iajs-1773	110	15	mitosis	mitosis	NOUN
iajs-1773	110	16	.	.	PUNCT
iajs-1773	111	1	zinc	zinc	NOUN
iajs-1773	111	2	can	can	AUX
iajs-1773	111	3	modulate	modulate	VERB
iajs-1773	111	4	cellular	cellular	ADJ
iajs-1773	111	5	signal	signal	NOUN
iajs-1773	111	6	recognition	recognition	NOUN
iajs-1773	111	7	,	,	PUNCT
iajs-1773	111	8	second	second	ADJ
iajs-1773	111	9	messenger	messenger	NOUN
iajs-1773	111	10	metabolism	metabolism	NOUN
iajs-1773	111	11	,	,	PUNCT
iajs-1773	111	12	protein	protein	NOUN
iajs-1773	111	13	kinase	kinase	NOUN
iajs-1773	111	14	and	and	CCONJ
iajs-1773	111	15	protein	protein	NOUN
iajs-1773	111	16	phosphatase	phosphatase	NOUN
iajs-1773	111	17	activity	activity	NOUN
iajs-1773	111	18	and	and	CCONJ
iajs-1773	111	19	it	it	PRON
iajs-1773	111	20	may	may	AUX
iajs-1773	111	21	stimulate	stimulate	VERB
iajs-1773	111	22	or	or	CCONJ
iajs-1773	111	23	inhibit	inhibit	VERB
iajs-1773	111	24	transcription	transcription	NOUN
iajs-1773	111	25	factor	factor	NOUN
iajs-1773	111	26	which	which	PRON
iajs-1773	111	27	required	require	VERB
iajs-1773	111	28	in	in	ADP
iajs-1773	111	29	signal	signal	ADJ
iajs-1773	111	30	transduction	transduction	NOUN
iajs-1773	112	1	[	[	X
iajs-1773	112	2	40	40	NUM
iajs-1773	112	3	,	,	PUNCT
iajs-1773	112	4	41	41	NUM
iajs-1773	112	5	]	]	PUNCT
iajs-1773	112	6	.	.	PUNCT
iajs-1773	113	1	we	we	PRON
iajs-1773	113	2	can	can	AUX
iajs-1773	113	3	suggest	suggest	VERB
iajs-1773	113	4	that	that	SCONJ
iajs-1773	113	5	the	the	DET
iajs-1773	113	6	low	low	ADJ
iajs-1773	113	7	zinc	zinc	NOUN
iajs-1773	113	8	level	level	NOUN
iajs-1773	113	9	in	in	ADP
iajs-1773	113	10	patient	patient	NOUN
iajs-1773	113	11	has	have	VERB
iajs-1773	113	12	a	a	DET
iajs-1773	113	13	role	role	NOUN
iajs-1773	113	14	in	in	ADP
iajs-1773	113	15	early	early	ADJ
iajs-1773	113	16	event	event	NOUN
iajs-1773	113	17	breast	breast	NOUN
iajs-1773	113	18	cancer	cancer	NOUN
iajs-1773	113	19	occurring	occur	VERB
iajs-1773	113	20	and	and	CCONJ
iajs-1773	113	21	it	it	PRON
iajs-1773	113	22	may	may	AUX
iajs-1773	113	23	associate	associate	VERB
iajs-1773	113	24	with	with	ADP
iajs-1773	113	25	danger	danger	NOUN
iajs-1773	113	26	breast	breast	NOUN
iajs-1773	113	27	cancer	cancer	NOUN
iajs-1773	113	28	type	type	NOUN
iajs-1773	113	29	.	.	PUNCT
iajs-1773	114	1	ihsciconf	ihsciconf	PROPN
iajs-1773	114	2	2017	2017	NUM
iajs-1773	114	3	special	special	ADJ
iajs-1773	114	4	issue	issue	NOUN
iajs-1773	114	5	ibn	ibn	PROPN
iajs-1773	114	6	al	al	PROPN
iajs-1773	114	7	-	-	PUNCT
iajs-1773	114	8	haitham	haitham	PROPN
iajs-1773	114	9	journal	journal	PROPN
iajs-1773	114	10	for	for	ADP
iajs-1773	114	11	pure	pure	ADJ
iajs-1773	114	12	and	and	CCONJ
iajs-1773	114	13	applied	apply	VERB
iajs-1773	114	14	science	science	NOUN
iajs-1773	114	15	https://doi.org/	https://doi.org/	NOUN
iajs-1773	114	16	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	114	17	.	.	PUNCT
iajs-1773	114	18	 	 	SPACE
iajs-1773	114	19	1773	1773	NUM
iajs-1773	114	20	for	for	ADP
iajs-1773	114	21	more	more	ADJ
iajs-1773	114	22	information	information	NOUN
iajs-1773	114	23	about	about	ADP
iajs-1773	114	24	the	the	DET
iajs-1773	114	25	conference	conference	NOUN
iajs-1773	114	26	please	please	INTJ
iajs-1773	114	27	visit	visit	VERB
iajs-1773	114	28	the	the	DET
iajs-1773	114	29	websites	website	NOUN
iajs-1773	114	30	:	:	PUNCT
iajs-1773	114	31	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	114	32	  	  	SPACE
iajs-1773	114	33	www.ihsciconf.org	www.ihsciconf.org	ADV
iajs-1773	114	34	  	  	SPACE
iajs-1773	114	35	biology|78	biology|78	PUNCT
iajs-1773	114	36	3.2.2	3.2.2	NUM
iajs-1773	114	37	.	.	PUNCT
iajs-1773	115	1	vitamin	vitamin	NOUN
iajs-1773	115	2	c	c	NOUN
iajs-1773	115	3	level	level	NOUN
iajs-1773	115	4	in	in	ADP
iajs-1773	115	5	serum	serum	NOUN
iajs-1773	115	6	ascorbic	ascorbic	NOUN
iajs-1773	115	7	acid	acid	NOUN
iajs-1773	115	8	was	be	AUX
iajs-1773	115	9	first	first	ADV
iajs-1773	115	10	specified	specify	VERB
iajs-1773	115	11	in	in	ADP
iajs-1773	115	12	vegetables	vegetable	NOUN
iajs-1773	115	13	,	,	PUNCT
iajs-1773	115	14	fruits	fruit	NOUN
iajs-1773	115	15	(	(	PUNCT
iajs-1773	115	16	citrus	citrus	NOUN
iajs-1773	115	17	)	)	PUNCT
iajs-1773	115	18	,	,	PUNCT
iajs-1773	115	19	and	and	CCONJ
iajs-1773	115	20	adrenal	adrenal	ADJ
iajs-1773	115	21	glands	gland	NOUN
iajs-1773	115	22	.	.	PUNCT
iajs-1773	116	1	it	it	PRON
iajs-1773	116	2	was	be	AUX
iajs-1773	116	3	at	at	ADP
iajs-1773	116	4	a	a	DET
iajs-1773	116	5	later	later	ADJ
iajs-1773	116	6	time	time	NOUN
iajs-1773	116	7	named	name	VERB
iajs-1773	116	8	vitamin	vitamin	NOUN
iajs-1773	116	9	c	c	NOUN
iajs-1773	116	10	,	,	PUNCT
iajs-1773	116	11	vitamin	vitamin	NOUN
iajs-1773	116	12	c	c	NOUN
iajs-1773	116	13	is	be	AUX
iajs-1773	116	14	very	very	ADV
iajs-1773	116	15	important	important	ADJ
iajs-1773	116	16	factor	factor	NOUN
iajs-1773	116	17	to	to	ADP
iajs-1773	116	18	human	human	ADJ
iajs-1773	116	19	health	health	NOUN
iajs-1773	116	20	.	.	PUNCT
iajs-1773	117	1	this	this	DET
iajs-1773	117	2	vitamin	vitamin	NOUN
iajs-1773	117	3	can	can	AUX
iajs-1773	117	4	not	not	PART
iajs-1773	117	5	be	be	AUX
iajs-1773	117	6	created	create	VERB
iajs-1773	117	7	via	via	ADP
iajs-1773	117	8	humans	human	NOUN
iajs-1773	117	9	,	,	PUNCT
iajs-1773	117	10	there	there	ADV
iajs-1773	117	11	for	for	ADP
iajs-1773	117	12	it	it	PRON
iajs-1773	117	13	is	be	AUX
iajs-1773	117	14	major	major	ADJ
iajs-1773	117	15	that	that	SCONJ
iajs-1773	117	16	vitamin	vitamin	NOUN
iajs-1773	117	17	c	c	AUX
iajs-1773	117	18	be	be	AUX
iajs-1773	117	19	combined	combine	VERB
iajs-1773	117	20	into	into	ADP
iajs-1773	117	21	our	our	PRON
iajs-1773	117	22	diet	diet	NOUN
iajs-1773	118	1	[	[	X
iajs-1773	118	2	42	42	NUM
iajs-1773	118	3	]	]	PUNCT
iajs-1773	118	4	.	.	PUNCT
iajs-1773	119	1	the	the	DET
iajs-1773	119	2	present	present	ADJ
iajs-1773	119	3	study	study	NOUN
iajs-1773	119	4	showed	show	VERB
iajs-1773	119	5	a	a	DET
iajs-1773	119	6	significant	significant	ADJ
iajs-1773	119	7	decreasing	decreasing	NOUN
iajs-1773	119	8	in	in	ADP
iajs-1773	119	9	breast	breast	NOUN
iajs-1773	119	10	cancer	cancer	NOUN
iajs-1773	119	11	patient	patient	NOUN
iajs-1773	119	12	(	(	PUNCT
iajs-1773	119	13	3.85±0.48	3.85±0.48	NUM
iajs-1773	119	14	)	)	PUNCT
iajs-1773	119	15	ppm	ppm	NOUN
iajs-1773	119	16	compared	compare	VERB
iajs-1773	119	17	with	with	ADP
iajs-1773	119	18	control	control	NOUN
iajs-1773	119	19	(	(	PUNCT
iajs-1773	119	20	5.72±0.49	5.72±0.49	NOUN
iajs-1773	119	21	)	)	PUNCT
iajs-1773	119	22	ppm	ppm	NOUN
iajs-1773	119	23	(	(	PUNCT
iajs-1773	119	24	p<0.05	p<0.05	NOUN
iajs-1773	119	25	)	)	PUNCT
iajs-1773	119	26	as	as	SCONJ
iajs-1773	119	27	shown	show	VERB
iajs-1773	119	28	in	in	ADP
iajs-1773	119	29	(	(	PUNCT
iajs-1773	119	30	table	table	NOUN
iajs-1773	119	31	3	3	NUM
iajs-1773	119	32	)	)	PUNCT
iajs-1773	119	33	.	.	PUNCT
iajs-1773	120	1	the	the	DET
iajs-1773	120	2	present	present	ADJ
iajs-1773	120	3	data	datum	NOUN
iajs-1773	120	4	was	be	AUX
iajs-1773	120	5	in	in	ADP
iajs-1773	120	6	agree	agree	NOUN
iajs-1773	120	7	with	with	ADP
iajs-1773	120	8	ray	ray	NOUN
iajs-1773	120	9	and	and	CCONJ
iajs-1773	120	10	girija	girija	NOUN
iajs-1773	121	1	[	[	X
iajs-1773	121	2	43,44	43,44	X
iajs-1773	121	3	]	]	PUNCT
iajs-1773	121	4	which	which	PRON
iajs-1773	121	5	showed	show	VERB
iajs-1773	121	6	a	a	DET
iajs-1773	121	7	lower	low	ADJ
iajs-1773	121	8	mean	mean	NOUN
iajs-1773	121	9	and	and	CCONJ
iajs-1773	121	10	se	se	X
iajs-1773	121	11	in	in	ADP
iajs-1773	121	12	serum	serum	NOUN
iajs-1773	121	13	level	level	NOUN
iajs-1773	121	14	of	of	ADP
iajs-1773	121	15	vitamin	vitamin	NOUN
iajs-1773	121	16	c	c	NOUN
iajs-1773	121	17	in	in	ADP
iajs-1773	121	18	patients	patient	NOUN
iajs-1773	121	19	as	as	SCONJ
iajs-1773	121	20	compared	compare	VERB
iajs-1773	121	21	with	with	ADP
iajs-1773	121	22	control	control	NOUN
iajs-1773	121	23	while	while	SCONJ
iajs-1773	121	24	it	it	PRON
iajs-1773	121	25	was	be	AUX
iajs-1773	121	26	disagree	disagree	VERB
iajs-1773	121	27	with	with	ADP
iajs-1773	121	28	zhang	zhang	PROPN
iajs-1773	121	29	et	et	PROPN
iajs-1773	121	30	al	al	PROPN
iajs-1773	122	1	[	[	X
iajs-1773	122	2	46	46	NUM
iajs-1773	122	3	]	]	PUNCT
iajs-1773	122	4	which	which	PRON
iajs-1773	122	5	revealed	reveal	VERB
iajs-1773	122	6	that	that	SCONJ
iajs-1773	122	7	there	there	PRON
iajs-1773	122	8	was	be	VERB
iajs-1773	122	9	a	a	DET
iajs-1773	122	10	significant	significant	ADJ
iajs-1773	122	11	relation	relation	NOUN
iajs-1773	122	12	between	between	ADP
iajs-1773	122	13	vitamin	vitamin	NOUN
iajs-1773	122	14	c	c	PROPN
iajs-1773	122	15	intake	intake	NOUN
iajs-1773	122	16	and	and	CCONJ
iajs-1773	122	17	breast	breast	NOUN
iajs-1773	122	18	cancer	cancer	NOUN
iajs-1773	122	19	risk	risk	NOUN
iajs-1773	122	20	.	.	PUNCT
iajs-1773	123	1	so	so	ADV
iajs-1773	123	2	we	we	PRON
iajs-1773	123	3	need	need	VERB
iajs-1773	123	4	a	a	DET
iajs-1773	123	5	lot	lot	NOUN
iajs-1773	123	6	of	of	ADP
iajs-1773	123	7	evidence	evidence	NOUN
iajs-1773	123	8	to	to	PART
iajs-1773	123	9	support	support	VERB
iajs-1773	123	10	the	the	DET
iajs-1773	123	11	idea	idea	NOUN
iajs-1773	123	12	that	that	SCONJ
iajs-1773	123	13	vitamin	vitamin	NOUN
iajs-1773	123	14	c	c	NOUN
iajs-1773	123	15	may	may	AUX
iajs-1773	123	16	has	have	AUX
iajs-1773	123	17	an	an	DET
iajs-1773	123	18	essential	essential	ADJ
iajs-1773	123	19	role	role	NOUN
iajs-1773	123	20	in	in	ADP
iajs-1773	123	21	breast	breast	NOUN
iajs-1773	123	22	cancer	cancer	NOUN
iajs-1773	123	23	occurring	occurring	NOUN
iajs-1773	123	24	and	and	CCONJ
iajs-1773	123	25	its	its	PRON
iajs-1773	123	26	supplementation	supplementation	NOUN
iajs-1773	123	27	may	may	AUX
iajs-1773	123	28	enhance	enhance	VERB
iajs-1773	123	29	the	the	DET
iajs-1773	123	30	antitumor	antitumor	PROPN
iajs-1773	123	31	impact	impact	NOUN
iajs-1773	123	32	of	of	ADP
iajs-1773	123	33	chemotherapy	chemotherapy	NOUN
iajs-1773	123	34	or	or	CCONJ
iajs-1773	123	35	reduce	reduce	VERB
iajs-1773	123	36	its	its	PRON
iajs-1773	123	37	toxicity	toxicity	NOUN
iajs-1773	123	38	[	[	X
iajs-1773	123	39	11	11	NUM
iajs-1773	123	40	]	]	PUNCT
iajs-1773	123	41	.	.	PUNCT
iajs-1773	124	1	harris	harris	PROPN
iajs-1773	124	2	et	et	PROPN
iajs-1773	124	3	al	al	PROPN
iajs-1773	124	4	.	.	PROPN
iajs-1773	124	5	revealed	reveal	VERB
iajs-1773	124	6	that	that	SCONJ
iajs-1773	124	7	the	the	DET
iajs-1773	124	8	significant	significant	ADJ
iajs-1773	124	9	increasing	increasing	NOUN
iajs-1773	124	10	of	of	ADP
iajs-1773	124	11	vitamin	vitamin	NOUN
iajs-1773	124	12	c	c	NOUN
iajs-1773	124	13	in	in	ADP
iajs-1773	124	14	serum	serum	NOUN
iajs-1773	124	15	level	level	NOUN
iajs-1773	124	16	was	be	AUX
iajs-1773	124	17	linked	link	VERB
iajs-1773	124	18	with	with	ADP
iajs-1773	124	19	a	a	DET
iajs-1773	124	20	lower	low	ADJ
iajs-1773	124	21	danger	danger	NOUN
iajs-1773	124	22	of	of	ADP
iajs-1773	124	23	total	total	ADJ
iajs-1773	124	24	death	death	NOUN
iajs-1773	124	25	–	–	PUNCT
iajs-1773	124	26	rate	rate	NOUN
iajs-1773	124	27	and	and	CCONJ
iajs-1773	124	28	breast	breast	NOUN
iajs-1773	124	29	cancer	cancer	NOUN
iajs-1773	124	30	particular	particular	ADJ
iajs-1773	124	31	death	death	NOUN
iajs-1773	124	32	–	–	PUNCT
iajs-1773	124	33	rate	rate	NOUN
iajs-1773	125	1	[	[	X
iajs-1773	125	2	45	45	NUM
iajs-1773	125	3	]	]	PUNCT
iajs-1773	125	4	.	.	PUNCT
iajs-1773	126	1	3.3	3.3	NUM
iajs-1773	126	2	.	.	PUNCT
iajs-1773	127	1	correlation	correlation	NOUN
iajs-1773	127	2	coefficient	coefficient	NOUN
iajs-1773	127	3	of	of	ADP
iajs-1773	127	4	integrin	integrin	PROPN
iajs-1773	127	5	α	α	PROPN
iajs-1773	127	6	2	2	NUM
iajs-1773	127	7	itga2	itga2	NOUN
iajs-1773	127	8	and	and	CCONJ
iajs-1773	127	9	other	other	ADJ
iajs-1773	127	10	parameters	parameter	NOUN
iajs-1773	127	11	data	datum	NOUN
iajs-1773	127	12	in	in	ADP
iajs-1773	127	13	(	(	PUNCT
iajs-1773	127	14	table	table	NOUN
iajs-1773	127	15	4	4	NUM
iajs-1773	127	16	)	)	PUNCT
iajs-1773	127	17	showed	show	VERB
iajs-1773	127	18	a	a	DET
iajs-1773	127	19	significant	significant	ADJ
iajs-1773	127	20	correlation	correlation	NOUN
iajs-1773	127	21	coefficient	coefficient	NOUN
iajs-1773	127	22	(	(	PUNCT
iajs-1773	127	23	p<0.05	p<0.05	NOUN
iajs-1773	127	24	)	)	PUNCT
iajs-1773	127	25	among	among	ADP
iajs-1773	127	26	itga2	itga2	NOUN
iajs-1773	127	27	,	,	PUNCT
iajs-1773	127	28	progesterone	progesterone	NOUN
iajs-1773	127	29	and	and	CCONJ
iajs-1773	127	30	vitamin	vitamin	NOUN
iajs-1773	127	31	c	c	NOUN
iajs-1773	127	32	while	while	SCONJ
iajs-1773	127	33	there	there	PRON
iajs-1773	127	34	was	be	VERB
iajs-1773	127	35	a	a	DET
iajs-1773	127	36	non	non	ADJ
iajs-1773	127	37	-	-	ADJ
iajs-1773	127	38	significant	significant	ADJ
iajs-1773	127	39	correlation	correlation	NOUN
iajs-1773	127	40	with	with	ADP
iajs-1773	127	41	other	other	ADJ
iajs-1773	127	42	parameters	parameter	NOUN
iajs-1773	127	43	(	(	PUNCT
iajs-1773	127	44	pr	pr	NOUN
iajs-1773	127	45	,	,	PUNCT
iajs-1773	127	46	es	es	NOUN
iajs-1773	127	47	,	,	PUNCT
iajs-1773	127	48	zn	zn	NOUN
iajs-1773	127	49	,	,	PUNCT
iajs-1773	127	50	age	age	NOUN
iajs-1773	127	51	)	)	PUNCT
iajs-1773	127	52	.	.	PUNCT
iajs-1773	128	1	table	table	NOUN
iajs-1773	128	2	(	(	PUNCT
iajs-1773	128	3	4	4	NUM
iajs-1773	128	4	):	):	PUNCT
iajs-1773	128	5	correlation	correlation	NOUN
iajs-1773	128	6	coefficient	coefficient	NOUN
iajs-1773	128	7	between	between	ADP
iajs-1773	128	8	itga2	itga2	PROPN
iajs-1773	128	9	and	and	CCONJ
iajs-1773	128	10	other	other	ADJ
iajs-1773	128	11	parameters	parameter	NOUN
iajs-1773	128	12	parameters	parameter	NOUN
iajs-1773	128	13	correlation	correlation	NOUN
iajs-1773	128	14	coefficient	coefficient	NOUN
iajs-1773	128	15	–	–	PUNCT
iajs-1773	128	16	r	r	NOUN
iajs-1773	128	17	with	with	ADP
iajs-1773	128	18	itga2	itga2	NOUN
iajs-1773	128	19	p	p	ADJ
iajs-1773	128	20	-	-	PUNCT
iajs-1773	128	21	value	value	NOUN
iajs-1773	128	22	progesterone	progesterone	NOUN
iajs-1773	128	23	0.24	0.24	NUM
iajs-1773	128	24	0.0493	0.0493	NUM
iajs-1773	128	25	*	*	PUNCT
iajs-1773	128	26	prolactin	prolactin	ADJ
iajs-1773	128	27	0.02	0.02	NUM
iajs-1773	128	28	0.905	0.905	NUM
iajs-1773	128	29	ns	ns	NUM
iajs-1773	128	30	estradiol	estradiol	PROPN
iajs-1773	128	31	0.09	0.09	NUM
iajs-1773	128	32	0.384	0.384	NUM
iajs-1773	128	33	ns	ns	NUM
iajs-1773	128	34	zinc	zinc	NOUN
iajs-1773	128	35	-0.05	-0.05	NUM
iajs-1773	128	36	0.626	0.626	NUM
iajs-1773	128	37	ns	ns	NUM
iajs-1773	128	38	vitamin	vitamin	NOUN
iajs-1773	128	39	.	.	PUNCT
iajs-1773	129	1	c	c	NOUN
iajs-1773	129	2	0.26	0.26	NUM
iajs-1773	129	3	0.0460	0.0460	NUM
iajs-1773	129	4	*	*	PUNCT
iajs-1773	129	5	age	age	NOUN
iajs-1773	129	6	0.14	0.14	NUM
iajs-1773	129	7	0.180	0.180	NUM
iajs-1773	129	8	ns	ns	PROPN
iajs-1773	129	9	*	*	PUNCT
iajs-1773	129	10	(	(	PUNCT
iajs-1773	129	11	p<0.05	p<0.05	NOUN
iajs-1773	129	12	)	)	PUNCT
iajs-1773	129	13	significant	significant	ADJ
iajs-1773	129	14	,	,	PUNCT
iajs-1773	129	15	ns	ns	NUM
iajs-1773	129	16	:	:	PUNCT
iajs-1773	129	17	non	non	ADJ
iajs-1773	129	18	-	-	ADJ
iajs-1773	129	19	significant	significant	ADJ
iajs-1773	129	20	.	.	PUNCT
iajs-1773	130	1	this	this	DET
iajs-1773	130	2	result	result	NOUN
iajs-1773	130	3	was	be	AUX
iajs-1773	130	4	agreeing	agree	VERB
iajs-1773	130	5	with	with	ADP
iajs-1773	130	6	ding	ding	NOUN
iajs-1773	130	7	et	et	NOUN
iajs-1773	130	8	al	al	PROPN
iajs-1773	131	1	[	[	X
iajs-1773	131	2	15	15	NUM
iajs-1773	131	3	]	]	PUNCT
iajs-1773	131	4	who	who	PRON
iajs-1773	131	5	revealed	reveal	VERB
iajs-1773	131	6	that	that	SCONJ
iajs-1773	131	7	integrin	integrin	PROPN
iajs-1773	131	8	α2	α2	PROPN
iajs-1773	131	9	itga2	itga2	PROPN
iajs-1773	131	10	protein	protein	NOUN
iajs-1773	131	11	level	level	NOUN
iajs-1773	131	12	in	in	ADP
iajs-1773	131	13	breast	breast	NOUN
iajs-1773	131	14	tissue	tissue	NOUN
iajs-1773	131	15	was	be	AUX
iajs-1773	131	16	not	not	PART
iajs-1773	131	17	correlation	correlation	NOUN
iajs-1773	131	18	with	with	ADP
iajs-1773	131	19	age	age	NOUN
iajs-1773	131	20	group	group	NOUN
iajs-1773	131	21	,	,	PUNCT
iajs-1773	131	22	estrogen	estrogen	NOUN
iajs-1773	131	23	and	and	CCONJ
iajs-1773	131	24	progesterone	progesterone	NOUN
iajs-1773	131	25	.	.	PUNCT
iajs-1773	132	1	sklidum	sklidum	PROPN
iajs-1773	132	2	et	et	PROPN
iajs-1773	132	3	al	al	PROPN
iajs-1773	132	4	.	.	PUNCT
iajs-1773	133	1	[	[	X
iajs-1773	133	2	47	47	NUM
iajs-1773	133	3	]	]	PUNCT
iajs-1773	133	4	who	who	PRON
iajs-1773	133	5	revealed	reveal	VERB
iajs-1773	133	6	that	that	SCONJ
iajs-1773	133	7	pr	pr	NOUN
iajs-1773	133	8	has	have	VERB
iajs-1773	133	9	a	a	DET
iajs-1773	133	10	diverse	diverse	ADJ
iajs-1773	133	11	function	function	NOUN
iajs-1773	133	12	as	as	ADP
iajs-1773	133	13	a	a	DET
iajs-1773	133	14	cytoplasmic	cytoplasmic	ADJ
iajs-1773	133	15	signaling	signal	VERB
iajs-1773	133	16	molecule	molecule	NOUN
iajs-1773	133	17	and	and	CCONJ
iajs-1773	133	18	as	as	ADP
iajs-1773	133	19	a	a	DET
iajs-1773	133	20	nuclear	nuclear	ADJ
iajs-1773	133	21	transcription	transcription	NOUN
iajs-1773	133	22	factor	factor	NOUN
iajs-1773	133	23	.	.	PUNCT
iajs-1773	134	1	the	the	DET
iajs-1773	134	2	loss	loss	NOUN
iajs-1773	134	3	of	of	ADP
iajs-1773	134	4	itga2	itga2	NOUN
iajs-1773	134	5	expression	expression	NOUN
iajs-1773	134	6	was	be	AUX
iajs-1773	134	7	helpful	helpful	ADJ
iajs-1773	134	8	for	for	ADP
iajs-1773	134	9	malignant	malignant	ADJ
iajs-1773	134	10	progression	progression	NOUN
iajs-1773	134	11	and	and	CCONJ
iajs-1773	134	12	metastasis	metastasis	PRON
iajs-1773	134	13	[	[	X
iajs-1773	134	14	15	15	NUM
iajs-1773	134	15	]	]	PUNCT
iajs-1773	134	16	.	.	PUNCT
iajs-1773	135	1	our	our	PRON
iajs-1773	135	2	data	datum	NOUN
iajs-1773	135	3	may	may	AUX
iajs-1773	135	4	explain	explain	VERB
iajs-1773	135	5	the	the	DET
iajs-1773	135	6	significant	significant	ADJ
iajs-1773	135	7	correlation	correlation	NOUN
iajs-1773	135	8	among	among	ADP
iajs-1773	135	9	integrin	integrin	NOUN
iajs-1773	135	10	,	,	PUNCT
iajs-1773	135	11	progesterone	progesterone	NOUN
iajs-1773	135	12	and	and	CCONJ
iajs-1773	135	13	vitamin	vitamin	NOUN
iajs-1773	135	14	c	c	NOUN
iajs-1773	135	15	,	,	PUNCT
iajs-1773	135	16	was	be	AUX
iajs-1773	135	17	based	base	VERB
iajs-1773	135	18	on	on	ADP
iajs-1773	135	19	their	their	PRON
iajs-1773	135	20	roles	role	NOUN
iajs-1773	135	21	whereas	whereas	SCONJ
iajs-1773	135	22	vitamin	vitamin	NOUN
iajs-1773	135	23	c	c	NOUN
iajs-1773	135	24	regulate	regulate	VERB
iajs-1773	135	25	ecm	ecm	NOUN
iajs-1773	135	26	which	which	DET
iajs-1773	135	27	integrin	integrin	NOUN
iajs-1773	135	28	considered	consider	VERB
iajs-1773	135	29	one	one	NUM
iajs-1773	135	30	of	of	ADP
iajs-1773	135	31	its	its	PRON
iajs-1773	135	32	components	component	NOUN
iajs-1773	135	33	,	,	PUNCT
iajs-1773	135	34	the	the	DET
iajs-1773	135	35	effects	effect	NOUN
iajs-1773	135	36	of	of	ADP
iajs-1773	135	37	ecm	ecm	NOUN
iajs-1773	135	38	are	be	AUX
iajs-1773	135	39	primarily	primarily	ADV
iajs-1773	135	40	mediated	mediate	VERB
iajs-1773	135	41	by	by	ADP
iajs-1773	135	42	integrin	integrin	NOUN
iajs-1773	135	43	,	,	PUNCT
iajs-1773	135	44	a	a	DET
iajs-1773	135	45	family	family	NOUN
iajs-1773	135	46	of	of	ADP
iajs-1773	135	47	cell	cell	NOUN
iajs-1773	135	48	surface	surface	NOUN
iajs-1773	135	49	receptor	receptor	NOUN
iajs-1773	135	50	that	that	PRON
iajs-1773	135	51	mediate	mediate	VERB
iajs-1773	135	52	the	the	DET
iajs-1773	135	53	mechanical	mechanical	ADJ
iajs-1773	135	54	and	and	CCONJ
iajs-1773	135	55	chemical	chemical	NOUN
iajs-1773	135	56	signals	signal	NOUN
iajs-1773	135	57	.these	.these	VERB
iajs-1773	135	58	signals	signal	NOUN
iajs-1773	135	59	are	be	AUX
iajs-1773	135	60	regulate	regulate	VERB
iajs-1773	135	61	the	the	DET
iajs-1773	135	62	activation	activation	NOUN
iajs-1773	135	63	of	of	ADP
iajs-1773	135	64	cytoplasmic	cytoplasmic	ADJ
iajs-1773	135	65	kinases	kinase	NOUN
iajs-1773	135	66	,	,	PUNCT
iajs-1773	135	67	growth	growth	NOUN
iajs-1773	135	68	factor	factor	NOUN
iajs-1773	135	69	receptor	receptor	NOUN
iajs-1773	135	70	,	,	PUNCT
iajs-1773	135	71	ion	ion	NOUN
iajs-1773	135	72	channels	channel	NOUN
iajs-1773	135	73	and	and	CCONJ
iajs-1773	135	74	control	control	VERB
iajs-1773	135	75	the	the	DET
iajs-1773	135	76	organization	organization	NOUN
iajs-1773	135	77	of	of	ADP
iajs-1773	135	78	intracellular	intracellular	ADJ
iajs-1773	135	79	actin	actin	NOUN
iajs-1773	135	80	cytoskeleton	cytoskeleton	NOUN
iajs-1773	135	81	.	.	PUNCT
iajs-1773	136	1	many	many	ADJ
iajs-1773	136	2	integrin	integrin	NOUN
iajs-1773	136	3	signals	signal	NOUN
iajs-1773	136	4	may	may	AUX
iajs-1773	136	5	regulate	regulate	VERB
iajs-1773	136	6	cell	cell	NOUN
iajs-1773	136	7	cycle	cycle	NOUN
iajs-1773	136	8	,	,	PUNCT
iajs-1773	136	9	directing	direct	VERB
iajs-1773	136	10	cell	cell	NOUN
iajs-1773	136	11	to	to	PART
iajs-1773	136	12	live	live	VERB
iajs-1773	136	13	or	or	CCONJ
iajs-1773	136	14	die	die	VERB
iajs-1773	136	15	,	,	PUNCT
iajs-1773	136	16	proliferate	proliferate	VERB
iajs-1773	136	17	and	and	CCONJ
iajs-1773	136	18	differentiate	differentiate	VERB
iajs-1773	136	19	as	as	ADV
iajs-1773	136	20	well	well	ADV
iajs-1773	136	21	as	as	ADP
iajs-1773	136	22	inhibition	inhibition	NOUN
iajs-1773	136	23	of	of	ADP
iajs-1773	136	24	cell	cell	NOUN
iajs-1773	136	25	growth	growth	NOUN
iajs-1773	136	26	by	by	ADP
iajs-1773	136	27	activation	activation	NOUN
iajs-1773	136	28	of	of	ADP
iajs-1773	136	29	transcription	transcription	NOUN
iajs-1773	136	30	factor	factor	NOUN
iajs-1773	136	31	(	(	PUNCT
iajs-1773	136	32	nf	nf	NOUN
iajs-1773	136	33	-	-	PUNCT
iajs-1773	136	34	kappa	kappa	ADJ
iajs-1773	136	35	)	)	PUNCT
iajs-1773	136	36	affected	affect	VERB
iajs-1773	136	37	by	by	ADP
iajs-1773	136	38	vitamin	vitamin	NOUN
iajs-1773	136	39	c.	c.	PROPN
iajs-1773	136	40	progesterone	progesterone	NOUN
iajs-1773	136	41	is	be	AUX
iajs-1773	136	42	also	also	ADV
iajs-1773	136	43	believe	believe	VERB
iajs-1773	136	44	to	to	PART
iajs-1773	136	45	mediate	mediate	VERB
iajs-1773	136	46	cell	cell	NOUN
iajs-1773	136	47	cycle	cycle	NOUN
iajs-1773	136	48	progression	progression	NOUN
iajs-1773	136	49	through	through	ADP
iajs-1773	136	50	activation	activation	NOUN
iajs-1773	136	51	of	of	ADP
iajs-1773	136	52	cytoplasmic	cytoplasmic	ADJ
iajs-1773	136	53	kinase	kinase	NOUN
iajs-1773	136	54	and	and	CCONJ
iajs-1773	136	55	independently	independently	ADV
iajs-1773	136	56	of	of	ADP
iajs-1773	136	57	direct	direct	ADJ
iajs-1773	136	58	regulation	regulation	NOUN
iajs-1773	136	59	of	of	ADP
iajs-1773	136	60	transcription	transcription	NOUN
iajs-1773	136	61	factors	factor	NOUN
iajs-1773	136	62	which	which	PRON
iajs-1773	136	63	involved	involve	VERB
iajs-1773	136	64	in	in	ADP
iajs-1773	136	65	cell	cell	NOUN
iajs-1773	136	66	cycle	cycle	NOUN
iajs-1773	136	67	progression	progression	NOUN
iajs-1773	136	68	;	;	PUNCT
iajs-1773	136	69	thus	thus	ADV
iajs-1773	136	70	the	the	DET
iajs-1773	136	71	loss	loss	NOUN
iajs-1773	136	72	of	of	ADP
iajs-1773	136	73	itga2	itga2	NOUN
iajs-1773	136	74	expression	expression	NOUN
iajs-1773	136	75	was	be	AUX
iajs-1773	136	76	helpful	helpful	ADJ
iajs-1773	136	77	for	for	ADP
iajs-1773	136	78	malignant	malignant	ADJ
iajs-1773	136	79	progression	progression	NOUN
iajs-1773	136	80	and	and	CCONJ
iajs-1773	136	81	metastasis	metastasis	NOUN
iajs-1773	136	82	.	.	PUNCT
iajs-1773	137	1	ihsciconf	ihsciconf	PROPN
iajs-1773	137	2	2017	2017	NUM
iajs-1773	137	3	special	special	ADJ
iajs-1773	137	4	issue	issue	NOUN
iajs-1773	137	5	ibn	ibn	PROPN
iajs-1773	137	6	al	al	PROPN
iajs-1773	137	7	-	-	PUNCT
iajs-1773	137	8	haitham	haitham	PROPN
iajs-1773	137	9	journal	journal	PROPN
iajs-1773	137	10	for	for	ADP
iajs-1773	137	11	pure	pure	ADJ
iajs-1773	137	12	and	and	CCONJ
iajs-1773	137	13	applied	apply	VERB
iajs-1773	137	14	science	science	NOUN
iajs-1773	137	15	https://doi.org/	https://doi.org/	NOUN
iajs-1773	137	16	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	137	17	.	.	PUNCT
iajs-1773	137	18	 	 	SPACE
iajs-1773	137	19	1773	1773	NUM
iajs-1773	137	20	for	for	ADP
iajs-1773	137	21	more	more	ADJ
iajs-1773	137	22	information	information	NOUN
iajs-1773	137	23	about	about	ADP
iajs-1773	137	24	the	the	DET
iajs-1773	137	25	conference	conference	NOUN
iajs-1773	137	26	please	please	INTJ
iajs-1773	137	27	visit	visit	VERB
iajs-1773	137	28	the	the	DET
iajs-1773	137	29	websites	website	NOUN
iajs-1773	137	30	:	:	PUNCT
iajs-1773	137	31	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	137	32	  	  	SPACE
iajs-1773	137	33	www.ihsciconf.org	www.ihsciconf.org	NOUN
iajs-1773	137	34	  	  	SPACE
iajs-1773	137	35	biology|79	biology|79	X
iajs-1773	137	36	3.4	3.4	NUM
iajs-1773	137	37	.	.	PUNCT
iajs-1773	138	1	associated	associate	VERB
iajs-1773	138	2	of	of	ADP
iajs-1773	138	3	all	all	DET
iajs-1773	138	4	parameters	parameter	NOUN
iajs-1773	138	5	with	with	ADP
iajs-1773	138	6	clinical	clinical	ADJ
iajs-1773	138	7	histological	histological	ADJ
iajs-1773	138	8	characteristics	characteristic	NOUN
iajs-1773	138	9	3.4.1	3.4.1	NUM
iajs-1773	138	10	.	.	PUNCT
iajs-1773	139	1	integrin	integrin	NOUN
iajs-1773	139	2	as	as	SCONJ
iajs-1773	139	3	shown	show	VERB
iajs-1773	139	4	in	in	ADP
iajs-1773	139	5	table	table	NOUN
iajs-1773	139	6	5	5	NUM
iajs-1773	139	7	which	which	PRON
iajs-1773	139	8	illustrated	illustrate	VERB
iajs-1773	139	9	the	the	DET
iajs-1773	139	10	association	association	NOUN
iajs-1773	139	11	of	of	ADP
iajs-1773	139	12	all	all	DET
iajs-1773	139	13	parameters	parameter	NOUN
iajs-1773	139	14	with	with	ADP
iajs-1773	139	15	histological	histological	ADJ
iajs-1773	139	16	characteristic	characteristic	NOUN
iajs-1773	139	17	,	,	PUNCT
iajs-1773	139	18	there	there	PRON
iajs-1773	139	19	was	be	VERB
iajs-1773	139	20	no	no	DET
iajs-1773	139	21	significant	significant	ADJ
iajs-1773	139	22	difference	difference	NOUN
iajs-1773	139	23	and	and	CCONJ
iajs-1773	139	24	the	the	DET
iajs-1773	139	25	result	result	NOUN
iajs-1773	139	26	of	of	ADP
iajs-1773	139	27	the	the	DET
iajs-1773	139	28	tumor	tumor	NOUN
iajs-1773	139	29	histological	histological	ADJ
iajs-1773	139	30	type	type	NOUN
iajs-1773	139	31	,	,	PUNCT
iajs-1773	139	32	stage	stage	NOUN
iajs-1773	139	33	,	,	PUNCT
iajs-1773	139	34	grade	grade	NOUN
iajs-1773	139	35	,	,	PUNCT
iajs-1773	139	36	age	age	NOUN
iajs-1773	139	37	groups	group	NOUN
iajs-1773	139	38	were	be	AUX
iajs-1773	139	39	(	(	PUNCT
iajs-1773	139	40	25.04±7.67+++	25.04±7.67+++	ADP
iajs-1773	139	41	,	,	PUNCT
iajs-1773	139	42	34.12±0.00	34.12±0.00	NUM
iajs-1773	139	43	+	+	ADJ
iajs-1773	139	44	,	,	PUNCT
iajs-1773	139	45	29.76±7.22+++	29.76±7.22+++	NUM
iajs-1773	139	46	,	,	PUNCT
iajs-1773	139	47	23.82±4.96	23.82±4.96	PROPN
iajs-1773	139	48	+	+	PROPN
iajs-1773	139	49	,	,	PUNCT
iajs-1773	139	50	27.54±6.21++	27.54±6.21++	NUM
iajs-1773	139	51	,	,	PUNCT
iajs-1773	139	52	26.03±2.96+++	26.03±2.96+++	NUM
iajs-1773	139	53	,	,	PUNCT
iajs-1773	139	54	22.50±2.17	22.50±2.17	PROPN
iajs-1773	139	55	+	+	PROPN
iajs-1773	139	56	,	,	PUNCT
iajs-1773	139	57	26.24±3.84+++	26.24±3.84+++	NUM
iajs-1773	139	58	,	,	PUNCT
iajs-1773	139	59	26.22±3.75+++,33.17±5.88+++	26.22±3.75+++,33.17±5.88+++	NUM
iajs-1773	139	60	,	,	PUNCT
iajs-1773	139	61	22.68±4.07	22.68±4.07	NUM
iajs-1773	139	62	+	+	ADJ
iajs-1773	139	63	,	,	PUNCT
iajs-1773	139	64	27.29±8.64++	27.29±8.64++	NOUN
iajs-1773	139	65	)	)	PUNCT
iajs-1773	139	66	respectively	respectively	ADV
iajs-1773	139	67	.	.	PUNCT
iajs-1773	140	1	our	our	PRON
iajs-1773	140	2	study	study	NOUN
iajs-1773	140	3	showed	show	VERB
iajs-1773	140	4	that	that	SCONJ
iajs-1773	140	5	itga2	itga2	NOUN
iajs-1773	140	6	protein	protein	NOUN
iajs-1773	140	7	level	level	NOUN
iajs-1773	140	8	in	in	ADP
iajs-1773	140	9	serum	serum	NOUN
iajs-1773	140	10	was	be	AUX
iajs-1773	140	11	no	no	DET
iajs-1773	140	12	association	association	NOUN
iajs-1773	140	13	with	with	ADP
iajs-1773	140	14	all	all	DET
iajs-1773	140	15	data	datum	NOUN
iajs-1773	140	16	,	,	PUNCT
iajs-1773	140	17	this	this	DET
iajs-1773	140	18	result	result	NOUN
iajs-1773	140	19	was	be	AUX
iajs-1773	140	20	agreeing	agree	VERB
iajs-1773	140	21	with	with	ADP
iajs-1773	140	22	ding	ding	NOUN
iajs-1773	140	23	et	et	NOUN
iajs-1773	140	24	al	al	PROPN
iajs-1773	141	1	[	[	X
iajs-1773	141	2	15	15	NUM
iajs-1773	141	3	]	]	PUNCT
iajs-1773	141	4	who	who	PRON
iajs-1773	141	5	revealed	reveal	VERB
iajs-1773	141	6	that	that	SCONJ
iajs-1773	141	7	itga2	itga2	NOUN
iajs-1773	141	8	protein	protein	NOUN
iajs-1773	141	9	level	level	NOUN
iajs-1773	141	10	was	be	AUX
iajs-1773	141	11	not	not	PART
iajs-1773	141	12	related	relate	VERB
iajs-1773	141	13	to	to	ADP
iajs-1773	141	14	tnm	tnm	NUM
iajs-1773	141	15	stage	stage	NOUN
iajs-1773	141	16	,	,	PUNCT
iajs-1773	141	17	histological	histological	ADJ
iajs-1773	141	18	grad	grad	NOUN
iajs-1773	141	19	,	,	PUNCT
iajs-1773	141	20	age	age	NOUN
iajs-1773	141	21	group	group	NOUN
iajs-1773	141	22	.	.	PUNCT
iajs-1773	142	1	table	table	NOUN
iajs-1773	142	2	(	(	PUNCT
iajs-1773	142	3	5	5	NUM
iajs-1773	142	4	):	):	PUNCT
iajs-1773	142	5	association	association	NOUN
iajs-1773	142	6	of	of	ADP
iajs-1773	142	7	serum	serum	PROPN
iajs-1773	142	8	integrin	integrin	PROPN
iajs-1773	142	9	α2	α2	PROPN
iajs-1773	142	10	itga2	itga2	PROPN
iajs-1773	143	1	(	(	PUNCT
iajs-1773	143	2	ng	ng	PROPN
iajs-1773	143	3	/	/	SYM
iajs-1773	143	4	ml	ml	NOUN
iajs-1773	143	5	)	)	PUNCT
iajs-1773	143	6	level	level	NOUN
iajs-1773	143	7	with	with	ADP
iajs-1773	143	8	clinical	clinical	ADJ
iajs-1773	143	9	histological	histological	ADJ
iajs-1773	143	10	characteristics	characteristic	NOUN
iajs-1773	143	11	.	.	PUNCT
iajs-1773	144	1	value	value	NOUN
iajs-1773	144	2	lsd	lsd	NOUN
iajs-1773	144	3	se±mean	se±mean	NOUN
iajs-1773	144	4	no	no	DET
iajs-1773	144	5	characteristic	characteristic	ADJ
iajs-1773	144	6	17.348	17.348	NUM
iajs-1773	144	7	ns	ns	NUM
iajs-1773	144	8	25.04±7.67	25.04±7.67	PROPN
iajs-1773	144	9	(	(	PUNCT
iajs-1773	144	10	+	+	PROPN
iajs-1773	144	11	+	+	ADJ
iajs-1773	144	12	+	+	NOUN
iajs-1773	144	13	)	)	PUNCT
iajs-1773	144	14	34.12±0.00	34.12±0.00	NUM
iajs-1773	144	15	(	(	PUNCT
iajs-1773	144	16	+	+	NOUN
iajs-1773	144	17	)	)	PUNCT
iajs-1773	144	18	67	67	NUM
iajs-1773	144	19	1	1	NUM
iajs-1773	144	20	histilogic	histilogic	NOUN
iajs-1773	144	21	subtype	subtype	NOUN
iajs-1773	144	22	ductal	ductal	NOUN
iajs-1773	144	23	lobular	lobular	ADJ
iajs-1773	144	24	8.048	8.048	NUM
iajs-1773	144	25	ns	ns	NUM
iajs-1773	144	26	29.76±7.22	29.76±7.22	NUM
iajs-1773	144	27	(	(	PUNCT
iajs-1773	144	28	+	+	PROPN
iajs-1773	144	29	+	+	ADJ
iajs-1773	144	30	+	+	ADJ
iajs-1773	144	31	)	)	PUNCT
iajs-1773	144	32	23.82±4.96	23.82±4.96	NUM
iajs-1773	144	33	(	(	PUNCT
iajs-1773	144	34	+	+	NOUN
iajs-1773	144	35	)	)	PUNCT
iajs-1773	144	36	27.54±6.21(++	27.54±6.21(++	NOUN
iajs-1773	144	37	)	)	PUNCT
iajs-1773	144	38	4	4	NUM
iajs-1773	144	39	46	46	NUM
iajs-1773	144	40	18	18	NUM
iajs-1773	144	41	grade	grade	NOUN
iajs-1773	144	42	1	1	NUM
iajs-1773	144	43	2	2	NUM
iajs-1773	144	44	3	3	NUM
iajs-1773	144	45	9.975	9.975	NUM
iajs-1773	144	46	ns	ns	NUM
iajs-1773	144	47	26.03±2.96	26.03±2.96	PROPN
iajs-1773	144	48	(	(	PUNCT
iajs-1773	144	49	+	+	PROPN
iajs-1773	144	50	+	+	ADJ
iajs-1773	144	51	+	+	NOUN
iajs-1773	144	52	)	)	PUNCT
iajs-1773	144	53	22.50±2.17	22.50±2.17	PROPN
iajs-1773	144	54	(	(	PUNCT
iajs-1773	144	55	+	+	NOUN
iajs-1773	144	56	)	)	PUNCT
iajs-1773	144	57	26.24±3.84	26.24±3.84	PROPN
iajs-1773	144	58	(	(	PUNCT
iajs-1773	144	59	+	+	ADJ
iajs-1773	144	60	+	+	ADJ
iajs-1773	144	61	+	+	NOUN
iajs-1773	144	62	)	)	PUNCT
iajs-1773	144	63	26.22±3.75	26.22±3.75	NUM
iajs-1773	144	64	(	(	PUNCT
iajs-1773	144	65	+	+	PROPN
iajs-1773	144	66	+	+	NOUN
iajs-1773	144	67	+	+	NOUN
iajs-1773	144	68	)	)	PUNCT
iajs-1773	144	69	46	46	NUM
iajs-1773	144	70	9	9	NUM
iajs-1773	144	71	7	7	NUM
iajs-1773	144	72	6	6	NUM
iajs-1773	144	73	stage	stage	NOUN
iajs-1773	144	74	bii	bii	NOUN
iajs-1773	144	75	aii	aii	PROPN
iajs-1773	144	76	ciii	ciii	PROPN
iajs-1773	144	77	aiii	aiii	VERB
iajs-1773	144	78	14.478ns	14.478ns	NUM
iajs-1773	144	79	33.17±5.88(+++	33.17±5.88(+++	NUM
iajs-1773	144	80	)	)	PUNCT
iajs-1773	145	1	22.68±4.07(+	22.68±4.07(+	NUM
iajs-1773	145	2	)	)	PUNCT
iajs-1773	145	3	27.29±8.64(++	27.29±8.64(++	NUM
iajs-1773	145	4	)	)	PUNCT
iajs-1773	145	5	16	16	NUM
iajs-1773	145	6	30	30	NUM
iajs-1773	145	7	22	22	NUM
iajs-1773	145	8	age	age	NOUN
iajs-1773	145	9	(	(	PUNCT
iajs-1773	145	10	25	25	NUM
iajs-1773	145	11	-	-	SYM
iajs-1773	145	12	55	55	NUM
iajs-1773	145	13	)	)	PUNCT
iajs-1773	145	14	less	less	ADJ
iajs-1773	145	15	than	than	ADP
iajs-1773	145	16	35	35	NUM
iajs-1773	145	17	35	35	NUM
iajs-1773	145	18	-	-	SYM
iajs-1773	145	19	45	45	NUM
iajs-1773	145	20	more	more	ADJ
iajs-1773	145	21	than	than	ADP
iajs-1773	145	22	45	45	NUM
iajs-1773	145	23	ns	ns	NUM
iajs-1773	145	24	:	:	PUNCT
iajs-1773	145	25	non	non	ADJ
iajs-1773	145	26	-	-	ADJ
iajs-1773	145	27	significant	significant	ADJ
iajs-1773	145	28	low	low	ADJ
iajs-1773	145	29	(	(	PUNCT
iajs-1773	145	30	+	+	NOUN
iajs-1773	145	31	)	)	PUNCT
iajs-1773	145	32	,	,	PUNCT
iajs-1773	145	33	medium(++	medium(++	PROPN
iajs-1773	145	34	)	)	PUNCT
iajs-1773	145	35	,	,	PUNCT
iajs-1773	145	36	high	high	ADJ
iajs-1773	145	37	(	(	PUNCT
iajs-1773	145	38	+	+	ADJ
iajs-1773	145	39	+	+	ADJ
iajs-1773	145	40	+	+	ADJ
iajs-1773	145	41	)	)	PUNCT
iajs-1773	145	42	3.4.2	3.4.2	NUM
iajs-1773	145	43	.	.	PUNCT
iajs-1773	146	1	progesterone	progesterone	VERB
iajs-1773	146	2	the	the	DET
iajs-1773	146	3	result	result	NOUN
iajs-1773	146	4	of	of	ADP
iajs-1773	146	5	the	the	DET
iajs-1773	146	6	present	present	ADJ
iajs-1773	146	7	study	study	NOUN
iajs-1773	146	8	showed	show	VERB
iajs-1773	146	9	a	a	DET
iajs-1773	146	10	non	non	ADJ
iajs-1773	146	11	-	-	ADJ
iajs-1773	146	12	significant	significant	ADJ
iajs-1773	146	13	differences	difference	NOUN
iajs-1773	146	14	in	in	ADP
iajs-1773	146	15	association	association	NOUN
iajs-1773	146	16	between	between	ADP
iajs-1773	146	17	progesterone	progesterone	NOUN
iajs-1773	146	18	serum	serum	NOUN
iajs-1773	146	19	level	level	NOUN
iajs-1773	146	20	and	and	CCONJ
iajs-1773	146	21	the	the	DET
iajs-1773	146	22	histological	histological	ADJ
iajs-1773	146	23	properties	property	NOUN
iajs-1773	146	24	which	which	PRON
iajs-1773	146	25	included	include	VERB
iajs-1773	146	26	histological	histological	ADJ
iajs-1773	146	27	type	type	NOUN
iajs-1773	146	28	(	(	PUNCT
iajs-1773	146	29	ductal	ductal	NOUN
iajs-1773	146	30	and	and	CCONJ
iajs-1773	146	31	lobular	lobular	ADJ
iajs-1773	146	32	)	)	PUNCT
iajs-1773	146	33	the	the	DET
iajs-1773	146	34	result	result	NOUN
iajs-1773	146	35	of	of	ADP
iajs-1773	146	36	mean	mean	PROPN
iajs-1773	146	37	±	±	NUM
iajs-1773	146	38	se	se	X
iajs-1773	146	39	for	for	ADP
iajs-1773	146	40	the	the	DET
iajs-1773	146	41	progesterone	progesterone	NOUN
iajs-1773	146	42	serum	serum	NOUN
iajs-1773	146	43	level	level	NOUN
iajs-1773	146	44	were	be	AUX
iajs-1773	146	45	(	(	PUNCT
iajs-1773	146	46	6.32	6.32	NUM
iajs-1773	146	47	±	±	NUM
iajs-1773	146	48	2.71	2.71	NUM
iajs-1773	146	49	,	,	PUNCT
iajs-1773	146	50	6.12	6.12	NUM
iajs-1773	146	51	±	±	NUM
iajs-1773	146	52	0.00	0.00	NUM
iajs-1773	146	53	)	)	PUNCT
iajs-1773	146	54	respectively	respectively	ADV
iajs-1773	146	55	,	,	PUNCT
iajs-1773	146	56	grade	grade	NOUN
iajs-1773	146	57	1,2	1,2	NUM
iajs-1773	146	58	,	,	PUNCT
iajs-1773	146	59	3	3	NUM
iajs-1773	146	60	(	(	PUNCT
iajs-1773	146	61	6.13	6.13	NUM
iajs-1773	146	62	±	±	NUM
iajs-1773	146	63	1.97	1.97	NUM
iajs-1773	146	64	,	,	PUNCT
iajs-1773	146	65	5.43	5.43	NUM
iajs-1773	146	66	±	±	NUM
iajs-1773	146	67	2.03	2.03	NUM
iajs-1773	146	68	,	,	PUNCT
iajs-1773	146	69	8.59	8.59	NUM
iajs-1773	146	70	±	±	NUM
iajs-1773	146	71	2.94	2.94	NUM
iajs-1773	146	72	)	)	PUNCT
iajs-1773	146	73	respectively	respectively	ADV
iajs-1773	146	74	,	,	PUNCT
iajs-1773	146	75	while	while	SCONJ
iajs-1773	146	76	there	there	PRON
iajs-1773	146	77	was	be	VERB
iajs-1773	146	78	a	a	DET
iajs-1773	146	79	significant	significant	ADJ
iajs-1773	146	80	difference	difference	NOUN
iajs-1773	146	81	in	in	ADP
iajs-1773	146	82	association	association	NOUN
iajs-1773	146	83	between	between	ADP
iajs-1773	146	84	zinc	zinc	NOUN
iajs-1773	146	85	with	with	ADP
iajs-1773	146	86	stage	stage	NOUN
iajs-1773	146	87	ii	ii	PROPN
iajs-1773	146	88	b	b	PROPN
iajs-1773	146	89	,	,	PUNCT
iajs-1773	146	90	ii	ii	PROPN
iajs-1773	146	91	a	a	PRON
iajs-1773	146	92	,	,	PUNCT
iajs-1773	146	93	iii	iii	PROPN
iajs-1773	146	94	a	a	X
iajs-1773	146	95	,	,	PUNCT
iajs-1773	146	96	iii	iii	X
iajs-1773	146	97	c	c	NOUN
iajs-1773	146	98	the	the	DET
iajs-1773	146	99	result	result	NOUN
iajs-1773	146	100	was	be	AUX
iajs-1773	146	101	(	(	PUNCT
iajs-1773	146	102	5.66	5.66	NUM
iajs-1773	146	103	±	±	NUM
iajs-1773	146	104	0.81	0.81	NUM
iajs-1773	146	105	,	,	PUNCT
iajs-1773	146	106	6.22	6.22	NUM
iajs-1773	146	107	±	±	NUM
iajs-1773	146	108	1.04	1.04	NUM
iajs-1773	146	109	,	,	PUNCT
iajs-1773	146	110	14.38	14.38	NUM
iajs-1773	146	111	±	±	NUM
iajs-1773	146	112	1.16	1.16	NUM
iajs-1773	146	113	,	,	PUNCT
iajs-1773	146	114	7.74	7.74	NUM
iajs-1773	146	115	±	±	NUM
iajs-1773	146	116	1.13	1.13	NUM
iajs-1773	146	117	)	)	PUNCT
iajs-1773	146	118	respectively	respectively	ADV
iajs-1773	146	119	and	and	CCONJ
iajs-1773	146	120	for	for	ADP
iajs-1773	146	121	age	age	NOUN
iajs-1773	146	122	group	group	NOUN
iajs-1773	146	123	<	<	X
iajs-1773	146	124	35,35	35,35	NUM
iajs-1773	146	125	-	-	SYM
iajs-1773	146	126	45	45	NUM
iajs-1773	146	127	,	,	PUNCT
iajs-1773	146	128	>	>	X
iajs-1773	146	129	45	45	NUM
iajs-1773	146	130	the	the	DET
iajs-1773	146	131	result	result	NOUN
iajs-1773	146	132	was	be	AUX
iajs-1773	146	133	(	(	PUNCT
iajs-1773	146	134	2.74	2.74	NUM
iajs-1773	146	135	±	±	NUM
iajs-1773	146	136	0.87	0.87	NUM
iajs-1773	146	137	,	,	PUNCT
iajs-1773	146	138	5.75	5.75	NUM
iajs-1773	146	139	±	±	NUM
iajs-1773	146	140	2.35	2.35	NUM
iajs-1773	146	141	,	,	PUNCT
iajs-1773	146	142	5.01	5.01	NUM
iajs-1773	146	143	±	±	NUM
iajs-1773	146	144	1.82	1.82	NUM
iajs-1773	146	145	)	)	PUNCT
iajs-1773	146	146	respectively	respectively	ADV
iajs-1773	146	147	as	as	SCONJ
iajs-1773	146	148	described	describe	VERB
iajs-1773	146	149	in	in	ADP
iajs-1773	146	150	table	table	NOUN
iajs-1773	146	151	4	4	NUM
iajs-1773	146	152	-	-	SYM
iajs-1773	146	153	8	8	NUM
iajs-1773	146	154	.	.	PUNCT
iajs-1773	147	1	there	there	PRON
iajs-1773	147	2	is	be	VERB
iajs-1773	147	3	no	no	DET
iajs-1773	147	4	previous	previous	ADJ
iajs-1773	147	5	studies	study	NOUN
iajs-1773	147	6	that	that	PRON
iajs-1773	147	7	agree	agree	VERB
iajs-1773	147	8	or	or	CCONJ
iajs-1773	147	9	dis	dis	PRON
iajs-1773	147	10	agree	agree	VERB
iajs-1773	147	11	with	with	ADP
iajs-1773	147	12	our	our	PRON
iajs-1773	147	13	finding	finding	NOUN
iajs-1773	147	14	,	,	PUNCT
iajs-1773	147	15	but	but	CCONJ
iajs-1773	147	16	according	accord	VERB
iajs-1773	147	17	to	to	ADP
iajs-1773	147	18	the	the	DET
iajs-1773	147	19	present	present	ADJ
iajs-1773	147	20	result	result	NOUN
iajs-1773	147	21	we	we	PRON
iajs-1773	147	22	may	may	AUX
iajs-1773	147	23	conclude	conclude	VERB
iajs-1773	147	24	that	that	DET
iajs-1773	147	25	stage	stage	NOUN
iajs-1773	147	26	of	of	ADP
iajs-1773	147	27	breast	breast	NOUN
iajs-1773	147	28	cancer	cancer	NOUN
iajs-1773	147	29	and	and	CCONJ
iajs-1773	147	30	age	age	NOUN
iajs-1773	147	31	of	of	ADP
iajs-1773	147	32	patients	patient	NOUN
iajs-1773	147	33	affected	affect	VERB
iajs-1773	147	34	with	with	ADP
iajs-1773	147	35	the	the	DET
iajs-1773	147	36	level	level	NOUN
iajs-1773	147	37	of	of	ADP
iajs-1773	147	38	progesterone	progesterone	NOUN
iajs-1773	147	39	and	and	CCONJ
iajs-1773	147	40	the	the	DET
iajs-1773	147	41	most	most	ADV
iajs-1773	147	42	affected	affected	ADJ
iajs-1773	147	43	sub	sub	NOUN
iajs-1773	147	44	group	group	NOUN
iajs-1773	147	45	was	be	AUX
iajs-1773	147	46	stage	stage	NOUN
iajs-1773	147	47	which	which	PRON
iajs-1773	147	48	has	have	VERB
iajs-1773	147	49	the	the	DET
iajs-1773	147	50	highest	high	ADJ
iajs-1773	147	51	mean	mean	NOUN
iajs-1773	147	52	(	(	PUNCT
iajs-1773	147	53	14.38	14.38	NUM
iajs-1773	147	54	±	±	NUM
iajs-1773	147	55	1.16	1.16	NUM
iajs-1773	147	56	)	)	PUNCT
iajs-1773	147	57	and	and	CCONJ
iajs-1773	147	58	the	the	DET
iajs-1773	147	59	most	most	ADV
iajs-1773	147	60	affected	affected	ADJ
iajs-1773	147	61	age	age	NOUN
iajs-1773	147	62	sub	sub	NOUN
iajs-1773	147	63	group	group	NOUN
iajs-1773	147	64	was	be	AUX
iajs-1773	147	65	<	<	X
iajs-1773	147	66	35which	35which	PRON
iajs-1773	147	67	consider	consider	VERB
iajs-1773	147	68	the	the	DET
iajs-1773	147	69	youth	youth	NOUN
iajs-1773	147	70	age	age	NOUN
iajs-1773	147	71	.	.	PUNCT
iajs-1773	148	1	ihsciconf	ihsciconf	PROPN
iajs-1773	148	2	2017	2017	NUM
iajs-1773	148	3	special	special	ADJ
iajs-1773	148	4	issue	issue	NOUN
iajs-1773	148	5	ibn	ibn	PROPN
iajs-1773	148	6	al	al	PROPN
iajs-1773	148	7	-	-	PUNCT
iajs-1773	148	8	haitham	haitham	PROPN
iajs-1773	148	9	journal	journal	PROPN
iajs-1773	148	10	for	for	ADP
iajs-1773	148	11	pure	pure	ADJ
iajs-1773	148	12	and	and	CCONJ
iajs-1773	148	13	applied	apply	VERB
iajs-1773	148	14	science	science	NOUN
iajs-1773	148	15	https://doi.org/	https://doi.org/	NOUN
iajs-1773	148	16	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	148	17	.	.	PUNCT
iajs-1773	148	18	 	 	SPACE
iajs-1773	148	19	1773	1773	NUM
iajs-1773	148	20	for	for	ADP
iajs-1773	148	21	more	more	ADJ
iajs-1773	148	22	information	information	NOUN
iajs-1773	148	23	about	about	ADP
iajs-1773	148	24	the	the	DET
iajs-1773	148	25	conference	conference	NOUN
iajs-1773	148	26	please	please	INTJ
iajs-1773	148	27	visit	visit	VERB
iajs-1773	148	28	the	the	DET
iajs-1773	148	29	websites	website	NOUN
iajs-1773	148	30	:	:	PUNCT
iajs-1773	148	31	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	148	32	  	  	SPACE
iajs-1773	148	33	www.ihsciconf.org	www.ihsciconf.org	ADV
iajs-1773	148	34	  	  	SPACE
iajs-1773	148	35	biology|80	biology|80	PUNCT
iajs-1773	148	36	table	table	NOUN
iajs-1773	148	37	(	(	PUNCT
iajs-1773	148	38	6	6	NUM
iajs-1773	148	39	):	):	PUNCT
iajs-1773	148	40	association	association	NOUN
iajs-1773	148	41	of	of	ADP
iajs-1773	148	42	serum	serum	PROPN
iajs-1773	148	43	progesterone	progesterone	PROPN
iajs-1773	148	44	(	(	PUNCT
iajs-1773	148	45	pr	pr	NOUN
iajs-1773	148	46	)	)	PUNCT
iajs-1773	148	47	level	level	NOUN
iajs-1773	148	48	with	with	ADP
iajs-1773	148	49	clinical	clinical	ADJ
iajs-1773	148	50	histological	histological	ADJ
iajs-1773	148	51	characteristics	characteristic	NOUN
iajs-1773	148	52	pathology	pathology	NOUN
iajs-1773	148	53	no	no	PRON
iajs-1773	148	54	mean±se	mean±se	NOUN
iajs-1773	148	55	lsd	lsd	PROPN
iajs-1773	148	56	value	value	NOUN
iajs-1773	148	57	histological	histological	ADJ
iajs-1773	148	58	type	type	NOUN
iajs-1773	148	59	ductal	ductal	NOUN
iajs-1773	148	60	lobular	lobular	ADJ
iajs-1773	148	61	67	67	NUM
iajs-1773	148	62	1	1	NUM
iajs-1773	148	63	6.32	6.32	NUM
iajs-1773	148	64	±	±	NUM
iajs-1773	148	65	2.71	2.71	NUM
iajs-1773	148	66	6.12	6.12	NUM
iajs-1773	148	67	±	±	NUM
iajs-1773	148	68	0.00	0.00	NUM
iajs-1773	148	69	11.835	11.835	NUM
iajs-1773	148	70	ns	ns	NUM
iajs-1773	148	71	grade	grade	NOUN
iajs-1773	148	72	1	1	NUM
iajs-1773	148	73	2	2	NUM
iajs-1773	148	74	3	3	NUM
iajs-1773	148	75	4	4	NUM
iajs-1773	148	76	46	46	NUM
iajs-1773	148	77	18	18	NUM
iajs-1773	148	78	6.13	6.13	NUM
iajs-1773	148	79	±	±	NUM
iajs-1773	148	80	1.97	1.97	NUM
iajs-1773	148	81	5.43	5.43	NUM
iajs-1773	148	82	±	±	NUM
iajs-1773	148	83	2.03	2.03	NUM
iajs-1773	148	84	8.59	8.59	NUM
iajs-1773	148	85	±	±	NUM
iajs-1773	148	86	2.94	2.94	NUM
iajs-1773	148	87	5.490	5.490	NUM
iajs-1773	148	88	ns	ns	ADJ
iajs-1773	148	89	stage	stage	NOUN
iajs-1773	148	90	ii	ii	PROPN
iajs-1773	148	91	b	b	PROPN
iajs-1773	148	92	ii	ii	PROPN
iajs-1773	148	93	a	a	DET
iajs-1773	148	94	iii	iii	NOUN
iajs-1773	148	95	a	a	PRON
iajs-1773	148	96	iii	iii	NOUN
iajs-1773	148	97	c	c	NOUN
iajs-1773	148	98	46	46	NUM
iajs-1773	148	99	9	9	NUM
iajs-1773	148	100	7	7	NUM
iajs-1773	148	101	6	6	NUM
iajs-1773	148	102	5.66	5.66	NUM
iajs-1773	148	103	±	±	NUM
iajs-1773	148	104	0.81	0.81	NUM
iajs-1773	148	105	6.22	6.22	NUM
iajs-1773	148	106	±	±	NUM
iajs-1773	148	107	1.04	1.04	NUM
iajs-1773	148	108	14.38	14.38	NUM
iajs-1773	148	109	±	±	NUM
iajs-1773	148	110	1.16	1.16	NUM
iajs-1773	148	111	7.74	7.74	NUM
iajs-1773	148	112	±	±	NUM
iajs-1773	148	113	1.13	1.13	NUM
iajs-1773	148	114	6.031	6.031	NUM
iajs-1773	148	115	ns	ns	ADJ
iajs-1773	148	116	age	age	NOUN
iajs-1773	148	117	group	group	NOUN
iajs-1773	148	118	less	less	ADJ
iajs-1773	148	119	than	than	ADP
iajs-1773	148	120	35	35	NUM
iajs-1773	148	121	35	35	NUM
iajs-1773	148	122	-	-	SYM
iajs-1773	148	123	45	45	NUM
iajs-1773	148	124	more	more	ADJ
iajs-1773	148	125	than	than	ADP
iajs-1773	148	126	45	45	NUM
iajs-1773	148	127	16	16	NUM
iajs-1773	148	128	30	30	NUM
iajs-1773	148	129	22	22	NUM
iajs-1773	148	130	2.74	2.74	NUM
iajs-1773	148	131	±	±	NUM
iajs-1773	148	132	0.87	0.87	NUM
iajs-1773	148	133	5.75	5.75	NUM
iajs-1773	148	134	±	±	NUM
iajs-1773	148	135	2.35	2.35	NUM
iajs-1773	148	136	5.01	5.01	NUM
iajs-1773	148	137	±	±	NUM
iajs-1773	148	138	1.82	1.82	NUM
iajs-1773	148	139	9.877	9.877	NUM
iajs-1773	148	140	ns	ns	NUM
iajs-1773	148	141	ns	ns	PROPN
iajs-1773	148	142	(	(	PUNCT
iajs-1773	148	143	non	non	ADJ
iajs-1773	148	144	-	-	ADJ
iajs-1773	148	145	significant	significant	ADJ
iajs-1773	148	146	)	)	PUNCT
iajs-1773	148	147	4.3.3	4.3.3	NOUN
iajs-1773	148	148	.	.	PUNCT
iajs-1773	149	1	prolactin	prolactin	NOUN
iajs-1773	149	2	(	(	PUNCT
iajs-1773	149	3	plr	plr	NOUN
iajs-1773	149	4	)	)	PUNCT
iajs-1773	149	5	as	as	SCONJ
iajs-1773	149	6	shown	show	VERB
iajs-1773	149	7	in	in	ADP
iajs-1773	149	8	table	table	NOUN
iajs-1773	149	9	7	7	NUM
iajs-1773	149	10	.the	.the	PROPN
iajs-1773	149	11	association	association	NOUN
iajs-1773	149	12	of	of	ADP
iajs-1773	149	13	prolactin	prolactin	ADJ
iajs-1773	149	14	level	level	NOUN
iajs-1773	149	15	(	(	PUNCT
iajs-1773	149	16	plr	plr	NOUN
iajs-1773	149	17	)	)	PUNCT
iajs-1773	149	18	with	with	ADP
iajs-1773	149	19	histological	histological	ADJ
iajs-1773	149	20	study	study	NOUN
iajs-1773	149	21	showed	show	VERB
iajs-1773	149	22	a	a	DET
iajs-1773	149	23	significant	significant	ADJ
iajs-1773	149	24	differences	difference	NOUN
iajs-1773	149	25	start	start	VERB
iajs-1773	149	26	with	with	ADP
iajs-1773	149	27	histological	histological	ADJ
iajs-1773	149	28	type	type	NOUN
iajs-1773	149	29	(	(	PUNCT
iajs-1773	149	30	ductal	ductal	NOUN
iajs-1773	149	31	,	,	PUNCT
iajs-1773	149	32	lobular	lobular	ADJ
iajs-1773	149	33	)	)	PUNCT
iajs-1773	149	34	were	be	AUX
iajs-1773	149	35	(	(	PUNCT
iajs-1773	149	36	25.14	25.14	NUM
iajs-1773	149	37	±	±	NUM
iajs-1773	149	38	7.84	7.84	NUM
iajs-1773	149	39	,	,	PUNCT
iajs-1773	149	40	8.99	8.99	NUM
iajs-1773	149	41	±	±	NUM
iajs-1773	149	42	0.00	0.00	NUM
iajs-1773	149	43	)	)	PUNCT
iajs-1773	149	44	respectively	respectively	ADV
iajs-1773	149	45	,	,	PUNCT
iajs-1773	149	46	grade	grade	NOUN
iajs-1773	149	47	1	1	NUM
iajs-1773	149	48	,	,	PUNCT
iajs-1773	149	49	2	2	NUM
iajs-1773	149	50	,	,	PUNCT
iajs-1773	149	51	3	3	NUM
iajs-1773	149	52	(	(	PUNCT
iajs-1773	149	53	14.25	14.25	NUM
iajs-1773	149	54	±	±	NUM
iajs-1773	149	55	2.68	2.68	NUM
iajs-1773	149	56	,	,	PUNCT
iajs-1773	149	57	20.94	20.94	NUM
iajs-1773	149	58	±	±	NUM
iajs-1773	149	59	2.77	2.77	NUM
iajs-1773	149	60	,	,	PUNCT
iajs-1773	149	61	37.14	37.14	NUM
iajs-1773	149	62	±	±	NUM
iajs-1773	149	63	5.63	5.63	NUM
iajs-1773	149	64	)	)	PUNCT
iajs-1773	149	65	respectively	respectively	ADV
iajs-1773	149	66	(	(	PUNCT
iajs-1773	149	67	p	p	X
iajs-1773	149	68	<	<	X
iajs-1773	149	69	0.05	0.05	NUM
iajs-1773	149	70	)	)	PUNCT
iajs-1773	149	71	,	,	PUNCT
iajs-1773	149	72	while	while	SCONJ
iajs-1773	149	73	it	it	PRON
iajs-1773	149	74	has	have	AUX
iajs-1773	149	75	been	be	AUX
iajs-1773	149	76	recorded	record	VERB
iajs-1773	149	77	a	a	DET
iajs-1773	149	78	non	non	ADJ
iajs-1773	149	79	-	-	ADJ
iajs-1773	149	80	significant	significant	ADJ
iajs-1773	149	81	association	association	NOUN
iajs-1773	149	82	between	between	ADP
iajs-1773	149	83	all	all	DET
iajs-1773	149	84	stage	stage	NOUN
iajs-1773	149	85	i	i	PROPN
iajs-1773	149	86	b	b	PROPN
iajs-1773	149	87	,	,	PUNCT
iajs-1773	149	88	ii	ii	PROPN
iajs-1773	149	89	a	a	PRON
iajs-1773	149	90	,	,	PUNCT
iajs-1773	149	91	iii	iii	PROPN
iajs-1773	149	92	a	a	X
iajs-1773	149	93	,	,	PUNCT
iajs-1773	149	94	iii	iii	X
iajs-1773	149	95	c	c	NOUN
iajs-1773	149	96	the	the	DET
iajs-1773	149	97	result	result	NOUN
iajs-1773	149	98	was	be	AUX
iajs-1773	149	99	(	(	PUNCT
iajs-1773	149	100	27.49	27.49	NUM
iajs-1773	149	101	±	±	NUM
iajs-1773	149	102	2.67	2.67	NUM
iajs-1773	149	103	,	,	PUNCT
iajs-1773	149	104	18.41	18.41	NUM
iajs-1773	149	105	±	±	NUM
iajs-1773	149	106	2.58	2.58	NUM
iajs-1773	149	107	,	,	PUNCT
iajs-1773	149	108	24.73	24.73	NUM
iajs-1773	149	109	±	±	NUM
iajs-1773	149	110	2.61	2.61	NUM
iajs-1773	149	111	,	,	PUNCT
iajs-1773	149	112	17.73	17.73	NUM
iajs-1773	149	113	±	±	NUM
iajs-1773	149	114	3.42	3.42	NUM
iajs-1773	149	115	)	)	PUNCT
iajs-1773	149	116	respectively	respectively	ADV
iajs-1773	149	117	,	,	PUNCT
iajs-1773	149	118	and	and	CCONJ
iajs-1773	149	119	finally	finally	ADV
iajs-1773	149	120	for	for	ADP
iajs-1773	149	121	age	age	NOUN
iajs-1773	149	122	group	group	NOUN
iajs-1773	149	123	<	<	X
iajs-1773	149	124	35,35	35,35	NUM
iajs-1773	149	125	-	-	PUNCT
iajs-1773	149	126	45,>45	45,>45	NOUN
iajs-1773	149	127	(	(	PUNCT
iajs-1773	149	128	15.89	15.89	NUM
iajs-1773	149	129	±	±	NUM
iajs-1773	149	130	3.78	3.78	NUM
iajs-1773	149	131	,	,	PUNCT
iajs-1773	149	132	21.28	21.28	NUM
iajs-1773	149	133	±	±	NUM
iajs-1773	149	134	6.52	6.52	NUM
iajs-1773	149	135	,	,	PUNCT
iajs-1773	149	136	23.88	23.88	NUM
iajs-1773	149	137	±	±	NUM
iajs-1773	149	138	5.94	5.94	NUM
iajs-1773	149	139	)	)	PUNCT
iajs-1773	149	140	respectively	respectively	ADV
iajs-1773	149	141	.	.	PUNCT
iajs-1773	150	1	this	this	DET
iajs-1773	150	2	study	study	NOUN
iajs-1773	150	3	was	be	AUX
iajs-1773	150	4	agreeing	agree	VERB
iajs-1773	150	5	with	with	ADP
iajs-1773	150	6	hachim	hachim	PRON
iajs-1773	150	7	et	et	NOUN
iajs-1773	150	8	al	al	PROPN
iajs-1773	151	1	[	[	X
iajs-1773	151	2	23	23	NUM
iajs-1773	151	3	]	]	PUNCT
iajs-1773	151	4	.	.	PUNCT
iajs-1773	152	1	which	which	PRON
iajs-1773	152	2	it	it	PRON
iajs-1773	152	3	was	be	AUX
iajs-1773	152	4	disagree	disagree	VERB
iajs-1773	152	5	with	with	ADP
iajs-1773	152	6	hachim	hachim	PRON
iajs-1773	152	7	et	et	PROPN
iajs-1773	152	8	al	al	PROPN
iajs-1773	152	9	.	.	PUNCT
iajs-1773	153	1	[	[	X
iajs-1773	153	2	23	23	NUM
iajs-1773	153	3	]	]	PUNCT
iajs-1773	153	4	who	who	PRON
iajs-1773	153	5	estimated	estimate	VERB
iajs-1773	153	6	the	the	DET
iajs-1773	153	7	concentration	concentration	NOUN
iajs-1773	153	8	of	of	ADP
iajs-1773	153	9	prolactin	prolactin	NOUN
iajs-1773	153	10	in	in	ADP
iajs-1773	153	11	tissue	tissue	NOUN
iajs-1773	153	12	and	and	CCONJ
iajs-1773	153	13	recorded	record	VERB
iajs-1773	153	14	an	an	DET
iajs-1773	153	15	association	association	NOUN
iajs-1773	153	16	between	between	ADP
iajs-1773	153	17	plr	plr	NOUN
iajs-1773	153	18	and	and	CCONJ
iajs-1773	153	19	histological	histological	ADJ
iajs-1773	153	20	outcome	outcome	NOUN
iajs-1773	153	21	except	except	SCONJ
iajs-1773	153	22	the	the	DET
iajs-1773	153	23	stage	stage	NOUN
iajs-1773	153	24	which	which	PRON
iajs-1773	153	25	showed	show	VERB
iajs-1773	153	26	a	a	DET
iajs-1773	153	27	non	non	ADJ
iajs-1773	153	28	-	-	ADJ
iajs-1773	153	29	significant	significant	ADJ
iajs-1773	153	30	difference	difference	NOUN
iajs-1773	153	31	and	and	CCONJ
iajs-1773	153	32	has	have	VERB
iajs-1773	153	33	no	no	DET
iajs-1773	153	34	association	association	NOUN
iajs-1773	153	35	with	with	ADP
iajs-1773	153	36	plr	plr	NOUN
iajs-1773	153	37	level	level	NOUN
iajs-1773	153	38	in	in	ADP
iajs-1773	153	39	tissue	tissue	NOUN
iajs-1773	154	1	[	[	X
iajs-1773	154	2	23	23	NUM
iajs-1773	154	3	]	]	PUNCT
iajs-1773	154	4	.	.	PUNCT
iajs-1773	155	1	as	as	ADP
iajs-1773	155	2	a	a	DET
iajs-1773	155	3	conclusion	conclusion	NOUN
iajs-1773	155	4	there	there	PRON
iajs-1773	155	5	was	be	VERB
iajs-1773	155	6	a	a	DET
iajs-1773	155	7	significant	significant	ADJ
iajs-1773	155	8	linked	link	VERB
iajs-1773	155	9	between	between	ADP
iajs-1773	155	10	prolactin	prolactin	NOUN
iajs-1773	155	11	and	and	CCONJ
iajs-1773	155	12	prolonged	prolonged	ADJ
iajs-1773	155	13	distant	distant	ADJ
iajs-1773	155	14	metastasis	metastasis	NOUN
iajs-1773	155	15	–	–	PUNCT
iajs-1773	155	16	free	free	ADJ
iajs-1773	155	17	survival	survival	NOUN
iajs-1773	155	18	in	in	ADP
iajs-1773	155	19	breast	breast	NOUN
iajs-1773	155	20	cancer	cancer	NOUN
iajs-1773	155	21	patients	patient	NOUN
iajs-1773	155	22	.	.	PUNCT
iajs-1773	156	1	table	table	NOUN
iajs-1773	156	2	(	(	PUNCT
iajs-1773	156	3	7	7	NUM
iajs-1773	156	4	):	):	PUNCT
iajs-1773	156	5	association	association	NOUN
iajs-1773	156	6	of	of	ADP
iajs-1773	156	7	serum	serum	PROPN
iajs-1773	156	8	prl	prl	PROPN
iajs-1773	156	9	(	(	PUNCT
iajs-1773	156	10	prolactin	prolactin	NOUN
iajs-1773	156	11	)	)	PUNCT
iajs-1773	156	12	level	level	NOUN
iajs-1773	156	13	with	with	ADP
iajs-1773	156	14	clinical	clinical	ADJ
iajs-1773	156	15	histological	histological	ADJ
iajs-1773	156	16	characteristics	characteristic	NOUN
iajs-1773	156	17	.	.	PUNCT
iajs-1773	157	1	pathology	pathology	NOUN
iajs-1773	157	2	no	no	PRON
iajs-1773	157	3	mean±se	mean±se	NOUN
iajs-1773	157	4	lsd	lsd	PROPN
iajs-1773	157	5	value	value	NOUN
iajs-1773	157	6	histological	histological	ADJ
iajs-1773	157	7	type	type	NOUN
iajs-1773	157	8	ductal	ductal	NOUN
iajs-1773	157	9	lobular	lobular	ADJ
iajs-1773	157	10	67	67	NUM
iajs-1773	157	11	1	1	NUM
iajs-1773	157	12	25.14	25.14	NUM
iajs-1773	157	13	±	±	NUM
iajs-1773	157	14	7.84	7.84	NUM
iajs-1773	157	15	8.99	8.99	NUM
iajs-1773	157	16	±	±	NUM
iajs-1773	157	17	0.00	0.00	NUM
iajs-1773	157	18	11.53	11.53	NUM
iajs-1773	157	19	*	*	PUNCT
iajs-1773	157	20	grade	grade	NOUN
iajs-1773	157	21	1	1	NUM
iajs-1773	157	22	2	2	NUM
iajs-1773	157	23	3	3	NUM
iajs-1773	157	24	4	4	NUM
iajs-1773	157	25	46	46	NUM
iajs-1773	157	26	18	18	NUM
iajs-1773	157	27	14.25	14.25	NUM
iajs-1773	157	28	±	±	NUM
iajs-1773	157	29	2.68	2.68	NUM
iajs-1773	157	30	20.94	20.94	NUM
iajs-1773	157	31	±	±	NUM
iajs-1773	157	32	2.77	2.77	NUM
iajs-1773	157	33	37.14	37.14	NUM
iajs-1773	157	34	±	±	NUM
iajs-1773	157	35	5.63	5.63	NUM
iajs-1773	157	36	13.905	13.905	NUM
iajs-1773	157	37	*	*	PUNCT
iajs-1773	157	38	stage	stage	PROPN
iajs-1773	157	39	ii	ii	PROPN
iajs-1773	157	40	b	b	PROPN
iajs-1773	157	41	ii	ii	PROPN
iajs-1773	157	42	a	a	DET
iajs-1773	157	43	iii	iii	NOUN
iajs-1773	157	44	a	a	PRON
iajs-1773	157	45	iii	iii	NOUN
iajs-1773	157	46	c	c	NOUN
iajs-1773	157	47	46	46	NUM
iajs-1773	157	48	9	9	NUM
iajs-1773	157	49	7	7	NUM
iajs-1773	157	50	6	6	NUM
iajs-1773	157	51	27.49	27.49	NUM
iajs-1773	157	52	±	±	NUM
iajs-1773	157	53	2.67	2.67	NUM
iajs-1773	157	54	18.41	18.41	NUM
iajs-1773	157	55	±	±	NUM
iajs-1773	157	56	2.58	2.58	NUM
iajs-1773	157	57	24.73	24.73	NUM
iajs-1773	157	58	±	±	NUM
iajs-1773	157	59	2.61	2.61	NUM
iajs-1773	157	60	17.73	17.73	NUM
iajs-1773	157	61	±	±	NUM
iajs-1773	157	62	3.42	3.42	NUM
iajs-1773	157	63	28.591	28.591	NUM
iajs-1773	157	64	ns	ns	NUM
iajs-1773	157	65	age	age	NOUN
iajs-1773	157	66	group	group	NOUN
iajs-1773	157	67	less	less	ADJ
iajs-1773	157	68	than	than	ADP
iajs-1773	157	69	35	35	NUM
iajs-1773	157	70	35	35	NUM
iajs-1773	157	71	-	-	SYM
iajs-1773	157	72	45	45	NUM
iajs-1773	157	73	more	more	ADJ
iajs-1773	157	74	than	than	ADP
iajs-1773	157	75	45	45	NUM
iajs-1773	157	76	16	16	NUM
iajs-1773	157	77	30	30	NUM
iajs-1773	157	78	22	22	NUM
iajs-1773	157	79	15.89	15.89	NUM
iajs-1773	157	80	±	±	NUM
iajs-1773	157	81	3.78	3.78	NUM
iajs-1773	157	82	21.28	21.28	NUM
iajs-1773	157	83	±	±	NUM
iajs-1773	157	84	6.52	6.52	NUM
iajs-1773	157	85	23.88	23.88	NUM
iajs-1773	157	86	±	±	NUM
iajs-1773	157	87	5.94	5.94	NUM
iajs-1773	157	88	13.001	13.001	NUM
iajs-1773	157	89	ns	ns	NOUN
iajs-1773	157	90	*	*	PUNCT
iajs-1773	157	91	p	p	X
iajs-1773	157	92	<	<	X
iajs-1773	157	93	0.05	0.05	NUM
iajs-1773	157	94	significant	significant	ADJ
iajs-1773	157	95	,	,	PUNCT
iajs-1773	157	96	ns	ns	NUM
iajs-1773	157	97	(	(	PUNCT
iajs-1773	157	98	non	non	ADJ
iajs-1773	157	99	-	-	ADJ
iajs-1773	157	100	significant	significant	ADJ
iajs-1773	157	101	)	)	PUNCT
iajs-1773	157	102	ihsciconf	ihsciconf	NOUN
iajs-1773	157	103	2017	2017	NUM
iajs-1773	157	104	special	special	ADJ
iajs-1773	157	105	issue	issue	NOUN
iajs-1773	157	106	ibn	ibn	PROPN
iajs-1773	157	107	al	al	PROPN
iajs-1773	157	108	-	-	PUNCT
iajs-1773	157	109	haitham	haitham	PROPN
iajs-1773	157	110	journal	journal	PROPN
iajs-1773	157	111	for	for	ADP
iajs-1773	157	112	pure	pure	ADJ
iajs-1773	157	113	and	and	CCONJ
iajs-1773	157	114	applied	apply	VERB
iajs-1773	157	115	science	science	NOUN
iajs-1773	157	116	https://doi.org/	https://doi.org/	NOUN
iajs-1773	157	117	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	157	118	.	.	PUNCT
iajs-1773	157	119	 	 	SPACE
iajs-1773	157	120	1773	1773	NUM
iajs-1773	157	121	for	for	ADP
iajs-1773	157	122	more	more	ADJ
iajs-1773	157	123	information	information	NOUN
iajs-1773	157	124	about	about	ADP
iajs-1773	157	125	the	the	DET
iajs-1773	157	126	conference	conference	NOUN
iajs-1773	157	127	please	please	INTJ
iajs-1773	157	128	visit	visit	VERB
iajs-1773	157	129	the	the	DET
iajs-1773	157	130	websites	website	NOUN
iajs-1773	157	131	:	:	PUNCT
iajs-1773	157	132	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	157	133	  	  	SPACE
iajs-1773	157	134	www.ihsciconf.org	www.ihsciconf.org	NOUN
iajs-1773	157	135	  	  	SPACE
iajs-1773	157	136	biology|81	biology|81	PROPN
iajs-1773	157	137	3.4.4	3.4.4	NUM
iajs-1773	157	138	.	.	PUNCT
iajs-1773	157	139	estradiol	estradiol	PROPN
iajs-1773	157	140	as	as	SCONJ
iajs-1773	157	141	shown	show	VERB
iajs-1773	157	142	in	in	ADP
iajs-1773	157	143	table	table	NOUN
iajs-1773	157	144	8	8	NUM
iajs-1773	157	145	,	,	PUNCT
iajs-1773	157	146	there	there	PRON
iajs-1773	157	147	was	be	VERB
iajs-1773	157	148	no	no	DET
iajs-1773	157	149	association	association	NOUN
iajs-1773	157	150	between	between	ADP
iajs-1773	157	151	estradiol	estradiol	PROPN
iajs-1773	157	152	(	(	PUNCT
iajs-1773	157	153	e2	e2	PROPN
iajs-1773	157	154	)	)	PUNCT
iajs-1773	157	155	serum	serum	NOUN
iajs-1773	157	156	level	level	NOUN
iajs-1773	157	157	with	with	ADP
iajs-1773	157	158	the	the	DET
iajs-1773	157	159	tumor	tumor	NOUN
iajs-1773	157	160	histological	histological	VERB
iajs-1773	157	161	out	out	ADP
iajs-1773	157	162	come	come	VERB
iajs-1773	158	1	and	and	CCONJ
iajs-1773	158	2	there	there	PRON
iajs-1773	158	3	was	be	VERB
iajs-1773	158	4	no	no	DET
iajs-1773	158	5	significant	significant	ADJ
iajs-1773	158	6	difference	difference	NOUN
iajs-1773	158	7	by	by	ADP
iajs-1773	158	8	using	use	VERB
iajs-1773	158	9	lsd	lsd	NOUN
iajs-1773	158	10	the	the	DET
iajs-1773	158	11	result	result	NOUN
iajs-1773	158	12	was	be	AUX
iajs-1773	158	13	as	as	ADV
iajs-1773	158	14	follow	follow	VERB
iajs-1773	158	15	,	,	PUNCT
iajs-1773	158	16	the	the	DET
iajs-1773	158	17	mean	mean	ADJ
iajs-1773	158	18	±se	±se	NOUN
iajs-1773	158	19	of	of	ADP
iajs-1773	158	20	e2	e2	PROPN
iajs-1773	158	21	for	for	ADP
iajs-1773	158	22	the	the	DET
iajs-1773	158	23	histological	histological	ADJ
iajs-1773	158	24	type	type	NOUN
iajs-1773	158	25	(	(	PUNCT
iajs-1773	158	26	ductal	ductal	NOUN
iajs-1773	158	27	,	,	PUNCT
iajs-1773	158	28	lobular	lobular	ADJ
iajs-1773	158	29	)	)	PUNCT
iajs-1773	158	30	were	be	AUX
iajs-1773	158	31	(	(	PUNCT
iajs-1773	158	32	541.50±	541.50±	NUM
iajs-1773	158	33	138.2	138.2	NUM
iajs-1773	158	34	,	,	PUNCT
iajs-1773	158	35	503.10	503.10	NUM
iajs-1773	158	36	±	±	NUM
iajs-1773	158	37	0.00	0.00	NUM
iajs-1773	158	38	)	)	PUNCT
iajs-1773	158	39	respectively	respectively	ADV
iajs-1773	158	40	.	.	PUNCT
iajs-1773	159	1	for	for	ADP
iajs-1773	159	2	grade	grade	NOUN
iajs-1773	159	3	1	1	NUM
iajs-1773	159	4	,	,	PUNCT
iajs-1773	159	5	2	2	NUM
iajs-1773	159	6	,	,	PUNCT
iajs-1773	159	7	3	3	NUM
iajs-1773	159	8	were	be	AUX
iajs-1773	159	9	(	(	PUNCT
iajs-1773	159	10	477.70	477.70	NUM
iajs-1773	159	11	±	±	NUM
iajs-1773	159	12	116.3	116.3	NUM
iajs-1773	159	13	,	,	PUNCT
iajs-1773	159	14	535.04	535.04	NUM
iajs-1773	159	15	±	±	NOUN
iajs-1773	159	16	84.2	84.2	NUM
iajs-1773	159	17	,	,	PUNCT
iajs-1773	159	18	569.52	569.52	NUM
iajs-1773	159	19	±	±	NUM
iajs-1773	159	20	136.4	136.4	NUM
iajs-1773	159	21	)	)	PUNCT
iajs-1773	159	22	respectively	respectively	ADV
iajs-1773	159	23	.	.	PUNCT
iajs-1773	160	1	for	for	ADP
iajs-1773	160	2	stage	stage	NOUN
iajs-1773	160	3	ii	ii	PROPN
iajs-1773	160	4	b	b	PROPN
iajs-1773	160	5	,	,	PUNCT
iajs-1773	160	6	ii	ii	PROPN
iajs-1773	160	7	a	a	PRON
iajs-1773	160	8	,	,	PUNCT
iajs-1773	160	9	iii	iii	PROPN
iajs-1773	160	10	a	a	X
iajs-1773	160	11	,	,	PUNCT
iajs-1773	160	12	iii	iii	X
iajs-1773	160	13	c	c	NOUN
iajs-1773	160	14	were	be	AUX
iajs-1773	160	15	(	(	PUNCT
iajs-1773	160	16	547.06	547.06	NUM
iajs-1773	160	17	±	±	NUM
iajs-1773	160	18	94.24	94.24	NUM
iajs-1773	160	19	,	,	PUNCT
iajs-1773	160	20	452.07	452.07	NUM
iajs-1773	160	21	±	±	NUM
iajs-1773	160	22	78.12	78.12	NUM
iajs-1773	160	23	,	,	PUNCT
iajs-1773	160	24	563.41	563.41	NUM
iajs-1773	160	25	±	±	NUM
iajs-1773	160	26	102.7	102.7	NUM
iajs-1773	160	27	,	,	PUNCT
iajs-1773	160	28	496.53	496.53	NUM
iajs-1773	160	29	±	±	NUM
iajs-1773	160	30	85.61	85.61	NUM
iajs-1773	160	31	)	)	PUNCT
iajs-1773	160	32	respectively	respectively	ADV
iajs-1773	160	33	,	,	PUNCT
iajs-1773	160	34	and	and	CCONJ
iajs-1773	160	35	finally	finally	ADV
iajs-1773	160	36	for	for	ADP
iajs-1773	160	37	age	age	NOUN
iajs-1773	160	38	group	group	NOUN
iajs-1773	160	39	(	(	PUNCT
iajs-1773	160	40	<	<	X
iajs-1773	160	41	35,35	35,35	NUM
iajs-1773	160	42	-	-	SYM
iajs-1773	160	43	45	45	NUM
iajs-1773	160	44	,	,	PUNCT
iajs-1773	160	45	>	>	X
iajs-1773	160	46	45	45	NUM
iajs-1773	160	47	)	)	PUNCT
iajs-1773	160	48	were	be	AUX
iajs-1773	160	49	(	(	PUNCT
iajs-1773	160	50	537.18	537.18	NUM
iajs-1773	160	51	±	±	NOUN
iajs-1773	160	52	135.9	135.9	NUM
iajs-1773	160	53	,	,	PUNCT
iajs-1773	160	54	553.91	553.91	NUM
iajs-1773	160	55	±	±	NUM
iajs-1773	160	56	109.5	109.5	NUM
iajs-1773	160	57	,	,	PUNCT
iajs-1773	160	58	528.73	528.73	NUM
iajs-1773	160	59	±	±	NUM
iajs-1773	160	60	97.2	97.2	NUM
iajs-1773	160	61	respectively	respectively	ADV
iajs-1773	160	62	.	.	PUNCT
iajs-1773	161	1	table	table	NOUN
iajs-1773	161	2	(	(	PUNCT
iajs-1773	161	3	8	8	NUM
iajs-1773	161	4	:)	:)	INTJ
iajs-1773	161	5	association	association	NOUN
iajs-1773	161	6	of	of	ADP
iajs-1773	161	7	serum	serum	PROPN
iajs-1773	161	8	estradiol	estradiol	PROPN
iajs-1773	161	9	(	(	PUNCT
iajs-1773	161	10	e2	e2	PROPN
iajs-1773	161	11	)	)	PUNCT
iajs-1773	161	12	level	level	NOUN
iajs-1773	161	13	with	with	ADP
iajs-1773	161	14	clinical	clinical	ADJ
iajs-1773	161	15	histological	histological	ADJ
iajs-1773	161	16	characteristics	characteristic	NOUN
iajs-1773	161	17	.	.	PUNCT
iajs-1773	162	1	pathology	pathology	NOUN
iajs-1773	162	2	no	no	PRON
iajs-1773	162	3	mean±se	mean±se	NOUN
iajs-1773	162	4	lsd	lsd	PROPN
iajs-1773	162	5	value	value	NOUN
iajs-1773	162	6	histological	histological	ADJ
iajs-1773	162	7	type	type	NOUN
iajs-1773	162	8	ductal	ductal	NOUN
iajs-1773	162	9	lobular	lobular	ADJ
iajs-1773	162	10	67	67	NUM
iajs-1773	162	11	1	1	NUM
iajs-1773	162	12	541.50	541.50	NUM
iajs-1773	162	13	±	±	NUM
iajs-1773	162	14	138.2	138.2	NUM
iajs-1773	162	15	503.10	503.10	NUM
iajs-1773	162	16	±	±	NUM
iajs-1773	162	17	0.00	0.00	NUM
iajs-1773	162	18	229.81	229.81	NUM
iajs-1773	162	19	ns	ns	ADJ
iajs-1773	162	20	grade	grade	NOUN
iajs-1773	162	21	1	1	NUM
iajs-1773	162	22	2	2	NUM
iajs-1773	162	23	3	3	NUM
iajs-1773	162	24	4	4	NUM
iajs-1773	162	25	46	46	NUM
iajs-1773	162	26	18	18	NUM
iajs-1773	162	27	477.70	477.70	NUM
iajs-1773	162	28	±	±	NUM
iajs-1773	162	29	116.3	116.3	NUM
iajs-1773	162	30	535.04	535.04	NUM
iajs-1773	162	31	±	±	NUM
iajs-1773	162	32	84.2	84.2	NUM
iajs-1773	162	33	569.52	569.52	NUM
iajs-1773	162	34	±	±	NUM
iajs-1773	162	35	136.4	136.4	NUM
iajs-1773	162	36	106.62	106.62	NUM
iajs-1773	162	37	ns	ns	NUM
iajs-1773	162	38	stage	stage	NOUN
iajs-1773	162	39	ii	ii	PROPN
iajs-1773	162	40	b	b	PROPN
iajs-1773	162	41	ii	ii	PROPN
iajs-1773	162	42	a	a	DET
iajs-1773	162	43	iii	iii	NOUN
iajs-1773	162	44	a	a	DET
iajs-1773	162	45	iii	iii	NOUN
iajs-1773	162	46	c	c	NOUN
iajs-1773	162	47	46	46	NUM
iajs-1773	162	48	9	9	NUM
iajs-1773	162	49	7	7	NUM
iajs-1773	162	50	6	6	NUM
iajs-1773	162	51	547.06	547.06	NUM
iajs-1773	162	52	±	±	NUM
iajs-1773	162	53	94.24	94.24	NUM
iajs-1773	162	54	452.07	452.07	NUM
iajs-1773	162	55	±	±	NOUN
iajs-1773	162	56	78.12	78.12	NUM
iajs-1773	162	57	563.41	563.41	NUM
iajs-1773	162	58	±	±	NUM
iajs-1773	162	59	102.7	102.7	NUM
iajs-1773	162	60	496.53	496.53	NUM
iajs-1773	162	61	±	±	NOUN
iajs-1773	162	62	85.61	85.61	NUM
iajs-1773	162	63	129.65	129.65	NUM
iajs-1773	162	64	ns	ns	NUM
iajs-1773	162	65	age	age	NOUN
iajs-1773	162	66	group	group	NOUN
iajs-1773	162	67	less	less	ADJ
iajs-1773	162	68	than	than	ADP
iajs-1773	162	69	35	35	NUM
iajs-1773	162	70	35	35	NUM
iajs-1773	162	71	-	-	SYM
iajs-1773	162	72	45	45	NUM
iajs-1773	162	73	more	more	ADJ
iajs-1773	162	74	than	than	ADP
iajs-1773	162	75	45	45	NUM
iajs-1773	162	76	16	16	NUM
iajs-1773	162	77	30	30	NUM
iajs-1773	162	78	22	22	NUM
iajs-1773	162	79	537.18	537.18	NUM
iajs-1773	162	80	±	±	NOUN
iajs-1773	162	81	135.9	135.9	NUM
iajs-1773	162	82	553.91	553.91	NUM
iajs-1773	162	83	±	±	NUM
iajs-1773	162	84	109.5	109.5	NUM
iajs-1773	162	85	528.73	528.73	NUM
iajs-1773	162	86	±	±	NUM
iajs-1773	162	87	97.2	97.2	NUM
iajs-1773	162	88	191.80	191.80	NUM
iajs-1773	162	89	ns	ns	NUM
iajs-1773	162	90	the	the	DET
iajs-1773	162	91	present	present	ADJ
iajs-1773	162	92	result	result	NOUN
iajs-1773	162	93	was	be	AUX
iajs-1773	162	94	disagreeing	disagree	VERB
iajs-1773	162	95	with	with	ADP
iajs-1773	162	96	shaaban	shaaban	PROPN
iajs-1773	162	97	et	et	PROPN
iajs-1773	162	98	al	al	PROPN
iajs-1773	162	99	.	.	PUNCT
iajs-1773	163	1	[	[	X
iajs-1773	163	2	48	48	NUM
iajs-1773	163	3	]	]	PUNCT
iajs-1773	163	4	who	who	PRON
iajs-1773	163	5	showed	show	VERB
iajs-1773	163	6	that	that	SCONJ
iajs-1773	163	7	the	the	DET
iajs-1773	163	8	er	er	INTJ
iajs-1773	163	9	β	β	X
iajs-1773	163	10	(	(	PUNCT
iajs-1773	163	11	estradiol)in	estradiol)in	DET
iajs-1773	163	12	tissue	tissue	NOUN
iajs-1773	163	13	recorded	record	VERB
iajs-1773	163	14	a	a	DET
iajs-1773	163	15	significant	significant	ADJ
iajs-1773	163	16	decreasing	decreasing	NOUN
iajs-1773	163	17	as	as	SCONJ
iajs-1773	163	18	compared	compare	VERB
iajs-1773	163	19	with	with	ADP
iajs-1773	163	20	control	control	NOUN
iajs-1773	163	21	(	(	PUNCT
iajs-1773	163	22	p=0.009	p=0.009	X
iajs-1773	163	23	)	)	PUNCT
iajs-1773	164	1	but	but	CCONJ
iajs-1773	164	2	there	there	PRON
iajs-1773	164	3	was	be	VERB
iajs-1773	164	4	a	a	DET
iajs-1773	164	5	non	non	ADJ
iajs-1773	164	6	-	-	ADJ
iajs-1773	164	7	significant	significant	ADJ
iajs-1773	164	8	differences	difference	NOUN
iajs-1773	164	9	in	in	ADP
iajs-1773	164	10	association	association	NOUN
iajs-1773	164	11	between	between	ADP
iajs-1773	164	12	e2	e2	PROPN
iajs-1773	164	13	and	and	CCONJ
iajs-1773	164	14	grade	grade	NOUN
iajs-1773	164	15	of	of	ADP
iajs-1773	164	16	ductal	ductal	ADJ
iajs-1773	164	17	carcinoma	carcinoma	NOUN
iajs-1773	164	18	.	.	PUNCT
iajs-1773	165	1	while	while	SCONJ
iajs-1773	165	2	fuque	fuque	ADJ
iajs-1773	165	3	et	et	PROPN
iajs-1773	165	4	al	al	PROPN
iajs-1773	165	5	.	.	PUNCT
iajs-1773	166	1	[	[	X
iajs-1773	166	2	49	49	NUM
iajs-1773	166	3	]	]	PUNCT
iajs-1773	166	4	recorded	record	VERB
iajs-1773	166	5	a	a	DET
iajs-1773	166	6	significant	significant	ADJ
iajs-1773	166	7	association	association	NOUN
iajs-1773	166	8	between	between	ADP
iajs-1773	166	9	tumor	tumor	NOUN
iajs-1773	166	10	grade	grade	NOUN
iajs-1773	166	11	and	and	CCONJ
iajs-1773	166	12	e2	e2	NOUN
iajs-1773	166	13	receptor	receptor	NOUN
iajs-1773	166	14	expression	expression	NOUN
iajs-1773	166	15	tissue	tissue	NOUN
iajs-1773	166	16	.	.	PUNCT
iajs-1773	167	1	estradiol	estradiol	PROPN
iajs-1773	167	2	displayed	display	VERB
iajs-1773	167	3	a	a	DET
iajs-1773	167	4	borderline	borderline	NOUN
iajs-1773	167	5	significant	significant	ADJ
iajs-1773	167	6	heterogeneity	heterogeneity	NOUN
iajs-1773	167	7	with	with	ADP
iajs-1773	167	8	breast	breast	NOUN
iajs-1773	167	9	cancer	cancer	NOUN
iajs-1773	167	10	risk	risk	NOUN
iajs-1773	167	11	diagnosed	diagnose	VERB
iajs-1773	167	12	for	for	ADP
iajs-1773	167	13	age	age	NOUN
iajs-1773	167	14	above	above	ADP
iajs-1773	167	15	50	50	NUM
iajs-1773	168	1	[	[	SYM
iajs-1773	168	2	20	20	NUM
iajs-1773	168	3	]	]	PUNCT
iajs-1773	168	4	.	.	PUNCT
iajs-1773	169	1	3.4.5	3.4.5	NUM
iajs-1773	169	2	.	.	X
iajs-1773	169	3	zinc	zinc	NOUN
iajs-1773	169	4	as	as	SCONJ
iajs-1773	169	5	shown	show	VERB
iajs-1773	169	6	in	in	ADP
iajs-1773	169	7	table	table	NOUN
iajs-1773	169	8	9	9	NUM
iajs-1773	169	9	,	,	PUNCT
iajs-1773	169	10	the	the	DET
iajs-1773	169	11	result	result	NOUN
iajs-1773	169	12	of	of	ADP
iajs-1773	169	13	present	present	ADJ
iajs-1773	169	14	study	study	NOUN
iajs-1773	169	15	showed	show	VERB
iajs-1773	169	16	a	a	DET
iajs-1773	169	17	non	non	ADJ
iajs-1773	169	18	-	-	ADJ
iajs-1773	169	19	significant	significant	ADJ
iajs-1773	169	20	differences	difference	NOUN
iajs-1773	169	21	in	in	ADP
iajs-1773	169	22	association	association	NOUN
iajs-1773	169	23	between	between	ADP
iajs-1773	169	24	zinc	zinc	NOUN
iajs-1773	169	25	serum	serum	NOUN
iajs-1773	169	26	level	level	NOUN
iajs-1773	169	27	and	and	CCONJ
iajs-1773	169	28	the	the	DET
iajs-1773	169	29	histological	histological	ADJ
iajs-1773	169	30	properties	property	NOUN
iajs-1773	169	31	which	which	PRON
iajs-1773	169	32	included	include	VERB
iajs-1773	169	33	histological	histological	ADJ
iajs-1773	169	34	type	type	NOUN
iajs-1773	169	35	(	(	PUNCT
iajs-1773	169	36	ductal	ductal	NOUN
iajs-1773	169	37	and	and	CCONJ
iajs-1773	169	38	lobular	lobular	ADJ
iajs-1773	169	39	)	)	PUNCT
iajs-1773	169	40	the	the	DET
iajs-1773	169	41	result	result	NOUN
iajs-1773	169	42	of	of	ADP
iajs-1773	169	43	mean	mean	PROPN
iajs-1773	169	44	±	±	NUM
iajs-1773	169	45	se	se	X
iajs-1773	169	46	for	for	ADP
iajs-1773	169	47	the	the	DET
iajs-1773	169	48	zinc	zinc	NOUN
iajs-1773	169	49	serum	serum	NOUN
iajs-1773	169	50	level	level	NOUN
iajs-1773	169	51	was	be	AUX
iajs-1773	169	52	(	(	PUNCT
iajs-1773	169	53	39.90	39.90	NUM
iajs-1773	169	54	±	±	NUM
iajs-1773	169	55	8.31	8.31	NUM
iajs-1773	169	56	,	,	PUNCT
iajs-1773	169	57	41.54	41.54	NUM
iajs-1773	169	58	±	±	NUM
iajs-1773	169	59	0.00	0.00	NUM
iajs-1773	169	60	)	)	PUNCT
iajs-1773	169	61	respectively	respectively	ADV
iajs-1773	169	62	,	,	PUNCT
iajs-1773	169	63	grade	grade	NOUN
iajs-1773	169	64	1,2	1,2	NUM
iajs-1773	169	65	,	,	PUNCT
iajs-1773	169	66	3	3	NUM
iajs-1773	169	67	(	(	PUNCT
iajs-1773	169	68	60.79	60.79	NUM
iajs-1773	169	69	±	±	NUM
iajs-1773	169	70	16.23,39.35	16.23,39.35	NUM
iajs-1773	169	71	±	±	NOUN
iajs-1773	169	72	18.936.71	18.936.71	NUM
iajs-1773	169	73	±	±	NUM
iajs-1773	169	74	16.03)respectively	16.03)respectively	ADV
iajs-1773	169	75	,	,	PUNCT
iajs-1773	169	76	while	while	SCONJ
iajs-1773	169	77	there	there	PRON
iajs-1773	169	78	was	be	VERB
iajs-1773	169	79	a	a	DET
iajs-1773	169	80	significant	significant	ADJ
iajs-1773	169	81	difference	difference	NOUN
iajs-1773	169	82	in	in	ADP
iajs-1773	169	83	association	association	NOUN
iajs-1773	169	84	of	of	ADP
iajs-1773	169	85	zinc	zinc	NOUN
iajs-1773	169	86	with	with	ADP
iajs-1773	169	87	stage	stage	NOUN
iajs-1773	169	88	ii	ii	PROPN
iajs-1773	169	89	b	b	PROPN
iajs-1773	169	90	,	,	PUNCT
iajs-1773	169	91	ii	ii	PROPN
iajs-1773	169	92	a	a	PRON
iajs-1773	169	93	,	,	PUNCT
iajs-1773	169	94	iii	iii	PROPN
iajs-1773	169	95	a	a	X
iajs-1773	169	96	,	,	PUNCT
iajs-1773	169	97	iii	iii	PROPN
iajs-1773	169	98	c	c	NOUN
iajs-1773	169	99	34.54	34.54	NUM
iajs-1773	169	100	±	±	NUM
iajs-1773	169	101	4.51	4.51	NUM
iajs-1773	169	102	,	,	PUNCT
iajs-1773	169	103	46.62	46.62	NUM
iajs-1773	169	104	±	±	NUM
iajs-1773	169	105	7.09	7.09	NUM
iajs-1773	169	106	,	,	PUNCT
iajs-1773	169	107	62.60	62.60	NUM
iajs-1773	169	108	±	±	NUM
iajs-1773	169	109	5.85,28.54	5.85,28.54	NUM
iajs-1773	169	110	±	±	NUM
iajs-1773	169	111	5.02	5.02	NUM
iajs-1773	169	112	)	)	PUNCT
iajs-1773	169	113	respectively	respectively	ADV
iajs-1773	169	114	and	and	CCONJ
iajs-1773	169	115	age	age	NOUN
iajs-1773	169	116	group	group	NOUN
iajs-1773	169	117	<	<	X
iajs-1773	169	118	35,35	35,35	NUM
iajs-1773	169	119	-	-	SYM
iajs-1773	169	120	45	45	NUM
iajs-1773	169	121	,	,	PUNCT
iajs-1773	169	122	>	>	X
iajs-1773	169	123	45	45	NUM
iajs-1773	169	124	(	(	PUNCT
iajs-1773	169	125	58.51	58.51	NUM
iajs-1773	169	126	±	±	NUM
iajs-1773	169	127	12.73	12.73	NUM
iajs-1773	169	128	,	,	PUNCT
iajs-1773	169	129	34.06	34.06	NUM
iajs-1773	169	130	±	±	NUM
iajs-1773	169	131	9.24	9.24	NUM
iajs-1773	169	132	,	,	PUNCT
iajs-1773	169	133	40.95	40.95	NUM
iajs-1773	169	134	±	±	NUM
iajs-1773	169	135	11.50	11.50	NUM
iajs-1773	169	136	)	)	PUNCT
iajs-1773	169	137	respectively	respectively	ADV
iajs-1773	169	138	p<0.05	p<0.05	NOUN
iajs-1773	169	139	.	.	PUNCT
iajs-1773	170	1	there	there	PRON
iajs-1773	170	2	are	be	VERB
iajs-1773	170	3	no	no	DET
iajs-1773	170	4	previous	previous	ADJ
iajs-1773	170	5	studies	study	NOUN
iajs-1773	170	6	that	that	PRON
iajs-1773	170	7	agree	agree	VERB
iajs-1773	170	8	or	or	CCONJ
iajs-1773	170	9	disagree	disagree	VERB
iajs-1773	170	10	with	with	ADP
iajs-1773	170	11	the	the	DET
iajs-1773	170	12	present	present	ADJ
iajs-1773	170	13	data	datum	NOUN
iajs-1773	170	14	,	,	PUNCT
iajs-1773	170	15	but	but	CCONJ
iajs-1773	170	16	according	accord	VERB
iajs-1773	170	17	to	to	ADP
iajs-1773	170	18	the	the	DET
iajs-1773	170	19	present	present	ADJ
iajs-1773	170	20	results	result	NOUN
iajs-1773	170	21	we	we	PRON
iajs-1773	170	22	may	may	AUX
iajs-1773	170	23	conclude	conclude	VERB
iajs-1773	170	24	that	that	DET
iajs-1773	170	25	stage	stage	NOUN
iajs-1773	170	26	of	of	ADP
iajs-1773	170	27	breast	breast	NOUN
iajs-1773	170	28	cancer	cancer	NOUN
iajs-1773	170	29	and	and	CCONJ
iajs-1773	170	30	age	age	NOUN
iajs-1773	170	31	of	of	ADP
iajs-1773	170	32	patients	patient	NOUN
iajs-1773	170	33	affect	affect	VERB
iajs-1773	170	34	with	with	ADP
iajs-1773	170	35	level	level	NOUN
iajs-1773	170	36	of	of	ADP
iajs-1773	170	37	zinc	zinc	NOUN
iajs-1773	170	38	and	and	CCONJ
iajs-1773	170	39	the	the	DET
iajs-1773	170	40	most	most	ADV
iajs-1773	170	41	affected	affected	ADJ
iajs-1773	170	42	sub	sub	NOUN
iajs-1773	170	43	group	group	NOUN
iajs-1773	170	44	was	be	AUX
iajs-1773	170	45	stage	stage	NOUN
iajs-1773	170	46	iii	iii	NUM
iajs-1773	170	47	c	c	NOUN
iajs-1773	170	48	which	which	PRON
iajs-1773	170	49	has	have	VERB
iajs-1773	170	50	the	the	DET
iajs-1773	170	51	lowest	low	ADJ
iajs-1773	170	52	mean	mean	NOUN
iajs-1773	170	53	(	(	PUNCT
iajs-1773	170	54	28.54	28.54	NUM
iajs-1773	170	55	±	±	NUM
iajs-1773	170	56	5.02	5.02	NUM
iajs-1773	170	57	)	)	PUNCT
iajs-1773	170	58	and	and	CCONJ
iajs-1773	170	59	the	the	DET
iajs-1773	170	60	most	most	ADV
iajs-1773	170	61	affected	affected	ADJ
iajs-1773	170	62	age	age	NOUN
iajs-1773	170	63	sub	sub	NOUN
iajs-1773	170	64	group	group	NOUN
iajs-1773	170	65	was	be	AUX
iajs-1773	170	66	35	35	NUM
iajs-1773	170	67	-	-	SYM
iajs-1773	170	68	45	45	NUM
iajs-1773	170	69	which	which	PRON
iajs-1773	170	70	consider	consider	VERB
iajs-1773	170	71	the	the	DET
iajs-1773	170	72	youth	youth	NOUN
iajs-1773	170	73	age	age	NOUN
iajs-1773	170	74	.	.	PUNCT
iajs-1773	171	1	ihsciconf	ihsciconf	PROPN
iajs-1773	171	2	2017	2017	NUM
iajs-1773	171	3	special	special	ADJ
iajs-1773	171	4	issue	issue	NOUN
iajs-1773	171	5	ibn	ibn	PROPN
iajs-1773	171	6	al	al	PROPN
iajs-1773	171	7	-	-	PUNCT
iajs-1773	171	8	haitham	haitham	PROPN
iajs-1773	171	9	journal	journal	PROPN
iajs-1773	171	10	for	for	ADP
iajs-1773	171	11	pure	pure	ADJ
iajs-1773	171	12	and	and	CCONJ
iajs-1773	171	13	applied	apply	VERB
iajs-1773	171	14	science	science	NOUN
iajs-1773	171	15	https://doi.org/	https://doi.org/	NOUN
iajs-1773	171	16	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	171	17	.	.	PUNCT
iajs-1773	171	18	 	 	SPACE
iajs-1773	171	19	1773	1773	NUM
iajs-1773	171	20	for	for	ADP
iajs-1773	171	21	more	more	ADJ
iajs-1773	171	22	information	information	NOUN
iajs-1773	171	23	about	about	ADP
iajs-1773	171	24	the	the	DET
iajs-1773	171	25	conference	conference	NOUN
iajs-1773	171	26	please	please	INTJ
iajs-1773	171	27	visit	visit	VERB
iajs-1773	171	28	the	the	DET
iajs-1773	171	29	websites	website	NOUN
iajs-1773	171	30	:	:	PUNCT
iajs-1773	171	31	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	171	32	  	  	SPACE
iajs-1773	171	33	www.ihsciconf.org	www.ihsciconf.org	ADJ
iajs-1773	171	34	  	  	SPACE
iajs-1773	171	35	biology|82	biology|82	ADJ
iajs-1773	171	36	table	table	NOUN
iajs-1773	171	37	(	(	PUNCT
iajs-1773	171	38	9	9	NUM
iajs-1773	171	39	):	):	PUNCT
iajs-1773	171	40	association	association	NOUN
iajs-1773	171	41	of	of	ADP
iajs-1773	171	42	serum	serum	PROPN
iajs-1773	171	43	zinc	zinc	NOUN
iajs-1773	171	44	level	level	NOUN
iajs-1773	171	45	with	with	ADP
iajs-1773	171	46	clinic	clinic	ADJ
iajs-1773	171	47	histological	histological	ADJ
iajs-1773	171	48	characteristics	characteristic	NOUN
iajs-1773	171	49	.	.	PUNCT
iajs-1773	172	1	pathology	pathology	NOUN
iajs-1773	172	2	no	no	PRON
iajs-1773	172	3	mean±se	mean±se	NOUN
iajs-1773	172	4	lsd	lsd	PROPN
iajs-1773	172	5	value	value	NOUN
iajs-1773	172	6	histological	histological	ADJ
iajs-1773	172	7	type	type	NOUN
iajs-1773	172	8	ductal	ductal	NOUN
iajs-1773	172	9	lobular	lobular	ADJ
iajs-1773	172	10	67	67	NUM
iajs-1773	172	11	1	1	NUM
iajs-1773	172	12	39.90	39.90	NUM
iajs-1773	172	13	±	±	NUM
iajs-1773	172	14	8.31	8.31	NUM
iajs-1773	172	15	41.54	41.54	NUM
iajs-1773	172	16	±	±	NUM
iajs-1773	172	17	0.00	0.00	NUM
iajs-1773	172	18	23.212	23.212	NUM
iajs-1773	172	19	ns	ns	NUM
iajs-1773	172	20	grade	grade	NOUN
iajs-1773	172	21	1	1	NUM
iajs-1773	172	22	2	2	NUM
iajs-1773	172	23	3	3	NUM
iajs-1773	172	24	4	4	NUM
iajs-1773	172	25	46	46	NUM
iajs-1773	172	26	18	18	NUM
iajs-1773	172	27	60.79	60.79	NUM
iajs-1773	172	28	±	±	NUM
iajs-1773	172	29	16.23	16.23	NUM
iajs-1773	172	30	39.35	39.35	NUM
iajs-1773	172	31	±	±	NUM
iajs-1773	172	32	18.9	18.9	NUM
iajs-1773	172	33	36.71	36.71	NUM
iajs-1773	172	34	±	±	NUM
iajs-1773	172	35	16.03	16.03	NUM
iajs-1773	172	36	24.688	24.688	NUM
iajs-1773	172	37	ns	ns	NUM
iajs-1773	172	38	stage	stage	NOUN
iajs-1773	172	39	ii	ii	PROPN
iajs-1773	172	40	b	b	PROPN
iajs-1773	172	41	ii	ii	PROPN
iajs-1773	172	42	a	a	DET
iajs-1773	172	43	iii	iii	NOUN
iajs-1773	172	44	a	a	PRON
iajs-1773	172	45	iii	iii	NOUN
iajs-1773	172	46	c	c	NOUN
iajs-1773	172	47	46	46	NUM
iajs-1773	172	48	9	9	NUM
iajs-1773	172	49	7	7	NUM
iajs-1773	172	50	6	6	NUM
iajs-1773	172	51	34.54	34.54	NUM
iajs-1773	172	52	±	±	NUM
iajs-1773	172	53	4.51	4.51	NUM
iajs-1773	172	54	46.62	46.62	NUM
iajs-1773	172	55	±	±	NUM
iajs-1773	172	56	7.09	7.09	NUM
iajs-1773	172	57	62.60	62.60	NUM
iajs-1773	172	58	±	±	NUM
iajs-1773	172	59	5.85	5.85	NUM
iajs-1773	172	60	28.54	28.54	NUM
iajs-1773	172	61	±	±	NUM
iajs-1773	172	62	5.02	5.02	NUM
iajs-1773	172	63	27.438	27.438	NUM
iajs-1773	172	64	*	*	PUNCT
iajs-1773	172	65	age	age	NOUN
iajs-1773	172	66	group	group	NOUN
iajs-1773	172	67	less	less	ADJ
iajs-1773	172	68	than	than	ADP
iajs-1773	172	69	35	35	NUM
iajs-1773	172	70	35	35	NUM
iajs-1773	172	71	-	-	SYM
iajs-1773	172	72	45	45	NUM
iajs-1773	172	73	more	more	ADJ
iajs-1773	172	74	than	than	ADP
iajs-1773	172	75	45	45	NUM
iajs-1773	172	76	16	16	NUM
iajs-1773	172	77	30	30	NUM
iajs-1773	172	78	22	22	NUM
iajs-1773	172	79	58.51	58.51	NUM
iajs-1773	172	80	±	±	NUM
iajs-1773	172	81	12.73	12.73	NUM
iajs-1773	172	82	34.06	34.06	NUM
iajs-1773	172	83	±	±	NUM
iajs-1773	172	84	9.24	9.24	NUM
iajs-1773	172	85	40.95	40.95	NUM
iajs-1773	172	86	±	±	NOUN
iajs-1773	172	87	11.50	11.50	NUM
iajs-1773	172	88	22.411	22.411	NUM
iajs-1773	172	89	*	*	PUNCT
iajs-1773	172	90	*	*	PUNCT
iajs-1773	172	91	p<0.05	p<0.05	NOUN
iajs-1773	172	92	significant	significant	ADJ
iajs-1773	172	93	3.4.6	3.4.6	NUM
iajs-1773	172	94	.	.	PUNCT
iajs-1773	173	1	vitamin	vitamin	NOUN
iajs-1773	173	2	c	c	NOUN
iajs-1773	173	3	(	(	PUNCT
iajs-1773	173	4	ascorbic	ascorbic	NOUN
iajs-1773	173	5	acid	acid	NOUN
iajs-1773	173	6	)	)	PUNCT
iajs-1773	173	7	as	as	SCONJ
iajs-1773	173	8	shown	show	VERB
iajs-1773	173	9	in	in	ADP
iajs-1773	173	10	table	table	NOUN
iajs-1773	173	11	10	10	NUM
iajs-1773	173	12	.	.	PUNCT
iajs-1773	174	1	the	the	DET
iajs-1773	174	2	present	present	ADJ
iajs-1773	174	3	study	study	NOUN
iajs-1773	174	4	revealed	reveal	VERB
iajs-1773	174	5	that	that	SCONJ
iajs-1773	174	6	there	there	PRON
iajs-1773	174	7	was	be	VERB
iajs-1773	174	8	no	no	DET
iajs-1773	174	9	association	association	NOUN
iajs-1773	174	10	between	between	ADP
iajs-1773	174	11	vitamin	vitamin	NOUN
iajs-1773	174	12	c	c	NOUN
iajs-1773	174	13	and	and	CCONJ
iajs-1773	174	14	histological	histological	ADJ
iajs-1773	174	15	characteristics	characteristic	NOUN
iajs-1773	174	16	.and	.and	PUNCT
iajs-1773	175	1	there	there	PRON
iajs-1773	175	2	was	be	VERB
iajs-1773	175	3	no	no	DET
iajs-1773	175	4	significance	significance	NOUN
iajs-1773	175	5	difference	difference	NOUN
iajs-1773	175	6	by	by	ADP
iajs-1773	175	7	using	use	VERB
iajs-1773	175	8	lsd	lsd	NOUN
iajs-1773	175	9	value	value	NOUN
iajs-1773	175	10	.the	.the	PRON
iajs-1773	175	11	result	result	NOUN
iajs-1773	175	12	of	of	ADP
iajs-1773	175	13	the	the	DET
iajs-1773	175	14	histological	histological	ADJ
iajs-1773	175	15	type	type	NOUN
iajs-1773	175	16	(	(	PUNCT
iajs-1773	175	17	ductal	ductal	ADJ
iajs-1773	175	18	,	,	PUNCT
iajs-1773	175	19	lobular	lobular	ADJ
iajs-1773	175	20	)	)	PUNCT
iajs-1773	175	21	was	be	AUX
iajs-1773	175	22	(	(	PUNCT
iajs-1773	175	23	3.86	3.86	NUM
iajs-1773	175	24	±	±	NUM
iajs-1773	175	25	1.04	1.04	NUM
iajs-1773	175	26	,	,	PUNCT
iajs-1773	175	27	3.13	3.13	NUM
iajs-1773	175	28	±	±	NUM
iajs-1773	175	29	0.00	0.00	NUM
iajs-1773	175	30	)	)	PUNCT
iajs-1773	175	31	respectively	respectively	ADV
iajs-1773	175	32	,	,	PUNCT
iajs-1773	175	33	grade	grade	NOUN
iajs-1773	175	34	1,2,3	1,2,3	NUM
iajs-1773	175	35	was	be	AUX
iajs-1773	175	36	(	(	PUNCT
iajs-1773	175	37	4.17	4.17	NUM
iajs-1773	175	38	±	±	NUM
iajs-1773	175	39	0.96	0.96	NUM
iajs-1773	175	40	,	,	PUNCT
iajs-1773	175	41	3.27	3.27	NUM
iajs-1773	175	42	±	±	NUM
iajs-1773	175	43	1.15	1.15	NUM
iajs-1773	175	44	,	,	PUNCT
iajs-1773	175	45	5.31	5.31	NUM
iajs-1773	175	46	±	±	NUM
iajs-1773	175	47	1.33	1.33	NUM
iajs-1773	175	48	)	)	PUNCT
iajs-1773	175	49	respectively	respectively	ADV
iajs-1773	175	50	,	,	PUNCT
iajs-1773	175	51	stage	stage	NOUN
iajs-1773	175	52	ii	ii	PROPN
iajs-1773	175	53	b	b	PROPN
iajs-1773	175	54	,	,	PUNCT
iajs-1773	175	55	ii	ii	PROPN
iajs-1773	175	56	a	a	PRON
iajs-1773	175	57	,	,	PUNCT
iajs-1773	175	58	iii	iii	PROPN
iajs-1773	175	59	a	a	X
iajs-1773	175	60	,	,	PUNCT
iajs-1773	175	61	iii	iii	X
iajs-1773	175	62	c	c	NOUN
iajs-1773	175	63	was	be	AUX
iajs-1773	175	64	(	(	PUNCT
iajs-1773	175	65	3.73	3.73	NUM
iajs-1773	175	66	±	±	NUM
iajs-1773	175	67	0.77	0.77	NUM
iajs-1773	175	68	,	,	PUNCT
iajs-1773	175	69	4.06	4.06	NUM
iajs-1773	175	70	±	±	NUM
iajs-1773	175	71	0.83	0.83	NUM
iajs-1773	175	72	,	,	PUNCT
iajs-1773	175	73	4.99	4.99	NUM
iajs-1773	175	74	±	±	NUM
iajs-1773	175	75	0.94	0.94	NUM
iajs-1773	175	76	,	,	PUNCT
iajs-1773	175	77	3.94	3.94	NUM
iajs-1773	175	78	±	±	NUM
iajs-1773	175	79	0.71	0.71	NUM
iajs-1773	175	80	)	)	PUNCT
iajs-1773	175	81	respectively	respectively	ADV
iajs-1773	175	82	and	and	CCONJ
iajs-1773	175	83	finally	finally	ADV
iajs-1773	175	84	the	the	DET
iajs-1773	175	85	age	age	NOUN
iajs-1773	175	86	group	group	NOUN
iajs-1773	175	87	(	(	PUNCT
iajs-1773	175	88	<	<	X
iajs-1773	175	89	35,35	35,35	NUM
iajs-1773	175	90	-	-	PUNCT
iajs-1773	175	91	45,>45	45,>45	NOUN
iajs-1773	175	92	)	)	PUNCT
iajs-1773	175	93	was	be	AUX
iajs-1773	175	94	(	(	PUNCT
iajs-1773	175	95	6.908	6.908	NUM
iajs-1773	175	96	±	±	NUM
iajs-1773	175	97	2.57	2.57	NUM
iajs-1773	175	98	,	,	PUNCT
iajs-1773	175	99	4.60	4.60	NUM
iajs-1773	175	100	±	±	NUM
iajs-1773	175	101	2.07	2.07	NUM
iajs-1773	175	102	,	,	PUNCT
iajs-1773	175	103	5.93	5.93	NUM
iajs-1773	175	104	±	±	NUM
iajs-1773	175	105	2.88	2.88	NUM
iajs-1773	175	106	)	)	PUNCT
iajs-1773	175	107	respectively	respectively	ADV
iajs-1773	175	108	.	.	PUNCT
iajs-1773	175	109	table	table	NOUN
iajs-1773	175	110	(	(	PUNCT
iajs-1773	175	111	10	10	NUM
iajs-1773	175	112	):	):	PUNCT
iajs-1773	175	113	associated	associate	VERB
iajs-1773	175	114	of	of	ADP
iajs-1773	175	115	vitamin	vitamin	NOUN
iajs-1773	175	116	c	c	NOUN
iajs-1773	175	117	level	level	NOUN
iajs-1773	175	118	in	in	ADP
iajs-1773	175	119	serum	serum	NOUN
iajs-1773	175	120	with	with	ADP
iajs-1773	175	121	clinical	clinical	ADJ
iajs-1773	175	122	histological	histological	ADJ
iajs-1773	175	123	characteristics	characteristic	NOUN
iajs-1773	175	124	pathology	pathology	NOUN
iajs-1773	175	125	no	no	PRON
iajs-1773	175	126	mean±se	mean±se	NOUN
iajs-1773	175	127	lsd	lsd	PROPN
iajs-1773	175	128	value	value	NOUN
iajs-1773	175	129	histological	histological	ADJ
iajs-1773	175	130	type	type	NOUN
iajs-1773	175	131	ductal	ductal	NOUN
iajs-1773	175	132	lobular	lobular	ADJ
iajs-1773	175	133	67	67	NUM
iajs-1773	175	134	1	1	NUM
iajs-1773	175	135	3.86	3.86	NUM
iajs-1773	175	136	±	±	NUM
iajs-1773	175	137	1.04	1.04	NUM
iajs-1773	175	138	3.13	3.13	NUM
iajs-1773	175	139	±	±	NUM
iajs-1773	175	140	0.00	0.00	NUM
iajs-1773	175	141	8.115	8.115	NUM
iajs-1773	175	142	ns	ns	ADJ
iajs-1773	175	143	grade	grade	NOUN
iajs-1773	175	144	1	1	NUM
iajs-1773	175	145	2	2	NUM
iajs-1773	175	146	3	3	NUM
iajs-1773	175	147	4	4	NUM
iajs-1773	175	148	46	46	NUM
iajs-1773	175	149	18	18	NUM
iajs-1773	175	150	4.17	4.17	NUM
iajs-1773	175	151	±	±	NUM
iajs-1773	175	152	0.96	0.96	NUM
iajs-1773	175	153	3.27	3.27	NUM
iajs-1773	175	154	±	±	NUM
iajs-1773	175	155	1.15	1.15	NUM
iajs-1773	175	156	5.31	5.31	NUM
iajs-1773	175	157	±	±	NUM
iajs-1773	175	158	1.33	1.33	NUM
iajs-1773	175	159	3.783	3.783	NUM
iajs-1773	175	160	ns	ns	ADJ
iajs-1773	175	161	stage	stage	PROPN
iajs-1773	175	162	ii	ii	PROPN
iajs-1773	175	163	b	b	PROPN
iajs-1773	175	164	ii	ii	PROPN
iajs-1773	175	165	a	a	DET
iajs-1773	175	166	iii	iii	NOUN
iajs-1773	175	167	a	a	PRON
iajs-1773	175	168	iii	iii	NOUN
iajs-1773	175	169	c	c	NOUN
iajs-1773	175	170	46	46	NUM
iajs-1773	175	171	9	9	NUM
iajs-1773	175	172	7	7	NUM
iajs-1773	175	173	6	6	NUM
iajs-1773	175	174	3.73	3.73	NUM
iajs-1773	175	175	±	±	NUM
iajs-1773	175	176	0.77	0.77	NUM
iajs-1773	175	177	4.06	4.06	NUM
iajs-1773	175	178	±	±	NUM
iajs-1773	175	179	0.83	0.83	NUM
iajs-1773	175	180	4.99	4.99	NUM
iajs-1773	175	181	±	±	NUM
iajs-1773	175	182	0.94	0.94	NUM
iajs-1773	175	183	3.94	3.94	NUM
iajs-1773	175	184	±	±	NUM
iajs-1773	175	185	0.71	0.71	NUM
iajs-1773	175	186	4.024	4.024	NUM
iajs-1773	175	187	ns	ns	ADJ
iajs-1773	175	188	age	age	NOUN
iajs-1773	175	189	group	group	NOUN
iajs-1773	175	190	less	less	ADJ
iajs-1773	175	191	than	than	ADP
iajs-1773	175	192	35	35	NUM
iajs-1773	175	193	35	35	NUM
iajs-1773	175	194	-	-	SYM
iajs-1773	175	195	45	45	NUM
iajs-1773	175	196	more	more	ADJ
iajs-1773	175	197	than	than	ADP
iajs-1773	175	198	45	45	NUM
iajs-1773	175	199	16	16	NUM
iajs-1773	175	200	30	30	NUM
iajs-1773	175	201	22	22	NUM
iajs-1773	175	202	6.908	6.908	NUM
iajs-1773	175	203	±	±	NUM
iajs-1773	175	204	2.57	2.57	NUM
iajs-1773	175	205	4.60	4.60	NUM
iajs-1773	175	206	±	±	NUM
iajs-1773	175	207	2.07	2.07	NUM
iajs-1773	175	208	5.93	5.93	NUM
iajs-1773	175	209	±	±	NUM
iajs-1773	175	210	2.88	2.88	NUM
iajs-1773	175	211	4.775	4.775	NUM
iajs-1773	175	212	ns	ns	NUM
iajs-1773	175	213	ns	ns	PROPN
iajs-1773	175	214	,	,	PUNCT
iajs-1773	175	215	non	non	ADJ
iajs-1773	175	216	-	-	ADJ
iajs-1773	175	217	significant	significant	ADJ
iajs-1773	175	218	the	the	DET
iajs-1773	175	219	present	present	ADJ
iajs-1773	175	220	data	datum	NOUN
iajs-1773	175	221	was	be	AUX
iajs-1773	175	222	disagree	disagree	VERB
iajs-1773	175	223	with	with	ADP
iajs-1773	175	224	the	the	DET
iajs-1773	175	225	study	study	NOUN
iajs-1773	175	226	by	by	ADP
iajs-1773	175	227	ray	ray	NOUN
iajs-1773	176	1	[	[	X
iajs-1773	176	2	43	43	NUM
iajs-1773	176	3	]	]	PUNCT
iajs-1773	176	4	who	who	PRON
iajs-1773	176	5	showed	show	VERB
iajs-1773	176	6	that	that	SCONJ
iajs-1773	176	7	the	the	DET
iajs-1773	176	8	vitamin	vitamin	NOUN
iajs-1773	176	9	c	c	NOUN
iajs-1773	176	10	recorded	record	VERB
iajs-1773	176	11	a	a	DET
iajs-1773	176	12	significantly	significantly	ADV
iajs-1773	176	13	decreasing	decrease	VERB
iajs-1773	176	14	in	in	ADP
iajs-1773	176	15	serum	serum	NOUN
iajs-1773	176	16	level	level	NOUN
iajs-1773	176	17	in	in	ADP
iajs-1773	176	18	progress	progress	NOUN
iajs-1773	176	19	stages	stage	NOUN
iajs-1773	176	20	of	of	ADP
iajs-1773	176	21	breast	breast	NOUN
iajs-1773	176	22	ihsciconf	ihsciconf	NOUN
iajs-1773	176	23	2017	2017	NUM
iajs-1773	176	24	special	special	ADJ
iajs-1773	176	25	issue	issue	NOUN
iajs-1773	176	26	ibn	ibn	PROPN
iajs-1773	176	27	al	al	PROPN
iajs-1773	176	28	-	-	PUNCT
iajs-1773	176	29	haitham	haitham	PROPN
iajs-1773	176	30	journal	journal	PROPN
iajs-1773	176	31	for	for	ADP
iajs-1773	176	32	pure	pure	ADJ
iajs-1773	176	33	and	and	CCONJ
iajs-1773	176	34	applied	apply	VERB
iajs-1773	176	35	science	science	NOUN
iajs-1773	176	36	https://doi.org/	https://doi.org/	NOUN
iajs-1773	176	37	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	176	38	.	.	PUNCT
iajs-1773	176	39	 	 	SPACE
iajs-1773	176	40	1773	1773	NUM
iajs-1773	176	41	for	for	ADP
iajs-1773	176	42	more	more	ADJ
iajs-1773	176	43	information	information	NOUN
iajs-1773	176	44	about	about	ADP
iajs-1773	176	45	the	the	DET
iajs-1773	176	46	conference	conference	NOUN
iajs-1773	176	47	please	please	INTJ
iajs-1773	176	48	visit	visit	VERB
iajs-1773	176	49	the	the	DET
iajs-1773	176	50	websites	website	NOUN
iajs-1773	176	51	:	:	PUNCT
iajs-1773	176	52	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	176	53	  	  	SPACE
iajs-1773	176	54	www.ihsciconf.org	www.ihsciconf.org	ADV
iajs-1773	176	55	  	  	SPACE
iajs-1773	176	56	biology|83	biology|83	PROPN
iajs-1773	176	57	cancer	cancer	NOUN
iajs-1773	176	58	(	(	PUNCT
iajs-1773	176	59	p	p	X
iajs-1773	176	60	<	<	X
iajs-1773	176	61	0.01	0.01	NUM
iajs-1773	176	62	)	)	PUNCT
iajs-1773	176	63	,	,	PUNCT
iajs-1773	176	64	also	also	ADV
iajs-1773	176	65	it	it	PRON
iajs-1773	176	66	was	be	AUX
iajs-1773	176	67	disagree	disagree	VERB
iajs-1773	176	68	with	with	ADP
iajs-1773	176	69	greenlee	greenlee	PROPN
iajs-1773	176	70	et	et	PROPN
iajs-1773	176	71	al	al	PROPN
iajs-1773	176	72	.	.	PUNCT
iajs-1773	177	1	[	[	X
iajs-1773	177	2	50	50	NUM
iajs-1773	177	3	]	]	PUNCT
iajs-1773	177	4	which	which	PRON
iajs-1773	177	5	recorded	record	VERB
iajs-1773	177	6	a	a	DET
iajs-1773	177	7	significantly	significantly	ADV
iajs-1773	177	8	increasing	increase	VERB
iajs-1773	177	9	in	in	ADP
iajs-1773	177	10	serum	serum	NOUN
iajs-1773	177	11	level	level	NOUN
iajs-1773	177	12	of	of	ADP
iajs-1773	177	13	vitamin	vitamin	NOUN
iajs-1773	177	14	c	c	NOUN
iajs-1773	177	15	related	relate	VERB
iajs-1773	177	16	with	with	ADP
iajs-1773	177	17	stages	stage	NOUN
iajs-1773	177	18	and	and	CCONJ
iajs-1773	177	19	age	age	NOUN
iajs-1773	177	20	group	group	NOUN
iajs-1773	177	21	.	.	PUNCT
iajs-1773	178	1	while	while	SCONJ
iajs-1773	178	2	gallie	gallie	PROPN
iajs-1773	178	3	[	[	X
iajs-1773	178	4	44	44	NUM
iajs-1773	178	5	]	]	PUNCT
iajs-1773	178	6	recorded	record	VERB
iajs-1773	178	7	that	that	SCONJ
iajs-1773	178	8	the	the	DET
iajs-1773	178	9	serum	serum	NOUN
iajs-1773	178	10	level	level	NOUN
iajs-1773	178	11	of	of	ADP
iajs-1773	178	12	vitamin	vitamin	NOUN
iajs-1773	178	13	c	c	NOUN
iajs-1773	178	14	will	will	AUX
iajs-1773	178	15	increasing	increase	VERB
iajs-1773	178	16	with	with	ADP
iajs-1773	178	17	the	the	DET
iajs-1773	178	18	progress	progress	NOUN
iajs-1773	178	19	stage	stage	NOUN
iajs-1773	178	20	of	of	ADP
iajs-1773	178	21	the	the	DET
iajs-1773	178	22	disease	disease	NOUN
iajs-1773	178	23	.	.	PUNCT
iajs-1773	179	1	references	reference	NOUN
iajs-1773	179	2	[	[	X
iajs-1773	179	3	1	1	NUM
iajs-1773	179	4	]	]	PUNCT
iajs-1773	179	5	a.d.s.j	a.d.s.j	PROPN
iajs-1773	179	6	.	.	PROPN
iajs-1773	179	7	lsaed	lsaed	PROPN
iajs-1773	179	8	and	and	CCONJ
iajs-1773	179	9	j.d.m	j.d.m	PROPN
iajs-1773	179	10	.	.	PUNCT
iajs-1773	180	1	alsar	alsar	PROPN
iajs-1773	180	2	.	.	PUNCT
iajs-1773	181	1	iraqi	iraqi	ADJ
iajs-1773	181	2	cancer	cancer	NOUN
iajs-1773	181	3	registery	registery	NOUN
iajs-1773	181	4	(	(	PUNCT
iajs-1773	181	5	2011	2011	NUM
iajs-1773	181	6	)	)	PUNCT
iajs-1773	181	7	.	.	PUNCT
iajs-1773	182	1	[	[	X
iajs-1773	182	2	2	2	X
iajs-1773	182	3	]	]	PUNCT
iajs-1773	182	4	j.	j.	PROPN
iajs-1773	182	5	sariego	sariego	PROPN
iajs-1773	182	6	,	,	PUNCT
iajs-1773	182	7	breast	breast	NOUN
iajs-1773	182	8	cancer	cancer	NOUN
iajs-1773	182	9	in	in	ADP
iajs-1773	182	10	the	the	DET
iajs-1773	182	11	young	young	ADJ
iajs-1773	182	12	patient	patient	NOUN
iajs-1773	182	13	.	.	PUNCT
iajs-1773	183	1	the	the	DET
iajs-1773	183	2	american	american	PROPN
iajs-1773	183	3	surgeon	surgeon	PROPN
iajs-1773	183	4	,	,	PUNCT
iajs-1773	183	5	76(12	76(12	NUM
iajs-1773	183	6	):	):	PUNCT
iajs-1773	183	7	1397–1400	1397–1400	NUM
iajs-1773	183	8	.	.	PUNCT
iajs-1773	183	9	2010	2010	NUM
iajs-1773	184	1	[	[	X
iajs-1773	184	2	3	3	NUM
iajs-1773	184	3	]	]	X
iajs-1773	184	4	j.c	j.c	PROPN
iajs-1773	184	5	.	.	PROPN
iajs-1773	184	6	adams	adams	PROPN
iajs-1773	184	7	,	,	PUNCT
iajs-1773	184	8	and	and	CCONJ
iajs-1773	184	9	f.m	f.m	PROPN
iajs-1773	184	10	.	.	PROPN
iajs-1773	184	11	watt	watt	NOUN
iajs-1773	184	12	,	,	PUNCT
iajs-1773	184	13	regulation	regulation	NOUN
iajs-1773	184	14	of	of	ADP
iajs-1773	184	15	development	development	NOUN
iajs-1773	184	16	and	and	CCONJ
iajs-1773	184	17	differentiation	differentiation	NOUN
iajs-1773	184	18	by	by	ADP
iajs-1773	184	19	the	the	DET
iajs-1773	184	20	extracellular	extracellular	ADJ
iajs-1773	184	21	matrix	matrix	NOUN
iajs-1773	184	22	.	.	PUNCT
iajs-1773	185	1	development	development	NOUN
iajs-1773	185	2	,	,	PUNCT
iajs-1773	185	3	117(4	117(4	NUM
iajs-1773	185	4	)	)	PUNCT
iajs-1773	185	5	1183	1183	NUM
iajs-1773	185	6	-	-	SYM
iajs-1773	185	7	1198	1198	NUM
iajs-1773	185	8	.	.	PUNCT
iajs-1773	186	1	1993	1993	NUM
iajs-1773	187	1	[	[	X
iajs-1773	187	2	4	4	NUM
iajs-1773	187	3	]	]	X
iajs-1773	187	4	c.	c.	NOUN
iajs-1773	187	5	bonnans	bonnan	NOUN
iajs-1773	187	6	;	;	PUNCT
iajs-1773	187	7	j.	j.	PROPN
iajs-1773	187	8	chou	chou	PROPN
iajs-1773	187	9	,	,	PUNCT
iajs-1773	187	10	and	and	CCONJ
iajs-1773	187	11	z.	z.	PROPN
iajs-1773	187	12	werb	werb	NOUN
iajs-1773	187	13	,	,	PUNCT
iajs-1773	187	14	remodelling	remodelle	VERB
iajs-1773	187	15	the	the	DET
iajs-1773	187	16	extracellular	extracellular	ADJ
iajs-1773	187	17	matrix	matrix	NOUN
iajs-1773	187	18	in	in	ADP
iajs-1773	187	19	development	development	NOUN
iajs-1773	187	20	and	and	CCONJ
iajs-1773	187	21	disease	disease	NOUN
iajs-1773	187	22	.	.	PUNCT
iajs-1773	188	1	nature	nature	NOUN
iajs-1773	188	2	reviews	review	NOUN
iajs-1773	188	3	.	.	PUNCT
iajs-1773	189	1	molecular	molecular	ADJ
iajs-1773	189	2	cell	cell	NOUN
iajs-1773	189	3	biology	biology	NOUN
iajs-1773	189	4	,	,	PUNCT
iajs-1773	189	5	15(12	15(12	NUM
iajs-1773	189	6	):	):	PUNCT
iajs-1773	189	7	786	786	NUM
iajs-1773	189	8	.	.	PUNCT
iajs-1773	189	9	2014	2014	NUM
iajs-1773	190	1	[	[	X
iajs-1773	190	2	5	5	NUM
iajs-1773	190	3	]	]	PUNCT
iajs-1773	190	4	f.	f.	PROPN
iajs-1773	190	5	vignon;s	vignon;s	PROPN
iajs-1773	190	6	.	.	PUNCT
iajs-1773	191	1	bardon;d	bardon;d	PROPN
iajs-1773	191	2	.chalbos	.chalbos	PUNCT
iajs-1773	191	3	and	and	CCONJ
iajs-1773	191	4	h.	h.	PROPN
iajs-1773	191	5	rochefort	rochefort	PROPN
iajs-1773	191	6	.	.	PUNCT
iajs-1773	192	1	antiestrogenic	antiestrogenic	ADJ
iajs-1773	192	2	effect	effect	NOUN
iajs-1773	192	3	of	of	ADP
iajs-1773	192	4	r5020	r5020	PROPN
iajs-1773	192	5	,	,	PUNCT
iajs-1773	192	6	a	a	DET
iajs-1773	192	7	synthetic	synthetic	ADJ
iajs-1773	192	8	progestin	progestin	NOUN
iajs-1773	192	9	in	in	ADP
iajs-1773	192	10	human	human	ADJ
iajs-1773	192	11	breast	breast	NOUN
iajs-1773	192	12	cancer	cancer	NOUN
iajs-1773	192	13	cells	cell	NOUN
iajs-1773	192	14	in	in	ADP
iajs-1773	192	15	culture	culture	NOUN
iajs-1773	192	16	.	.	PUNCT
iajs-1773	193	1	the	the	DET
iajs-1773	193	2	journal	journal	NOUN
iajs-1773	193	3	of	of	ADP
iajs-1773	193	4	clinical	clinical	ADJ
iajs-1773	193	5	endocrinology	endocrinology	NOUN
iajs-1773	193	6	&	&	CCONJ
iajs-1773	193	7	metabolism	metabolism	NOUN
iajs-1773	193	8	,	,	PUNCT
iajs-1773	193	9	56(6	56(6	NUM
iajs-1773	193	10	)	)	PUNCT
iajs-1773	193	11	,	,	PUNCT
iajs-1773	193	12	1124	1124	NUM
iajs-1773	193	13	-	-	SYM
iajs-1773	193	14	1130	1130	NUM
iajs-1773	193	15	.	.	PUNCT
iajs-1773	194	1	1983	1983	NUM
iajs-1773	195	1	[	[	X
iajs-1773	195	2	6	6	NUM
iajs-1773	195	3	]	]	PUNCT
iajs-1773	195	4	c.	c.	PROPN
iajs-1773	195	5	c.chen;d	c.chen;d	PROPN
iajs-1773	195	6	.	.	PUNCT
iajs-1773	196	1	b	b	X
iajs-1773	196	2	hardy	hardy	ADJ
iajs-1773	196	3	,	,	PUNCT
iajs-1773	196	4	and	and	CCONJ
iajs-1773	196	5	c.	c.	PROPN
iajs-1773	196	6	r	r	PROPN
iajs-1773	196	7	mendelson	mendelson	PROPN
iajs-1773	196	8	,	,	PUNCT
iajs-1773	196	9	progesterone	progesterone	NOUN
iajs-1773	196	10	receptor	receptor	NOUN
iajs-1773	196	11	inhibits	inhibit	VERB
iajs-1773	196	12	proliferation	proliferation	NOUN
iajs-1773	196	13	of	of	ADP
iajs-1773	196	14	human	human	ADJ
iajs-1773	196	15	breast	breast	NOUN
iajs-1773	196	16	cancer	cancer	NOUN
iajs-1773	196	17	cells	cell	NOUN
iajs-1773	196	18	via	via	ADP
iajs-1773	196	19	induction	induction	NOUN
iajs-1773	196	20	of	of	ADP
iajs-1773	196	21	mapk	mapk	ADJ
iajs-1773	196	22	phosphatase	phosphatase	NOUN
iajs-1773	196	23	1	1	NUM
iajs-1773	196	24	(	(	PUNCT
iajs-1773	196	25	mkp-1	mkp-1	X
iajs-1773	196	26	/	/	SYM
iajs-1773	196	27	dusp1	dusp1	NOUN
iajs-1773	196	28	)	)	PUNCT
iajs-1773	196	29	.	.	PUNCT
iajs-1773	197	1	journal	journal	NOUN
iajs-1773	197	2	of	of	ADP
iajs-1773	197	3	biological	biological	ADJ
iajs-1773	197	4	chemistry	chemistry	NOUN
iajs-1773	197	5	,	,	PUNCT
iajs-1773	197	6	286(50	286(50	NUM
iajs-1773	197	7	)	)	PUNCT
iajs-1773	197	8	,	,	PUNCT
iajs-1773	197	9	43091	43091	NUM
iajs-1773	197	10	-	-	SYM
iajs-1773	197	11	43102	43102	NUM
iajs-1773	197	12	.	.	PUNCT
iajs-1773	198	1	2011	2011	NUM
iajs-1773	199	1	[	[	X
iajs-1773	199	2	7	7	X
iajs-1773	199	3	]	]	X
iajs-1773	199	4	c.m.perks;a.j.keith	c.m.perks;a.j.keith	NOUN
iajs-1773	199	5	;	;	PUNCT
iajs-1773	199	6	k.l	k.l	PROPN
iajs-1773	199	7	.	.	NOUN
iajs-1773	199	8	goodhe;p.b	goodhe;p.b	NOUN
iajs-1773	199	9	savage	savage	NOUN
iajs-1773	199	10	;	;	PUNCT
iajs-1773	199	11	z.e	z.e	PROPN
iajs-1773	199	12	.	.	PROPN
iajs-1773	199	13	winters	winter	NOUN
iajs-1773	199	14	,	,	PUNCT
iajs-1773	199	15	and	and	CCONJ
iajs-1773	199	16	j.m	j.m	PROPN
iajs-1773	199	17	.	.	PROPN
iajs-1773	199	18	holly	holly	PROPN
iajs-1773	199	19	,	,	PUNCT
iajs-1773	199	20	prolactin	prolactin	NOUN
iajs-1773	199	21	acts	act	VERB
iajs-1773	199	22	as	as	ADP
iajs-1773	199	23	a	a	DET
iajs-1773	199	24	potent	potent	ADJ
iajs-1773	199	25	survival	survival	NOUN
iajs-1773	199	26	factor	factor	NOUN
iajs-1773	199	27	for	for	ADP
iajs-1773	199	28	human	human	ADJ
iajs-1773	199	29	breast	breast	NOUN
iajs-1773	199	30	cancer	cancer	NOUN
iajs-1773	199	31	cell	cell	NOUN
iajs-1773	199	32	lines	line	NOUN
iajs-1773	199	33	.	.	PUNCT
iajs-1773	200	1	british	british	ADJ
iajs-1773	200	2	journal	journal	PROPN
iajs-1773	200	3	of	of	ADP
iajs-1773	200	4	cancer	cancer	NOUN
iajs-1773	200	5	,	,	PUNCT
iajs-1773	200	6	91:305–311	91:305–311	NOUN
iajs-1773	200	7	.	.	PUNCT
iajs-1773	200	8	2004	2004	NUM
iajs-1773	201	1	[	[	X
iajs-1773	201	2	8	8	NUM
iajs-1773	201	3	]	]	X
iajs-1773	201	4	n.	n.	NOUN
iajs-1773	201	5	honma;s.saji;m.hirose;s.i	honma;s.saji;m.hirose;s.i	PROPN
iajs-1773	201	6	.	.	PUNCT
iajs-1773	202	1	horiguchi;k	horiguchi;k	PROPN
iajs-1773	202	2	.	.	PUNCT
iajs-1773	203	1	kuroi;s	kuroi;s	PROPN
iajs-1773	203	2	.	.	PUNCT
iajs-1773	204	1	i.hayashi;t	i.hayashi;t	PROPN
iajs-1773	204	2	.	.	PUNCT
iajs-1773	205	1	utsumi	utsumi	ADJ
iajs-1773	205	2	,	,	PUNCT
iajs-1773	205	3	and	and	CCONJ
iajs-1773	205	4	n.	n.	PROPN
iajs-1773	205	5	harada	harada	PROPN
iajs-1773	205	6	,	,	PUNCT
iajs-1773	205	7	sex	sex	NOUN
iajs-1773	205	8	steroid	steroid	NOUN
iajs-1773	205	9	hormones	hormone	NOUN
iajs-1773	205	10	in	in	ADP
iajs-1773	205	11	pairs	pair	NOUN
iajs-1773	205	12	of	of	ADP
iajs-1773	205	13	tumor	tumor	NOUN
iajs-1773	205	14	and	and	CCONJ
iajs-1773	205	15	serum	serum	NOUN
iajs-1773	205	16	from	from	ADP
iajs-1773	205	17	breast	breast	NOUN
iajs-1773	205	18	cancer	cancer	NOUN
iajs-1773	205	19	patients	patient	NOUN
iajs-1773	205	20	and	and	CCONJ
iajs-1773	205	21	pathobiological	pathobiological	ADJ
iajs-1773	205	22	role	role	NOUN
iajs-1773	205	23	of	of	ADP
iajs-1773	205	24	androstene-3β	androstene-3β	PROPN
iajs-1773	205	25	,	,	PUNCT
iajs-1773	205	26	17β	17β	NUM
iajs-1773	205	27	-	-	PUNCT
iajs-1773	205	28	diol	diol	NOUN
iajs-1773	205	29	.	.	PUNCT
iajs-1773	206	1	cancer	cancer	NOUN
iajs-1773	206	2	science	science	NOUN
iajs-1773	206	3	,	,	PUNCT
iajs-1773	206	4	102(10	102(10	NUM
iajs-1773	206	5	)	)	PUNCT
iajs-1773	206	6	,	,	PUNCT
iajs-1773	206	7	1848	1848	NUM
iajs-1773	206	8	-	-	SYM
iajs-1773	206	9	1854	1854	NUM
iajs-1773	206	10	.	.	PUNCT
iajs-1773	207	1	2011	2011	NUM
iajs-1773	208	1	[	[	X
iajs-1773	208	2	9	9	NUM
iajs-1773	208	3	]	]	PUNCT
iajs-1773	208	4	e.	e.	PROPN
iajs-1773	208	5	j.	j.	PROPN
iajs-1773	208	6	margalioth	margalioth	PROPN
iajs-1773	208	7	;	;	PUNCT
iajs-1773	208	8	j.g	j.g	PROPN
iajs-1773	208	9	.	.	PROPN
iajs-1773	208	10	schenker	schenker	PROPN
iajs-1773	208	11	and	and	CCONJ
iajs-1773	208	12	m.	m.	NOUN
iajs-1773	208	13	chevion	chevion	NOUN
iajs-1773	208	14	.	.	PUNCT
iajs-1773	209	1	copper	copper	NOUN
iajs-1773	209	2	and	and	CCONJ
iajs-1773	209	3	zinc	zinc	NOUN
iajs-1773	209	4	levels	level	NOUN
iajs-1773	209	5	in	in	ADP
iajs-1773	209	6	normal	normal	ADJ
iajs-1773	209	7	and	and	CCONJ
iajs-1773	209	8	malignant	malignant	ADJ
iajs-1773	209	9	tissues	tissue	NOUN
iajs-1773	209	10	.	.	PUNCT
iajs-1773	210	1	cancer	cancer	NOUN
iajs-1773	210	2	,	,	PUNCT
iajs-1773	210	3	52(5	52(5	NUM
iajs-1773	210	4	)	)	PUNCT
iajs-1773	210	5	,	,	PUNCT
iajs-1773	210	6	868	868	NUM
iajs-1773	210	7	-	-	SYM
iajs-1773	210	8	872	872	NUM
iajs-1773	210	9	.	.	PUNCT
iajs-1773	210	10	1983	1983	NUM
iajs-1773	211	1	[	[	X
iajs-1773	211	2	10	10	NUM
iajs-1773	211	3	]	]	X
iajs-1773	211	4	c.	c.	PROPN
iajs-1773	211	5	t.	t.	PROPN
iajs-1773	211	6	chasapis;a	chasapis;a	PROPN
iajs-1773	211	7	.	.	PUNCT
iajs-1773	212	1	c.	c.	PROPN
iajs-1773	212	2	loutsidou;c	loutsidou;c	PROPN
iajs-1773	212	3	.	.	PUNCT
iajs-1773	212	4	a.	a.	NOUN
iajs-1773	212	5	spiliopoulou	spiliopoulou	PROPN
iajs-1773	212	6	,	,	PUNCT
iajs-1773	212	7	and	and	CCONJ
iajs-1773	212	8	m.	m.	PROPN
iajs-1773	212	9	e.	e.	PROPN
iajs-1773	212	10	stefanidou	stefanidou	PROPN
iajs-1773	212	11	,	,	PUNCT
iajs-1773	212	12	zinc	zinc	NOUN
iajs-1773	212	13	and	and	CCONJ
iajs-1773	212	14	human	human	ADJ
iajs-1773	212	15	health	health	NOUN
iajs-1773	212	16	:	:	PUNCT
iajs-1773	212	17	an	an	DET
iajs-1773	212	18	update	update	NOUN
iajs-1773	212	19	.	.	PUNCT
iajs-1773	213	1	archives	archive	NOUN
iajs-1773	213	2	of	of	ADP
iajs-1773	213	3	toxicology	toxicology	NOUN
iajs-1773	213	4	,	,	PUNCT
iajs-1773	213	5	86(4	86(4	NUM
iajs-1773	213	6	)	)	PUNCT
iajs-1773	213	7	,	,	PUNCT
iajs-1773	213	8	521	521	NUM
iajs-1773	213	9	-	-	SYM
iajs-1773	213	10	534	534	NUM
iajs-1773	213	11	.	.	PUNCT
iajs-1773	213	12	2012	2012	NUM
iajs-1773	214	1	[	[	X
iajs-1773	214	2	11	11	NUM
iajs-1773	214	3	]	]	PUNCT
iajs-1773	214	4	c.jacobs;b	c.jacobs;b	PROPN
iajs-1773	214	5	.	.	PUNCT
iajs-1773	215	1	hutton;t	hutton;t	PROPN
iajs-1773	215	2	.	.	PUNCT
iajs-1773	216	1	ng	ng	PROPN
iajs-1773	216	2	,	,	PUNCT
iajs-1773	216	3	r	r	PROPN
iajs-1773	216	4	.shorr	.shorr	PROPN
iajs-1773	216	5	,	,	PUNCT
iajs-1773	216	6	and	and	CCONJ
iajs-1773	216	7	m.	m.	NOUN
iajs-1773	216	8	clemons	clemon	NOUN
iajs-1773	216	9	,	,	PUNCT
iajs-1773	216	10	is	be	AUX
iajs-1773	216	11	there	there	PRON
iajs-1773	216	12	a	a	DET
iajs-1773	216	13	role	role	NOUN
iajs-1773	216	14	for	for	ADP
iajs-1773	216	15	oral	oral	ADJ
iajs-1773	216	16	or	or	CCONJ
iajs-1773	216	17	intravenous	intravenous	ADJ
iajs-1773	216	18	ascorbate	ascorbate	NOUN
iajs-1773	216	19	(	(	PUNCT
iajs-1773	216	20	vitamin	vitamin	NOUN
iajs-1773	216	21	c	c	NOUN
iajs-1773	216	22	)	)	PUNCT
iajs-1773	216	23	in	in	ADP
iajs-1773	216	24	treating	treat	VERB
iajs-1773	216	25	patients	patient	NOUN
iajs-1773	216	26	with	with	ADP
iajs-1773	216	27	cancer	cancer	NOUN
iajs-1773	216	28	?	?	PUNCT
iajs-1773	217	1	a	a	DET
iajs-1773	217	2	systematic	systematic	ADJ
iajs-1773	217	3	review	review	NOUN
iajs-1773	217	4	theoncologist	theoncologist	NOUN
iajs-1773	217	5	;	;	PUNCT
iajs-1773	218	1	20:210–223	20:210–223	NUM
iajs-1773	218	2	.	.	PUNCT
iajs-1773	218	3	2015	2015	NUM
iajs-1773	219	1	[	[	X
iajs-1773	219	2	12	12	NUM
iajs-1773	219	3	]	]	PUNCT
iajs-1773	219	4	sas	sas	X
iajs-1773	219	5	.	.	PUNCT
iajs-1773	220	1	statistical	statistical	ADJ
iajs-1773	220	2	analysis	analysis	NOUN
iajs-1773	220	3	system	system	NOUN
iajs-1773	220	4	,	,	PUNCT
iajs-1773	220	5	user	user	NOUN
iajs-1773	220	6	's	's	PART
iajs-1773	220	7	guide	guide	NOUN
iajs-1773	220	8	.	.	PUNCT
iajs-1773	221	1	statistical	statistical	ADJ
iajs-1773	221	2	.	.	PUNCT
iajs-1773	221	3	version	version	NOUN
iajs-1773	222	1	9.1th	9.1th	NUM
iajs-1773	222	2	ed	ed	NOUN
iajs-1773	222	3	.	.	PUNCT
iajs-1773	222	4	sas	sas	PROPN
iajs-1773	222	5	.	.	PROPN
iajs-1773	222	6	inst	inst	PROPN
iajs-1773	222	7	.	.	PROPN
iajs-1773	222	8	inc	inc	PROPN
iajs-1773	222	9	.	.	PROPN
iajs-1773	222	10	cary	cary	PROPN
iajs-1773	222	11	.	.	PUNCT
iajs-1773	223	1	n.c	n.c	PROPN
iajs-1773	223	2	.	.	PROPN
iajs-1773	223	3	usa	usa	PROPN
iajs-1773	223	4	.2012	.2012	PROPN
iajs-1773	224	1	[	[	X
iajs-1773	224	2	13	13	NUM
iajs-1773	224	3	]	]	PUNCT
iajs-1773	224	4	l.	l.	PROPN
iajs-1773	224	5	e.	e.	PROPN
iajs-1773	224	6	carlsson;s.santoso	carlsson;s.santoso	PROPN
iajs-1773	224	7	;	;	PUNCT
iajs-1773	224	8	c.spitzer	c.spitzer	NOUN
iajs-1773	224	9	;	;	PUNCT
iajs-1773	224	10	c	c	NOUN
iajs-1773	224	11	.kessler	.kessler	PUNCT
iajs-1773	224	12	,	,	PUNCT
iajs-1773	224	13	and	and	CCONJ
iajs-1773	224	14	a.	a.	NOUN
iajs-1773	224	15	greinacher	greinacher	PROPN
iajs-1773	224	16	,	,	PUNCT
iajs-1773	224	17	the	the	DET
iajs-1773	224	18	alpha	alpha	NOUN
iajs-1773	224	19	2	2	NUM
iajs-1773	224	20	gene	gene	NOUN
iajs-1773	224	21	coding	code	VERB
iajs-1773	224	22	sequence	sequence	NOUN
iajs-1773	224	23	t	t	PROPN
iajs-1773	224	24	807	807	NUM
iajs-1773	224	25	/	/	SYM
iajs-1773	224	26	a	a	DET
iajs-1773	224	27	873	873	NUM
iajs-1773	224	28	of	of	ADP
iajs-1773	224	29	the	the	DET
iajs-1773	224	30	platelet	platelet	NOUN
iajs-1773	224	31	collagen	collagen	NOUN
iajs-1773	224	32	receptor	receptor	NOUN
iajs-1773	224	33	integrin	integrin	NOUN
iajs-1773	224	34	2	2	NUM
iajs-1773	224	35	β	β	SYM
iajs-1773	224	36	1	1	NUM
iajs-1773	224	37	might	might	AUX
iajs-1773	224	38	be	be	AUX
iajs-1773	224	39	a	a	DET
iajs-1773	224	40	genetic	genetic	ADJ
iajs-1773	224	41	risk	risk	NOUN
iajs-1773	224	42	factor	factor	NOUN
iajs-1773	224	43	for	for	ADP
iajs-1773	224	44	the	the	DET
iajs-1773	224	45	development	development	NOUN
iajs-1773	224	46	of	of	ADP
iajs-1773	224	47	stroke	stroke	NOUN
iajs-1773	224	48	in	in	ADP
iajs-1773	224	49	younger	young	ADJ
iajs-1773	224	50	patients	patient	NOUN
iajs-1773	224	51	.	.	PUNCT
iajs-1773	225	1	blood	blood	NOUN
iajs-1773	225	2	,	,	PUNCT
iajs-1773	225	3	93(11	93(11	NUM
iajs-1773	225	4	)	)	PUNCT
iajs-1773	225	5	,	,	PUNCT
iajs-1773	225	6	3583	3583	NUM
iajs-1773	225	7	-	-	SYM
iajs-1773	225	8	3586	3586	NUM
iajs-1773	225	9	.	.	PUNCT
iajs-1773	226	1	1999	1999	NUM
iajs-1773	227	1	[	[	X
iajs-1773	227	2	14	14	NUM
iajs-1773	227	3	]	]	X
iajs-1773	227	4	h.	h.	PROPN
iajs-1773	227	5	koyama	koyama	PROPN
iajs-1773	227	6	;	;	PUNCT
iajs-1773	227	7	e.	e.	PROPN
iajs-1773	227	8	w.raines;k	w.raines;k	PROPN
iajs-1773	227	9	.	.	PUNCT
iajs-1773	228	1	e.	e.	PROPN
iajs-1773	228	2	bornfeldt;j	bornfeldt;j	PROPN
iajs-1773	228	3	.	.	PUNCT
iajs-1773	229	1	m	m	PROPN
iajs-1773	229	2	roberts	roberts	PROPN
iajs-1773	229	3	,	,	PUNCT
iajs-1773	229	4	and	and	CCONJ
iajs-1773	229	5	r.	r.	PROPN
iajs-1773	229	6	ross	ross	PROPN
iajs-1773	229	7	,	,	PUNCT
iajs-1773	229	8	fibrillar	fibrillar	ADJ
iajs-1773	229	9	collagen	collagen	NOUN
iajs-1773	229	10	inhibits	inhibit	VERB
iajs-1773	229	11	arterial	arterial	ADJ
iajs-1773	229	12	smooth	smooth	ADJ
iajs-1773	229	13	muscle	muscle	NOUN
iajs-1773	229	14	proliferation	proliferation	NOUN
iajs-1773	229	15	through	through	ADP
iajs-1773	229	16	regulation	regulation	NOUN
iajs-1773	229	17	of	of	ADP
iajs-1773	229	18	cdk2	cdk2	PROPN
iajs-1773	229	19	inhibitors	inhibitor	NOUN
iajs-1773	229	20	.	.	PUNCT
iajs-1773	230	1	cell	cell	NOUN
iajs-1773	230	2	,	,	PUNCT
iajs-1773	230	3	87(6	87(6	NUM
iajs-1773	230	4	)	)	PUNCT
iajs-1773	230	5	,	,	PUNCT
iajs-1773	230	6	1069	1069	NUM
iajs-1773	230	7	-	-	SYM
iajs-1773	230	8	1078	1078	NUM
iajs-1773	230	9	.	.	PUNCT
iajs-1773	231	1	1996	1996	NUM
iajs-1773	231	2	[	[	X
iajs-1773	231	3	15	15	NUM
iajs-1773	231	4	]	]	X
iajs-1773	231	5	w.ding;x.l	w.ding;x.l	PROPN
iajs-1773	231	6	.	.	PUNCT
iajs-1773	231	7	fan;x	fan;x	PROPN
iajs-1773	231	8	.	.	PUNCT
iajs-1773	232	1	xu;j.z.huang;s.h	xu;j.z.huang;s.h	PROPN
iajs-1773	232	2	.	.	PUNCT
iajs-1773	233	1	xu	xu	PROPN
iajs-1773	233	2	;	;	PUNCT
iajs-1773	233	3	q.	q.	PROPN
iajs-1773	233	4	geng	geng	PROPN
iajs-1773	233	5	;	;	PUNCT
iajs-1773	233	6	r.	r.	PROPN
iajs-1773	233	7	li	li	PROPN
iajs-1773	233	8	;	;	PUNCT
iajs-1773	233	9	d.	d.	PROPN
iajs-1773	233	10	chen	chen	PROPN
iajs-1773	233	11	,	,	PUNCT
iajs-1773	233	12	and	and	CCONJ
iajs-1773	233	13	g.r	g.r	PROPN
iajs-1773	233	14	.	.	PROPN
iajs-1773	233	15	yan	yan	PROPN
iajs-1773	233	16	,	,	PUNCT
iajs-1773	233	17	epigenetic	epigenetic	ADJ
iajs-1773	233	18	silencing	silencing	NOUN
iajs-1773	233	19	of	of	ADP
iajs-1773	233	20	itga2	itga2	NOUN
iajs-1773	233	21	by	by	ADP
iajs-1773	233	22	mir-373	mir-373	NOUN
iajs-1773	233	23	promotes	promote	VERB
iajs-1773	233	24	cellmigration	cellmigration	NOUN
iajs-1773	233	25	in	in	ADP
iajs-1773	233	26	breast	breast	NOUN
iajs-1773	233	27	cancer	cancer	NOUN
iajs-1773	233	28	,	,	PUNCT
iajs-1773	233	29	public	public	ADJ
iajs-1773	233	30	library	library	NOUN
iajs-1773	233	31	of	of	ADP
iajs-1773	233	32	science	science	NOUN
iajs-1773	233	33	,	,	PUNCT
iajs-1773	233	34	10(8	10(8	NUM
iajs-1773	233	35	):	):	PUNCT
iajs-1773	233	36	e0135128	e0135128	PROPN
iajs-1773	233	37	.	.	NOUN
iajs-1773	233	38	2015	2015	NUM
iajs-1773	234	1	[	[	X
iajs-1773	234	2	16	16	NUM
iajs-1773	234	3	]	]	SYM
iajs-1773	234	4	h.liu	h.liu	NOUN
iajs-1773	234	5	;	;	PUNCT
iajs-1773	234	6	a.	a.	PROPN
iajs-1773	234	7	q.	q.	PROPN
iajs-1773	234	8	o.	o.	PROPN
iajs-1773	234	9	al	al	PROPN
iajs-1773	234	10	-	-	PUNCT
iajs-1773	234	11	aidaroos	aidaroos	PROPN
iajs-1773	234	12	;	;	PUNCT
iajs-1773	234	13	h.	h.	PROPN
iajs-1773	234	14	wang	wang	PROPN
iajs-1773	234	15	;	;	PUNCT
iajs-1773	234	16	k.	k.	PROPN
iajs-1773	234	17	guo	guo	PROPN
iajs-1773	234	18	;	;	PUNCT
iajs-1773	234	19	j.	j.	PROPN
iajs-1773	234	20	li	li	PROPN
iajs-1773	234	21	;	;	PUNCT
iajs-1773	234	22	h.	h.	PROPN
iajs-1773	234	23	zhang	zhang	PROPN
iajs-1773	234	24	,	,	PUNCT
iajs-1773	234	25	and	and	CCONJ
iajs-1773	234	26	q.	q.	PROPN
iajs-1773	234	27	fand	fand	PROPN
iajs-1773	234	28	zeng	zeng	PROPN
iajs-1773	234	29	,	,	PUNCT
iajs-1773	234	30	prl-3	prl-3	PRON
iajs-1773	234	31	suppresses	suppress	VERB
iajs-1773	234	32	c	c	NOUN
iajs-1773	234	33	-	-	PUNCT
iajs-1773	234	34	fos	fos	NOUN
iajs-1773	234	35	and	and	CCONJ
iajs-1773	234	36	integrin	integrin	NOUN
iajs-1773	234	37	α2	α2	ADJ
iajs-1773	234	38	expression	expression	NOUN
iajs-1773	234	39	in	in	ADP
iajs-1773	234	40	ovarian	ovarian	ADJ
iajs-1773	234	41	cancer	cancer	NOUN
iajs-1773	234	42	cells	cell	NOUN
iajs-1773	234	43	.	.	PUNCT
iajs-1773	235	1	biomed	biome	VERB
iajs-1773	235	2	central	central	ADJ
iajs-1773	235	3	cancer	cancer	NOUN
iajs-1773	235	4	,	,	PUNCT
iajs-1773	235	5	13(1	13(1	NUM
iajs-1773	235	6	)	)	PUNCT
iajs-1773	235	7	,	,	PUNCT
iajs-1773	235	8	80	80	NUM
iajs-1773	235	9	.	.	PUNCT
iajs-1773	236	1	2013	2013	NUM
iajs-1773	236	2	ihsciconf	ihsciconf	PROPN
iajs-1773	236	3	2017	2017	NUM
iajs-1773	236	4	special	special	ADJ
iajs-1773	236	5	issue	issue	NOUN
iajs-1773	236	6	ibn	ibn	PROPN
iajs-1773	236	7	al	al	PROPN
iajs-1773	236	8	-	-	PUNCT
iajs-1773	236	9	haitham	haitham	PROPN
iajs-1773	236	10	journal	journal	PROPN
iajs-1773	236	11	for	for	ADP
iajs-1773	236	12	pure	pure	ADJ
iajs-1773	236	13	and	and	CCONJ
iajs-1773	236	14	applied	apply	VERB
iajs-1773	236	15	science	science	NOUN
iajs-1773	236	16	https://doi.org/	https://doi.org/	NOUN
iajs-1773	236	17	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	236	18	.	.	PUNCT
iajs-1773	236	19	 	 	SPACE
iajs-1773	236	20	1773	1773	NUM
iajs-1773	236	21	for	for	ADP
iajs-1773	236	22	more	more	ADJ
iajs-1773	236	23	information	information	NOUN
iajs-1773	236	24	about	about	ADP
iajs-1773	236	25	the	the	DET
iajs-1773	236	26	conference	conference	NOUN
iajs-1773	236	27	please	please	INTJ
iajs-1773	236	28	visit	visit	VERB
iajs-1773	236	29	the	the	DET
iajs-1773	236	30	websites	website	NOUN
iajs-1773	236	31	:	:	PUNCT
iajs-1773	236	32	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	236	33	  	  	SPACE
iajs-1773	236	34	www.ihsciconf.org	www.ihsciconf.org	ADJ
iajs-1773	236	35	  	  	SPACE
iajs-1773	236	36	biology|84	biology|84	PROPN
iajs-1773	237	1	[	[	X
iajs-1773	237	2	17	17	NUM
iajs-1773	237	3	]	]	PUNCT
iajs-1773	237	4	j.	j.	PROPN
iajs-1773	237	5	f.liu;y	f.liu;y	PROPN
iajs-1773	237	6	.	.	PUNCT
iajs-1773	238	1	c.fong	c.fong	PROPN
iajs-1773	238	2	;	;	PUNCT
iajs-1773	238	3	c.	c.	PROPN
iajs-1773	238	4	s.chang	s.chang	PROPN
iajs-1773	238	5	;	;	PUNCT
iajs-1773	238	6	c.	c.	PROPN
iajs-1773	238	7	y.huang;h	y.huang;h	PROPN
iajs-1773	238	8	.	.	PUNCT
iajs-1773	239	1	t.chen	t.chen	ADV
iajs-1773	239	2	;	;	PUNCT
iajs-1773	239	3	w.	w.	PROPN
iajs-1773	239	4	h.	h.	PROPN
iajs-1773	239	5	yang	yang	PROPN
iajs-1773	239	6	,	,	PUNCT
iajs-1773	239	7	and	and	CCONJ
iajs-1773	239	8	c.	c.	PROPN
iajs-1773	239	9	h.	h.	PROPN
iajs-1773	239	10	tang	tang	PROPN
iajs-1773	239	11	;	;	PUNCT
iajs-1773	239	12	cyclooxygenase-2	cyclooxygenase-2	NUM
iajs-1773	239	13	enhances	enhance	VERB
iajs-1773	239	14	α2β1	α2β1	X
iajs-1773	239	15	integrin	integrin	NOUN
iajs-1773	239	16	expression	expression	NOUN
iajs-1773	239	17	and	and	CCONJ
iajs-1773	239	18	cell	cell	NOUN
iajs-1773	239	19	migration	migration	NOUN
iajs-1773	239	20	via	via	ADP
iajs-1773	239	21	ep1	ep1	NOUN
iajs-1773	239	22	dependent	dependent	ADJ
iajs-1773	239	23	signaling	signal	VERB
iajs-1773	239	24	pathway	pathway	NOUN
iajs-1773	239	25	in	in	ADP
iajs-1773	239	26	human	human	ADJ
iajs-1773	239	27	chondrosarcoma	chondrosarcoma	NOUN
iajs-1773	239	28	cells	cell	NOUN
iajs-1773	239	29	.	.	PUNCT
iajs-1773	240	1	molecular	molecular	ADJ
iajs-1773	240	2	cancer	cancer	NOUN
iajs-1773	240	3	,	,	PUNCT
iajs-1773	240	4	9(1	9(1	NUM
iajs-1773	240	5	)	)	PUNCT
iajs-1773	240	6	,	,	PUNCT
iajs-1773	240	7	43	43	NUM
iajs-1773	240	8	.	.	PUNCT
iajs-1773	240	9	2010	2010	NUM
iajs-1773	241	1	[	[	X
iajs-1773	241	2	18	18	NUM
iajs-1773	241	3	]	]	PUNCT
iajs-1773	241	4	b.	b.	PROPN
iajs-1773	241	5	cathrin	cathrin	NOUN
iajs-1773	241	6	.	.	PUNCT
iajs-1773	242	1	progesterone	progesterone	NOUN
iajs-1773	242	2	signaling	signal	VERB
iajs-1773	242	3	in	in	ADP
iajs-1773	242	4	breast	breast	NOUN
iajs-1773	242	5	cancer	cancer	NOUN
iajs-1773	242	6	:	:	PUNCT
iajs-1773	242	7	aneglected	aneglecte	VERB
iajs-1773	242	8	hormone	hormone	NOUN
iajs-1773	242	9	coming	come	VERB
iajs-1773	242	10	in	in	ADP
iajs-1773	242	11	to	to	ADP
iajs-1773	242	12	the	the	DET
iajs-1773	242	13	limelight	limelight	NOUN
iajs-1773	242	14	,	,	PUNCT
iajs-1773	242	15	2013	2013	NUM
iajs-1773	242	16	[	[	X
iajs-1773	242	17	19	19	NUM
iajs-1773	242	18	]	]	PUNCT
iajs-1773	242	19	h.	h.	PROPN
iajs-1773	242	20	mohammed	mohammed	PROPN
iajs-1773	242	21	;	;	PUNCT
iajs-1773	242	22	i.	i.	PROPN
iajs-1773	242	23	a.	a.	PROPN
iajs-1773	242	24	russell	russell	PROPN
iajs-1773	242	25	;	;	PUNCT
iajs-1773	242	26	r.	r.	PROPN
iajs-1773	242	27	stark;o.m	stark;o.m	PROPN
iajs-1773	242	28	.	.	PUNCT
iajs-1773	243	1	rueda	rueda	PROPN
iajs-1773	243	2	;	;	PUNCT
iajs-1773	243	3	t.	t.	PROPN
iajs-1773	243	4	e.hickey	e.hickey	PROPN
iajs-1773	243	5	;	;	PUNCT
iajs-1773	243	6	g.a	g.a	PROPN
iajs-1773	243	7	.	.	PROPN
iajs-1773	243	8	tarulli	tarulli	PROPN
iajs-1773	243	9	,	,	PUNCT
iajs-1773	243	10	and	and	CCONJ
iajs-1773	243	11	s.	s.	PROPN
iajs-1773	243	12	menon	menon	PROPN
iajs-1773	243	13	,	,	PUNCT
iajs-1773	243	14	progesterone	progesterone	NOUN
iajs-1773	243	15	receptor	receptor	NOUN
iajs-1773	243	16	modulates	modulate	NOUN
iajs-1773	243	17	er	er	INTJ
iajs-1773	243	18	α	α	PRON
iajs-1773	243	19	action	action	NOUN
iajs-1773	243	20	in	in	ADP
iajs-1773	243	21	breast	breast	NOUN
iajs-1773	243	22	cancer	cancer	NOUN
iajs-1773	243	23	.	.	PUNCT
iajs-1773	244	1	nature,523(7560	nature,523(7560	ADV
iajs-1773	244	2	)	)	PUNCT
iajs-1773	245	1	,	,	PUNCT
iajs-1773	245	2	313	313	NUM
iajs-1773	245	3	-	-	SYM
iajs-1773	245	4	317	317	NUM
iajs-1773	245	5	.	.	NOUN
iajs-1773	246	1	2015	2015	NUM
iajs-1773	247	1	[	[	SYM
iajs-1773	247	2	20	20	NUM
iajs-1773	247	3	]	]	PUNCT
iajs-1773	247	4	r.	r.	PROPN
iajs-1773	247	5	kaaks	kaaks	PROPN
iajs-1773	247	6	;	;	PUNCT
iajs-1773	247	7	k.	k.	PROPN
iajs-1773	247	8	tikk	tikk	PROPN
iajs-1773	247	9	;	;	PUNCT
iajs-1773	247	10	d.	d.	PROPN
iajs-1773	247	11	sookthai	sookthai	PROPN
iajs-1773	247	12	;	;	PUNCT
iajs-1773	247	13	h.	h.	PROPN
iajs-1773	247	14	schock	schock	PROPN
iajs-1773	247	15	;	;	PUNCT
iajs-1773	247	16	t.	t.	PROPN
iajs-1773	247	17	johnson;a.tjønnel	johnson;a.tjønnel	PROPN
iajs-1773	247	18	,	,	PUNCT
iajs-1773	247	19	and	and	CCONJ
iajs-1773	247	20	l.	l.	PROPN
iajs-1773	247	21	baglietto	baglietto	PROPN
iajs-1773	247	22	,	,	PUNCT
iajs-1773	247	23	premenopausal	premenopausal	NOUN
iajs-1773	247	24	serum	serum	NOUN
iajs-1773	247	25	sex	sex	NOUN
iajs-1773	247	26	hormone	hormone	NOUN
iajs-1773	247	27	levels	level	NOUN
iajs-1773	247	28	in	in	ADP
iajs-1773	247	29	relation	relation	NOUN
iajs-1773	247	30	to	to	ADP
iajs-1773	247	31	breast	breast	NOUN
iajs-1773	247	32	cancer	cancer	NOUN
iajs-1773	247	33	risk	risk	NOUN
iajs-1773	247	34	,	,	PUNCT
iajs-1773	247	35	overall	overall	ADJ
iajs-1773	247	36	and	and	CCONJ
iajs-1773	247	37	by	by	ADP
iajs-1773	247	38	hormone	hormone	NOUN
iajs-1773	247	39	receptor	receptor	NOUN
iajs-1773	247	40	status	status	NOUN
iajs-1773	247	41	—	—	PUNCT
iajs-1773	247	42	results	result	VERB
iajs-1773	247	43	from	from	ADP
iajs-1773	247	44	the	the	DET
iajs-1773	247	45	epic	epic	ADJ
iajs-1773	247	46	cohort	cohort	NOUN
iajs-1773	247	47	.	.	PUNCT
iajs-1773	248	1	international	international	ADJ
iajs-1773	248	2	journal	journal	PROPN
iajs-1773	248	3	of	of	ADP
iajs-1773	248	4	cancer	cancer	NOUN
iajs-1773	248	5	,	,	PUNCT
iajs-1773	248	6	134(8	134(8	NUM
iajs-1773	248	7	):	):	PUNCT
iajs-1773	248	8	1947	1947	NUM
iajs-1773	248	9	-	-	SYM
iajs-1773	248	10	1957	1957	NUM
iajs-1773	248	11	.	.	PUNCT
iajs-1773	249	1	2014	2014	NUM
iajs-1773	250	1	[	[	X
iajs-1773	250	2	21	21	NUM
iajs-1773	250	3	]	]	X
iajs-1773	250	4	m	m	VERB
iajs-1773	250	5	.dowsett	.dowsett	ADJ
iajs-1773	250	6	,	,	PUNCT
iajs-1773	250	7	and	and	CCONJ
iajs-1773	250	8	e.	e.	PROPN
iajs-1773	250	9	folkerd	folkerd	PROPN
iajs-1773	250	10	,	,	PUNCT
iajs-1773	250	11	reduced	reduce	VERB
iajs-1773	250	12	progesterone	progesterone	NOUN
iajs-1773	250	13	levels	level	NOUN
iajs-1773	250	14	explain	explain	VERB
iajs-1773	250	15	the	the	DET
iajs-1773	250	16	reduced	reduced	ADJ
iajs-1773	250	17	risk	risk	NOUN
iajs-1773	250	18	of	of	ADP
iajs-1773	250	19	breast	breast	NOUN
iajs-1773	250	20	cancer	cancer	NOUN
iajs-1773	250	21	in	in	ADP
iajs-1773	250	22	obese	obese	ADJ
iajs-1773	250	23	premenopausal	premenopausal	NOUN
iajs-1773	250	24	women	woman	NOUN
iajs-1773	250	25	:	:	PUNCT
iajs-1773	250	26	a	a	DET
iajs-1773	250	27	new	new	ADJ
iajs-1773	250	28	hypothesis	hypothesis	NOUN
iajs-1773	250	29	.	.	PUNCT
iajs-1773	251	1	breast	breast	NOUN
iajs-1773	251	2	cancer	cancer	NOUN
iajs-1773	251	3	research	research	NOUN
iajs-1773	251	4	and	and	CCONJ
iajs-1773	251	5	treatment	treatment	NOUN
iajs-1773	251	6	,	,	PUNCT
iajs-1773	251	7	149(1	149(1	NUM
iajs-1773	251	8	)	)	PUNCT
iajs-1773	251	9	,	,	PUNCT
iajs-1773	251	10	1	1	NUM
iajs-1773	251	11	-	-	SYM
iajs-1773	251	12	4	4	NUM
iajs-1773	251	13	.	.	NOUN
iajs-1773	251	14	2015	2015	NUM
iajs-1773	252	1	[	[	X
iajs-1773	252	2	22	22	NUM
iajs-1773	252	3	]	]	PUNCT
iajs-1773	252	4	a.matsuoka	a.matsuoka	PROPN
iajs-1773	252	5	;	;	PUNCT
iajs-1773	252	6	s.	s.	PROPN
iajs-1773	252	7	tate	tate	PROPN
iajs-1773	252	8	;	;	PUNCT
iajs-1773	252	9	k.	k.	PROPN
iajs-1773	252	10	nishikimi	nishikimi	PROPN
iajs-1773	252	11	;	;	PUNCT
iajs-1773	252	12	h.ishikawa	h.ishikawa	PROPN
iajs-1773	252	13	,	,	PUNCT
iajs-1773	252	14	and	and	CCONJ
iajs-1773	252	15	m.shozu	m.shozu	NOUN
iajs-1773	252	16	,	,	PUNCT
iajs-1773	252	17	elevated	elevate	VERB
iajs-1773	252	18	serum	serum	NOUN
iajs-1773	252	19	progesterone	progesterone	NOUN
iajs-1773	252	20	levels	level	NOUN
iajs-1773	252	21	in	in	ADP
iajs-1773	252	22	postmenopausal	postmenopausal	ADJ
iajs-1773	252	23	women	woman	NOUN
iajs-1773	252	24	with	with	ADP
iajs-1773	252	25	mucinous	mucinous	ADJ
iajs-1773	252	26	ovarian	ovarian	ADJ
iajs-1773	252	27	tumors	tumor	NOUN
iajs-1773	252	28	.	.	PUNCT
iajs-1773	253	1	menopause	menopause	NOUN
iajs-1773	253	2	,	,	PUNCT
iajs-1773	253	3	23(5	23(5	NUM
iajs-1773	253	4	)	)	PUNCT
iajs-1773	253	5	,	,	PUNCT
iajs-1773	253	6	544	544	NUM
iajs-1773	253	7	-	-	SYM
iajs-1773	253	8	549	549	NUM
iajs-1773	253	9	.	.	NOUN
iajs-1773	253	10	2016	2016	NUM
iajs-1773	254	1	[	[	X
iajs-1773	254	2	23	23	NUM
iajs-1773	254	3	]	]	PUNCT
iajs-1773	254	4	i.	i.	PROPN
iajs-1773	254	5	y.	y.	PROPN
iajs-1773	254	6	hachim;m	hachim;m	PROPN
iajs-1773	254	7	.	.	PUNCT
iajs-1773	255	1	y.	y.	PROPN
iajs-1773	255	2	hachim	hachim	PROPN
iajs-1773	255	3	;	;	PUNCT
iajs-1773	256	1	v.	v.	ADP
iajs-1773	256	2	m.	m.	NOUN
iajs-1773	256	3	lopez	lopez	PROPN
iajs-1773	256	4	;	;	PUNCT
iajs-1773	256	5	j.	j.	PROPN
iajs-1773	256	6	j.	j.	PROPN
iajs-1773	256	7	lebrun	lebrun	PROPN
iajs-1773	256	8	,	,	PUNCT
iajs-1773	256	9	and	and	CCONJ
iajs-1773	256	10	s.	s.	PROPN
iajs-1773	256	11	ali	ali	PROPN
iajs-1773	256	12	,	,	PUNCT
iajs-1773	256	13	prolactin	prolactin	ADJ
iajs-1773	256	14	receptor	receptor	NOUN
iajs-1773	256	15	expression	expression	NOUN
iajs-1773	256	16	is	be	AUX
iajs-1773	256	17	an	an	DET
iajs-1773	256	18	independent	independent	ADJ
iajs-1773	256	19	favorable	favorable	ADJ
iajs-1773	256	20	prognostic	prognostic	ADJ
iajs-1773	256	21	marker	marker	NOUN
iajs-1773	256	22	in	in	ADP
iajs-1773	256	23	human	human	ADJ
iajs-1773	256	24	breast	breast	NOUN
iajs-1773	256	25	cancer	cancer	NOUN
iajs-1773	256	26	.	.	PUNCT
iajs-1773	257	1	applied	apply	VERB
iajs-1773	257	2	immunohistochemistry	immunohistochemistry	NOUN
iajs-1773	257	3	&	&	CCONJ
iajs-1773	257	4	molecular	molecular	ADJ
iajs-1773	257	5	morphology	morphology	NOUN
iajs-1773	257	6	,	,	PUNCT
iajs-1773	257	7	24(4	24(4	NUM
iajs-1773	257	8	)	)	PUNCT
iajs-1773	257	9	,	,	PUNCT
iajs-1773	257	10	238	238	NUM
iajs-1773	257	11	-	-	SYM
iajs-1773	257	12	245	245	NUM
iajs-1773	257	13	.	.	PUNCT
iajs-1773	257	14	2016	2016	NUM
iajs-1773	258	1	[	[	X
iajs-1773	258	2	24	24	NUM
iajs-1773	258	3	]	]	PUNCT
iajs-1773	258	4	s.	s.	PROPN
iajs-1773	258	5	j.	j.	PROPN
iajs-1773	258	6	nyante	nyante	PROPN
iajs-1773	258	7	;	;	PUNCT
iajs-1773	258	8	j.	j.	PROPN
iajs-1773	258	9	m.	m.	PROPN
iajs-1773	258	10	faupel	faupel	PROPN
iajs-1773	258	11	-	-	PUNCT
iajs-1773	258	12	badger	badger	NOUN
iajs-1773	258	13	;	;	PUNCT
iajs-1773	258	14	m.	m.	NOUN
iajs-1773	258	15	e.sherman;r	e.sherman;r	PROPN
iajs-1773	258	16	.	.	PUNCT
iajs-1773	259	1	m.pfeiffer	m.pfeiffer	PROPN
iajs-1773	259	2	;	;	PUNCT
iajs-1773	259	3	m.	m.	NOUN
iajs-1773	259	4	m.gaudet	m.gaudet	PROPN
iajs-1773	259	5	;	;	PUNCT
iajs-1773	259	6	r.	r.	PROPN
iajs-1773	259	7	t.	t.	PROPN
iajs-1773	259	8	falk;a.a	falk;a.a	PROPN
iajs-1773	259	9	.	.	PUNCT
iajs-1773	260	1	andaya	andaya	PROPN
iajs-1773	260	2	;	;	PUNCT
iajs-1773	260	3	j.	j.	PROPN
iajs-1773	260	4	lissowska;l.a.brinton;b	lissowska;l.a.brinton;b	PROPN
iajs-1773	260	5	.	.	PROPN
iajs-1773	260	6	peplonska	peplonska	PROPN
iajs-1773	260	7	;	;	PUNCT
iajs-1773	261	1	b.	b.	PROPN
iajs-1773	261	2	k	k	PROPN
iajs-1773	262	1	.vonderhaar;s	.vonderhaar;s	PROPN
iajs-1773	262	2	.	.	PUNCT
iajs-1773	262	3	chanock	chanock	NOUN
iajs-1773	262	4	;	;	PUNCT
iajs-1773	262	5	m.garcia	m.garcia	NOUN
iajs-1773	262	6	-	-	PUNCT
iajs-1773	262	7	closas	closas	PROPN
iajs-1773	262	8	,	,	PUNCT
iajs-1773	262	9	and	and	CCONJ
iajs-1773	262	10	j.	j.	PROPN
iajs-1773	262	11	d.figuero	d.figuero	PROPN
iajs-1773	262	12	,	,	PUNCT
iajs-1773	262	13	genetic	genetic	ADJ
iajs-1773	262	14	variation	variation	NOUN
iajs-1773	262	15	in	in	ADP
iajs-1773	262	16	prl	prl	PROPN
iajs-1773	262	17	and	and	CCONJ
iajs-1773	262	18	prlr	prlr	NOUN
iajs-1773	262	19	,	,	PUNCT
iajs-1773	262	20	and	and	CCONJ
iajs-1773	262	21	relationships	relationship	NOUN
iajs-1773	262	22	with	with	ADP
iajs-1773	262	23	serum	serum	NOUN
iajs-1773	262	24	prolactin	prolactin	NOUN
iajs-1773	262	25	levels	level	NOUN
iajs-1773	262	26	and	and	CCONJ
iajs-1773	262	27	breast	breast	NOUN
iajs-1773	262	28	cancer	cancer	NOUN
iajs-1773	262	29	risk	risk	NOUN
iajs-1773	262	30	:	:	PUNCT
iajs-1773	262	31	results	result	VERB
iajs-1773	262	32	from	from	ADP
iajs-1773	262	33	a	a	DET
iajs-1773	262	34	populationbased	populationbase	VERB
iajs-1773	262	35	case	case	NOUN
iajs-1773	262	36	-	-	PUNCT
iajs-1773	262	37	control	control	NOUN
iajs-1773	262	38	study	study	NOUN
iajs-1773	262	39	in	in	ADP
iajs-1773	262	40	poland	poland	PROPN
iajs-1773	262	41	.	.	PUNCT
iajs-1773	263	1	breast	breast	NOUN
iajs-1773	263	2	cancer	cancer	NOUN
iajs-1773	263	3	research	research	NOUN
iajs-1773	263	4	,	,	PUNCT
iajs-1773	263	5	13(2	13(2	PROPN
iajs-1773	263	6	)	)	PUNCT
iajs-1773	263	7	,	,	PUNCT
iajs-1773	263	8	r42	r42	NOUN
iajs-1773	263	9	.	.	PUNCT
iajs-1773	263	10	2011	2011	NUM
iajs-1773	264	1	[	[	X
iajs-1773	264	2	25	25	NUM
iajs-1773	264	3	]	]	X
iajs-1773	264	4	s	s	X
iajs-1773	264	5	.tworoger	.tworoger	NOUN
iajs-1773	264	6	,	,	PUNCT
iajs-1773	264	7	and	and	CCONJ
iajs-1773	264	8	s	s	PROPN
iajs-1773	264	9	,	,	PUNCT
iajs-1773	264	10	e.	e.	PROPN
iajs-1773	264	11	hankinon	hankinon	PROPN
iajs-1773	264	12	,	,	PUNCT
iajs-1773	264	13	prolactin	prolactin	ADJ
iajs-1773	264	14	and	and	CCONJ
iajs-1773	264	15	breast	breast	NOUN
iajs-1773	264	16	cancer	cancer	NOUN
iajs-1773	264	17	risk	risk	NOUN
iajs-1773	264	18	cancer	cancer	NOUN
iajs-1773	264	19	letters	letter	NOUN
iajs-1773	264	20	243	243	NUM
iajs-1773	264	21	160–169	160–169	NUM
iajs-1773	264	22	.	.	PUNCT
iajs-1773	265	1	2006	2006	NUM
iajs-1773	266	1	[	[	X
iajs-1773	266	2	26	26	NUM
iajs-1773	266	3	]	]	PUNCT
iajs-1773	266	4	k.	k.	PROPN
iajs-1773	266	5	tikk	tikk	PROPN
iajs-1773	266	6	;	;	PUNCT
iajs-1773	266	7	d.	d.	PROPN
iajs-1773	266	8	sookthai	sookthai	PROPN
iajs-1773	266	9	;	;	PUNCT
iajs-1773	266	10	r.t	r.t	PROPN
iajs-1773	266	11	.	.	PROPN
iajs-1773	266	12	fortner	fortner	PROPN
iajs-1773	266	13	;	;	PUNCT
iajs-1773	266	14	t.	t.	PROPN
iajs-1773	266	15	johnson	johnson	PROPN
iajs-1773	266	16	;	;	PUNCT
iajs-1773	266	17	s.	s.	PROPN
iajs-1773	266	18	rinaldi	rinaldi	PROPN
iajs-1773	266	19	;	;	PUNCT
iajs-1773	266	20	i.	i.	NOUN
iajs-1773	266	21	romieu	romieu	PROPN
iajs-1773	266	22	;	;	PUNCT
iajs-1773	266	23	et	et	PROPN
iajs-1773	266	24	al	al	PROPN
iajs-1773	266	25	and	and	CCONJ
iajs-1773	266	26	l.	l.	PROPN
iajs-1773	266	27	baglietto	baglietto	PROPN
iajs-1773	266	28	,	,	PUNCT
iajs-1773	266	29	circulating	circulate	VERB
iajs-1773	266	30	prolactin	prolactin	NOUN
iajs-1773	266	31	and	and	CCONJ
iajs-1773	266	32	in	in	ADP
iajs-1773	266	33	situ	situ	ADJ
iajs-1773	266	34	breast	breast	NOUN
iajs-1773	266	35	cancer	cancer	NOUN
iajs-1773	266	36	risk	risk	NOUN
iajs-1773	266	37	in	in	ADP
iajs-1773	266	38	the	the	DET
iajs-1773	266	39	european	european	ADJ
iajs-1773	266	40	epic	epic	PROPN
iajs-1773	266	41	cohort	cohort	PROPN
iajs-1773	266	42	:	:	PUNCT
iajs-1773	266	43	a	a	DET
iajs-1773	266	44	case	case	NOUN
iajs-1773	266	45	-	-	PUNCT
iajs-1773	266	46	control	control	NOUN
iajs-1773	266	47	study	study	NOUN
iajs-1773	266	48	.	.	PUNCT
iajs-1773	267	1	breast	breast	NOUN
iajs-1773	267	2	cancer	cancer	NOUN
iajs-1773	267	3	research	research	NOUN
iajs-1773	267	4	,	,	PUNCT
iajs-1773	267	5	17(1	17(1	NUM
iajs-1773	267	6	)	)	PUNCT
iajs-1773	267	7	,	,	PUNCT
iajs-1773	267	8	49.2015	49.2015	NUM
iajs-1773	267	9	.	.	PUNCT
iajs-1773	268	1	[	[	X
iajs-1773	268	2	27	27	NUM
iajs-1773	268	3	]	]	PUNCT
iajs-1773	268	4	t.	t.	PROPN
iajs-1773	268	5	v.	v.	PROPN
iajs-1773	268	6	clendenen	clendenen	PROPN
iajs-1773	268	7	;	;	PUNCT
iajs-1773	268	8	a.	a.	PROPN
iajs-1773	268	9	a.	a.	PROPN
iajs-1773	268	10	arslan	arslan	PROPN
iajs-1773	268	11	;	;	PUNCT
iajs-1773	268	12	a.	a.	PROPN
iajs-1773	268	13	e.	e.	PROPN
iajs-1773	268	14	lokshin	lokshin	PROPN
iajs-1773	268	15	;	;	PUNCT
iajs-1773	268	16	m.	m.	PROPN
iajs-1773	268	17	liu	liu	PROPN
iajs-1773	268	18	;	;	PUNCT
iajs-1773	268	19	e.	e.	PROPN
iajs-1773	268	20	lundin	lundin	PROPN
iajs-1773	268	21	;	;	PUNCT
iajs-1773	268	22	k.	k.	PROPN
iajs-1773	268	23	l.koenig	l.koenig	PROPN
iajs-1773	268	24	,	,	PUNCT
iajs-1773	268	25	and	and	CCONJ
iajs-1773	268	26	a.	a.	NOUN
iajs-1773	268	27	lukanova	lukanova	PROPN
iajs-1773	268	28	,	,	PUNCT
iajs-1773	268	29	circulating	circulate	VERB
iajs-1773	268	30	prolactin	prolactin	NOUN
iajs-1773	268	31	levels	level	NOUN
iajs-1773	268	32	and	and	CCONJ
iajs-1773	268	33	risk	risk	NOUN
iajs-1773	268	34	of	of	ADP
iajs-1773	268	35	epithelial	epithelial	ADJ
iajs-1773	268	36	ovarian	ovarian	ADJ
iajs-1773	268	37	cancer	cancer	NOUN
iajs-1773	268	38	.	.	PUNCT
iajs-1773	269	1	cancer	cancer	NOUN
iajs-1773	269	2	causes	cause	NOUN
iajs-1773	269	3	&	&	CCONJ
iajs-1773	269	4	control	control	NOUN
iajs-1773	269	5	,	,	PUNCT
iajs-1773	269	6	24(4	24(4	NUM
iajs-1773	269	7	)	)	PUNCT
iajs-1773	269	8	,	,	PUNCT
iajs-1773	269	9	741	741	NUM
iajs-1773	269	10	-	-	SYM
iajs-1773	269	11	748	748	NUM
iajs-1773	269	12	.	.	PUNCT
iajs-1773	270	1	2013	2013	NUM
iajs-1773	271	1	[	[	X
iajs-1773	271	2	28	28	NUM
iajs-1773	271	3	]	]	X
iajs-1773	271	4	j.	j.	PROPN
iajs-1773	271	5	white	white	PROPN
iajs-1773	271	6	,	,	PUNCT
iajs-1773	271	7	neur493	neur493	PROPN
iajs-1773	271	8	thesis	thesis	VERB
iajs-1773	271	9	the	the	DET
iajs-1773	271	10	effects	effect	NOUN
iajs-1773	271	11	of	of	ADP
iajs-1773	271	12	hormonal	hormonal	ADJ
iajs-1773	271	13	contraception	contraception	NOUN
iajs-1773	271	14	on	on	ADP
iajs-1773	271	15	hippocampal	hippocampal	ADJ
iajs-1773	271	16	volume	volume	NOUN
iajs-1773	271	17	in	in	ADP
iajs-1773	271	18	young	young	ADJ
iajs-1773	271	19	women	woman	NOUN
iajs-1773	271	20	:	:	PUNCT
iajs-1773	271	21	a	a	DET
iajs-1773	271	22	neuroimaging	neuroimage	VERB
iajs-1773	271	23	study	study	NOUN
iajs-1773	271	24	,	,	PUNCT
iajs-1773	271	25	(	(	PUNCT
iajs-1773	271	26	2017	2017	NUM
iajs-1773	271	27	)	)	PUNCT
iajs-1773	271	28	.	.	PUNCT
iajs-1773	272	1	[	[	X
iajs-1773	272	2	29	29	NUM
iajs-1773	272	3	]	]	X
iajs-1773	272	4	y.	y.	PROPN
iajs-1773	272	5	kakugawa;h.tada	kakugawa;h.tada	PROPN
iajs-1773	272	6	;	;	PUNCT
iajs-1773	272	7	m.kawai	m.kawai	NOUN
iajs-1773	272	8	;	;	PUNCT
iajs-1773	272	9	t.suzuki	t.suzuki	NUM
iajs-1773	272	10	;	;	PUNCT
iajs-1773	272	11	y.nishino	y.nishino	NUM
iajs-1773	272	12	;	;	PUNCT
iajs-1773	272	13	s.	s.	PROPN
iajs-1773	272	14	kanemura	kanemura	PROPN
iajs-1773	272	15	;	;	PUNCT
iajs-1773	272	16	t	t	PROPN
iajs-1773	272	17	.	.	PUNCT
iajs-1773	273	1	ishida	ishida	PROPN
iajs-1773	273	2	;	;	PUNCT
iajs-1773	273	3	n.	n.	PROPN
iajs-1773	273	4	ohuchi	ohuchi	PROPN
iajs-1773	273	5	,	,	PUNCT
iajs-1773	273	6	and	and	CCONJ
iajs-1773	273	7	y.minami	y.minami	NOUN
iajs-1773	273	8	,	,	PUNCT
iajs-1773	273	9	associations	association	NOUN
iajs-1773	273	10	of	of	ADP
iajs-1773	273	11	obesity	obesity	NOUN
iajs-1773	273	12	and	and	CCONJ
iajs-1773	273	13	physical	physical	ADJ
iajs-1773	273	14	activity	activity	NOUN
iajs-1773	273	15	with	with	ADP
iajs-1773	273	16	serum	serum	NOUN
iajs-1773	273	17	and	and	CCONJ
iajs-1773	273	18	intratumoral	intratumoral	ADJ
iajs-1773	273	19	sex	sex	NOUN
iajs-1773	273	20	steroid	steroid	NOUN
iajs-1773	273	21	hormone	hormone	NOUN
iajs-1773	273	22	levels	level	NOUN
iajs-1773	273	23	among	among	ADP
iajs-1773	273	24	postmenopausal	postmenopausal	ADJ
iajs-1773	273	25	women	woman	NOUN
iajs-1773	273	26	with	with	ADP
iajs-1773	273	27	breast	breast	NOUN
iajs-1773	273	28	cancer	cancer	NOUN
iajs-1773	273	29	:	:	PUNCT
iajs-1773	273	30	analysis	analysis	NOUN
iajs-1773	273	31	of	of	ADP
iajs-1773	273	32	paired	pair	VERB
iajs-1773	273	33	serum	serum	NOUN
iajs-1773	273	34	and	and	CCONJ
iajs-1773	273	35	tumor	tumor	NOUN
iajs-1773	273	36	tissue	tissue	NOUN
iajs-1773	273	37	samples	sample	NOUN
iajs-1773	273	38	.	.	PUNCT
iajs-1773	274	1	breast	breast	NOUN
iajs-1773	274	2	cancer	cancer	NOUN
iajs-1773	274	3	research	research	NOUN
iajs-1773	274	4	and	and	CCONJ
iajs-1773	274	5	treatment	treatment	NOUN
iajs-1773	274	6	,	,	PUNCT
iajs-1773	274	7	162(1	162(1	NUM
iajs-1773	274	8	)	)	PUNCT
iajs-1773	274	9	,	,	PUNCT
iajs-1773	274	10	115	115	NUM
iajs-1773	274	11	-	-	SYM
iajs-1773	274	12	125	125	NUM
iajs-1773	274	13	.	.	NOUN
iajs-1773	274	14	2017	2017	NUM
iajs-1773	275	1	[	[	SYM
iajs-1773	275	2	30	30	NUM
iajs-1773	275	3	]	]	PUNCT
iajs-1773	275	4	j.	j.	PROPN
iajs-1773	275	5	r.	r.	PROPN
iajs-1773	275	6	pasqualini	pasqualini	PROPN
iajs-1773	275	7	;	;	PUNCT
iajs-1773	275	8	g.	g.	PROPN
iajs-1773	275	9	chetrite	chetrite	PROPN
iajs-1773	275	10	;	;	PUNCT
iajs-1773	275	11	c.	c.	PROPN
iajs-1773	275	12	blacker	blacker	PROPN
iajs-1773	275	13	;	;	PUNCT
iajs-1773	275	14	m.	m.	PROPN
iajs-1773	275	15	c.	c.	PROPN
iajs-1773	275	16	feinstein	feinstein	PROPN
iajs-1773	275	17	;	;	PUNCT
iajs-1773	275	18	l.	l.	PROPN
iajs-1773	275	19	delalonde	delalonde	PROPN
iajs-1773	275	20	;	;	PUNCT
iajs-1773	275	21	m.	m.	NOUN
iajs-1773	275	22	talbi	talbi	PROPN
iajs-1773	275	23	,	,	PUNCT
iajs-1773	275	24	and	and	CCONJ
iajs-1773	275	25	c.	c.	PROPN
iajs-1773	275	26	maloche	maloche	PROPN
iajs-1773	275	27	,	,	PUNCT
iajs-1773	275	28	concentrations	concentration	NOUN
iajs-1773	275	29	of	of	ADP
iajs-1773	275	30	estrone	estrone	NOUN
iajs-1773	275	31	,	,	PUNCT
iajs-1773	275	32	estradiol	estradiol	PROPN
iajs-1773	275	33	,	,	PUNCT
iajs-1773	275	34	and	and	CCONJ
iajs-1773	275	35	estrone	estrone	NOUN
iajs-1773	275	36	sulfate	sulfate	NOUN
iajs-1773	275	37	and	and	CCONJ
iajs-1773	275	38	evaluation	evaluation	NOUN
iajs-1773	275	39	of	of	ADP
iajs-1773	275	40	sulfatase	sulfatase	NOUN
iajs-1773	275	41	and	and	CCONJ
iajs-1773	275	42	aromatase	aromatase	NOUN
iajs-1773	275	43	activities	activity	NOUN
iajs-1773	275	44	in	in	ADP
iajs-1773	275	45	pre	pre	ADJ
iajs-1773	275	46	-	-	ADJ
iajs-1773	275	47	and	and	CCONJ
iajs-1773	275	48	postmenopausal	postmenopausal	ADJ
iajs-1773	275	49	breast	breast	NOUN
iajs-1773	275	50	cancer	cancer	NOUN
iajs-1773	275	51	patients	patient	NOUN
iajs-1773	275	52	.	.	PUNCT
iajs-1773	276	1	the	the	DET
iajs-1773	276	2	journal	journal	NOUN
iajs-1773	276	3	of	of	ADP
iajs-1773	276	4	clinical	clinical	ADJ
iajs-1773	276	5	endocrinology	endocrinology	NOUN
iajs-1773	276	6	&	&	CCONJ
iajs-1773	276	7	metabolism	metabolism	NOUN
iajs-1773	276	8	,	,	PUNCT
iajs-1773	276	9	81(4	81(4	NUM
iajs-1773	276	10	)	)	PUNCT
iajs-1773	276	11	,	,	PUNCT
iajs-1773	276	12	1460	1460	NUM
iajs-1773	276	13	-	-	SYM
iajs-1773	276	14	1464	1464	NUM
iajs-1773	276	15	.	.	PUNCT
iajs-1773	276	16	1996	1996	NUM
iajs-1773	276	17	ihsciconf	ihsciconf	PROPN
iajs-1773	276	18	2017	2017	NUM
iajs-1773	276	19	special	special	ADJ
iajs-1773	276	20	issue	issue	NOUN
iajs-1773	276	21	ibn	ibn	PROPN
iajs-1773	276	22	al	al	PROPN
iajs-1773	276	23	-	-	PUNCT
iajs-1773	276	24	haitham	haitham	PROPN
iajs-1773	276	25	journal	journal	PROPN
iajs-1773	276	26	for	for	ADP
iajs-1773	276	27	pure	pure	ADJ
iajs-1773	276	28	and	and	CCONJ
iajs-1773	276	29	applied	apply	VERB
iajs-1773	276	30	science	science	NOUN
iajs-1773	276	31	https://doi.org/	https://doi.org/	NOUN
iajs-1773	276	32	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	276	33	.	.	PUNCT
iajs-1773	276	34	 	 	SPACE
iajs-1773	276	35	1773	1773	NUM
iajs-1773	276	36	for	for	ADP
iajs-1773	276	37	more	more	ADJ
iajs-1773	276	38	information	information	NOUN
iajs-1773	276	39	about	about	ADP
iajs-1773	276	40	the	the	DET
iajs-1773	276	41	conference	conference	NOUN
iajs-1773	276	42	please	please	INTJ
iajs-1773	276	43	visit	visit	VERB
iajs-1773	276	44	the	the	DET
iajs-1773	276	45	websites	website	NOUN
iajs-1773	276	46	:	:	PUNCT
iajs-1773	276	47	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	276	48	  	  	SPACE
iajs-1773	276	49	www.ihsciconf.org	www.ihsciconf.org	NOUN
iajs-1773	276	50	  	  	SPACE
iajs-1773	276	51	biology|85	biology|85	PROPN
iajs-1773	277	1	[	[	X
iajs-1773	277	2	31	31	NUM
iajs-1773	277	3	]	]	X
iajs-1773	277	4	l.	l.	PROPN
iajs-1773	277	5	baglietto	baglietto	PROPN
iajs-1773	277	6	;	;	PUNCT
iajs-1773	277	7	g.	g.	PROPN
iajs-1773	277	8	severi	severi	PROPN
iajs-1773	277	9	;	;	PUNCT
iajs-1773	277	10	d.	d.	PROPN
iajs-1773	277	11	r.	r.	PROPN
iajs-1773	277	12	english	english	PROPN
iajs-1773	277	13	;	;	PUNCT
iajs-1773	277	14	k.	k.	PROPN
iajs-1773	277	15	krishnan	krishnan	PROPN
iajs-1773	277	16	;	;	PUNCT
iajs-1773	277	17	j.	j.	PROPN
iajs-1773	277	18	l.	l.	PROPN
iajs-1773	277	19	hopper	hopper	PROPN
iajs-1773	277	20	;	;	PUNCT
iajs-1773	277	21	c.	c.	PROPN
iajs-1773	277	22	mclean	mclean	PROPN
iajs-1773	277	23	;	;	PUNCT
iajs-1773	277	24	h.a	h.a	PROPN
iajs-1773	277	25	.	.	PROPN
iajs-1773	277	26	morris	morris	PROPN
iajs-1773	277	27	;	;	PUNCT
iajs-1773	277	28	w.d	w.d	PROPN
iajs-1773	277	29	.	.	PROPN
iajs-1773	277	30	tilley	tilley	PROPN
iajs-1773	277	31	,	,	PUNCT
iajs-1773	277	32	and	and	CCONJ
iajs-1773	277	33	g.	g.	PROPN
iajs-1773	277	34	g.	g.	PROPN
iajs-1773	277	35	giles	giles	PROPN
iajs-1773	277	36	,	,	PUNCT
iajs-1773	277	37	circulating	circulate	VERB
iajs-1773	277	38	steroid	steroid	NOUN
iajs-1773	277	39	hormone	hormone	NOUN
iajs-1773	277	40	levels	level	NOUN
iajs-1773	277	41	and	and	CCONJ
iajs-1773	277	42	risk	risk	NOUN
iajs-1773	277	43	of	of	ADP
iajs-1773	277	44	breast	breast	NOUN
iajs-1773	277	45	cancer	cancer	NOUN
iajs-1773	277	46	for	for	ADP
iajs-1773	277	47	postmenopausal	postmenopausal	ADJ
iajs-1773	277	48	women	woman	NOUN
iajs-1773	277	49	.	.	PUNCT
iajs-1773	278	1	cancer	cancer	NOUN
iajs-1773	278	2	epidemiology	epidemiology	NOUN
iajs-1773	278	3	and	and	CCONJ
iajs-1773	278	4	preventio	preventio	NOUN
iajs-1773	278	5	,	,	PUNCT
iajs-1773	278	6	19:492–502	19:492–502	PROPN
iajs-1773	278	7	.	.	PUNCT
iajs-1773	279	1	2010	2010	NUM
iajs-1773	280	1	[	[	X
iajs-1773	280	2	32	32	NUM
iajs-1773	280	3	]	]	X
iajs-1773	280	4	f	f	PROPN
iajs-1773	280	5	.	.	PUNCT
iajs-1773	281	1	mungenast	mungenast	PROPN
iajs-1773	281	2	,	,	PUNCT
iajs-1773	281	3	and	and	CCONJ
iajs-1773	281	4	t	t	PROPN
iajs-1773	281	5	.	.	PUNCT
iajs-1773	282	1	thalhammer	thalhammer	NOUN
iajs-1773	282	2	,	,	PUNCT
iajs-1773	282	3	estrogen	estrogen	NOUN
iajs-1773	282	4	biosynthesis	biosynthesis	NOUN
iajs-1773	282	5	and	and	CCONJ
iajs-1773	282	6	action	action	NOUN
iajs-1773	282	7	in	in	ADP
iajs-1773	282	8	ovarian	ovarian	ADJ
iajs-1773	282	9	cancer	cancer	NOUN
iajs-1773	282	10	.	.	PUNCT
iajs-1773	283	1	frontiers	frontier	NOUN
iajs-1773	283	2	in	in	ADP
iajs-1773	283	3	endocrinology	endocrinology	NOUN
iajs-1773	283	4	,	,	PUNCT
iajs-1773	283	5	5	5	NUM
iajs-1773	283	6	,	,	PUNCT
iajs-1773	283	7	(	(	PUNCT
iajs-1773	283	8	2014	2014	NUM
iajs-1773	283	9	)	)	PUNCT
iajs-1773	283	10	.	.	PUNCT
iajs-1773	284	1	[	[	X
iajs-1773	284	2	33	33	NUM
iajs-1773	284	3	]	]	PUNCT
iajs-1773	284	4	b.	b.	PROPN
iajs-1773	284	5	j.grattan	j.grattan	PROPN
iajs-1773	284	6	,	,	PUNCT
iajs-1773	284	7	and	and	CCONJ
iajs-1773	284	8	h.	h.	PROPN
iajs-1773	284	9	c.	c.	PROPN
iajs-1773	284	10	freake	freake	PROPN
iajs-1773	284	11	,	,	PUNCT
iajs-1773	284	12	zinc	zinc	NOUN
iajs-1773	284	13	and	and	CCONJ
iajs-1773	284	14	cancer	cancer	NOUN
iajs-1773	284	15	:	:	PUNCT
iajs-1773	284	16	implications	implication	NOUN
iajs-1773	284	17	for	for	ADP
iajs-1773	284	18	liv-1	liv-1	PUNCT
iajs-1773	284	19	in	in	ADP
iajs-1773	284	20	breast	breast	NOUN
iajs-1773	284	21	cancer	cancer	NOUN
iajs-1773	284	22	.	.	PUNCT
iajs-1773	285	1	nutrients	nutrient	NOUN
iajs-1773	285	2	,	,	PUNCT
iajs-1773	285	3	4(7	4(7	NUM
iajs-1773	285	4	)	)	PUNCT
iajs-1773	285	5	,	,	PUNCT
iajs-1773	285	6	648	648	NUM
iajs-1773	285	7	-	-	SYM
iajs-1773	285	8	675	675	NUM
iajs-1773	285	9	.	.	NOUN
iajs-1773	285	10	2012	2012	NUM
iajs-1773	286	1	[	[	X
iajs-1773	286	2	34	34	NUM
iajs-1773	286	3	]	]	X
iajs-1773	286	4	v.	v.	X
iajs-1773	286	5	pavithra	pavithra	PROPN
iajs-1773	286	6	;	;	PUNCT
iajs-1773	286	7	t.	t.	PROPN
iajs-1773	286	8	g.	g.	PROPN
iajs-1773	286	9	sathisha	sathisha	PROPN
iajs-1773	286	10	;	;	PUNCT
iajs-1773	286	11	k.	k.	PROPN
iajs-1773	286	12	kasturi	kasturi	PROPN
iajs-1773	286	13	;	;	PUNCT
iajs-1773	286	14	d.	d.	PROPN
iajs-1773	286	15	s.	s.	PROPN
iajs-1773	286	16	mallika	mallika	PROPN
iajs-1773	286	17	;	;	PUNCT
iajs-1773	286	18	s.	s.	PROPN
iajs-1773	286	19	j	j	PROPN
iajs-1773	286	20	amos	amos	PROPN
iajs-1773	286	21	,	,	PUNCT
iajs-1773	286	22	and	and	CCONJ
iajs-1773	286	23	s.	s.	PROPN
iajs-1773	286	24	ragunatha	ragunatha	PROPN
iajs-1773	286	25	,	,	PUNCT
iajs-1773	286	26	serum	serum	NOUN
iajs-1773	286	27	levels	level	NOUN
iajs-1773	286	28	of	of	ADP
iajs-1773	286	29	metal	metal	NOUN
iajs-1773	286	30	ions	ion	NOUN
iajs-1773	286	31	in	in	ADP
iajs-1773	286	32	female	female	ADJ
iajs-1773	286	33	patients	patient	NOUN
iajs-1773	286	34	with	with	ADP
iajs-1773	286	35	breast	breast	NOUN
iajs-1773	286	36	cancer	cancer	NOUN
iajs-1773	286	37	.	.	PUNCT
iajs-1773	287	1	journal	journal	NOUN
iajs-1773	287	2	of	of	ADP
iajs-1773	287	3	clinical	clinical	ADJ
iajs-1773	287	4	and	and	CCONJ
iajs-1773	287	5	diagnostic	diagnostic	ADJ
iajs-1773	287	6	research	research	NOUN
iajs-1773	287	7	,	,	PUNCT
iajs-1773	287	8	9(1	9(1	NUM
iajs-1773	287	9	):	):	PUNCT
iajs-1773	287	10	bc25.-c27	bc25.-c27	NOUN
iajs-1773	287	11	.	.	PUNCT
iajs-1773	288	1	2015	2015	NUM
iajs-1773	289	1	[	[	SYM
iajs-1773	289	2	35	35	NUM
iajs-1773	289	3	]	]	X
iajs-1773	289	4	l.c	l.c	PROPN
iajs-1773	289	5	.	.	PROPN
iajs-1773	289	6	costello	costello	PROPN
iajs-1773	289	7	,	,	PUNCT
iajs-1773	289	8	and	and	CCONJ
iajs-1773	289	9	r.b	r.b	PROPN
iajs-1773	289	10	.	.	PROPN
iajs-1773	289	11	franklin	franklin	PROPN
iajs-1773	289	12	,	,	PUNCT
iajs-1773	289	13	a	a	DET
iajs-1773	289	14	review	review	NOUN
iajs-1773	289	15	of	of	ADP
iajs-1773	289	16	the	the	DET
iajs-1773	289	17	current	current	ADJ
iajs-1773	289	18	status	status	NOUN
iajs-1773	289	19	and	and	CCONJ
iajs-1773	289	20	concept	concept	NOUN
iajs-1773	289	21	of	of	ADP
iajs-1773	289	22	the	the	DET
iajs-1773	289	23	emerging	emerge	VERB
iajs-1773	289	24	implications	implication	NOUN
iajs-1773	289	25	of	of	ADP
iajs-1773	289	26	zinc	zinc	NOUN
iajs-1773	289	27	and	and	CCONJ
iajs-1773	289	28	zinc	zinc	NOUN
iajs-1773	289	29	transporters	transporter	NOUN
iajs-1773	289	30	in	in	ADP
iajs-1773	289	31	the	the	DET
iajs-1773	289	32	development	development	NOUN
iajs-1773	289	33	of	of	ADP
iajs-1773	289	34	pancreatic	pancreatic	ADJ
iajs-1773	289	35	cancer	cancer	NOUN
iajs-1773	289	36	.	.	PUNCT
iajs-1773	290	1	pancreatic	pancreatic	ADJ
iajs-1773	290	2	disorders	disorder	NOUN
iajs-1773	290	3	&	&	CCONJ
iajs-1773	290	4	therapy,.4	therapy,.4	NOUN
iajs-1773	290	5	:	:	PUNCT
iajs-1773	290	6	002	002	NUM
iajs-1773	290	7	.	.	PUNCT
iajs-1773	291	1	2013	2013	NUM
iajs-1773	292	1	[	[	X
iajs-1773	292	2	36	36	NUM
iajs-1773	292	3	]	]	PUNCT
iajs-1773	292	4	m.	m.	NOUN
iajs-1773	292	5	m.	m.	PROPN
iajs-1773	292	6	epstein	epstein	PROPN
iajs-1773	292	7	;	;	PUNCT
iajs-1773	292	8	j.	j.	PROPN
iajs-1773	292	9	l.	l.	PROPN
iajs-1773	292	10	kasperzyk	kasperzyk	PROPN
iajs-1773	292	11	;	;	PUNCT
iajs-1773	292	12	o.	o.	PROPN
iajs-1773	292	13	andrén	andrén	PROPN
iajs-1773	292	14	;	;	PUNCT
iajs-1773	292	15	e.	e.	PROPN
iajs-1773	292	16	l.	l.	PROPN
iajs-1773	292	17	giovannucci;a	giovannucci;a	PROPN
iajs-1773	292	18	.	.	PUNCT
iajs-1773	293	1	wolk	wolk	NOUN
iajs-1773	293	2	;	;	PUNCT
iajs-1773	293	3	n.	n.	NOUN
iajs-1773	293	4	håkansson	håkansson	PROPN
iajs-1773	293	5	,	,	PUNCT
iajs-1773	293	6	et	et	PROPN
iajs-1773	293	7	al	al	PROPN
iajs-1773	293	8	and	and	CCONJ
iajs-1773	293	9	l.	l.	PROPN
iajs-1773	293	10	a.	a.	PROPN
iajs-1773	293	11	mucci	mucci	PROPN
iajs-1773	293	12	,	,	PUNCT
iajs-1773	293	13	dietary	dietary	ADJ
iajs-1773	293	14	zinc	zinc	NOUN
iajs-1773	293	15	and	and	CCONJ
iajs-1773	293	16	prostate	prostate	NOUN
iajs-1773	293	17	cancer	cancer	NOUN
iajs-1773	293	18	survival	survival	NOUN
iajs-1773	293	19	in	in	ADP
iajs-1773	293	20	a	a	DET
iajs-1773	293	21	swedish	swedish	ADJ
iajs-1773	293	22	cohort	cohort	NOUN
iajs-1773	293	23	.	.	PUNCT
iajs-1773	294	1	the	the	DET
iajs-1773	294	2	american	american	PROPN
iajs-1773	294	3	journal	journal	PROPN
iajs-1773	294	4	of	of	ADP
iajs-1773	294	5	clinical	clinical	ADJ
iajs-1773	294	6	nutrition	nutrition	NOUN
iajs-1773	294	7	,	,	PUNCT
iajs-1773	294	8	93(3	93(3	NUM
iajs-1773	294	9	)	)	PUNCT
iajs-1773	294	10	,	,	PUNCT
iajs-1773	294	11	586	586	NUM
iajs-1773	294	12	-	-	SYM
iajs-1773	294	13	593	593	NUM
iajs-1773	294	14	.	.	PUNCT
iajs-1773	294	15	2011	2011	NUM
iajs-1773	295	1	[	[	X
iajs-1773	295	2	37	37	NUM
iajs-1773	295	3	]	]	PUNCT
iajs-1773	295	4	x.	x.	NOUN
iajs-1773	295	5	wu	wu	PROPN
iajs-1773	295	6	;	;	PUNCT
iajs-1773	295	7	j.	j.	PROPN
iajs-1773	295	8	tang	tang	PROPN
iajs-1773	295	9	,	,	PUNCT
iajs-1773	295	10	and	and	CCONJ
iajs-1773	295	11	m.	m.	PROPN
iajs-1773	295	12	xie	xie	PROPN
iajs-1773	295	13	,	,	PUNCT
iajs-1773	295	14	serum	serum	NOUN
iajs-1773	295	15	and	and	CCONJ
iajs-1773	295	16	hair	hair	NOUN
iajs-1773	295	17	zinc	zinc	NOUN
iajs-1773	295	18	levels	level	NOUN
iajs-1773	295	19	in	in	ADP
iajs-1773	295	20	breast	breast	NOUN
iajs-1773	295	21	cancer	cancer	NOUN
iajs-1773	295	22	:	:	PUNCT
iajs-1773	295	23	a	a	DET
iajs-1773	295	24	metaanalysis	metaanalysis	NOUN
iajs-1773	295	25	.	.	PUNCT
iajs-1773	296	1	scientific	scientific	ADJ
iajs-1773	296	2	reports	report	NOUN
iajs-1773	296	3	.	.	PUNCT
iajs-1773	297	1	|	|	ADV
iajs-1773	297	2	5:12249	5:12249	NUM
iajs-1773	297	3	|	|	ADV
iajs-1773	297	4	doi	doi	NOUN
iajs-1773	297	5	:	:	PUNCT
iajs-1773	297	6	10.1038	10.1038	NUM
iajs-1773	297	7	/	/	SYM
iajs-1773	297	8	srep12249	srep12249	PROPN
iajs-1773	297	9	.	.	PUNCT
iajs-1773	298	1	2015	2015	NUM
iajs-1773	299	1	[	[	X
iajs-1773	299	2	38	38	NUM
iajs-1773	299	3	]	]	PUNCT
iajs-1773	299	4	h.	h.	PROPN
iajs-1773	299	5	w.	w.	PROPN
iajs-1773	299	6	kuo	kuo	PROPN
iajs-1773	299	7	;	;	PUNCT
iajs-1773	299	8	s.	s.	PROPN
iajs-1773	299	9	f.	f.	PROPN
iajs-1773	299	10	chen	chen	PROPN
iajs-1773	299	11	;	;	PUNCT
iajs-1773	299	12	c.	c.	PROPN
iajs-1773	299	13	c.wu	c.wu	PROPN
iajs-1773	299	14	;	;	PUNCT
iajs-1773	299	15	r.	r.	PROPN
iajs-1773	299	16	chen	chen	PROPN
iajs-1773	299	17	,	,	PUNCT
iajs-1773	299	18	and	and	CCONJ
iajs-1773	299	19	j.	j.	PROPN
iajs-1773	299	20	h	h	PROPN
iajs-1773	299	21	,	,	PUNCT
iajs-1773	299	22	lee	lee	PROPN
iajs-1773	299	23	.	.	PROPN
iajs-1773	299	24	serum	serum	PROPN
iajs-1773	299	25	and	and	CCONJ
iajs-1773	299	26	tissue	tissue	NOUN
iajs-1773	299	27	trace	trace	NOUN
iajs-1773	299	28	elements	element	NOUN
iajs-1773	299	29	in	in	ADP
iajs-1773	299	30	patients	patient	NOUN
iajs-1773	299	31	with	with	ADP
iajs-1773	299	32	breast	breast	NOUN
iajs-1773	299	33	cancer	cancer	NOUN
iajs-1773	299	34	in	in	ADP
iajs-1773	299	35	taiwan	taiwan	PROPN
iajs-1773	299	36	.	.	PUNCT
iajs-1773	300	1	biological	biological	ADJ
iajs-1773	300	2	trace	trace	NOUN
iajs-1773	300	3	element	element	NOUN
iajs-1773	300	4	research	research	NOUN
iajs-1773	300	5	,	,	PUNCT
iajs-1773	300	6	89(1	89(1	NUM
iajs-1773	300	7	)	)	PUNCT
iajs-1773	300	8	,	,	PUNCT
iajs-1773	300	9	1	1	NUM
iajs-1773	300	10	-	-	SYM
iajs-1773	300	11	11	11	NUM
iajs-1773	300	12	.	.	PUNCT
iajs-1773	300	13	2002	2002	NUM
iajs-1773	301	1	[	[	X
iajs-1773	301	2	39	39	NUM
iajs-1773	301	3	]	]	PUNCT
iajs-1773	301	4	a.h.shankar	a.h.shankar	NOUN
iajs-1773	301	5	,	,	PUNCT
iajs-1773	301	6	and	and	CCONJ
iajs-1773	301	7	a.	a.	PROPN
iajs-1773	301	8	s.	s.	PROPN
iajs-1773	301	9	prasad	prasad	PROPN
iajs-1773	301	10	,	,	PUNCT
iajs-1773	301	11	zinc	zinc	NOUN
iajs-1773	301	12	and	and	CCONJ
iajs-1773	301	13	immune	immune	ADJ
iajs-1773	301	14	function	function	NOUN
iajs-1773	301	15	:	:	PUNCT
iajs-1773	301	16	the	the	DET
iajs-1773	301	17	biological	biological	ADJ
iajs-1773	301	18	basis	basis	NOUN
iajs-1773	301	19	of	of	ADP
iajs-1773	301	20	altered	altered	ADJ
iajs-1773	301	21	resistance	resistance	NOUN
iajs-1773	301	22	to	to	ADP
iajs-1773	301	23	infection	infection	NOUN
iajs-1773	301	24	.	.	PUNCT
iajs-1773	302	1	the	the	DET
iajs-1773	302	2	american	american	PROPN
iajs-1773	302	3	journal	journal	PROPN
iajs-1773	302	4	of	of	ADP
iajs-1773	302	5	clinical	clinical	ADJ
iajs-1773	302	6	nutrition	nutrition	NOUN
iajs-1773	302	7	,	,	PUNCT
iajs-1773	302	8	68(2	68(2	NOUN
iajs-1773	302	9	)	)	PUNCT
iajs-1773	302	10	,	,	PUNCT
iajs-1773	302	11	447s-463s	447s-463s	NUM
iajs-1773	302	12	.	.	PUNCT
iajs-1773	302	13	1998	1998	NUM
iajs-1773	303	1	[	[	X
iajs-1773	303	2	40	40	NUM
iajs-1773	303	3	]	]	PUNCT
iajs-1773	303	4	j.	j.	PROPN
iajs-1773	303	5	k.	k.	PROPN
iajs-1773	303	6	chesters	chester	VERB
iajs-1773	303	7	,	,	PUNCT
iajs-1773	303	8	and	and	CCONJ
iajs-1773	303	9	r	r	NOUN
iajs-1773	303	10	.	.	PUNCT
iajs-1773	304	1	boyne	boyne	PROPN
iajs-1773	304	2	,	,	PUNCT
iajs-1773	304	3	nature	nature	NOUN
iajs-1773	304	4	of	of	ADP
iajs-1773	304	5	the	the	DET
iajs-1773	304	6	zn2	zn2	PROPN
iajs-1773	304	7	+	+	PROPN
iajs-1773	304	8	requirement	requirement	NOUN
iajs-1773	304	9	for	for	ADP
iajs-1773	304	10	dna	dna	ADJ
iajs-1773	304	11	synthesis	synthesis	NOUN
iajs-1773	304	12	by	by	ADP
iajs-1773	304	13	3t3	3t3	NUM
iajs-1773	304	14	cells	cell	NOUN
iajs-1773	304	15	.	.	PUNCT
iajs-1773	305	1	experimental	experimental	ADJ
iajs-1773	305	2	cell	cell	NOUN
iajs-1773	305	3	research	research	NOUN
iajs-1773	305	4	,	,	PUNCT
iajs-1773	305	5	192(2	192(2	NUM
iajs-1773	305	6	)	)	PUNCT
iajs-1773	305	7	,	,	PUNCT
iajs-1773	305	8	631	631	NUM
iajs-1773	305	9	-	-	SYM
iajs-1773	305	10	634	634	NUM
iajs-1773	305	11	.	.	PUNCT
iajs-1773	305	12	1991	1991	NUM
iajs-1773	306	1	[	[	X
iajs-1773	306	2	41	41	NUM
iajs-1773	306	3	]	]	PUNCT
iajs-1773	306	4	r.	r.	PROPN
iajs-1773	306	5	s.	s.	PROPN
iajs-1773	306	6	macdonald	macdonald	PROPN
iajs-1773	306	7	,	,	PUNCT
iajs-1773	306	8	the	the	DET
iajs-1773	306	9	role	role	NOUN
iajs-1773	306	10	of	of	ADP
iajs-1773	306	11	zinc	zinc	NOUN
iajs-1773	306	12	in	in	ADP
iajs-1773	306	13	growth	growth	NOUN
iajs-1773	306	14	and	and	CCONJ
iajs-1773	306	15	cell	cell	NOUN
iajs-1773	306	16	proliferation	proliferation	NOUN
iajs-1773	306	17	.	.	PUNCT
iajs-1773	307	1	the	the	DET
iajs-1773	307	2	journal	journal	NOUN
iajs-1773	307	3	of	of	ADP
iajs-1773	307	4	nutrition	nutrition	NOUN
iajs-1773	307	5	,	,	PUNCT
iajs-1773	307	6	130(5	130(5	NUM
iajs-1773	307	7	)	)	PUNCT
iajs-1773	307	8	,	,	PUNCT
iajs-1773	307	9	1500s-1508s	1500s-1508s	NUM
iajs-1773	307	10	.	.	NOUN
iajs-1773	307	11	2000	2000	NUM
iajs-1773	308	1	[	[	X
iajs-1773	308	2	42	42	NUM
iajs-1773	308	3	]	]	X
iajs-1773	308	4	d.	d.	PROPN
iajs-1773	308	5	r.	r.	PROPN
iajs-1773	308	6	gallie	gallie	PROPN
iajs-1773	308	7	,	,	PUNCT
iajs-1773	308	8	increasing	increase	VERB
iajs-1773	308	9	vitamin	vitamin	NOUN
iajs-1773	308	10	c	c	NOUN
iajs-1773	308	11	content	content	NOUN
iajs-1773	308	12	in	in	ADP
iajs-1773	308	13	plant	plant	NOUN
iajs-1773	308	14	foods	food	NOUN
iajs-1773	308	15	to	to	PART
iajs-1773	308	16	improve	improve	VERB
iajs-1773	308	17	their	their	PRON
iajs-1773	308	18	nutritional	nutritional	ADJ
iajs-1773	308	19	value	value	NOUN
iajs-1773	308	20	—	—	PUNCT
iajs-1773	308	21	successes	success	NOUN
iajs-1773	308	22	and	and	CCONJ
iajs-1773	308	23	challenges	challenge	NOUN
iajs-1773	308	24	.	.	PUNCT
iajs-1773	309	1	nutrients	nutrient	NOUN
iajs-1773	309	2	,	,	PUNCT
iajs-1773	309	3	5(9	5(9	NUM
iajs-1773	309	4	)	)	PUNCT
iajs-1773	309	5	,	,	PUNCT
iajs-1773	309	6	3424	3424	NUM
iajs-1773	309	7	-	-	SYM
iajs-1773	309	8	3446	3446	NUM
iajs-1773	309	9	.	.	PUNCT
iajs-1773	310	1	2013	2013	NUM
iajs-1773	311	1	[	[	X
iajs-1773	311	2	43	43	NUM
iajs-1773	311	3	]	]	X
iajs-1773	311	4	g	g	PROPN
iajs-1773	311	5	.ray	.ray	PROPN
iajs-1773	311	6	,	,	PUNCT
iajs-1773	311	7	and	and	CCONJ
iajs-1773	311	8	s.	s.	PROPN
iajs-1773	311	9	a.	a.	PROPN
iajs-1773	311	10	husain	husain	PROPN
iajs-1773	311	11	.	.	PUNCT
iajs-1773	312	1	role	role	NOUN
iajs-1773	312	2	of	of	ADP
iajs-1773	312	3	lipids	lipid	NOUN
iajs-1773	312	4	,	,	PUNCT
iajs-1773	312	5	lipoproteins	lipoprotein	NOUN
iajs-1773	312	6	and	and	CCONJ
iajs-1773	312	7	vitamins	vitamin	NOUN
iajs-1773	312	8	in	in	ADP
iajs-1773	312	9	women	woman	NOUN
iajs-1773	312	10	with	with	ADP
iajs-1773	312	11	breast	breast	NOUN
iajs-1773	312	12	cancer	cancer	NOUN
iajs-1773	312	13	.	.	PUNCT
iajs-1773	313	1	clinical	clinical	ADJ
iajs-1773	313	2	biochemistry	biochemistry	NOUN
iajs-1773	313	3	,	,	PUNCT
iajs-1773	313	4	34(1	34(1	NUM
iajs-1773	313	5	)	)	PUNCT
iajs-1773	313	6	,	,	PUNCT
iajs-1773	313	7	71	71	NUM
iajs-1773	313	8	-	-	SYM
iajs-1773	313	9	76	76	NUM
iajs-1773	313	10	.	.	PUNCT
iajs-1773	314	1	2001	2001	NUM
iajs-1773	315	1	[	[	X
iajs-1773	315	2	44	44	NUM
iajs-1773	315	3	]	]	X
iajs-1773	315	4	r	r	NOUN
iajs-1773	315	5	.girija	.girija	NOUN
iajs-1773	315	6	,	,	PUNCT
iajs-1773	315	7	and	and	CCONJ
iajs-1773	315	8	l.	l.	PROPN
iajs-1773	315	9	krishnamoorthy	krishnamoorthy	PROPN
iajs-1773	315	10	,	,	PUNCT
iajs-1773	315	11	serum	serum	NOUN
iajs-1773	315	12	carotene	carotene	NOUN
iajs-1773	315	13	,	,	PUNCT
iajs-1773	315	14	vitamin	vitamin	NOUN
iajs-1773	315	15	a	a	PRON
iajs-1773	315	16	,	,	PUNCT
iajs-1773	315	17	and	and	CCONJ
iajs-1773	315	18	vitamin	vitamin	NOUN
iajs-1773	315	19	c	c	NOUN
iajs-1773	315	20	levels	level	NOUN
iajs-1773	315	21	in	in	ADP
iajs-1773	315	22	breast	breast	NOUN
iajs-1773	315	23	cancer	cancer	NOUN
iajs-1773	315	24	and	and	CCONJ
iajs-1773	315	25	cancer	cancer	NOUN
iajs-1773	315	26	of	of	ADP
iajs-1773	315	27	the	the	DET
iajs-1773	315	28	uterine	uterine	ADJ
iajs-1773	315	29	cervix	cervix	NOUN
iajs-1773	315	30	.	.	PUNCT
iajs-1773	316	1	nutrition	nutrition	NOUN
iajs-1773	316	2	and	and	CCONJ
iajs-1773	316	3	cancer	cancer	NOUN
iajs-1773	316	4	,	,	PUNCT
iajs-1773	316	5	25	25	NUM
iajs-1773	316	6	,	,	PUNCT
iajs-1773	316	7	173	173	NUM
iajs-1773	316	8	-	-	SYM
iajs-1773	316	9	177	177	NUM
iajs-1773	316	10	.	.	PUNCT
iajs-1773	316	11	1996	1996	NUM
iajs-1773	317	1	[	[	X
iajs-1773	317	2	45	45	NUM
iajs-1773	317	3	]	]	X
iajs-1773	317	4	h.r.harris	h.r.harris	PROPN
iajs-1773	317	5	,	,	PUNCT
iajs-1773	317	6	h.n	h.n	PROPN
iajs-1773	317	7	.	.	PROPN
iajs-1773	317	8	orsini	orsini	PROPN
iajs-1773	317	9	,	,	PUNCT
iajs-1773	317	10	and	and	CCONJ
iajs-1773	317	11	a.	a.	NOUN
iajs-1773	317	12	wolk	wolk	NOUN
iajs-1773	317	13	.	.	PUNCT
iajs-1773	318	1	vitamin	vitamin	NOUN
iajs-1773	318	2	c	c	PROPN
iajs-1773	318	3	and	and	CCONJ
iajs-1773	318	4	survival	survival	NOUN
iajs-1773	318	5	among	among	ADP
iajs-1773	318	6	women	woman	NOUN
iajs-1773	318	7	with	with	ADP
iajs-1773	318	8	breast	breast	NOUN
iajs-1773	318	9	cancer	cancer	NOUN
iajs-1773	318	10	:	:	PUNCT
iajs-1773	318	11	a	a	DET
iajs-1773	318	12	meta	meta	ADJ
iajs-1773	318	13	-	-	PUNCT
iajs-1773	318	14	analysis	analysis	NOUN
iajs-1773	318	15	.	.	PUNCT
iajs-1773	319	1	european	european	ADJ
iajs-1773	319	2	journal	journal	PROPN
iajs-1773	319	3	of	of	ADP
iajs-1773	319	4	cancer	cancer	NOUN
iajs-1773	319	5	,	,	PUNCT
iajs-1773	319	6	50	50	NUM
iajs-1773	319	7	:	:	SYM
iajs-1773	319	8	1223	1223	NUM
iajs-1773	319	9	–	–	PUNCT
iajs-1773	319	10	1231	1231	NUM
iajs-1773	319	11	.	.	PUNCT
iajs-1773	320	1	2014	2014	NUM
iajs-1773	321	1	[	[	X
iajs-1773	321	2	46	46	NUM
iajs-1773	321	3	]	]	PUNCT
iajs-1773	321	4	s.	s.	PROPN
iajs-1773	321	5	zhang	zhang	PROPN
iajs-1773	321	6	,	,	PUNCT
iajs-1773	321	7	d.	d.	PROPN
iajs-1773	321	8	j.	j.	PROPN
iajs-1773	321	9	hunter	hunter	PROPN
iajs-1773	321	10	,	,	PUNCT
iajs-1773	321	11	m.	m.	PROPN
iajs-1773	321	12	r.	r.	PROPN
iajs-1773	321	13	forman	forman	PROPN
iajs-1773	321	14	,	,	PUNCT
iajs-1773	321	15	b.	b.	PROPN
iajs-1773	321	16	a.	a.	PROPN
iajs-1773	321	17	rosner	rosner	PROPN
iajs-1773	321	18	,	,	PUNCT
iajs-1773	321	19	f.	f.	PROPN
iajs-1773	321	20	e.	e.	PROPN
iajs-1773	321	21	speizer	speizer	PROPN
iajs-1773	321	22	,	,	PUNCT
iajs-1773	321	23	g.	g.	PROPN
iajs-1773	321	24	a.	a.	PROPN
iajs-1773	321	25	colditz	colditz	PROPN
iajs-1773	321	26	and	and	CCONJ
iajs-1773	321	27	w.	w.	PROPN
iajs-1773	321	28	c	c	PROPN
iajs-1773	321	29	.willett	.willett	X
iajs-1773	321	30	.	.	PUNCT
iajs-1773	322	1	dietary	dietary	ADJ
iajs-1773	322	2	carotenoids	carotenoid	NOUN
iajs-1773	322	3	and	and	CCONJ
iajs-1773	322	4	vitamins	vitamin	NOUN
iajs-1773	322	5	a	a	PRON
iajs-1773	322	6	,	,	PUNCT
iajs-1773	322	7	c	c	NOUN
iajs-1773	322	8	,	,	PUNCT
iajs-1773	322	9	and	and	CCONJ
iajs-1773	322	10	e	e	NOUN
iajs-1773	322	11	and	and	CCONJ
iajs-1773	322	12	risk	risk	NOUN
iajs-1773	322	13	of	of	ADP
iajs-1773	322	14	breast	breast	NOUN
iajs-1773	322	15	cancer	cancer	NOUN
iajs-1773	322	16	.	.	PUNCT
iajs-1773	323	1	journal	journal	NOUN
iajs-1773	323	2	of	of	ADP
iajs-1773	323	3	the	the	DET
iajs-1773	323	4	national	national	PROPN
iajs-1773	323	5	cancer	cancer	PROPN
iajs-1773	323	6	institute	institute	PROPN
iajs-1773	323	7	,	,	PUNCT
iajs-1773	323	8	91(6	91(6	NOUN
iajs-1773	323	9	)	)	PUNCT
iajs-1773	323	10	,	,	PUNCT
iajs-1773	323	11	547	547	NUM
iajs-1773	323	12	-	-	SYM
iajs-1773	323	13	556	556	NUM
iajs-1773	323	14	.	.	NOUN
iajs-1773	323	15	1999	1999	NUM
iajs-1773	324	1	[	[	X
iajs-1773	324	2	47	47	NUM
iajs-1773	324	3	]	]	PUNCT
iajs-1773	324	4	a.	a.	NOUN
iajs-1773	324	5	skildum	skildum	PROPN
iajs-1773	324	6	;	;	PUNCT
iajs-1773	324	7	e.	e.	PROPN
iajs-1773	324	8	faivre	faivre	PROPN
iajs-1773	324	9	,	,	PUNCT
iajs-1773	324	10	and	and	CCONJ
iajs-1773	324	11	c.a	c.a	PROPN
iajs-1773	324	12	.	.	PROPN
iajs-1773	324	13	lang	lang	PROPN
iajs-1773	324	14	,	,	PUNCT
iajs-1773	324	15	progesterone	progesterone	NOUN
iajs-1773	324	16	receptors	receptor	NOUN
iajs-1773	324	17	induce	induce	VERB
iajs-1773	324	18	cell	cell	NOUN
iajs-1773	324	19	cycle	cycle	NOUN
iajs-1773	324	20	progression	progression	NOUN
iajs-1773	324	21	via	via	ADP
iajs-1773	324	22	activation	activation	NOUN
iajs-1773	324	23	of	of	ADP
iajs-1773	324	24	mitogen	mitogen	NOUN
iajs-1773	324	25	-	-	PUNCT
iajs-1773	324	26	activated	activate	VERB
iajs-1773	324	27	protein	protein	NOUN
iajs-1773	324	28	kinases	kinase	NOUN
iajs-1773	324	29	.	.	PUNCT
iajs-1773	325	1	molecular	molecular	ADJ
iajs-1773	325	2	endocrinology	endocrinology	NOUN
iajs-1773	325	3	,	,	PUNCT
iajs-1773	325	4	19(2	19(2	NUM
iajs-1773	325	5	)	)	PUNCT
iajs-1773	325	6	,	,	PUNCT
iajs-1773	325	7	327	327	NUM
iajs-1773	325	8	-	-	SYM
iajs-1773	325	9	339	339	NUM
iajs-1773	325	10	.	.	PUNCT
iajs-1773	325	11	2005	2005	NUM
iajs-1773	326	1	[	[	X
iajs-1773	326	2	48	48	NUM
iajs-1773	326	3	]	]	PUNCT
iajs-1773	326	4	a.m.	a.m.	NOUN
iajs-1773	326	5	shaaban;p.a	shaaban;p.a	PROPN
iajs-1773	326	6	.	.	PUNCT
iajs-1773	327	1	o'neill;m	o'neill;m	NOUN
iajs-1773	327	2	.	.	PUNCT
iajs-1773	328	1	p.	p.	NOUN
iajs-1773	328	2	davies	davy	NOUN
iajs-1773	328	3	;	;	PUNCT
iajs-1773	328	4	r.	r.	PROPN
iajs-1773	328	5	sibson	sibson	PROPN
iajs-1773	328	6	;	;	PUNCT
iajs-1773	328	7	c.	c.	PROPN
iajs-1773	328	8	r.	r.	PROPN
iajs-1773	328	9	west	west	PROPN
iajs-1773	328	10	;	;	PUNCT
iajs-1773	328	11	p.	p.	PROPN
iajs-1773	328	12	h.	h.	PROPN
iajs-1773	328	13	smith	smith	PROPN
iajs-1773	328	14	,	,	PUNCT
iajs-1773	328	15	and	and	CCONJ
iajs-1773	328	16	c.	c.	PROPN
iajs-1773	328	17	s	s	PROPN
iajs-1773	328	18	foster	foster	ADJ
iajs-1773	328	19	,	,	PUNCT
iajs-1773	328	20	declining	decline	VERB
iajs-1773	328	21	estrogen	estrogen	NOUN
iajs-1773	328	22	receptor	receptor	NOUN
iajs-1773	328	23	-	-	PUNCT
iajs-1773	328	24	β	β	NOUN
iajs-1773	328	25	expression	expression	NOUN
iajs-1773	328	26	defines	define	VERB
iajs-1773	328	27	malignant	malignant	ADJ
iajs-1773	328	28	progression	progression	NOUN
iajs-1773	328	29	of	of	ADP
iajs-1773	328	30	human	human	ADJ
iajs-1773	328	31	breast	breast	NOUN
iajs-1773	328	32	neoplasia	neoplasia	NOUN
iajs-1773	328	33	.	.	PUNCT
iajs-1773	329	1	the	the	DET
iajs-1773	329	2	american	american	PROPN
iajs-1773	329	3	journal	journal	PROPN
iajs-1773	329	4	of	of	ADP
iajs-1773	329	5	surgical	surgical	ADJ
iajs-1773	329	6	pathology	pathology	NOUN
iajs-1773	329	7	,	,	PUNCT
iajs-1773	329	8	27(12	27(12	NUM
iajs-1773	329	9	)	)	PUNCT
iajs-1773	329	10	,	,	PUNCT
iajs-1773	329	11	1502	1502	NUM
iajs-1773	329	12	-	-	SYM
iajs-1773	329	13	1512	1512	NUM
iajs-1773	329	14	.	.	PUNCT
iajs-1773	330	1	2003	2003	NUM
iajs-1773	331	1	[	[	X
iajs-1773	331	2	49	49	NUM
iajs-1773	331	3	]	]	PUNCT
iajs-1773	331	4	s.	s.	PROPN
iajs-1773	331	5	a.fuqua	a.fuqua	PROPN
iajs-1773	331	6	;	;	PUNCT
iajs-1773	331	7	r.	r.	PROPN
iajs-1773	331	8	schiff	schiff	PROPN
iajs-1773	331	9	;	;	PUNCT
iajs-1773	331	10	i.	i.	PROPN
iajs-1773	331	11	parra	parra	PROPN
iajs-1773	331	12	;	;	PUNCT
iajs-1773	331	13	j.	j.	PROPN
iajs-1773	331	14	t.	t.	PROPN
iajs-1773	331	15	moore	moore	PROPN
iajs-1773	331	16	;	;	PUNCT
iajs-1773	331	17	s.	s.	PROPN
iajs-1773	331	18	k.	k.	PROPN
iajs-1773	331	19	mohsin	mohsin	PROPN
iajs-1773	331	20	;	;	PUNCT
iajs-1773	331	21	c.k	c.k	PROPN
iajs-1773	331	22	.	.	PROPN
iajs-1773	331	23	osborne	osborne	PROPN
iajs-1773	331	24	,	,	PUNCT
iajs-1773	331	25	and	and	CCONJ
iajs-1773	331	26	d.	d.	PROPN
iajs-1773	331	27	c.	c.	PROPN
iajs-1773	331	28	allred	allred	PROPN
iajs-1773	331	29	,	,	PUNCT
iajs-1773	331	30	estrogen	estrogen	NOUN
iajs-1773	331	31	receptor	receptor	NOUN
iajs-1773	331	32	β	β	NOUN
iajs-1773	331	33	protein	protein	NOUN
iajs-1773	331	34	in	in	ADP
iajs-1773	331	35	human	human	ADJ
iajs-1773	331	36	breast	breast	NOUN
iajs-1773	331	37	cancer	cancer	NOUN
iajs-1773	331	38	.	.	PUNCT
iajs-1773	332	1	cancer	cancer	NOUN
iajs-1773	332	2	research	research	NOUN
iajs-1773	332	3	,	,	PUNCT
iajs-1773	332	4	63(10	63(10	NOUN
iajs-1773	332	5	)	)	PUNCT
iajs-1773	332	6	,	,	PUNCT
iajs-1773	332	7	2434	2434	NUM
iajs-1773	332	8	-	-	SYM
iajs-1773	332	9	2439	2439	NUM
iajs-1773	332	10	.	.	PUNCT
iajs-1773	333	1	2003	2003	NUM
iajs-1773	333	2	ihsciconf	ihsciconf	PROPN
iajs-1773	333	3	2017	2017	NUM
iajs-1773	333	4	special	special	ADJ
iajs-1773	333	5	issue	issue	NOUN
iajs-1773	333	6	ibn	ibn	PROPN
iajs-1773	333	7	al	al	PROPN
iajs-1773	333	8	-	-	PUNCT
iajs-1773	333	9	haitham	haitham	PROPN
iajs-1773	333	10	journal	journal	PROPN
iajs-1773	333	11	for	for	ADP
iajs-1773	333	12	pure	pure	ADJ
iajs-1773	333	13	and	and	CCONJ
iajs-1773	333	14	applied	apply	VERB
iajs-1773	333	15	science	science	NOUN
iajs-1773	333	16	https://doi.org/	https://doi.org/	NOUN
iajs-1773	333	17	10.30526/2017.ihsciconf	10.30526/2017.ihsciconf	NUM
iajs-1773	333	18	.	.	PUNCT
iajs-1773	333	19	 	 	SPACE
iajs-1773	333	20	1773	1773	NUM
iajs-1773	333	21	for	for	ADP
iajs-1773	333	22	more	more	ADJ
iajs-1773	333	23	information	information	NOUN
iajs-1773	333	24	about	about	ADP
iajs-1773	333	25	the	the	DET
iajs-1773	333	26	conference	conference	NOUN
iajs-1773	333	27	please	please	INTJ
iajs-1773	333	28	visit	visit	VERB
iajs-1773	333	29	the	the	DET
iajs-1773	333	30	websites	website	NOUN
iajs-1773	333	31	:	:	PUNCT
iajs-1773	333	32	http://www.ihsciconf.org/conf/	http://www.ihsciconf.org/conf/	VERB
iajs-1773	333	33	  	  	SPACE
iajs-1773	333	34	www.ihsciconf.org	www.ihsciconf.org	ADV
iajs-1773	333	35	  	  	SPACE
iajs-1773	333	36	biology|86	biology|86	PROPN
iajs-1773	334	1	[	[	X
iajs-1773	334	2	50	50	NUM
iajs-1773	334	3	]	]	PUNCT
iajs-1773	334	4	h.	h.	PROPN
iajs-1773	334	5	greenlee;m	greenlee;m	PROPN
iajs-1773	334	6	.	.	PUNCT
iajs-1773	335	1	l.kwan	l.kwan	PROPN
iajs-1773	335	2	;	;	PUNCT
iajs-1773	335	3	l.	l.	PROPN
iajs-1773	335	4	h.	h.	PROPN
iajs-1773	335	5	kushi	kushi	PROPN
iajs-1773	335	6	;	;	PUNCT
iajs-1773	335	7	j.	j.	PROPN
iajs-1773	335	8	song	song	PROPN
iajs-1773	335	9	;	;	PUNCT
iajs-1773	335	10	a.castillo	a.castillo	PROPN
iajs-1773	335	11	;	;	PUNCT
iajs-1773	335	12	e.	e.	PROPN
iajs-1773	335	13	weltzien	weltzien	PROPN
iajs-1773	335	14	,	,	PUNCT
iajs-1773	335	15	and	and	CCONJ
iajs-1773	335	16	b.	b.	PROPN
iajs-1773	335	17	j.	j.	PROPN
iajs-1773	335	18	caan	caan	PROPN
iajs-1773	335	19	,	,	PUNCT
iajs-1773	335	20	antioxidant	antioxidant	ADJ
iajs-1773	335	21	supplement	supplement	NOUN
iajs-1773	335	22	use	use	NOUN
iajs-1773	335	23	after	after	ADP
iajs-1773	335	24	breast	breast	NOUN
iajs-1773	335	25	cancer	cancer	NOUN
iajs-1773	335	26	diagnosis	diagnosis	NOUN
iajs-1773	335	27	and	and	CCONJ
iajs-1773	335	28	mortality	mortality	NOUN
iajs-1773	335	29	in	in	ADP
iajs-1773	335	30	the	the	DET
iajs-1773	335	31	life	life	NOUN
iajs-1773	335	32	after	after	ADP
iajs-1773	335	33	cancer	cancer	NOUN
iajs-1773	335	34	epidemiology	epidemiology	NOUN
iajs-1773	335	35	(	(	PUNCT
iajs-1773	335	36	lace	lace	NOUN
iajs-1773	335	37	)	)	PUNCT
iajs-1773	335	38	cohort	cohort	NOUN
iajs-1773	335	39	.	.	PUNCT
iajs-1773	336	1	cancer	cancer	NOUN
iajs-1773	336	2	,	,	PUNCT
iajs-1773	336	3	118(8	118(8	NUM
iajs-1773	336	4	)	)	PUNCT
iajs-1773	336	5	,	,	PUNCT
iajs-1773	336	6	2048	2048	NUM
iajs-1773	336	7	-	-	SYM
iajs-1773	336	8	2058	2058	NUM
iajs-1773	336	9	.	.	PUNCT
iajs-1773	337	1	2012	2012	NUM
iajs-1773	337	2	  	  	SPACE